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Introduction. Substance use disorder (SUD) is a common condition that affects millions 
of Americans and represents a substantial burden to the U.S. healthcare system. 
Addressing SUD has been complicated by comorbid mental disorders and co-occurring 
substance use. Consequently, detailing and addressing SUD and comorbid SUD 
represent an important goal to improve the health of Americans. 
Objective. The research goal of this dissertation was to characterize the comorbidity 
between substance use, including tobacco use, and mental disorder symptoms 
measured as negative affect and externalizing symptoms in a population-based sample 
using latent variable and network approaches. Specifically, this project aims to: 
preliminarily assess comorbidity using multinomial regression between lifetime negative 
affect severity, externalizing severity and nicotine dependence, and current use of 
tobacco (cigarettes and e-cigarettes) and alcohol (Chapter 2); identify latent classes of 
 xi 
comorbid substance use as well as negative affect and externalizing symptoms and 
their ability to predict SUD severity (Chapter 3); detail substance use, negative affect, 
and externalizing symptom networks and test for differences in the network structure 
and connectivity by gender (Chapter 4); and use pairwise comparisons from the LCA 
and network results to address stability or movement of comorbidity structures over 
three waves of data (Chapter 5). 
Methods. Waves 1 – 3 from the Population Assessment of Tobacco and Health Study 
were used. Various statistical analyses were used to complete each project including 
multinomial and ordinal regression, latent class analysis, cumulative ROC curve 
analysis, and network analysis.  
Results. The associations between psychopathology (negative affect vs. externalizing 
severity) varied by different substance use combinations. Results from the latent class 
analysis identified a four-class solution as most optimal in characterizing comorbidity: 
low symptom (N=23,571, 72.9%), negative affect (N=4,098, 12.7%), externalizing 
(N=2,691, 8.3%), and comorbid (N=1,960, 6.1%). Network analysis results showed 
similarities between men and women. The strongest substance use/mental health 
symptom connections estimated as edge-weights (EW) in the network were between 
marijuana with lying (EW = 0.60, 95% CI = 0.49; 0.70), marijuana with engaging in fights 
(EW = 0.54, 95% CI = 0.27; 0.81), prescription drugs not prescribed (PDNP) with having 
trouble sleeping (EW = 0.53, 95% CI = 0.40; 0.66), and alcohol and impulsivity (EW = 
0.48, 95% CI = 0.42; 0.53). Both latent class analysis and network analysis results 
identified relationships between (1) exclusive cigarette, dual cigarette and e-cigarette, 
marijuana, and PDNP with negative affect symptoms, and (2) alcohol with externalizing 
 xii 
symptoms. Similar latent profiles emerged across the three waves specifically where the 
low symptom class was largest (65.5% to 72.9%) and the comorbid class was smallest 
(6.1% to 8.2%). Network structure and connectivity did not significantly differ by wave; 
however, edge-weight comparisons identified some stronger connections among the 
substance use behaviors and mental disorder symptoms from preceding to subsequent 
waves. 
Conclusions. The results from the four different studies fill extensive gaps in the 
comorbidity research. This dissertation identified specific combinations of substance 
use behaviors and mental disorder symptoms, determined which sociodemographic 
factors play a role in specific comorbidity profiles, and assessed the patterns of 
comorbidity among three waves of data. These results support the need to approach 
substance use and mental disorders from a more holistic perspective, taking 
comorbidity into account to better support the overall wellbeing of the individual. The 
results can inform robust and targeted prevention strategies to effectively mitigate the 













CHAPTER 2: THE ASSOCIATION BETWEEN NEGATIVE AFFECT AND 
EXTERNALIZING SEVERITY WITH CURRENT USE OF CIGARETTES, E-
CIGARETTES, AND ALCOHOL IN ADULTS: WAVE 1 OF THE POPULATION 
ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY 
 
Introduction. Concurrent tobacco/alcohol use is common in adults, and associated with 
the severity of symptoms experienced by those with mental health disorders. However, 
few studies have explored this relationship across different combinations of tobacco 
products [i.e., conventional cigarette (CIG) and electronic cigarette (ECIG)] and alcohol.  
Objective. Examine the association of lifetime mental disorder symptom severity and 
past 30-day combinations of CIG, ECIG, and alcohol use. 
Methods. Data from the Wave 1 (2013-2014) Population Assessment of Tobacco and 
Health study were used. A total of 15,947 adults aged 18 years or older with complete 
study information were included. Multinomial logistic regression analyses were 
performed to determine the relationship between lifetime negative affect/externalizing 
severity and past 30-day use of tobacco and alcohol, adjusting for nicotine dependence 
(ND), sex, age, race, education, and income. 
Results. Negative affect severity was more strongly associated with CIG and alcohol 
use (moderate AOR= 1.47, 95% CI= 1.22-1.77; high AOR= 1.29, 95% CI= 1.03-1.61) as 
well as alcohol-exclusive use (moderate AOR= 1.58, 95% CI= 1.27-1.96; high AOR= 
1.31, 95% CI= 1.05-1.64) while externalizing severity was more strongly associated with 
ECIG and alcohol use (high AOR= 2.97, 95% CI= 1.84-4.81, moderate AOR= 2.29, 95% 
CI= 1.53-3.43) when accounting for ND compared to none. The relationship between 
externalizing severity with ECIG use was dependent on alcohol being used with ECIG.  
Conclusions. The associations between psychopathology (negative affect vs. 
externalizing severity) vary by different combinations of alcohol, CIG, and ECIG. 
Further, these relationships may be mediated through ND. Future investigations into the 
comorbidity between mental disorder symptoms with tobacco and alcohol use should 




CHAPTER 3: LATENT CLASSES OF COMORBID SUBSTANCE USE AND 
NEGATIVE AFFECT AND EXTERNALIZING SYMPTOMS AND THEIR ROLE IN 
ADULT SUBSTANCE USE DISORDER SEVERITY  
 
Introduction. SUD poses a substantial burden on the United States’ health system. 
Many prevention efforts exist to slow the progression or prevent SUD from occurring. 
Substance use and mental health comorbidity profiles could predict SUD severity, 
further informing prevention and intervention strategies. 
Objective. Identify latent classes of comorbid substance use as well as negative affect 
and externalizing symptoms and assess their ability to predict SUD severity. 
Methods. Latent class analysis of past-month endorsement of negative affect and 
externalizing symptoms and past 30-day substance use will be used for each wave 
separately. We tested the degree to which demographic and social factors influence the 
probability of class membership. The probability of comorbidity class membership will 
be included in regression models to test the predictive probability of SUD severity.  
Results. A four-class solution was considered to best fit the data and were categorized: 
low symptom (N=23,571, 72.9%), negative affect (N=4,098, 12.7%), externalizing 
(N=2,691, 8.3%), and comorbid (N=1,960, 6.1%). Substance use varied across the 
mental disorder symptoms. Exclusive cigarette use, dual cigarette and e-cigarette use, 
marijuana use, and prescription drugs not described more commonly occurred in the 
negative affect class while exclusive e-cigarette and alcohol use more commonly 
occurred with the externalizing class. Women and people with low socioeconomic status 
had higher odds of membership in the comorbid and negative affect classes. Social 
satisfaction was a very strong factor associated with the comorbid and negative affect 
classes. Latent class membership predicting SUD severity performed similarly to a 
model where the symptoms were grouped separately (i.e., negative affect symptoms, 
externalizing symptoms, and substance use behaviors). 
Conclusions. A four-class solution best described the comorbidity structure in a 
nationally representative sample of U.S. adults. Certain substance use behaviors were 
more commonly associated with specific mental disorder symptoms. Demographic 
factors and a potentially modifiable social factor were significantly associated with latent 
 xv 
class membership. Overall, prediction of SUD severity was poor for latent class 
membership as well as substance use behaviors and mental disorder symptoms group 
separately. These results identify the need for prevention efforts required to mitigate 
development of more severe course of illness. Future work should consider other 
methodological approaches (e.g., factor mixture modeling and network analysis) to 

































CHAPTER 4: A NETWORK APPROACH TO SUBSTANCE USE, NEGATIVE 
AFFECT, AND EXTERNALIZING COMORBIDITY IN U.S. ADULTS  
 
Introduction. Use of conventional cigarettes (CIG), alcohol, marijuana, and sedatives 
[i.e., benzodiazepines and barbiturates]) commonly co-occur with negative affect and 
externalizing disorders. It is unclear how these relationships extend to electronic 
cigarettes (ECIG) and prescription drugs not prescribed (i.e., sedatives, tranquilizers, 
and painkillers [PDNP]), and whether they differ by gender. 
Objective. Detail substance use, negative affect, and externalizing symptom networks, 
and compare by gender. 
Methods. Data from Wave 1 of the adult PATH sample was used to test a network 
model of past 30-day substance use, negative affect symptoms, and externalizing 
symptoms. Global and local differences in men and women networks were tested 
through visual comparisons, global strength invariance, network structure invariance, 
and edge strength invariance. 
Results. Overall, networks were consistent between men and women. The strongest 
substance use/mental health symptom connections estimated as edge-weights (EW) 
were between marijuana with lying (EW = 0.60, 95% CI = 0.49; 0.70), marijuana with 
engaging in fights (EW = 0.54, 95% CI = 0.27; 0.81), PDNP with having trouble sleeping 
(EW = 0.53, 95% CI = 0.40; 0.66), and alcohol and impulsivity (EW = 0.48, 95% CI = 
0.42; 0.53). 
Conclusions. There were many weak connections throughout the substance use and 
negative affect/externalizing network. A few important connections were identified and 
encourage future study. In particular, PDNP was most strongly associated with negative 
affect while marijuana, alcohol and PDNP use were most strongly associated with 




CHAPTER 5: PRELIMINARY PATTERNS OF SUBSTANCE USE AND MENTAL 
DISORDER SYMPTOM COMORBIDITY IN ADULTS OVER TIME 
 
Introduction. Patterns of co-occurring substance use and mental health conditions are 
well-described in youth and young adult populations. It remains unclear whether these 
patterns continue into adulthood. 
Objective. Perform a preliminary assessment to determine the stability of substance use 
and mental disorder comorbidity across three years of data (2013-2016) using both 
latent class and network analyses. 
Methods. Latent class analyses were conducted cross-sectionally for each wave of data 
(Wave 1, Wave 2, Wave 3). Class probability parameters, item response probability 
parameters, transition patterns and results from the multinomial logistic regression were 
compared across the three waves. Network models were estimated, and three tests of 
network invariance were used to test significant differences in network models by wave. 
Results. Four-class solutions generated from the latent class analyses were compared 
by wave. Similar latent profiles emerged across the three waves specifically where the 
low symptom class was largest (65.5% to 72.9%) and the comorbid class was smallest 
(6.1% to 8.2%). Overall, when individuals transitioned from one class to another, they 
typically transitioned into the low symptom class (62.3% to 66.8%) from preceding to 
subsequent wave. Network structure and connectivity did not significantly differ by 
wave; however, edge-weight comparisons identified some stronger connections among 
the substance use behaviors and mental disorder symptoms from preceding to 
subsequent waves. 
Conclusions. The comorbidity structure is consistent across waves. The connections 
between these behaviors and symptoms may become stronger at each wave. 
Therefore, investment of time, money, and other resources are encouraged to support 
those experiencing comorbidity as they are unlikely to change in adulthood
 18 
CHAPTER 1: INTRODUCTION 
 
Substance use disorder 
 Substance use disorder (SUD) develops as a result of prolonged use of any 
psychoactive substance at high doses and/or frequencies, and is defined as the 
continued use of alcohol and/or drugs despite clinically significant impairment, including 
health problems, disability, and failure to meet major responsibilities at work, school, or 
home.1–3 The essential feature of a SUD is a cluster of cognitive, behavioral, and 
physiological symptoms showing that the individual continues substance use despite 
significant substance-related problems.2 Diagnosis of SUD is based on a pathological 
pattern of behaviors related to the use of a substance.2 
 SUD represents a significant public health burden because of the life-years lost 
due to disability, impaired quality of life, disruption of work and family relationships, and 
death from accidents or overdose.4 In 2018, approximately 19.3 million American adults 
met diagnostic criteria for a past-year SUD,5 and drug abuse and addiction cost society 
an estimated $600 billion every year.6   
 
Substance use disorder and mental health comorbidity  
SUD commonly co-occurs across substances and with mental disorders. 
Approximately 6% of American adults are affected with SUD.2,7,8  Of those affected with 
SUD, about 50% have a co-occurring or comorbid mental illness such as negative affect 
(i.e., behaviors such as depression or anxiety where the distress of an affected 
individual is expressed inward) or externalizing disorders (i.e., behaviors such as 
attention-deficit hyperactivity disorder where the distress of an affected individual is 
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expressed outward).5 Further, many people affected with SUD also engage in use of 
other substances. For example, alcohol use disorder and nicotine dependence are 
commonly reported in approximately 25-50% of those with marijuana, cocaine, 
prescription opioid, and heroin use disorders.9 Some common mental disorders that 
have been associated with SUDs (e.g., tobacco, alcohol, marijuana, cocaine, sedatives) 
include anxiety disorders, depressive disorders, conduct disorder, ADHD, and antisocial 
personality disorder.9–17 
Comorbid substance use and mental disorders represent a substantial burden to 
the American health care system. Of the approximately 20 million adults in the United 
States (U.S.) who experience a SUD, half also have a co-occurring mental illness.5 
People with comorbid substance use and mental disorders suffer from more severe 
health outcomes compared to those who experience one disorder.18 Substance use and 
mental disorders are the leading cause of disease burden in the U.S. This has 
increased from 2779 DALYs (age standardized disability adjusted life years) in 1990 to 
3355 DALYs in 2015.19 Additionally, the U.S. has the highest rate of death due to 
substance use and mental disorders together at an age standardized death rate = 12.0 
per 100,000 compared to an average of 4.9 per 100,000 in similarly wealthy countries 
(e.g., France = 6.5 per 100,000; Canada = 5.8 per 100,000; United Kingdom = 5.2 per 
100,000; Netherlands = 2.5 per 100,000).19 The economic burden of substance use and 
mental disorder comorbidity, due to treatment spending from all public and private 
sources, is expected to increase from $171.7 billion in 2009 to $280.5 billion in 2020.20 
Co-occurring mental disorders, without SUD, are also common. Negative affect 
disorders like depression and anxiety are frequently associated with one another.21,22 
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Examples of negative affect symptoms include feeling depressed, feeling anxious, 
having sleep trouble, or becoming distressed or upset about the past. Negative affect 
symptoms are commonly reported in those with externalizing disorders.23 Externalizing 
disorders reflect distress expressed outward which is commonly diagnosed as attention 
deficit hyperactivity disorder (ADHD), oppositional defiant disorder, conduct disorder, 
antisocial personality disorder, and sometimes SUD.22 Examples of externalizing 
symptoms include having a hard time paying attention or listening, feeling restless, 
acting impulsively, lying or conning, threatening people, and starting physical fights with 
people.  
SUD is a common condition that affects millions of Americans and represents a 
substantial burden to the U.S. healthcare system. Addressing SUD has been 
complicated by comorbid mental disorders and co-occurring substance use. 
Consequently, detailing and addressing SUD and comorbid SUD represent an important 
goal to improve the health of Americans. 
 
Current state of SUD measurement 
The American Psychiatric Association’s Diagnostic and Statistical Manual of 
Mental Disorders, Fifth Edition (DSM-V) is a classification of mental disorders, including 
SUD, with associated criteria designed to facilitate more reliable diagnoses of these 
disorders.2 To date, the DSM-V is the standard reference for clinical practice and is 
considered the best description of how mental disorders are expressed.2 In the DSM-V, 
substance-related disorders encompass ten separate classes of drugs: alcohol; 
caffeine; cannabis; hallucinogens (with separate categories for phencyclidine [or 
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similarly acting arylcyclohexylamines] and other hallucinogens); inhalants; opioids; 
sedatives, hypnotics, and anxiolytics; stimulants (amphetamine-type substances, 
cocaine, and other stimulants); tobacco; and other (or unknown) substances. For a 
twelve-month period for diagnoses, two of the eleven criteria are required: (1) take 
substance in larger amounts or over longer period than intended, (2) express consistent 
desire to cut down or regulate use, (3) spent a great deal of time obtaining or using the 
substance, or recovering from its effects, (4) intense desire or urge for the substance 
(craving), (5) use results in failure to fulfill major role obligations, (6) continues use 
despite persistent social or interpersonal problem, (7) reduced involvement in activities 
because of use, (8) risky use in situations which are physically hazardous, (9) continued 
use despite physical or psychological problems, (10) requiring an increased dose of 
substance to achieve desired effect (tolerance), and (11) withdrawal symptoms. 
Diagnostic criteria allow a severity rating along with diagnosis: mild SUD defined as two 
or three symptoms, moderate SUD defined as four or five symptoms, and severe SUD 
defined as six or more symptoms.  
The International Classification of Disease, Tenth Revision, Clinical Modification 
(ICD-10-CM) is the other main diagnostic classification systems for SUD in the United 
States.24 The World Health Organization produces the ICD-10-CM with the primary 
focus for mental and behavioral disorder classification to help countries reduce the 
disease burden of mental disorders.24 It is the standard transaction code set for 
diagnosis under the Health Insurance Portability and Accountability Act (HIPAA) and is 
used to track disease burden, mortality statistics, and to ensure appropriate billing.25 
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The ICD-10-CM lists the same ten substances as the DSM followed by a list of 
specifiers under larger categories including abuse, dependence, and use.  
There are other instruments used in clinical and non-clinical settings to identify 
and measure SUD and SUD severity, overall or by specific substance. Common 
evidence-based instruments include the Addiction Severity Index (ASI), Alcohol Use 
Disorders Identification Test (AUDIT), Drug Abuse Screen Test (DAST), Fagerstrom 
Test for Nicotine Dependence (FTND), and the Global Appraisal for Individual Needs 
(GAIN).26–28 These tools are useful to assess SUD and SUD severity in settings such as 
epidemiologic research of large populations where it is impractical to establish 
diagnoses.27,28 This is important because substance use that does not result in a 
diagnosis of SUD remain pervasive throughout American society.8 For example, 85.6% 
of American adults engage in alcohol use.29 Of these, 25.8% engage in patterns of use 
that would not necessarily lead to a diagnosis of alcohol use disorder such as binge 
drinking (i.e., consuming 5 or more alcoholic drinks for males or 4 or more alcoholic 
drinks for females on the same occasion) in the past-month.29 Additionally, 8.3% of 
Americans 12 years of age and older reported past-month marijuana use with intensity 
of use increasing (i.g.,11.1% of heavy use in 1992 to 35.4% in 2014).30 Further, there is 
increasing evidence that environmental stressors such as the current COVID-19 
pandemic can influence sub-threshold use towards problematic use.31,32 Nevertheless, 
there are few effective strategies that address sub-threshold use in order to address 
population-level mental health issues in people with who do not meet criteria for SUD. 
Consequently, the use of other tools that can evaluate substance use beyond 
disordered substance use is particularly useful to detail population-level substance use 
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that measure sub-threshold SUD. Nevertheless, a common limitation of current SUD 
instruments is that none of these tools address SUD comorbidity. Therefore, it has been 
challenging to characterize SUD comorbidity with currently available measurement 
tools. Instead, research has focused on modeling SUD comorbidity across measures of 
substance use and mental disorders.  
 
Conceptual models of SUD-mental disorder comorbidity  
 Epidemiological research of substance use, negative affect, and externalizing 
disorders has typically studied comorbidity from three major perspectives. These 
models attempt to either identify or confirm an association between symptoms or 
disorders, test the causal relationship between comorbid disorders, or describe the 
patterns of overlap across disorders or symptoms.12,22,33–41 To date, these models have 
concluded: (1) substance use behaviors and disorders co-occur,34–36,42 (2) negative 
affect and externalizing symptoms and disorders co-occur,22,38–40 and (3) substance use 
behaviors/disorders co-occur with negative affect and externalizing 
symptoms/disorders.12,33,41 However, the use of each model has often been completed 
in isolation and this approach produces gaps in our understanding of comorbidity. The 
section below reviews the models that have been used to study comorbidity, their 
strengths and weaknesses, and identifies needs to expand insights that could be gained 
from these models.  
Common cause model. To date, the major psychiatric classification systems (i.e., 
DSM-V and ICD-10) measure SUD, negative affect, and externalizing disorders as 
single latent constructs based on observable symptoms.43 Therefore, SUD represents a 
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latent or unobservable construct of disease (denoted as a circle) that causes the 
observable symptoms (denoted as squares) which are measured to diagnose SUD 
(e.g., substance use taken in large amounts, cravings, social problems, and cessation 
attempts) (Figure 1.1). Based on the DSM’s approach to diagnosis, at least two of the 
eleven symptoms listed in the criteria above are needed to result in a diagnosis of SUD. 
This model is called the common cause model. It has also been referred to as the 
medical model and has also been applied to physical conditions.44,45 
 
Figure 1.1: Common Cause Model of Disease 
 
The common cause model assumes that the disease has a common pathogenic 
pathway or an etiology in which the mechanism is fully understood.45 However, common 
pathogenic pathways for mental disorders, including SUDs, have not been identified.45–
48 Additionally, the common cause model is unidimensional and does not account for 
comorbidity. These models become complicated to interpret when we take multiple 
disorders, and their overlapping symptomatology, into account. This is problematic 
because there is a high degree of comorbidity that is not accounted for through our 
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current diagnostic classification systems resulting in potential misclassification of 
disorder diagnosis. The internalizing-externalizing model presents an extension to the 
common cause model to account for comorbidity between internalizing and 
externalizing mental disorders. 
 Internalizing-Externalizing Model. The internalizing-externalizing model is a two-
factor model of internalizing and externalizing factors that explain the interrelationships 
of psychiatric disorders, seen in Figure 1.2.22,38  In this model, internalizing disorders 
like mood (major depressive disorder and dysthymia) and anxiety (generalized anxiety 
disorder, separation anxiety disorder, phobias, obsessive-compulsive disorder) 
disorders reflect a similar construct, and are associated with or explains the variance of 
the internalizing factor. Externalizing disorders like ADHD, oppositional defiant disorder, 
conduct disorder, antisocial personality disorder, and sometimes SUDs reflect a 
separate construct, an externalizing factor. The internalizing and externalizing factors 
can also be correlated in this model, indicating that internalizing and externalizing 
disorders are comorbid with each other.22 This model has received considerable 
attention for understanding co-occurring psychiatric disorders, including SUDs, as latent 
factors in adults.22,38–40 
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Figure 1.2: Internalizing-Externalizing Model. In the internalizing-externalizing model, the 
observable symptoms (in boxes) are caused by an unobserved internalizing and externalizing 
latent variables (in circles). This model allows there to be some correlation between the 
internalizing and externalizing latent variables. 
 
The internalizing-externalizing model assumes that negative affect disorders 
represent a latent negative affect construct with externalizing disorders, including SUD 
represent a latent externalizing construct. Statistically, these latent factors represent the 
proportion of variance shared between the observed disorder (i.e., depression) and the 
latent construct (i.e., internalizing). This model extends the common cause model 
because it accounts for the comorbidity between internalizing and externalizing 
disorders. This model predominantly focuses on mental disorders as latent constructs 
and does not include a robust set of substance use behaviors. This method explains the 
relationships between the observed disorders or symptoms that explain the latent 
construct by calculating the model implied covariance. However, this calculation does 
















comorbidity patterns in a population. This is a limitation of the negative internalizing-
externalizing model. 
 Network Model. The network model is a relatively new psychometric approach 
that can reduce the lack of clarity on the relationships between the observed disorders 
or symptoms that explain the latent construct and address the associations between the 
observed disorders or symptoms. A network model is likely to support a deeper 
understanding of comorbidity because it conceptualizes symptoms as mutually 
interacting, often reciprocally reinforcing elements of a complex network.46 The network 
approach is based on the idea that comorbidities arise from shared symptoms between 
disorders which can capture complexity and individual variation in psychopathology.49  
The network approach naturally accommodates comorbidities as a central part of its 
theory.50 In the network approach, comorbidity represents causal relationships between 
symptoms in which pathways can bridge symptoms that are part of multiple disorders.46 
Using a network model, symptoms, rather than disorders, are considered within the 
network structure. Rather than the disorder acting as the underlying cause of all 
symptoms, it is the symptoms that mutually interact and set a person into a disordered 
mental health state.  
An example of the use of a network model is detailed in Figure 1.3 to summarize 
comorbidity of symptoms for SUD and depression. Symptoms found in depression and 
SUD include insomnia and weight loss. Within a network model, the symptoms make up 
a comorbid network structure of several symptoms that is specific to the person. This 
model conceptualizes how symptoms of different disorders function together specifically 
to produce a comorbid disordered state. The network approach explains the co-
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occurrence of mental disorder symptoms, including substance use behaviors, as 
resulting from direct interactions between these symptoms.50 In network analysis, the 
term interaction is used to explain the reciprocal action or influence of symptoms. In the 
context of network analysis, interaction is not used to test whether an effect can be 
greater than (positive interaction, synergism) or less than what we would expect 
(negative interaction, antagonism).51 
 
Figure 1.3: Network Model of Depression and SUD symptoms. The network model of 
depression and SUD is made of nodes (circles) and edges (lines connecting nodes). This is a 
directed network (arrows are directed from source to target node) where one symptom can lead 
to the activation of another. The depression symptoms in red are clustered together to the left of 
the network. The SUD symptoms in blue are clustered together to the right of the network. 
Insomnia and weight loss (in purple) are symptoms that occur in both depression and SUD and 
act as bridges between the disorders. The positioning and the distance between the 
symptoms/nodes within the network have implications for the comorbidity structure of 
depression and SUD. 
 
Patterns of symptom-symptom or symptom-behavior interactions can be 
encoded in a network structure.45 Measured symptoms and behaviors are represented 























interactions between the nodes. Nodes that directly activate each other (i.e., 
demonstrate an association) are connected while nodes that do not directly activate 
each other are not. Changes that occur outside the network, external forces, can 
influence the symptoms and the interactions between the symptoms.45 
Principles underlying the network approach imply the etiology of mental disorders 
as a process of spreading activation in a symptom network.45 For example, if a 
symptom arises (for any reason), it may influence the probability that a connected 
symptom will activate as well.45 A mental disorder will arise when a group of tightly 
coupled symptoms activate, and the cluster becomes self-sustaining.45 Although 
symptom interactions may be most active within symptoms sets that are associated with 
a given mental disorder, these interactions do not stop at diagnostic boundaries.45 
In network theory, diagnosis is conceptualized as a process where the presence 
of symptoms is identified by clinicians and any symptom-symptom interactions that 
sustain themselves.45 An example of sustained symptom-symptom interactions could be 
a phenomenon in which one’s depressive mood results in a lack of restful sleep which 
could lead to greater fatigue which may ultimately sustain their depressed mood, 
rendering the person to be diagnosed with a depressive disorder. Treatment could then 
evolve to intervene on the symptom interactions (i.e., directly change the state of one or 
more symptoms), the external field (i.e., remove triggering causes or add a protective 
layer to mitigate the symptom activation), or the network (i.e., modify the symptom-
symptom connections).  
 
Longitudinal trends for SUD and comorbidity 
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 An inherent limitation of the models previously described is that the analysis is 
done at a single point in time. Previous studies have described that substance use 
behaviors, including past month substance use, can change over time. The gateway 
hypothesis of substance use posits that single and extensive use of alcohol and tobacco 
products can function as an entrance to polysubstance use, the use of at least two 
different psychotropic substances.52–54 There is also evidence that certain mental health 
conditions can increase the risk of developing future mental health conditions, 
sometimes more severe. For example, chronicity of depressive symptoms increases the 
likelihood of anxiety and substance use disorders.2,55,56 Studies of adolescents have 
reported that (1) externalizing problems (i.e., ADHD, ODD, CD) in youth precede 
substance use in both boys and girls whereas (2) substance use (i.e., alcohol and 
marijuana) in youth predict negative affect disorders in adulthood specifically for 
women.57–61 Less is known about how these trends continue in adulthood. Therefore, 
greater investigation into substance use behaviors over time with mental health 
conditions are necessary to further develop the literature around longitudinal trends for 
SUD and comorbidity. 
 
Common knowledge gaps across all chapters 
The gold-standard diagnostic classification systems (i.e., DSM and ICD-10-CM) 
in the United States describe disorders as single latent constructs or single dimensions 
rather than considering disorders as multidimensional. Nevertheless, the American 
Psychiatric Association recognizes that mental disorders do not always fit completely 
within the boundaries of a single disorder.2 This approach to diagnosis may be limited 
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and could benefit from additional insight because (1) comorbidity is common and (2) the 
current tools do not consider comorbidity within the context of diagnosis. Additionally, in 
order to receive a diagnosis, a person must have the appropriate number of criteria to 
reach a diagnostic threshold and access to a physician or person qualified to diagnose. 
Using a threshold approach in current classification systems may underestimate the 
number of people who experience substance use and mental disorders, especially 
those that present as comorbidities. Consequently, current SUD research suffers from 
the unidimensional approach that does not account for comorbidity. Further, addressing 
SUD comorbidity could benefit from knowledge of the patterns of the symptoms 
underlying an SUD diagnosis. Such a symptoms approach to measuring comorbidity 
(e.g., past-month substance use or endorsement of mental disorder symptom) may be 
better in estimate the prevalence of comorbidity correctly. Furthermore, better prediction 
of additional health outcomes and more targeted prevention and intervention strategies 
are likely to result in a more accurate representation of comorbidity prevalence. 
Patterns of comorbidity are not the same although current knowledge is based on 
homogeneous samples. People present with different combinations of substance use 
behaviors and mental health conditions due to biological, social, and environmental 
reasons.2,12,16,62–66 Further, much of the comorbidity research so far has been 
conducted in clinical samples rather than population-based samples. Therefore, a 
robust set of substance use behaviors and mental disorder symptoms in a large sample 
of nationally representative adults are required to close this knowledge gap and 
appropriately characterize comorbidity. This assessment of comorbidity in a larger 
sample of U.S. adults will shed light on the comorbidity profiles that exist in the general 
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population, expanding the current literature of clinical samples. Furthermore, factors that 
influence these associations must also be considered. Appropriate characterizations are 
important to target and personalize treatment and result in greater success in prognosis 
for people experiencing comorbidity. 
Although SUD comorbidity is persistent across the life course, it is unclear whether 
patterns of comorbidity remain stable or change over time. Some studies report that 
comorbidity does not readily change, while others explain shifts in substance use and 
mental health conditions.67–69 Consequently, assessment of comorbidity over time is 
needed to better understand the stability and/or continuity of comorbidity, and what 
factors may be associated with these trends. These studies will help to better 
understand the progression or regression of symptoms or behaviors in adults, and 
identify how to better support individuals experiencing comorbidity. 
 
The goal of the dissertation 
The research goal of this dissertation is to address the aforementioned 
knowledge gaps (current SUD research suffers from the unidimensional approach that 
does not account for comorbidity; patterns of comorbidity are not the same, although 
current knowledge is based on homogeneous samples; and it is unclear whether 
patterns of comorbidity remain stable or changes over time) by characterizing the 
comorbidity between substance use, including tobacco use, and mental disorder 
symptoms measured as negative affect and externalizing symptoms in a population-
based sample. This is characterized in Table 1.1. These characterizations are needed 
to better support people experiencing substance use and mental disorder comorbidity. 
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Table 1.1: Assumptions, strengths, and limitations of conceptual models 
 Assumptions Strengths Limitations Addressed in Dissertation 
Common 
cause model 
Disease has a 
common 
pathogenic 
pathway or an 
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Chapter 2 is a preliminary assessment of comorbidity. Multinomial logistic 
regression analyses will be used to determine the association between lifetime negative 
affect severity, externalizing severity and nicotine dependence (ND) and current use of 
tobacco (cigarettes and e-cigarettes) and alcohol, adjusting for sex, age, race, 
education and income. Two adjusted multinomial regression models are considered. 
The first model only includes negative affect and externalizing severity, adjusting for the 
correlation between the two factors. The second model builds on the first model by 
including ND to determine if ND explained more of the association between substance 
use. 
Chapter 3 addresses the knowledge gap of diagnostic classifications, comorbidity 
profiles, and addresses factors associated with the comorbidity profiles by (1) estimating 
latent classes of comorbid substance use as well as negative affect and externalizing 
symptoms and (2) assessing their ability to predict SUD severity. The latent class 
approach is a type of mixture modeling used to identify unobserved heterogeneity in a 
population and find meaningful groups of people that are similar based on their 
responses to measured items.70 This approach follows the common cause model in that 
the measured items (i.e., substance use behaviors and mental disorder symptoms) give 
rise to the latent unobservable disorder or in this case, comorbidity, and extends the 
internalizing-externalizing model by accounting for one overall latent class. Latent class 
analysis goes beyond the multinomial regression and allows for the consideration of 
multiple substance use and mental disorder symptom combinations. Analyses related to 
this chapter also move beyond the descriptiveness of the latent class approach and use 
the predictive probabilities generated from the latent class analysis to predict a health 
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outcome, SUD severity. The prediction analyses allow us to determine whether 
comorbidity versus a single construct (i.e., substance use, negative affect or 
externalizing separately) is important in predicting a distal health outcome. 
Chapter 4 builds on the knowledge developed in Chapter 3 by detailing 
substance use, negative affect, and externalizing symptom networks. Network analysis 
is a complement to the latent class approach. Network analysis does not follow the 
common cause model yet it posits that the substance use behaviors and mental 
disorder symptoms mutually interact and comorbidities arise from shared symptoms 
between disorders which can capture complexity and individual variation in 
psychopathology. The network approach allows for us to determine if symptoms cross 
over diagnostic boundaries. We also extend past the network approach and test 
whether there are differences in the network structure and connectivity by gender.   
Chapter 5 addresses the knowledge gap of stability or movement of comorbidity 
structures by assessing the structure over time using the results from the latent class 
and network analyses. Pairwise comparisons occur in two separate approaches. First, 
using results from latent class analyses of three waves of adult data, we (1) compare 
the class probabilities across the waves, (2) assess the item response patterns for each 
class by wave, and (3) identify the transition patterns to determine the stability or 
movement among the classes. Second, network comparison tests including global 
strength, network structure, and edge strength will be tested to determine if there are 
differences in the comorbidity networks by wave. 
 
Setting and measures 
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 All chapters use adult data from the Population Assessment of Tobacco and 
Health (PATH) Study.71 Chapters 2, 3, and 4 use data from the first wave of 
participants. Chapter 5 uses data from waves 1, 2, and 3 to assess the comorbidity 
patterns in adults across time. Information regarding the sample size, dates of data 
collection, and the weighted response rate among participants is provided in Table 1.2. 
Table 1.2: PATH Information for Waves 1, 2, and 3 
 Sample 




Wave 1 32,320 September 2013 – December 2014 74.0% 
Wave 2 28,362 October 2014 – October 2015 83.2% 
Wave 3 28,148 October 2015 – October 2016 78.4% 
*Weighted response rate among participants is conditional on Wave 1 participation. 
 
 The PATH study launched in 2011 in response to the Family Smoking Prevention 
and Tobacco Control Act in order to inform the Food and Drug Administration’s 
regulatory activities.71 This study is a collaborative effort among the National Institute on 
Drug Abuse, National Institutes of Health, and the Center for Tobacco Products at the 
Food and Drug Administration. There are eight primary objectives for the PATH study: 
1. “Identify and explain between-person differences and within-person changes in 
tobacco-use patterns, including the rate and length of use by specific product 
type and brand, product/brand switching over time, uptake of new products, and 
dual- and poly-use of tobacco products (i.e., use of multiple products within the 
same time period and switching between multiple products). 
2. Identify between-person differences and within-person changes in risk 
perceptions regarding harmful and potentially harmful constituents, new and 
emerging tobacco products, filters and other design features of tobacco products, 
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packaging, and labeling; and identify other factors that may affect use, such as 
social influences and individual preferences. 
3. Characterize the natural history of tobacco dependence, cessation, and relapse, 
including readiness and self-efficacy to quit, motivations for quitting, the number 
and length of quit attempts, and the length of abstinence related to various 
tobacco products. 
4. Update the comprehensive baseline and subsequent waves of data on tobacco-
use behaviors and related health conditions, including markers of exposure and 
tobacco-related disease processes identified from the collection and analysis of 
biospecimens, to assess between-person differences and within-person changes 
over time in health conditions potentially related to tobacco use, particularly with 
use of new and different tobacco products, including modified-risk tobacco 
products. 
5. Assess associations between TCA-specific actions and tobacco-product use, risk 
perceptions and attitudes, use patterns, cessation outcomes, and tobacco-
related intermediate endpoints (e.g., biomarkers of exposure and biomarkers 
related to disease). Analyses will attempt to account for other potential factors, 
such as demographics, local tobacco-control policies, and social, familial, and 
economic factors, that may influence the observed patterns. 
6. Assess between-person differences and within-person changes over time in 
attitudes, behaviors, exposure to tobacco products, and related biomarkers 
among and within population sub-groups identified by such characteristics as 
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race-ethnicity, gender, and/or age, or by risk factors, such as pregnancy or co-
occurring substance use or mental health disorders. 
7. To the extent to which sample sizes are sufficient, assess and compare samples 
of former and never users of tobacco products for between-person differences 
and within-person changes in relapse and uptake, risk perceptions, and 
indicators of tobacco exposure and disease processes. 
8. Use data from the PATH Study's baseline and follow-up waves on tobacco-use 
behaviors, attitudes, and related health conditions, including potential markers of 
exposure and related disease processes identified from the analysis of 
biospecimens, to screen and subsample respondents for participation in 
formative and/or nested studies conducted during and after the PATH Study's 
waves of data and biospecimen collection”71 
PATH is a nationally representative longitudinal cohort study of the civilian, non-
institutionalized household population of the U.S. aged 9 and older at Wave 1, and 
participants engaged in all levels of tobacco use ranging from never using tobacco to 
frequent use. Participants were selected through a four-stage stratified area probability 
sample design, with a two-phase design for sampling adults at the final stage71: 
1. Selected stratified sample of geographical primary sampling units (PSU) (i.e., 
county or group of counties) 
2. Within each PSU, smaller geographical segments were formed and a sample of 
these segments was drawn 
3. Sampling frame consisted of residential addresses located in the segments 
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4. Selected adults and youth from the sampled households identified at these 
addresses (with varying sampling rates of adults by age, race, and tobacco 
status). 
a. Adults were sampled in two phases: 
i. Sampling used information provided in the household screener 
ii. Sampling used information provided by the adult 
Study domains include tobacco use behavior, attitudes and beliefs, and tobacco-
related health outcomes. Specific topics are included in Table 1.3. 
Table 1.3: Topics assessed in PATH Study 











Smokeless tobacco (snus 
pouches and other forms of 
smokeless tobacco) 
Dissolvable tobacco 
Bidis and kreteks (youth only) 
Ever use 
Recency of use 
Frequency of use 
Amount of use 
Brands used 
Purchase details 




Reasons for use 
Poly use 
Nicotine dependence 
Packaging and health 
warnings 
Risk and harm perceptions 
Secondhand smoke exposure 








Peer and family influences 
 
Participants responded to tobacco-specific items including tobacco-use patterns, 
risk perceptions and attitudes towards current and newly emerging tobacco products, 
tobacco initiation, cessation, relapse behaviors, and health outcomes.72 Participants 
also responded to non-tobacco items (e.g., media use, peer and family influences, 
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health effect outcomes, and industry advertising and promotion).72 A detailed list of the 
measures used in the dissertation are provided below. 
Past Month Tobacco and Substance Use. Six substance use categories were 
used in this dissertation: exclusive cigarette, exclusive e-cigarette, dual cigarette and e-
cigarette, alcohol, marijuana, and prescription drugs not prescribed (PDNP) including 
painkillers, sedatives, tranquilizers. Current cigarette use was endorsed if the 
respondent indicated ever smoking a cigarette (even one or two puffs), has smoked at 
least 100 or more cigarettes in his or her entire life, and now smokes cigarettes every 
day or some days, while also excluding the current use of e-cigarettes. Current e-
cigarette use was endorsed if the respondent indicated ever using an e-cigarette (even 
one or two puffs), ever smoked e-cigarettes fairly regularly, and now uses e-cigarettes 
every day or some days, while also excluding the current use of cigarettes. Current dual 
cigarette and e-cigarette use was identified if the respondent indicated that they were a 
current cigarette and current e-cigarette user. Current alcohol, marijuana, and PDNP 
was endorsed if the respondent indicated ever using the substance and has used the 
substance within the past 30 days. Only past month or current use of the substances 
was considered (coded as 1, else = 0) to reduce the potential for recall bias and ensure 
for accurate overlap with negative affect and externalizing symptoms occurring in the 
same time frame. 
Negative Affect and Externalizing Severity and Symptoms. Negative affect and 
externalizing symptoms were measured using the Global Appraisal of Individual 
Needs—Short Screener (GAIN-SS).73 The GAIN-SS refers to negative affect as 
“internalizing symptoms”; however, these symptoms provided within the GAIN-SS are 
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better represented as “negative affect”. Negative affect refers to the experience of 
negative drive states such as depression, anxiety, and stress,74 and therefore, is a more 
appropriate term for these symptoms compared to “internalizing”. Negative affect will be 
the term used for the rest of the dissertation. 
The GAIN-SS is derived from the full GAIN instrument and identifies individuals at 
risk for mental health disorders using a continuous measure of severity.73 The full GAIN 
assessment is a validated, standardized biopsychosocial assessment and 
recommended for use in epidemiologic samples.28,73 Four questions were used to 
measure negative affect symptoms that asked the last time you had significant 
problems with:  
(1) “feeling trapped, lonely, sad, blue, depressed, or hopeless about the future,” 
(2)  “sleep trouble- such as bad dreams, sleeping restlessly or falling asleep during 
the day,”  
(3) “feeling very anxious, nervous, tense, scared, panicked or something bad was 
going to happen,” and  
(4) “becoming very distressed and upset when something reminded you of the past.”  
Externalizing symptoms were also measured using the GAIN-SS.28,73 Seven questions 
were used to assess externalizing symptoms. Items asked the last time you did the 
following two or more times:  
(1) “lied or conned to get things you wanted or to avoid having to do something,”  
(2) “had a hard time paying attention at school, work or home,”  
(3) “had a hard time listening to instructions at school, work or home,”  
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(4) “were a bully or threatened other people,”  
(5) “started physical fights with other people,”  
(6) “felt restless or the need to run around or climb on things” and  
(7) “gave answers before the other person finished asking the question.”  
The items selected to identify negative affect and externalizing symptoms from the 
GAIN-SS instrument are ordinal and measures people across four times periods: past 
month, 2 to 12 months, over a year ago, and never. 
Ethical considerations 
This research uses publicly available secondary data, where information is 
recorded by the investigator in a manner that subjects cannot be identified (either 
directly or through identifiers). Therefore, this is considered exempt by the Virginia 








CHAPTER 2: THE ASSOCIATION BETWEEN NEGATIVE AFFECT AND 
EXTERNALIZING SEVERITY WITH CURRENT USE OF CIGARETTES, E-
CIGARETTES, AND ALCOHOL IN ADULTS: WAVE 1 OF THE POPULATION 
ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY1 
 
INTRODUCTION 
Tobacco and alcohol are two of the most common substances used in the United 
States (U.S.).75,76  In 2018, approximately 20.9% of U.S. adults were current 
conventional cigarette (CIG) smokers and 55.3% reported drinking alcohol in the past 
month.77–79 Among individuals with alcohol use disorder, 23.8% also had nicotine 
dependence and 12.9% of individuals with nicotine dependence also had alcohol use 
disorder.9 Concurrent use of CIG and alcohol represents a major public health concern 
because they have been associated with more negative health outcomes such as 
increased risk of cardiovascular disease, cirrhosis, head and neck cancers, liver cancer, 
pancreatitis, and psychiatric comorbidity than the exclusive use of either substance.80–82 
To date, it is unclear whether the factors associated with co-occurring tobacco and 
alcohol use are specific to CIG or extend to electronic cigarettes (ECIG).  
Although dual use of ECIG and CIG is common and increasing in the U.S.,83 the 
trends related to this form of tobacco use with alcohol remain unclear. In 2018, 57.3% 
and 25.2% of former CIG users were engaged in ever-use and current-use of ECIGs, 
respectively.84 Approximately 9.7% of current ECIG users also engaged in CIG use.84 In 
2014, about 16% of current smokers were also current ECIG users.85 Recent studies 
have reported that current ECIG users are at an increased risk of harmful alcohol use 
 




compared to ECIG non-users,86,87 with dual CIG and ECIG use resulting in more past-
month total drinks compared to exclusive-ECIG users.88 However, compared to studies 
of CIG use and alcohol, there is far less knowledge regarding the co-occurring use of 
ECIG and alcohol. Consequently, there is a need to examine the use of ECIG, CIG, and 
alcohol, which may be associated with more severe or different risk factors than dual or 
exclusive use of any of these three substances.  
Negative affect (e.g., depression and anxiety) and externalizing [e.g., attention-
deficit hyperactivity disorder (ADHD) and conduct disorder] psychopathology2,16,73,89–91 
are important mental health factors that have been consistently associated with 
exclusive use of either CIG or alcohol. A meta-analysis reported that current CIG 
smokers had a two-fold increased risk of depression relative to never and former CIG 
users.92 Further, adults with depression are more likely to smoke and are less likely to 
be successful at quitting than adults without depression.93 Whether this bidirectional 
association is maintained among ECIG users is unclear. The relationship between the 
use of alcohol, CIG, and ECIG, and negative affect and externalizing psychopathology 
is currently undetermined. Prior studies of the relationship between psychopathology 
and tobacco products, specifically ECIG, as well as alcohol typically focus on youth and 
young adults. These results indicate ECIGs are commonly used with other substances 
(i.e., CIG, alcohol, marijuana and opiates) and associated with mental health 
symptomatology (i.e., diagnosis of ADHD, PTSD, anxiety, and substance use 
disorders).94–97 However, it is unclear if these associations are specific to youth and 
young adults, or if they also occur across adulthood. 
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 This study addresses the aforementioned knowledge gaps by examining the 
association of lifetime mental disorder symptom severity and past 30-day combinations 
of CIG, ECIG, and alcohol use. We asked the following questions: (1) is there an 
association between negative affect/externalizing severity across combinations of CIG, 
ECIG, and alcohol use in US adults, and (2) is there a difference in severity based on 
tobacco product type (CIG vs. ECIG)? We expect (1) a significant, positive association 
between negative affect/externalizing severity across all combinations of CIG, ECIG, 
and alcohol use. For exploratory aim (2), we expect that this association varies with type 
and number of tobacco products used (i.e., CIG associated with negative affect; ECIG 




Study material and participants 
Data from 32,320 adults aged 18 years and older participating in the first wave 
(2013-2014) of the Population Assessment of Tobacco and Health (PATH) study were 
used.71 PATH is a nationally representative longitudinal cohort study of the civilian, non-
institutionalized adult household population of the U.S., and participants engaged in all 
levels of tobacco use.72 The household screener response rate was 54%.71 The 




 Participants with missing data on tobacco and alcohol measures, mental health 
symptoms, or covariates were not included in the analysis (N=16,373). Survey 
respondents of the analytic sample endorsed greater substance use overall, negative 
affect/externalizing severity, and nicotine dependence (ND) than those not included in 
the analytic sample. The participants in the analytic sample were more likely to be men, 
aged 25-54 with lower levels of education and lower annual household income than 
those who were missing. 
 
Measures 
Current tobacco and alcohol use. Current tobacco and alcohol use was 
measured as an aggregate variable indicating the degree of past-month use of CIG, 
ECIG, and alcohol, and was developed from individual current-use items defined 
according to the National Health Interview Survey (2017) and listed in Table 2.1.98  
 





Current Alcohol Use Current Cigarette (CC) Use 




• Ever used alcohol in 
past 30 days 
• Ever smoked a CC (even 
1-2 puffs) 
• Smoked ≥ 100 CC in 
lifetime 
• Smoke CC every day or 
some days 
• Ever used an EC (even 1-2 
times) 
• Ever smoked EC fairly 
regularly 




• Never used alcohol  
• Ever used alcohol but 
not in past 30 days 
• Never smoked a CC 
• Smoked ≤ 99 CC in 
lifetime 
• Do not smoke CC now 
• Never used an EC 
• Do not smoke EC regularly 
• Do not use EC now 
Depending on responses, subjects were classified as current users (coded as 1), or non-




The outcome variable was developed as an eight-level categorical variable: (1) 
alcohol-exclusive; (2) CIG-exclusive; (3) ECIG-exclusive; (4) CIG and alcohol; (5) ECIG 
and alcohol; (6) CIG and ECIG; (7) alcohol, CIG, and ECIG; and (8) non-use. This 
variable allowed us to evaluate the relationships between all combinations of alcohol, 
CIG, and ECIG use and negative affect/externalizing severity, with non-users as a 
reference group. 
Negative affect/ externalizing severity. Negative affect and externalizing severity 
were measured in PATH using the Global Appraisal of Individual Needs—Short 
Screener (GAIN-SS).73 The GAIN-SS is derived from the full GAIN instrument assessing 
individuals at risk for mental disorders using a continuous measure of severity. The full 
GAIN assessment is a reliable and validated biopsychosocial assessment 
recommended for use in epidemiologic samples.28,73,99 There was good internal 
consistency among the negative affect (Cronbach’s α=0.85) and externalizing 
(Cronbach’s α=0.80) items in the analytic sample. 
Items used to measure negative affect/externalizing symptoms are listed in Table 
2.2. Responses were measured across four time periods: past month, 2-12 months, 
over a year ago, and never. Lifetime negative affect/externalizing items were coded as 
past month, 2-12 months, or over a year ago = 1 vs never = 0. The binary responses 
were summed to reflect a scale score of the number of lifetime symptoms. The score 
ranging from 0-4 negative affect symptoms and 0-7 externalizing symptoms were 
categorized into low (0), moderate (1-2), and high (3+) severity). These cut points were 
previously recommended based on validation analyses of the dimensional measures 
and have high predictive validity in other samples.28,73,99 Higher scores indicate 
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increased severity, a greater likelihood for diagnosis with a mental health disorder, and 
increased need for services.73 Negative affect/externalizing severity were highly 
correlated with one another (r=0.68, ASE=0.0051, p<0.001). 
 





Last time respondent had significant problem with: 
• feeling trapped, lonely, sad, blue, depressed, or hopeless about the future 
• sleep trouble - such as bad dreams, sleeping restlessly or falling asleep during 
the day 
• feeling very anxious, nervous, tense, scared, panicked, or that something bad 
was going to happen 
• becoming very distressed and upset when something reminded you of the past 
Externalizing 
Symptoms* 
Last time respondent engaged in the following behaviors 2-3 times: 
• lied or conned to get things you wanted or to avoid having to do something 
• had a hard time paying attention at school, work or home 
• had a hard time listening to instructions at school, work, or home 
• were a bully or threatened other people 
• started physical fights with other people 
• felt restless or the need to run around or climb on things 






• I find myself reaching for [product] without thinking about. 
• I frequently crave [product]. 
• My urges keep getting stronger if I don’t use [product]. 
• Tobacco products control me. 
• My [product] use is out of control. 
• I usually want to use [product] right after I wake up. 
• I can only go a couple of hours without using [product]. 
• I frequently find myself almost using [product] without thinking about it. 
WISDM: Secondary 
• Using [product] would really help me feel better if I’ve been feeling down. 
• Using [product] helps me think better. 
• I [would] feel alone without my [product]. 
NDSS 
• I would find it really hard to stop using [product]. 
• I would find it hard to stop using [product]. 
• After not using [product] for a while, I need to use [product] in order to feel less 
restless and irritable. 
• After not using [product] for a while, I need to use [product] in order to keep 
myself from experiencing discomfort. 
DSM: Impaired Control 
• In the past 12 months, did you find it difficult to keep from using [product] in 
places where it was prohibited? 
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*Responses were measured across four time periods: past month, 2-12 months, over a year ago, and never. 
Participants indicating that they experienced a symptom at any time were coded as 1. Participants indicating that 
they never experienced an item were coded as 0. Binary responses were summed to reflect a scale score with a 
range of 0-4 symptoms for negative affect and 0-7 symptoms for externalizing. The scores were categorized into 
low (0), moderate (1-2), and high (3+) severity based on the recommended cut points. 
ǂ Responses for WIDSM: Primary, WIDSM: Secondary, and NDSS were measured based on level of agreement 
from 1 = not true of me at all to 5 = extremely true to me. Response option for DSM: Impaired Control was 1 = Yes 
and 0 = No. These were summed to reflect a scale score with a range of 0-76 with higher values indicating greater 
ND. 
 
Covariates. The role of nicotine dependence (ND) was included as a potential 
confounder. Adults with mental health disorders may have higher levels of ND as a 
result of tobacco product use.100,101 Similarly, there is a strong association between ND 
and all levels of alcohol use.102 People who engage in ECIG and CIG dual use have 
greater ND than exclusive use of either ECIG or CIG.103,104 Sixteen items [8 from 
Wisconsin Inventory of Smoking Dependence Motives (WIDSM): Primary, 3 from 
WISDM: Secondary, 4 from Nicotine Dependence Syndrome Scale (NDSS), 1 from 
Diagnostic and Statistical Manual of Mental Disorders (DSM): Impaired Control] were 
used to measure ND and are listed in Table 2.2. These 16 items were recommended to 
use as a common instrument to assess ND across different tobacco product users from 
a differential item function analysis.27 The items were summed into one continuous 
variable ranging from 0-76, with higher values indicating greater ND. 
Sex, age, race/ethnicity, education, and annual household income were also 
included as covariates because they are consistently associated with mental health, and 
tobacco and alcohol use.61,73,105–114 
Age, measured in PATH as a seven-level categorical variable, was re-
categorized to have a uniform distribution with six levels (18-24, 25-34, 35-44, 45-54, 
55-64, and 65 years or older). Education, measured in PATH as a six-level categorical 
variable, was re-categorized as a five-level categorical variable with a uniform 
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distribution [less than high school, GED/high school graduate, some college (no degree) 
or Associate’s degree, Bachelor’s degree, and Advanced degree]. Race/ethnicity was 
measured as a four-level categorical race variable and included information from a 
separate variable that accounted for Hispanic ethnicity (Non-Hispanic White, Non-
Hispanic Black, Non-Hispanic Other, and Hispanic Multicultural). The significance of the 
association between these variables and tobacco and alcohol use was tested as a 
series of unadjusted multinomial logistic regressions (Table 2.4). 
 
Statistical analyses 
 Unadjusted multinomial logistic regression was used to test the association 
between tobacco and alcohol use and negative affect/externalizing severity. Tests were 
repeated after adjustment for sex, age, race, education, and annual household income. 
Two adjusted multinomial regression models were considered: the first model included 
only negative affect/externalizing severity, adjusting for the correlation between the two 
factors, while the second model also included ND to determine the degree to which ND 
explained the association between mental health severity and substance use. Odds 
ratios (OR) or adjusted odds ratios (AOR) and 95% confidence intervals (95% CI), 
profiled from estimates of standard error, are reported. All analyses were performed in 
SAS software, Version 9.4 (SAS Institute Inc, Cary, NC) and accounted for complex 
survey design and sampling weight using PROC SURVEYFREQ and PROC 
SURVEYLOGISTIC. Fay’s method, a variant of balanced repeated replication method, 





 Data from 15,947 participants with complete information were analyzed. Almost 
one quarter of the population engaged in alcohol-exclusive use (24.0%), 22.4% in CIG-
exclusive use, and 1.3% in ECIG-exclusive use (Table 2.3). Across the different 
combinations of tobacco and alcohol use, 33.3% engaged in CIG and alcohol use, 1.7% 
engaged in ECIG and alcohol use, 2.0% engaged in CIG and ECIG, and 3.2% engaged 
in alcohol, CIG, and ECIG use. Almost half of the sample endorsed high negative affect 
(47.9%) and high externalizing (44.7%) severity. The mean ND was 37.0 (range=1-76, 
standard deviation=0.23) for the sample (Table 2.3). 
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Table 2.3: Overall Frequencies of the Analytic Sample (n = 15,947, Weighted N = 61,482,491)—PATH Wave 1 (2013-
2014)  
n (Weighted %)  n (Weighted %) 
Sex*  Negative Affect Severity*  
   Male 9039 (59.6)    Low  4310 (28.1) 
   Female 6908 (40.4)    Moderate  3731 (24.0) 
Age*     High  7906 (47.9) 
   18-24 years old 4304 (17.7) Externalizing Severity*  
   25-34 years old 3580 (24.3)    Low  4058 (26.8) 
   35-44 years old 2696 (18.3)    Moderate 4436 (28.5) 
   45-54 years old 2579 (18.5)    High  7453 (44.7) 
   55-64 years old 1871 (14.1) Nicotine Dependence     65 years or older 917 (7.1) 37.0 (0.23)a 
Race*  Tobacco and Alcohol Use*  
   Non-Hispanic White 10257 (68.2)    Alcohol only 3603 (24.0) 
   Non-Hispanic Black 2305 (13.8)    CC only 3678 (22.4) 
   Non-Hispanic Other 1218 (6.4)    EC only 219 (1.3) 
   Hispanic Multiracial 2167 (11.7)    CC and Alcohol 5387 (33.3) 
Education*     EC and Alcohol 288 (1.7) 
   Less than high school 2304 (13.4)    CC and EC 336 (2.0) 
   GED/High school graduate 5385 (35.5)    Alcohol, CC, and EC 558 (3.2) 
   Some college (no degree) or Associate’s degree 5931 (34.9)    None 1878 (12.2) 
   Bachelor's degree 1685 (11.9)   
   Advanced degree 642 (4.3)   
Annual Household Income*    
   Less than $10,000 3532 (19.5)   
   $10,000 to $24,999 4120 (24.8)   
   $25,000 to $49,999 3746 (24.2)   
   $50,000 to $99,999 2974 (20.2)   
   $100,000 or more 1575 (11.4)   
* Indicates a significant difference at p <0.05. 
a Indicates mean and standard deviation (95% CL for the mean = 36.6-37.5) 
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Unadjusted multinomial logistic regression analysis 
 Compared to subjects with low negative affect severity, those with high negative 
affect severity were significantly more likely to engage in alcohol, CIG, and ECIG use 
(OR=3.42, 95% CI=2.48-4.72), CIG and ECIG use (OR=2.24, 95% CI=1.63-3.08), ECIG 
and alcohol use (OR=2.20, 95% CI=1.57-3.09), CIG and alcohol use (OR=2.28, 95% 
CI=1.97-2.65), CIG-exclusive use (OR=1.69, 95% CI=1.42-2.02), and alcohol-exclusive 
use (OR=1.42, 95% CI=1.20-1.69) than no use. Relative to those with low externalizing 
severity, subjects with high externalizing severity were more likely than not to engage in 
every level of tobacco and alcohol use except ECIG use, especially alcohol, CIG, and 
ECIG use (OR=4.56, 95% CI=3.31-6.30) and ECIG and alcohol use (OR=4.23, 95% 
CI=2.84-6.29). There were significant, positive associations between ND and alcohol, 
CIG, and ECIG use (OR=1.05, 95% CI=1.05-1.06), CIG and ECIG use (OR=1.08, 95% 
CI=1.07-1.08), CIG and alcohol use (OR=1.05, 95% CI=1.04-1.05), and CIG-exclusive 
use (OR=1.06, 95% CI=1.06-1.07). Females, relative to males, had significantly 
increased odds for CIG and ECIG use (OR=1.74, 95% CI=1.35-2.25), CIG and alcohol 
use (OR=1.21, 95% CI=1.06-1.38), ECIG-exclusive use (OR=1.99, 95% CI=1.45-2.74), 
and CIG-exclusive use (OR=1.65, 95% CI=1.43-1.90), except for alcohol-exclusive use 
(OR=0.71, 95% CI=0.61-0.84). There were significant associations by age, race, 






















Variable OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Negative Affect Severity        
Low Reference Reference Reference Reference Reference Reference Reference 
Moderate  1.71 (1.14-2.56) 1.50 (0.96-2.36) 1.36 (0.89-2.08) 1.79 (1.52-2.11) 1.12 (0.71-1.77) 1.37 (1.10-1.71) 1.66 (1.36-2.01) 
High  3.42 (2.48-4.72) 2.24 (1.63-3.08) 2.20 (1.57-3.09) 2.28 (1.97-2.65) 1.30 (0.89-1.88) 1.69 (1.42-2.02) 1.42 (1.20-1.69) 
Externalizing Severity         
Low Reference Reference Reference Reference Reference Reference Reference 
Moderate 2.32 (1.59-3.39) 1.67 (1.15-2.42) 2.84 (1.91-4.23) 2.00 (1.68-2.38) 1.01 (0.67-1.52) 1.21 (1.01-1.43) 2.04 (1.70-2.44) 
High  4.56 (3.31-6.30) 2.22 (1.61-3.05) 4.23 (2.84-6.29) 2.58 (2.19-3.03) 1.31 (0.89-1.94) 1.31 (1.11-1.55) 2.29 (1.91-2.76) 
Nicotine Dependence        
1.05 (1.05-1.06) 1.08 (1.07-1.08) 1.00 (0.99-1.01) 1.05 (1.04-1.05) 1.00 (0.99-1.01) 1.06 (1.06-1.07) 0.97 (0.96-0.97) 
Sex        
Male Reference Reference Reference Reference Reference Reference Reference 
Female 1.24 (0.98-1.56) 1.74 (1.35-2.25) 1.26 (0.94-1.69) 1.21 (1.06-1.38) 1.99 (1.45-2.74) 1.65 (1.43-1.90) 0.71 (0.61-0.84) 
Age        
18-24 years old Reference Reference Reference Reference Reference Reference Reference 
25-34 years old 1.75 (1.37-2.25) 3.62 (2.53-5.20) 1.69 (1.21-2.35) 2.42 (2.02-2.89) 1.86 (1.08-3.20) 2.53 (2.04-3.12) 1.40 (1.17-1.67) 
35-44 years old 1.28 (0.87-1.88) 2.93 (2.00-4.31) 0.84 (0.55-1.30) 1.95 (1.57-2.42) 1.49 (0.89-2.51) 2.27 (1.81-2.86) 0.90 (0.72-1.12) 
45-54 years old 0.57 (0.41-0.79) 1.78 (1.15-2.75) 0.69 (0.44-1.10) 1.55 (1.28-1.87) 2.01 (1.26-3.21) 2.25 (1.89-2.68) 0.76 (0.63-0.93) 
55-64 years old 0.46 (0.32-0.66) 1.99 (1.31-3.02) 0.64 (0.38-1.07) 1.21 (0.98-1.49) 1.04 (0.60-1.80) 2.02 (1.64-2.49) 0.63 (0.48-0.83) 
65 years or older 0.16 (0.07-0.35) 1.42 (0.70-2.88) 0.31 (0.14-0.66) 0.60 (0.47-0.76) 1.03 (0.51-2.11) 1.90 (1.47-2.47) 0.47 (0.36-0.61) 
Race        
White Reference Reference Reference Reference Reference Reference Reference 
Non-Hispanic Black 0.23 (0.16-0.35) 0.35 (0.23-0.55) 0.45 (0.27-0.73) 0.61 (0.51-0.73) 0.37 (0.20-0.67) 0.50 (0.42-0.60) 0.63 (0.51-0.77) 
Non-Hispanic Other 0.70 (0.44-1.12) 0.60 (0.38-0.94) 0.98 (0.56-1.72) 0.72 (0.56-0.91) 1.00 (0.57-1.76) 0.66 (0.53-0.82) 0.81 (0.62-1.06) 
Hispanic Multicultural 0.32 (0.23-0.46) 0.32 (0.20-0.52) 0.35 (0.22-0.57) 0.48 (0.40-0.57) 0.58 (0.40-0.86) 0.50 (0.41-0.61) 0.67 (0.53-0.83) 
Education         
Less than high school Reference Reference Reference Reference Reference Reference Reference 
GED/High school 2.30 (1.61-3.28) 1.15 (0.75-1.78) 2.22 (1.16-4.26) 1.50 (1.24-1.81) 1.51 (0.90-2.53) 0.96 (0.80-1.17) 1.74 (1.39-2.17) 
Some college 4.79 (3.28-6.99) 1.72 (1.16-2.56) 4.75 (2.60-8.67) 2.13 (1.78-2.56) 2.31 (1.46-3.64) 0.96 (0.80-1.15) 3.58 (2.89-4.43) 
Bachelor's degree 4.91 (3.26-7.39) 1.68 (0.99-2.86) 5.04 (2.47-10.32) 2.34 (1.85-2.97) 1.86 (1.00-3.46) 0.65 (0.48-0.88) 7.16 (5.41-9.49) 
Advanced degree 3.67 (1.98-6.82) 0.69 (0.28-1.69) 2.32 (0.62-8.63) 1.50 (1.07-2.10) 1.85 (0.75-4.56) 0.40 (0.27-0.59) 6.73 (4.80-9.44) 
Income        
< $10,000 Reference Reference Reference Reference Reference Reference Reference 
$10,000-24,999 1.94 (1.42-2.64) 1.49 (1.05-2.12) 1.31 (0.82-2.09) 1.33 (1.09-1.62) 1.07 (0.62-1.83) 1.26 (1.03-1.54) 1.30 (1.07-1.59) 
$25,000-49,000 2.59 (1.85-3.62) 1.41 (0.98-2.02) 2.00 (1.41-2.83) 1.63 (1.36-1.97) 1.21 (0.77-1.92) 1.08 (0.89-1.31) 1.66 (1.35-2.05) 
$50,000-99,999 2.95 (2.01-4.32) 1.33 (0.86-2.05) 3.03 (2.06-4.46) 1.98 (1.58-2.48) 1.82 (1.07-3.08) 0.90 (0.71-1.14) 3.04 (2.42-3.82) 
>=$100,000 2.88 (1.83-4.53) 1.06 (0.59-1.91) 3.37 (2.16-5.24) 1.72 (1.38-2.14) 1.33 (0.68-2.62) 0.53 (0.38-0.72) 5.07 (3.91-6.57) 
Bolded values indicate estimate significant a p < 0.05 
The “none” category is used in reference for the tobacco and alcohol use outcome. 
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Adjusted multinomial logistic regression analysis 
Model 1: Negative affect/externalizing severity 
 Compared to subjects with low negative affect severity, those with high negative 
affect severity were significantly more likely to engage in alcohol, CIG, and ECIG use 
(AOR=2.01, 95% CI=1.30-3.09), CIG and alcohol use (AOR=1.61, 95% CI=1.30-2.00), 
and CIG-exclusive use (AOR=1.42, 95% CI=1.13-1.79) than none (Table 2.5). 
Participants with moderate negative affect severity, compared to low, were significantly 
more likely to engage in CIG and alcohol use (AOR=1.52, 95% CI=1.27-1.81), CIG-
exclusive use (AOR=1.26, 95% CI=1.01-1.58), and alcohol-exclusive use (AOR=1.53, 
95% CI=1.24-1.90) than none. Participants with high externalizing severity, compared to 
low, had 113% greater odds of alcohol, CIG, and ECIG use (AOR=2.13, 95% CI=1.36-
3.34), 54% greater odds of CIG and ECIG use (AOR=1.54, 95% CI=1.04-2.28), 196% 
greater odds of ECIG and alcohol use (AOR=2.96, 95% CI=1.82-4.80), 74% greater 
odds of CIG and alcohol use (AOR=1.74, 95% CI=1.38-2.20), and 69% greater odds of 
alcohol-exclusive use (AOR=1.69, 95% CI=1.33-2.14) than no use. Participants with 
moderate externalizing severity, compared to low, were significantly more likely to 
engage in alcohol, CIG, and ECIG use (AOR=1.56, 95% CI=1.02-2.40), ECIG and 
alcohol use (AOR=2.32, 95% CI=1.55-3.46), CIG and alcohol use (AOR=1.54, 95% 






















Variable AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) 
Negative Affect Severity         
Low Reference Reference Reference Reference Reference Reference Reference 
Moderate  1.37 (0.88-2.13) 1.23 (0.77-1.98) 0.98 (0.61-1.56) 1.52 (1.27-1.81) 1.03 (0.64-1.67) 1.26 (1.01-1.58) 1.53 (1.24-1.90) 
High  2.01 (1.30-3.09) 1.46 (0.99-2.14) 1.20 (0.78-1.83) 1.61 (1.30-2.00) 1.00 (0.62-1.61) 1.42 (1.13-1.79) 1.21 (0.97-1.51) 
Externalizing Severity         
Low Reference Reference Reference Reference Reference Reference Reference 
Moderate 1.56 (1.02-2.40) 1.33 (0.90-1.97) 2.32 (1.55-3.46) 1.54 (1.26-1.88) 0.88 (0.57-1.37) 1.04 (0.86-1.25) 1.60 (1.32-1.94) 
High  2.13 (1.36-3.34) 1.54 (1.04-2.28) 2.96 (1.82-4.80) 1.74 (1.38-2.20) 1.15 (0.69-1.93) 1.04 (0.82-1.32) 1.69 (1.33-2.14) 
Sex        
Male Reference Reference Reference Reference Reference Reference Reference 
Female 1.11 (0.87-1.40) 1.57 (1.19-2.06) 1.23 (0.91-1.66) 1.12 (0.98-1.29) 2.01 (1.45-2.79) 1.52 (1.30-1.78) 0.72 (0.61-0.84) 
Age        
18-24 years old Reference Reference Reference Reference Reference Reference Reference 
25-34 years old 1.72 (1.33-2.23) 3.95 (2.73-5.71) 1.70 (1.22-2.39) 2.44 (2.03-2.93) 1.97 (1.12-3.47) 2.74 (2.21-3.40) 1.21 (0.99-1.47) 
35-44 years old 1.22 (0.85-1.76) 3.25 (2.17-4.87) 0.80 (0.52-1.23) 1.93 (1.55-2.42) 1.54 (0.90-2.64) 2.53 (2.00-3.20) 0.70 (0.55-0.89) 
45-54 years old 0.57 (0.41-0.80) 1.90 (1.20-3.00) 0.70 (0.43-1.12) 1.54 (1.27-1.87) 2.08 (1.28-3.39) 2.32 (1.92-2.80) 0.65 (0.53-0.80) 
55-64 years old 0.48 (0.33-0.70) 2.13 (1.39-3.28) 0.68 (0.40-1.17) 1.23 (0.98-1.54) 1.11 (0.63-1.94) 2.07 (1.65-2.60) 0.55 (0.41-0.73) 
65 years or older 0.19 (0.09-0.40) 1.58 (0.76-3.30) 0.38 (0.17-0.85) 0.66 (0.50-0.88) 1.13 (0.53-2.42) 1.89 (1.41-2.54) 0.43 (0.32-0.59) 
Race        
White Reference Reference Reference Reference Reference Reference Reference 
Non-Hispanic Black 0.32 (0.21-0.48) 0.36 (0.23-0.57) 0.64 (0.38-1.08) 0.73 (0.60-0.88) 0.40 (0.22-0.73) 0.44 (0.37-0.53) 1.00 (0.81-1.25) 
Non-Hispanic Other 0.59 (0.38-0.93) 0.60 (0.38-0.94) 0.89 (0.51-1.56) 0.69 (0.55-0.88) 1.06 (0.62-1.81) 0.72 (0.58-0.89) 0.64 (0.49-0.84) 
Hispanic Multicultural 0.36 (0.25-0.52) 0.33 (0.20-0.54) 0.43 (0.26-0.73) 0.54 (0.44-0.66) 0.66 (0.44-0.99) 0.47 (0.38-0.59) 0.90 (0.71-1.14) 
Education         
Less than high school Reference Reference Reference Reference Reference Reference Reference 
GED/High school 1.68 (1.15-2.44) 0.98 (0.62-1.53) 1.63 (0.83-3.22) 1.23 (1.01-1.50) 1.32 (0.79-2.22) 0.90 (0.73-1.10) 1.43 (1.12-1.82) 
Some college 2.65 (1.77-3.97) 1.32 (0.85-2.05) 2.62 (1.39-4.97) 1.51 (1.23-1.86) 1.79 (1.12-2.86) 0.89 (0.72-1.09) 2.46 (1.94-3.13) 
Bachelor's degree 2.48 (1.63-3.77) 1.25 (0.69-2.28) 2.25 (1.07-4.72) 1.50 (1.15-1.96) 1.31 (0.72-2.40) 0.63 (0.46-0.87) 4.13 (3.04-5.62) 
Advanced degree 2.05 (1.07-3.90) 0.53 (0.21-1.35) 1.06 (0.29-3.95) 0.97 (0.68-1.40) 1.29 (0.53-3.15) 0.41 (0.28-0.59) 3.82 (2.59-5.63) 
Income        
< $10,000 Reference Reference Reference Reference Reference Reference Reference 
$10,000-24,999 1.78 (1.28-2.48) 1.28 (0.88-1.85) 1.22 (0.76-1.97) 1.25 (1.01-1.56) 0.95 (0.56-1.61) 1.12 (0.90-1.40) 1.26 (1.03-1.54) 
$25,000-49,000 2.05 (1.44-2.93) 1.05 (0.72-1.53) 1.70 (1.17-2.48) 1.38 (1.12-1.71) 0.98 (0.61-1.57) 0.92 (0.74-1.14) 1.39 (1.12-1.73) 
$50,000-99,999 2.17 (1.46-3.23) 0.94 (0.59-1.48) 2.47 (1.62-3.77) 1.61 (1.24-2.07) 1.37 (0.81-2.32) 0.76 (0.59-0.99) 2.22 (1.74-2.82) 
>=$100,000 2.04 (1.26-3.29) 0.80 (0.43-1.50) 2.76 (1.72-4.41) 1.43 (1.11-1.85) 1.03 (0.51-2.06) 0.51 (0.36-0.72) 3.13 (2.33-4.22) 
Bolded values indicate estimate significant a p < 0.05 
The “none” category is used in reference for the tobacco and alcohol use outcome. 
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 Participants with high negative affect severity, compared to low, had the greatest 
odds for alcohol, CIG, and ECIG use rather than no use while adjusting for externalizing 
severity, sex, age, race, education, and annual household income. Participants with 
high externalizing severity, compared to low, had the greatest odds for ECIG and 
alcohol use rather than no use while adjusting for negative affect severity, sex, age, 
race, education, and annual household income. 
 
Model 2: Negative affect, externalizing, and ND 
 Compared to subjects with low negative affect severity, those with high negative 
affect severity were more likely to engage in CIG and alcohol use (AOR=1.29, 95% 
CI=1.03-1.61) and alcohol-exclusive use (AOR=1.31, 95% CI=1.05-1.64) than no use 
(Table 2.6). Similar associations were found between moderate negative affect severity, 
relative to low, and CIG and alcohol use (AOR=1.47, 95% CI=1.22-1.77) and alcohol-
exclusive use (AOR=1.58, 95% CI=1.27-1.96) than no use. Participants with high 
externalizing severity, compared to low, had 79% greater odds for alcohol, CIG, and 
ECIG use (AOR=1.79, 95% CI=1.15-2.78), 197% greater odds of ECIG and alcohol use 
(AOR=2.97, 95% CI=1.84-4.81), 53% greater odds of CIG and alcohol use (AOR=1.53, 
95% CI=1.21-1.92), and 75% greater odds of alcohol-exclusive use (AOR=1.75, 95% 
CI=1.38-2.22) than no use. Subjects with moderate externalizing severity, compared to 
low, were more likely to engage in ECIG and alcohol use (AOR=2.29, 95% CI=1.53-
3.43), CIG and alcohol use (AOR=1.41, 95% CI=1.16-1.72), and alcohol-exclusive use 
(AOR=1.62, 95% CI=1.33-1.97) than no use when adjusting for ND. ND was 
significantly associated with all combinations of tobacco and alcohol use, compared to 
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none, except for ECIG and alcohol use (AOR=1.00, 95% CI=0.99-1.01) and ECIG-
exclusive use (AOR=1.00, 95% CI=0.99-1.01). 
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Variable AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) 
Negative Affect Severity        
Low Reference Reference Reference Reference Reference Reference Reference 
Moderate  1.33 (0.85-2.07) 1.21 (0.74-1.97) 0.97 (0.61-1.56) 1.47 (1.22-1.77) 1.04 (0.64-1.68) 1.22 (0.96-1.55) 1.58 (1.27-1.96) 
High  1.53 (1.00-2.36) 1.02 (0.68-1.53) 1.19 (0.78-1.81) 1.29 (1.03-1.61) 1.00 (0.62-1.60) 1.08 (0.85-1.38) 1.31 (1.05-1.64) 
Externalizing Severity         
Low Reference Reference Reference Reference Reference Reference Reference 
Moderate 1.42 (0.93-2.17) 1.16 (0.77-1.74) 2.29 (1.53-3.43) 1.41 (1.16-1.72) 0.87 (0.56-1.37) 0.92 (0.76-1.13) 1.62 (1.33-1.97) 
High  1.79 (1.15-2.78) 1.23 (0.82-1.85) 2.97 (1.84-4.81) 1.53 (1.21-1.92) 1.16 (0.69-1.95) 0.88 (0.70-1.11) 1.75 (1.38-2.22) 
Nicotine Dependence        
1.06 (1.05-1.07) 1.08 (1.07-1.09) 1.00 (0.99-1.01) 1.05 (1.04-1.05) 1.00 (0.99-1.01) 1.06 (1.05-1.06) 0.97 (0.97-0.98) 
Sex        
Male Reference Reference Reference Reference Reference Reference Reference 
Female 1.17 (0.92-1.48) 1.65 (1.26-2.16) 1.22 (0.91-1.65) 1.17 (1.01-1.35) 2.02 (1.46-2.80) 1.58 (1.34-1.86) 0.71 (0.60-0.83) 
Age        
18-24 years old Reference Reference Reference Reference Reference Reference Reference 
25-34 years old 1.30 (1.01-1.68) 2.76 (1.92-3.97) 1.74 (1.23-2.46) 1.96 (1.63-2.37) 2.01 (1.12-3.60) 2.11 (1.69-2.63) 1.32 (1.09-1.61) 
35-44 years old 0.76 (0.53-1.09) 1.74 (1.15-2.63) 0.82 (0.53-1.29) 1.34 (1.07-1.68) 1.58 (0.90-2.76) 1.62 (1.28-2.06) 0.82 (0.64-1.04) 
45-54 years old 0.33 (0.24-0.45) 0.92 (0.60-1.42) 0.72 (0.44-1.16) 1.00 (0.83-1.20) 2.12 (1.31-3.43) 1.38 (1.13-1.68) 0.77 (0.62-0.95) 
55-64 years old 0.28 (0.19-0.41) 1.06 (0.67-1.68) 0.70 (0.41-1.20) 0.81 (0.64-1.03) 1.12 (0.64-1.98) 1.26 (0.99-1.60) 0.65 (0.48-0.86) 
65 years or older 0.12 (0.06-0.27) 0.90 (0.43-1.92) 0.39 (0.17-0.89) 0.48 (0.36-0.64) 1.16 (0.53-2.53) 1.31 (0.96-1.77) 0.51 (0.37-0.70) 
Race        
White Reference Reference Reference Reference Reference Reference Reference 
Non-Hispanic Black 0.40 (0.26-0.61) 0.48 (0.30-0.77) 0.64 (0.38-1.08) 0.87 (0.71-1.06) 0.40 (0.22-0.73) 0.55 (0.45-0.67) 0.95 (0.76-1.19) 
Non-Hispanic Other 0.69 (0.44-1.09) 0.75 (0.48-1.18) 0.89 (0.51-1.57) 0.79 (0.62-1.00) 1.06 (0.62-1.83) 0.85 (0.67-1.08) 0.63 (0.48-0.83) 
Hispanic Multicultural 0.55 (0.38-0.81) 0.57 (0.35-0.94) 0.43 (0.25-0.73) 0.77 (0.62-0.95) 0.65 (0.43-1.00) 0.73 (0.58-0.91) 0.79 (0.62-1.01) 
Education        
Less than high school Reference Reference Reference Reference Reference Reference Reference 
GED/High school 1.82 (1.24-2.66) 1.10 (0.70-1.71) 1.60 (0.82-3.15) 1.31 (1.07-1.60) 1.31 (0.78-2.20) 0.97 (0.78-1.20) 1.39 (1.09-1.78) 
Some college 3.41 (2.26-5.14) 1.77 (1.13-2.76) 2.55 (1.33-4.87) 1.82 (1.46-2.25) 1.79 (1.12-2.85) 1.09 (0.87-1.37) 2.23 (1.73-2.85) 
Bachelor's degree 4.40 (2.83-6.85) 2.48 (1.37-4.52) 2.16 (1.00-4.67) 2.32 (1.76-3.06) 1.32 (0.72-2.40) 1.04 (0.75-1.46) 3.33 (2.43-4.56) 
Advanced degree 3.98 (2.09-7.59) 1.16 (0.46-2.92) 1.02 (0.27-3.84) 1.60 (1.11-2.31) 1.29 (0.52-3.19) 0.70 (0.48-1.03) 3.02 (2.02-4.52) 
Income         
< $10,000 Reference Reference Reference Reference Reference Reference Reference 
$10,000-24,999 1.86 (1.34-2.58) 1.39 (0.96-2.01) 1.22 (0.75-1.97) 1.30 (1.05-1.61) 0.94 (0.56-1.59) 1.18 (0.95-1.46) 1.26 (1.02-1.55) 
$25,000-49,000 2.32 (1.62-3.32) 1.27 (0.86-1.88) 1.69 (1.16-2.47) 1.52 (1.24-1.87) 0.96 (0.60-1.54) 1.04 (0.85-1.29) 1.37 (1.10-1.70) 
$50,000-99,999 2.45 (1.64-3.67) 1.12 (0.71-1.78) 2.44 (1.59-3.74) 1.76 (1.38-2.25) 1.35 (0.80-2.28) 0.86 (0.67-1.10) 2.15 (1.68-2.76) 
>=$100,000 2.57 (1.56-4.25) 1.09 (0.57-2.08) 2.74 (1.70-4.42) 1.74 (1.34-2.26) 1.02 (0.51-2.03) 0.65 (0.45-0.92) 2.87 (2.12-3.89) 
Bolded values indicate estimate significant a p < 0.05 
The “none” category is used in reference for the tobacco and alcohol use outcome. 
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 Participants with high negative affect severity, compared to low, had the greatest 
odds for alcohol-exclusive use rather than no use while adjusting for externalizing 
severity, ND, sex, age, race, education, and annual household income. Participants with 
high externalizing severity, compared to low, had the greatest odds for ECIG and 
alcohol use rather than no use while adjusting for negative affect severity, ND, sex, age, 
race, education, and annual household income.  
 Additional models compared results across all categories of reference groups to 
establish differences for each category of tobacco/alcohol use (Appendix A, 
Supplemental Table 2.1). All significant associations between negative 
affect/externalizing severity and tobacco and alcohol combinations were significantly 
lower when referencing alcohol, CIG, and ECIG as well as ECIG and alcohol use. 
Conversely, significant positive associations were found between negative 
affect/externalizing severity and tobacco and alcohol combinations when referencing 
CIG and ECIG use, ECIG-exclusive, and CIG-exclusive. Results were mixed when 
referencing CIG and alcohol use, and alcohol-exclusive use. 
  
DISCUSSION 
 Our study is one of the first to examine the relationships between negative 
affect/externalizing severity and combinations of CIG, ECIG, and alcohol use across 
adulthood. There were three major results. First, strong, positive associations with 
negative affect/externalizing severity at various levels of CIG, ECIG, and alcohol use 
were detected. Overall, negative affect severity was more strongly associated with CIG 
and alcohol use as well as alcohol-exclusive use while externalizing severity was more 
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strongly associated with ECIG and alcohol use when accounting for ND. Second, ECIG 
may represent a new and underappreciated substance related to externalizing 
psychopathology. Alcohol was significantly associated with psychopathology when 
ECIG was included. Third, ND may mediate the relationship between negative 
affect/externalizing severity and various levels of CIG, ECIG, and alcohol use. 
 
Patterns of tobacco and alcohol use vary by negative affect/externalizing severity  
We detected specific patterns of association between tobacco and alcohol use 
with negative affect/externalizing severity. Specifically, high negative affect severity had 
a higher magnitude of association with CIG and alcohol use as well as alcohol-exclusive 
use. In contrast, externalizing severity was more strongly associated with ECIG and 
alcohol use. These results expand on recent positive associations that were detected 
between mental disorder symptoms and exclusive use of tobacco products in adults.73  
Specifically, multiple mental disorder symptoms (i.e., higher severity) was generally 
associated with use of more than one substance, except for alcohol. To date, individuals 
with co-occurring mental health disorders have been reported to have a more severe 
course of illness, health and social consequences, more difficulties when seeking and in 
treatment, or worse treatment outcomes than people with a single disorder.18 
Additionally, tobacco use has been reported to be higher among people with mental 
health problems (e.g., major depressive disorder, generalized anxiety, schizophrenia, 
and/or antisocial personality/conduct disorder).90,115,116 These results suggest that 
patterns, rather than a dose-response, of tobacco and alcohol use are associated with 
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negative affect/externalizing severity. Further investigation of these comorbidity 
patterns, including tobacco use, is required. 
 
ECIG use associated with externalizing severity with co-occurring alcohol use 
Negative affect/externalizing severity were not significantly associated with 
ECIG-exclusive use. This is inconsistent with previous work, perhaps due to differences 
in defining ECIG use.73 Specifically, we expanded our study of “ECIG use” to include a 
commonly occurring form of tobacco use- dual use of ECIG and CIG. Our results 
provide a more detailed and nuanced description of the relationship between negative 
affect/externalizing psychopathology and ECIG use by parsing out co-occurring CIG 
and alcohol use from ECIG. 
Concurrent ECIG and alcohol use, however, was significantly associated with 
externalizing severity. Further, compared to low externalizing severity, high and 
moderate externalizing severity showed stronger association with alcohol use of any 
kind (i.e., alcohol, CIG, and ECIG use; ECIG and alcohol use; CIG and alcohol use; and 
alcohol-exclusive use). This association between externalizing and alcohol is consistent 
with prior studies,38,117,118 and this association remains when ECIGs are used with 
alcohol. This finding builds upon previous work that has established more harmful 
alcohol use with ECIG use in that externalizing symptoms are associated with this 
pattern of use. More research is needed to better understand the relationship between 
different combinations of tobacco and alcohol, including ECIG, and psychopathology.  
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ND may mediate the relationship between negative affect/externalizing severity and 
current tobacco and alcohol use in adults 
 The magnitude of the associations between negative affect/externalizing severity 
and levels of tobacco/alcohol use were reduced, although generally remained 
significant, when ND was included. The associations between negative affect severity 
and alcohol, CIG, and ECIG use and CIG-exclusive use as well as externalizing severity 
and CIG and ECIG use were no longer statistically significant. ND may explain more of 
the relationship between negative affect severity and alcohol, CIG, and ECIG use as 
well as CIG-exclusive use. Previous work has indicated that externalizing behaviors act 
as a precursor or factor involved in substance use, especially alcohol use.38,117,118 
Therefore, the relationship between externalizing severity and alcohol use in adults, 
whether exclusive or with tobacco, is expected to be mediated or have an indirect effect 
through ND. In an ad hoc mediation analysis,119 ND was determined to be a significant 
mediator between negative affect/externalizing and tobacco and alcohol use. This is 
consistent with prior work that has identified ND as a mediator between mental 
conditions.120 We also included a test for SUD severity (GAIN-SS) as a mediator in 
models including ND since it measures broader substance use behavior, including 
alcohol. However, no significant direct or indirect effect of SUD was detected. As 
mediation is inherently a causal hypothesis, we recommend future researchers to 
confirm this with a longitudinal analysis to accurately model a mediation pathway in the 
context of the transactional effect between tobacco initiation and ND development.  
 
Strengths and limitations 
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 These results should be interpreted while considering the following points. First, 
these data were collected in 2013-2014, so these analyses do not capture more recent 
ECIG products (i.e., pod-mods). Consequently, these results may not be generalizable 
to the current generation of ECIG devices. Second, the analytic sample size was 
reduced from the Wave 1 sample after removing participants with missing data. Many 
participants (N=13,865) were removed due to a skip pattern identified for the ND items 
used to calculate the composite ND item. If a participant was not a current tobacco user, 
a former 12-month tobacco user, or a current experimental tobacco user, they were not 
asked the ND items. ND is contingent upon tobacco initiation121; therefore, it was 
inappropriate to code these missing observations as 0. Therefore, there is systematic 
bias introduced by the missingness; however, results from sensitivity analyses in which 
all missing observations on the ND items were coded as 0 did not demonstrate 
differences that would alter the overall study conclusions. Third, use of self-reported 
data has the potential to introduce misclassification bias, which may underestimate the 
magnitude of associations. However, this would lead to an attenuation of effect sizes, 
rather than an overestimation. Fourth, the GAIN-SS measures negative 
affect/externalizing symptom severity rather than psychiatric diagnoses. We recognize 
use of symptom data as a strength, as we are more likely to capture true rates of mental 
health disorders without relying on disease-specific diagnoses. There is growing support 
for the use of subthreshold or transdiagnostic symptoms over traditional diagnoses to 
better explain the high rates of comorbidity among common mental disorders, 
particularly when characterizing population-based samples.122 Therefore, these results 
represent the full distribution of severity across several mental health domains. Future 
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investigations should test these associations with negative affect and externalizing 
symptoms rather than a composite severity score to further detail comorbidity patterns. 
Fifth, to answer our research questions, this study focused on current CIG, ECIG, and 
alcohol use, and ND. We could not determine if ND was due to the CIG or ECIG use or 
another tobacco product that was not included in these analyses. Future studies are 
encouraged to explore direct associations with other tobacco products and ND. Sixth, 
by using only data from Wave 1, direction of causation cannot be determined and future 
longitudinal studies are needed. 
 
Conclusions 
 Negative affect and externalizing severity were strongly associated with multiple 
levels of CIG, ECIG, and alcohol use in this study. The magnitude of association varied 
by the tobacco product used. Overall, negative affect severity was more strongly 
associated with CIG and alcohol use as well as alcohol-exclusive use while 
externalizing severity was more strongly associated with ECIG and alcohol use when 
accounting for ND. ECIG may represent a new and underappreciated substance related 
to externalizing psychopathology. The magnitudes of these associations were reduced 
when ND was included in the model, indicating that ND may mediate the association 
between negative affect/externalizing severity and current tobacco and alcohol use. 
Future work is encouraged to investigate the different patterns of tobacco and alcohol 
use (i.e., using latent variable and network approaches) since our results suggest 
patterns of use rather than a dose-response relationship between tobacco and alcohol 
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use and negative affect/externalizing severity. Longitudinal studies could provide deeper 
insight into the stability of these patterns over time. 
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CHAPTER 3: LATENT CLASSES OF COMORBID SUBSTANCE USE AND 
NEGATIVE AFFECT AND EXTERNALIZING SYMPTOMS AND THEIR ROLE IN 
ADULT SUBSTANCE USE DISORDER SEVERITY 
 
INTRODUCTION 
Substance use disorder (SUD) results from the prolonged use of any 
psychoactive substance at high doses and/or frequencies, and is defined as continued 
use despite associated health and social problems.2,123 SUD poses a substantial burden 
on the United States’ health system, with almost 20 million American adults meeting 
diagnostic criteria for a past-year SUD in 2018.5 Of the 20 million adults in the United 
States (U.S.) who experience a SUD, half also have a co-occurring mental disorder.5 
The co-occurrence of mental disorders is common among people who use substances 
or engage in polysubstance use, consuming more than one substance over a defined 
period.10,12,35 People with co-occurring tobacco use, substance use, and mental 
disorders have more severe courses of mental illness, more severe health and social 
consequences, more difficulties seeking and receiving treatment, and worse treatment 
outcomes compared to people with a singular disorder.18 Therefore, people who 
experience greater comorbidity may be at a greater risk for SUD severity. 
 
Study of Comorbidity Characterizes Common Patterns of Co-Occurring Disorders  
Historically, comorbidity research involving substance use or symptoms 
underlying mental disorders has generally focused on the identification and description 
of either polysubstance use or mental disorder classes, separately. These studies have 
identified several specific subcategories of either SUD or mental disorders. For 
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example, a recent study examined past-month polysubstance use among a small 
sample of psychiatric inpatients with co-occurring mental disorder and SUDs. This study 
identified three polysubstance use profiles: cannabis and alcohol (35.1%), alcohol only 
(49.3%), and polysubstance use including cocaine plus alcohol and marijuana 
(15.7%).35 Other latent class analyses of substance use focus on a sample of specific 
substance users. For example, a five-class solution was most optimal in describing 
polysubstance use in a small sample of lifetime cocaine users: past 30-day tobacco use 
only (45%), past 30-day alcohol, marijuana and tobacco use (31%), past 30-day 
tobacco, prescription opioid and sedative use (13%), past 30-day cocaine, alcohol, 
marijuana and tobacco use (9%), and past 30-day cocaine and multiple polysubstance 
use (2%).37 Another study of opioid-dependent patients identified a two-class solution: 
severe comorbidity with high rates of other SUDs specifically amphetamine and 
sedative (10%), and a less severe comorbidity class with moderate rates of nicotine, 
alcohol, cannabis, and cocaine disorders (90%).36 Overall, the comorbidity 
characteristics are different depending on the population being studied.  
In another study assessing only mental disorder comorbidity, a four-class 
solution best described the sample: low psychopathology (84.0%), internalizing (9.9%), 
externalizing (4.5%), and high psychopathology (1.6%).41 The high psychopathology 
class was more strongly associated with lifetime suicide attempt, compared to the 
internalizing and externalizing classes.41 The internalizing and externalizing classes had 
overall higher odds of lifetime affective and substance use disorders, respectively.41 
These four class solutions are commonly identified in mental disorder only 
comorbidity.41,124 
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Detailing comorbidity between substance use and mental disorders has only 
recently been addressed and confirms the strength of association between these two 
conditions. For example, a more recent study evaluated the class structure of substance 
use and mental disorders together and identified a four-class solution: low disorder 
(73.6%); mental health and low SUD (10.6%); alcohol, cannabis, and low mental health 
disorder (12.2%); and polysubstance use and moderate mental health disorder 
(3.5%).12 Mental disorders were more likely to occur with polysubstance use disorders 
in young adults.12 Another study accounting for both mental and SUDs also identified a 
four-class solution: little psychopathology (62.5%), internalizing disorders (16.9%), 
externalizing disorders (16.4%), and both internalizing/externalizing disorders (4.2%).124 
The most severe class, internalizing/externalizing disorder, demonstrated elevated rates 
for both mental disorders as well as alcohol (85.4%), cannabis (76.2%), and hard drug 
use disorders (61.1%) while the internalizing class had moderate alcohol use disorder 
endorsement (34.2%) and the externalizing class had greater endorsement of alcohol 
(84.2%), cannabis (82.0%), and hard drug disorders (53.7%).124  As a whole, these 
studies confirm and demonstrate a consistent comorbidity structure that likely takes 
form in four classes. These studies also identify a larger, low psychopathology group 
and a smaller yet more severe comorbidity group with more moderate comorbidity 
somewhere in between. The severe comorbidity group has higher endorsement of 
mental disorders and substance use behaviors. Understanding and identifying these 
comorbidity profiles have the potential to better support people with comorbidity through 
risk assessment and interventions.41 
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Limitations in Current Approach to Studying Comorbidity 
 Despite recent advancements in the study of comorbid SUD, several gaps in 
knowledge remain. First, the current comorbidity literature usually considers diagnosis 
to measure substance use and mental disorders. However, the overlap between 
symptoms from multiple disorders and the simultaneous co-occurrence of multiple 
disorders is very common. The current classification systems are limited in their ability 
to characterize comorbidity and may neglect to appropriately account for these 
overlaps. Therefore, using symptom-level data and a more recent measure of 
substance use behaviors (i.e., past-month substance use) will not only account for 
these overlaps, but these measurements could also indicate severity. For example, 
people who engaged in past-month use compared to people who used in the past-year 
may be more likely to have higher levels of SUD severity. Furthermore, there may be an 
underestimation of the population level burden of comorbidity due to the measurement 
of substance use and mental disorder through diagnostic classifications only. People 
who use substances or experience mental health problems that are not severe enough 
to receive a diagnosis or have access to a diagnosis are not included.117 Most 
substance-related health and social problems occur among individuals who are not 
addicted or have a SUD diagnosis.8 Consequently, using subthreshold measures may 
better address this issue of underreporting while also accounting for the overlap 
between substance use behaviors and mental health conditions. 
Second, tobacco use is rarely considered in comorbidity research, despite 
consistent literature supporting the association of tobacco use and mental 
disorders.12,41,92 Nicotine dependence occurs in a substantial proportion of individuals 
 71 
with alcohol use disorder (23.8%), marijuana use disorder (32.6%), cocaine use 
disorder (47.7%), prescription opioid use disorder (45.4%), and heroin use disorder 
(66.3%).9 Negative affect (e.g., depression and anxiety) and externalizing [e.g., 
attention-deficit hyperactivity disorder (ADHD) and conduct disorder] 
psychopathology2,16,73,89–91 are important mental health factors that have been 
consistently associated with exclusive use of conventional cigarettes (CIG). A meta-
analysis reported that current CIG users had a two-fold increased risk of depression 
relative to never and former CIG users.92 Further, adults with depression are more likely 
to smoke and are less likely to be successful at quitting than adults without 
depression.93 With the increase in access and use of electronic cigarettes (ECIG) alone 
and in CIG users,84,125 it is increasingly important to consider this alternative method of 
nicotine delivery in comorbidity research alongside CIG use. 
Third, comorbidity is typically studied using smaller samples of more severely 
disordered participants,35 which does not provide a sense of the etiology of comorbidity 
for people who are affected with lower levels of severity. This is unfortunate, because 
people with lower levels of comorbid severity are expected to make up at least 2/3 of 
the U.S. population.12,41,124 Consequently, there is a gap in our understanding of 
comorbidity across the population. Specifically, it is unclear whether the latent class 
structure of SUD comorbidity from clinical samples will be detected in a population-
based sample where severity of SUD is generally lower. Nevertheless, population-
based study samples can measure SUD severity using screeners like the Addiction 
Severity Index (ASI), Alcohol Use Disorders Identification Test (AUDIT), Drug Abuse 
Screen Test (DAST), Fagerstrom Test for Nicotine Dependence (FTND), and the Global 
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Appraisal for Individual Needs (GAIN).26–28 These instruments are useful to assess SUD 
and SUD severity in settings that cannot specifically assess diagnosis. Use of these 
instruments can therefore capture people who (1) have subthreshold levels of 
impairment, and (2) may not have access to a physician to receive a diagnosis. 
Therefore, it is possible to model the relationship among a robust set of substance use 
behaviors, including tobacco, and mental disorder symptoms in a large, nationally 
representative sample to detail the comorbidity between SUDs and mental disorders on 
a population-level.  
 
Use of Comorbidity Details to Predict SUD Severity 
In addition to the aforementioned limitations, the detailing of comorbidity between 
co-occurring substance use and mental disorder has primarily been descriptive (i.e., 
developing comorbidity profiles) with some tests of association between comorbidity 
profiles and other factors (i.e., demographic characteristics, early life factors [i.e., 
parental factors], psychiatric diagnoses, suicide attempts, self-efficacy in abstinence, 
and treatment involvement).12,35,41 However, there have been few advancements in 
improving treatment outcomes and reducing the prevalence of mental disorders and/or 
SUDs.9 Consequently, there has been a stated need for comorbidity research due to the 
“insufficient information” that exists today.126 Recent studies have suggested the value 
in accounting for patterns of substance use and comorbidity to categorize SUD. Such 
detail is expected to improve the identification of individuals at risk for high SUD 
severity.41 Consequently, it is possible that establishing a “comorbidity profile” may be 
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useful to screen individuals for SUD risk in order to appropriately address additional risk 
factors. 
 Comorbidity profiles are also expected to be associated with sociodemographic 
characteristics like sex, age, race, education, annual household income, and perceived 
social connectedness. Being female is a significant predictor of membership for a 
mental health disorder class,12 internalizing or negative affect class and high 
psychopathology class.41 People who are older in age (65 years and older) and black, 
non-Hispanic are significantly protected from membership in internalizing or negative 
affect, externalizing and high psychopathology classes.41 Higher income level is also 
indicative of a protective relationship from membership in internalizing or negative 
affect, externalizing, and high psychopathology classes.41 Perceived social 
connectedness and support have been found to protect adults against substance use 
behaviors and mental disorder symptoms.127,128  Therefore, these sociodemographic 
characteristics must be considered when developing comorbidity profiles to predict SUD 
severity. 
 
Purpose, research questions, and hypotheses 
Prediction modeling using the probability of class membership is an extension to 
previous LCA work that can further inform prevention and potential intervention 
strategies among polysubstance users with varying levels of mental disorder symptoms. 
The three goals for this study are: (1) identify latent classes of comorbid substance use 
behaviors and mental disorder symptoms using LCA, (2) determine if there are 
differences in comorbidity by demographic and social factors, and (3) predict SUD 
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severity using the probability of comorbidity class membership severity in the first wave 
of adult data from the Population Assessment of Tobacco and Health study. Based on 
previous literature, we expect substance use to vary across the mental disorder 
symptoms. More substance use behaviors will cluster with highly comorbid mental 
disorder classes. Certain demographic factors will increase the risk of highly comorbid 
class membership, while social satisfaction will decrease risk. Higher probabilities of 
class membership in the highly comorbid and externalizing classes will predict greater 
SUD severity compared to probability of class membership in the low comorbidity and 
negative affect classes. This research will support population-level strategies to prevent 
or treat SUDs, including nicotine dependence, and the development of more severe 




Wave 1 adult data (N=32,320) from the Population Assessment of Tobacco and 
Health (PATH) study was used.71 These data are cross-sectional and were collected 
between September 2013 and December 2014. PATH is a nationally representative 
longitudinal cohort study of the civilian, non-institutionalized household population of the 
U.S., and participants engaged in all levels of tobacco use ranging from never using 
tobacco to frequent use.  
The weighted response rate among participants was 74.0% for Wave 1.73 
Participants responded to tobacco-specific items including tobacco-use patterns, risk 
perceptions and attitudes towards current and newly emerging tobacco products, 
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tobacco initiation, cessation, relapse behaviors, and health outcomes.72 Participants 
also responded to non-tobacco items (e.g., media use, peer and family influences, 
health effect outcomes, and industry advertising and promotion).72 
 
Study representativeness 
 Participants with missing data on the substance use, negative affect, and 
externalizing measures were not included in the analysis (N= 2,109). Survey 
respondents of the analytic sample endorsed significantly greater substance use 
overall, negative affect symptoms, and externalizing symptoms (except for fighting) 
compared to those not included in the analytic sample. The participants in the analytic 
sample were more likely to be Non-Hispanic white, men, aged 25-54 with higher levels 
of education and annual household income than those who were missing. 
 
Measures 
Seventeen variables were studied: six substance use variables, four negative 
affect variables, and seven externalizing variables.  
 Past Month Tobacco and Substance Use. Six substance use categories were 
used in this study: exclusive cigarette, exclusive e-cigarette, dual cigarette and e-
cigarette, alcohol, marijuana, and prescription drugs not prescribed (PDNP) including 
painkillers, sedatives, tranquilizers. Only past month or current use of the substances 
was considered (coded as 1, else = 0) to reduce the potential for recall bias and ensure 
for accurate overlap with negative affect and externalizing symptoms occurring in the 
same time frame. 
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Past Month Negative Affect and Externalizing Symptoms. Negative affect and 
externalizing symptoms were measured using the Global Appraisal of Individual 
Needs—Short Screener (GAIN-SS).73 The items selected to identify negative affect and 
externalizing symptoms from the GAIN-SS instrument are ordinal and measures people 
across four times periods: past month, 2 to 12 months, over a year ago, and never. 
Participants indicating that they experienced a symptom within the past month were 
coded as 1. Participants indicating that they experienced the symptom 2 to 12 months 
ago, over a year ago, and never were coded as 0. Only past month or current negative 
affect and externalizing symptoms were considered reducing the potential for recall bias 
and ensure accurate overlap with substance use occurring in the same time frame. 
Past Month Substance Use Disorder Symptoms. Substance use disorder (SUD) 
severity was measured using the Global Appraisal of Individual Needs—Short Screener 
(GAIN-SS).73 Seven questions were used to measure SUD symptoms that asked the 
last time:  
(1) “used alcohol/drugs weekly or more often,”  
(2) “spent a lot of time getting alcohol/drugs,”  
(3) “spent a lot of time using or recovering from alcohol or other drugs,”  
(4) “kept using alcohol or other drugs even though it was causing social problems, 
leading to fights, or getting you into trouble with other people,”  
(5) “your use of alcohol or other drugs reduced your involvement in activities at work, 
school, home or social events,”  
(6) “had withdrawal problems such as shaky hands, throwing up, having trouble 
sitting still or sleeping,” and  
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(7) “use of alcohol/drugs to avoid withdrawal.”  
These items are ordinal and measures people across four time periods: past month, 
2 to 12 months, over a year ago, and never. Participants indicating that they 
experienced a symptom within the past month were coded as 1. Participants indicating 
that they experienced the symptom 2 to 12 months ago, over a year ago, and never 
were coded as 0. Only past month or current SUD symptoms was considered to reduce 
the potential for recall bias and ensure accurate overlap with substance use, negative 
affect symptoms, and externalizing symptoms occurring in the same time frame. The 
binary responses were summed to reflect a scale score of the number of current SUD 
symptoms. The score ranging from 0 to 7 SUD symptoms will be categorized into low 
(0), moderate (1-2), and high (3+) severity). This is the final measure used as the SUD 
severity outcome. These are the recommended cut points based on validation analyses 
of the dimensional measure.28 The ordinal severity categories were informed by other 
studies, showing concurrent and high predictive validity in other samples.28,73,99 A higher 
score indicates increased severity, a greater likelihood for diagnosis with a SUD, and 
increased need for services.73 There is substantial overlap with the symptoms identified 
in the GAIN-SS and the symptoms identified in the DSM-5 as the GAIN-SS uses 

















Taking substance in larger 
amounts or over a longer period 
than initially intended. 
Used alcohol/drugs weekly or 
more often 
Expressing a persistent desire to 
cut down or regulate use and may 
report unsuccessful attempts to do 
so. 
 
Spending a great deal of time 
obtaining the substance, using the 
substance, or recovering from its 
effects. 
Spent a lot of time getting 
alcohol/drugs 
Spent a lot of time using or 
recovering from alcohol or other 
drugs 
Craving manifested by an intense 
desire or urge for the drug that 
may occur at any time but is more 
likely in an environment in which 




Recurrent substance use results in 
failure to fulfill major role 
obligations at work, school, or 
home. 
Your use of alcohol or other 
drugs reduced your involvement 
in activities at work, school, 
home or social events 
Continuing substance use despite 
persistent social/interpersonal 
problems exacerbated by the 
effects of the substance. 
Kept using alcohol or other 
drugs even though it was 
causing social problems, 
leading to fights, or getting you 
into trouble with other people 
Giving up or reducing important 
social, occupational, or 
recreational activities because of 
substance use. 
Your use of alcohol or other 
drugs reduced your involvement 
in activities at work, school, 
home or social events 
Risky Use 
Recurrent substance use in 
physically hazardous situations. 
 
Continuing use despite knowledge 
that persistent physical or 
psychological problems are 
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exacerbated or caused by 
substance use. 
Pharmacology 
Markedly increased dose of the 
substance required to achieve 
desired effect. 
 
Withdrawal symptoms specific to a 
drug class. 
Had withdrawal problems such 
as shaky hands, throwing up, 
having trouble sitting still or 
sleeping 
Use of alcohol/drugs to avoid 
withdrawal 
Note: SUD is diagnosed with the occurrence of two or more symptoms.  2 – 3 
symptoms = mild presentation, 4 – 5 symptoms = moderate presentation and 6 or 
more symptoms = severe presentation. GAIN-SS symptom severity is categorized as 
0 symptoms = low severity, 1-2 symptoms = moderate severity, and 3 or more 
symptoms = high severity. 
 
 Covariates. Sociodemographic variables such as sex, age, race, education, 
annual household income, and social satisfaction were included as auxiliary variables to 
predict the probability of class membership. These factors were chosen because they 
have been identified by previous studies to significantly predict latent class 
membership.12,41,127,128 Sex was a binary variable with one level representing male and 
the other level representing female. Age, measured in PATH as a seven-level 
categorical variable, was re-categorized to have a uniform distribution with six levels 
(18-24, 25-34, 35-44, 45-54, 55-64, and 65 years or older). Race/ethnicity was 
measured as a four-level categorical race variable and included information from a 
separate variable that accounted for Hispanic ethnicity (Non-Hispanic White, Non-
Hispanic Black, Non-Hispanic Other, and Hispanic Multicultural). Education, measured 
in PATH as a six-level categorical variable, was re-categorized as a five-level 
categorical variable with a uniform distribution [less than high school, GED/high school 
graduate, some college (no degree) or Associate’s degree, Bachelor’s degree, and 
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Advanced degree]. Annual household income was measured as a five-level categorical 
variable: less than $10,000, $10,000 to $24,999, $25,000 to $49,999, $50,000 to 
$99,999, and $100,000 or more. Level of satisfaction with social activities and 
relationships was measured as a five-level categorical variable: extremely satisfied, very 
satisfied, moderately satisfied, a little satisfied, and not at all satisfied. 
 
Statistical analysis 
Latent Class Analysis. Latent Class Analysis (LCA) was used to assign 
participants into classes of substance use and/or mental disorders using their 
responses to self-report measures of substance use, negative affect, and externalizing 
symptoms while accounting for demographic and environmental factors as predictors of 
class membership. The general goal of an LCA is to define an unobserved, latent 
variable (i.e., comorbidity) as a set of classes where the observed variables or items 
(i.e., substance use and negative affect-externalizing symptoms) are locally 
independent.130 Local independence or conditional independence is a condition in which 
the observed items are independent of one another, condition on the level of the latent 
variable.130 This means that the relationship or correlation between the observed items 
represents a distinct domain that is fully explained by the level of the latent class and 
that there is no residual correlation between the items.70,131  LCA accounts for the 
observed covariation between substance use and mental disorder symptoms and offers 
objective indices of class classification accuracy that are not available in traditional 
cluster analysis methods.132 
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LCA models are produced by estimating item probability parameters and class 
probability parameters.70 Item probability parameters represent the probability of 
endorsing an item conditional on latent class membership. It can also be referred to as 
the item response probabilities or conditional item probabilities.70 An LCA estimates the 
probability of being in a latent class conditional on the probability of endorsing a 
measured item. The combination of these two parameters is used to estimate the 
probability of being in a latent class with the marginal item probability for item !! =
1	(& = 1,2, … *) given by: 





where ! is a categorical latent variable 0 with 3 classes (0	 = 	1; 	1	 = 	1, 2, … , 3) across 
* binary items.70  Specifically, class probability parameter ,(0 = 1) reflects the 
probability that a person in a given latent class has of endorsing the specific item.70 The 
class probability parameter specifies the prevalence of each class in the population or 
the relative frequency of class membership.70 Further, the item probability parameter or 
conditional item probability for a given class is defined by the logistic regression: 
 





where the ;!# is the logit for each of the !!′s for each of the latent classes, 1.70 The 
class probability parameter or the prevalence of each class in the population is =# =
,(0 = 1).70  
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Model Selection. Five LCA models, ranging from 2-6 classes were tested and 
included the seventeen variables of interest. Models were evaluated using measures of 
model fit, model parsimony, and entropy.   
Model fit quantifies how well a model explains the data. Model fit is assessed as 
the -2 log-likelihood which and reflects how much unexplained variation there is in the 
estimated model. Model fit comparisons generally test which model best explained the 
data by using a likelihood ratio test (LRT) which compares the relative fit of two models 
that differ by a set of parameter restrictions.133 The traditional LRT is a hypothesis test 
that compares two nested models: 
 






where G represents the likelihood for the null model and H represents the 
likelihood of the nested model. The estimated values of a traditional LRT follow a chi-
square distribution with the number of degrees of freedom equal to the difference in 
parameter numbers between the two models that will be compared.133,134  
Model fit comparisons for LCA do not meet certain regularity assumptions that 
must be satisfied133,134 and as such the use of classic LRT for model comparison is not 
appropriate. Specifically, LCA violates the assumption that the additive property of the 
likelihood ratio statistic can assess the statistical difference between pairs of 
hierarchically related models, meaning that one model is a constrained form of the 
other.135 Consequently, model fit for the LCA was assessed using a Lo-Mendell-Rubin 
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adjusted likelihood ratio test (LMRT) rather than the traditional LRT.133,134 The LMRT 
approximates the likelihood ratio test distribution which can be used for comparing 
nested latent class models.70 LMRT uses the adjusted asymptotic distribution of the 
likelihood ratio statistic and compares the improvement in fit between neighboring class 
models (i.e., comparing 1 − 1 and the 1 class models) with a p-value that can be used 
to determine if there is a statistically significant improvement in the fit for the inclusion of 
one more class.70   
Model parsimony was used to assess how well the model explains the data while 
accounting for differences in the number of model parameters estimated in models with 
different. Parsimony was evaluated using Akaike information criteria (AIC), Bayesian 
information criteria (BIC), and sample-size adjusted BIC. AIC was estimated as:  
 IJ0 = 	−2 log > + 2K (4) 
 
where L is the likelihood function, p is the number of free model parameters.70,136 
The benefit of using AIC is that it measures the closeness of the estimated model to the 
true model among the competing models.136 The smallest value of the AIC is selected 
as the more parsimonious model.136 
Bayesian information criteria (BIC)137 was estimated as:   
 
 LJ0 = 	−2 log > + K log(M) (5) 
 
where −2 log >  is -2 times the log-likelihood of the estimated model and M is the 
number of observations. BIC aids model selection by penalizing the number of factors in 
a model.138 The smaller BIC indicates a more parsimonious model. 
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Sample-size adjusted BIC139 builds on BIC by replacing the same size M in the 
BIC equation above with M*. It was estimated as: 
 M* = (M + 2)/24 (6) 
 
 




The benefit of sample-adjusted BIC is that it accounts for the sample size. 
Simulation studies have confirmed that BIC and sample-size adjusted BIC are better 
indicators of the number of latent classes than AIC.70   
Entropy is commonly used as a model selection criterion that indicates the 
model’s ability to classify a person in a latent class (i.e., level of separation).133 It 
measures aggregated classification uncertainty and reflects accuracy of class 
membership assignment.133 Classification uncertainty is assessed at the individual level 
by posterior probabilities from the estimated model.140 Therefore, entropy identifies the 
estimated model’s ability to classify an individual into a class based on their poster 
probability of having endorsed a specific item. There is little distinction between classes 
when posterior probabilities across the classes are very similar. Entropy ranges from 0 
to 1 and a higher entropy represents a better fit; values > 0.80 indicate the latent 
classes highly discriminate.133   
Joint evaluation of parsimony, entropy, and model fit was used to identify the 
LCA model that best explained the data. Consequently, models with lower values for 
AIC and BIC were preferred. Models with a larger entropy value were preferred because 
they strongly discriminate between classes. Statistically significant results from the 
LMRT were used to determine the model with the lowest number of classes that best fit 
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the data. Interpretability and average latent class probabilities were also considered in 
determining optimal class solution.70,141 
 The best fitting model was also used to assign class membership to each 
participant. This assignment of class membership was then used in the multinomial 
logistic regression and prediction analyses as detailed below.  
Multinomial Logistic Regression. Multinomial regression was used to determine 
whether any covariates were significantly associated with membership of a latent class. 
142 Multinomial regression was conducted using the three-step method (R3STEP) via 
the AUXILIARY statement in Mplus. This approach was used to identify the variables to 
use as covariates in the third step multinomial logistic regression. A multinomial 
regression tests the association between any set of categorical or continuous predictors 
with a categorical outcome as: 







where p has a categorical latent variable 0	with U as the covariate of interest (i.e., 
sex, age, race, education, annual household income, and level of satisfaction with social 
activities and relationships). The intercept is denoted as W and the regression coefficient 
is X. This approach was used in order for the latent class model and the latent class 
predictor model to be obtained automatically142 rather than introducing potential bias by 
performing a multinomial regression after the latent class models were selected.  
Prediction Analysis. Cumulative receiver operator characteristic (ROC) curves 
(developed from the cumRoc3 MACRO143) were used to: (1) estimate the ability of the 
class membership probabilities created from the LCA to predict SUD severity; (2) 
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estimate ability of the substance use variables, negative affect symptoms, and 
externalizing symptoms to each separately predict SUD severity; and (3) compare the 
predictive ability of the two approaches. This comparison was addressed in order to 
determine if establishing latent class membership performed better compared to the use 
of separate variables for predicting SUD severity.  
The classic ROC curve is computed by comparing a binary outcome Y with a 
continuous measure X where each observed level of X is evaluated as a candidate cut 
point discriminating observed Y = 1 (positive) from Y = 2 (negative).143 Traditionally, 
ROC curves have been used to establish the value of a diagnostic test measured as a 
binary outcome. Results from a ROC curve analysis provides results that support in the 
identification of the threshold that distinguishes a positive test from a negative test.144 
The correct classifications among positive outcomes are the true positives (TP). The 
correct classifications of the negative outcomes are the true negatives (TN). The 
incorrect classifications among negative outcomes are the false positives and the 
among the positive outcomes the false negatives. These classifications are used to 
compute the sensitivity (i.e., probability that an observation with a positive outcome is 
correctly classified as positive [sensitivity = TP/(TP + FN)]) and specificity (i.e., 
probability that an observation with a negative outcome is correctly classified as 
negative [specificity = TN/(TN + FP)]) of a test. The coordinates of a ROC curve are 
computed where the x-axis is the false positive rate (i.e., 1 – specificity) and the y-axis 
is the sensitivity or true positive rate.143  
A cumulative ROC curve analysis extends the classical empirical ROC curve by 
discriminating three or more ordinal outcome levels on a shared continuous scale.143 
 87 
The cumulative ROC calculates the area under the curve (AUC) which explains the 
ability of a continuous measurement to discriminate between ordinal outcome levels 
(i.e., 3-level SUD severity outcome). In this case, the AUC is the probability that an 
observation with a higher severity SUD outcome will have a higher continuous 
measurement (i.e., higher class probability) than an observation with a lower severity 
SUD outcome.143 An AUC of 0.5 represents no discriminating ability (i.e., no better than 
chance) versus an AUC of 1.0 represents perfect discrimination between the groups.145  
The probability of the SUD severity (P./0) for class membership (V%) was 




(1 + exp[X1 +	X%V%])
 (9) 
 
where X1 is the intercept, and X% is the estimated regression coefficient for the 
probability of latent class membership (V%).146 
 Predictive probabilities were generated from four ordinal logistic regression 
models. The main model of interest estimated the probability of class membership 
(generated from the LCA) and SUD severity. Three additional models were run using 
predictive probabilities from regressing substance use variables, negative affect 
symptoms, and externalizing symptoms separately on SUD severity. 
Statistical Programs, Handling Missingness and Complex Sampling Design. Data 
management, summary statistics, and the prediction analysis were performed in SAS 
9.4. All LCA was conducted in MPlus.147 Participants with missing data were not 
included in the latent class analysis (N = 2,109, missing data patterns = 256). Complex 
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sampling design was accounted for in SAS 9.4 using PROC SURVEYFREQ (to 
generate summary statistics) and PROC SURVEYLOGISTIC (to generate the predictive 





 The sample was 51.9% female and 66% Non-Hispanic White. Age was evenly 
distributed among the sample. Most of the sample had at least a GED or high school 
education (88.4%), had an annual household income of more than $25,000 (65.9%), 
and were very (46.1%) or extremely (22.3%) satisfied with their social activities and 
relationships. Current alcohol use was most frequently reported (52.4%), followed by 
exclusive cigarette use (16.6%), marijuana use (7.1%) and PDNP (5.1%). Sleep trouble 
was the most common past-month negative affect symptom reported (26.7%), followed 
by feeling very anxious (16.1%), feeling depressed (13.4%), and becoming distressed 
about the past (12.5%). The most frequently endorsed past-month externalizing 
symptom was giving answers before the other person finished asking the question 
(32.0%), followed by having a hard time paying attention (14.6%) and having a hard 
time listening to instructions (10.4%). Most of the sample indicated low past month SUD 





Table 3.2: Wave 1 Summary Statistics 
 Wave 1 
(N=32320) 
 N (Weighted %) 
Sex  
   Male 16306 (48.1) 
   Female 15980 (51.9) 
Age  
   18-24 9110 (13.0) 
   25-34 6337 (17.7) 
   35-44 4930 (16.5) 
   45-54 4846 (17.9) 
   55-64 3971 (16.6) 
   65+ 3110 (18.2) 
Race  
   Non-Hispanic White 19295 (66.0) 
   Non-Hispanic Black 4496 (11.2) 
   Non-Hispanic Other 2429 (7.5) 
   Hispanic Multiracial 4817 (13.3) 
Education  
   Less than high school 4233 (11.6) 
   GED/High school graduate 9765 (29.5) 
   Some college (no degree) 11300 (31.0) 
   Bachelor’s degree 4498 (17.8) 
   Advanced degree 2311 (10.1) 
Annual household income  
   Less than $10,000 5668 (13.7) 
   $10,000- $24,999 6768 (20.4) 
   $25,000- $49,999 6670 (23.0) 
   $50,000- $99,999 6140 (24.9) 
   $100,000 or more 3914 (18.0) 
Satisfaction with social activities and relationships  
   Extremely satisfied 6942 (22.3) 
   Very satisfied 13742 (46.1) 
   Moderately satisfied 8157 (23.7) 
   A little satisfied 2376 (5.6) 
   Not at all satisfied 1001 (2.3) 
Past month tobacco and substance use  
   Exclusive CIG 10381 (16.6) 
   Exclusive ECIG 578 (0.9) 
   Dual CIG + ECIG 996 (1.5) 
   Alcohol 17787 (52.4) 
   Marijuana 4392 (7.1) 
   PDNP  1950 (5.1) 
Past month negative affect symptoms   
   Depressed 5692 (13.4) 
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   Sleeping 9564 (26.7) 
   Anxious 6864 (16.1) 
   Distressed/Past 5605 (12.5) 
Past month externalizing symptoms   
   Lied 3245 (7.1) 
   Attention 5831 (14.6) 
   Listening 4128 (10.4) 
   Bully 737 (1.7) 
   Fights 404 (0.7) 
   Restless 2953 (6.2) 
   Answered 11399 (32.0) 
Past month SUD severity  
   Low 16481 (63.2) 
   Moderate 8985 (31.7) 




Class membership and item-response probabilities 
A four-class model was identified as best fitting the data and was selected to 
conduct additional analyses (Table 3.3). Classes from the 4-class model were labeled 
based on the highest conditional probabilities that characterized the class. The 
characteristics and patterns for each class are detailed below. Figure 3.1 displays the 
probability of being categorized within one of the four classes (i.e., the class 
membership probabilities) given the specific patterns of past-month substance use and 
endorsement of negative affect and externalizing symptoms in the past month (i.e., item 
response probabilities or conditional probability). 
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Table 3.3: Wave 1 LCA Model Fit and Parsimony 





Entropy Ho LL LMRT p-value LC 1 LC 2 LC 3 LC 4 LC 5 LC 6 
2 class 311322.5 311616 311504.7 0.864 -176279 41085.86 <0.05 7339 (22.7%) 
24981 
(77.3%)     




(69.0%)    






(12.7%)   




















NOTE: AIC = Akaike information criteria, BIC = Bayesian information criteria, LL = log likelihood, LMRT = Lo Mendell Rubin Test, LC = latent class 
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Low-Symptom Class. Most participants were categorized as being in the low 
symptom class (N=23,571, 72.9%). This class, overall, had lower conditional 
probabilities for endorsing all items compared to the other classes. Consequently, 
participants in this class had a low probability of endorsing most substance use and 
negative affect/externalizing items. However, the conditional probability of exclusive 
cigarette use was marginally higher for the low symptom class compared to the 
externalizing class (13.6% vs. 12.9%) meaning that a person in the low symptom class 
had a 13.6% probability for endorsing exclusive cigarette use in the past month.  
Negative Affect Class. The negative affect class (N=4,098, 12.7%) had higher 
conditional probabilities for the four negative affect symptoms compared to the low 
symptom class, and externalizing class. A person was more likely to endorse exclusive 
CIG, dual CIG and ECIG, marijuana, and PDNP use if they were in the negative affect 
class compared to the low symptom, and externalizing classes. This class represents a 
population of people who more commonly endorse the four negative affect symptoms 
along with past-month substance use, excluding ECIG. 
Externalizing Class. The externalizing class (N=2,691, 8.3%) had higher 
conditional probabilities for all seven externalizing symptoms compared to low 
symptom, and negative affect classes except for the “start physical fights with other 
people” (Externalizing class = 0.7%, Negative Affect class = 2.00%). The conditional 
probability for exclusive ECIG and alcohol use was greater for those in the externalizing 
class compared to the low symptom, and negative affect classes. Therefore, this class 
represents adults who experience higher levels of externalizing symptoms along with 
exclusive ECIG and alcohol use. 
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Comorbid Class. Approximately 6% of participants were categorized as being in 
the comorbid class (N=1,960, 6.1%).  Compared to the other classes, this class had 
higher conditional probabilities for all items except for alcohol use (Comorbid class = 
57.8%, Externalizing class = 64.4%). This class represents a small population of people 
who, overall, have high endorsement of all seventeen items and, therefore, may indicate 
more severe presentation of substance use and mental disorder symptom severity. 
 
Figure 3.1: Four class solution of substance use behaviors and mental disorder 
symptoms. 
Associations between Sociodemographic Factors and Substance Use/Mental Disorder 
Classes 
 Males were significantly less likely than females to be classified in the comorbid 
(OR = 0.72, 95% CI = 0.63-0.82, p < 0.05) and negative affect (OR = 0.74, 95% CI = 
























































































WAVE 1 - 4 CLASS SOLUTION
Comorbid N=1960 (6.1%) Externalizing N=2691 (8.3%)
Low Symptom N=23571 (72.9%) Negative Affect N=4098 (12.7%)
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As age increased, the odds of class membership decreased for all classes 
relative to the low symptom class. Therefore, the youngest age group (18-24 years) had 
the highest odds of class membership compared to the oldest age group (65 years and 
older), relative to the low symptom class (Comorbid Class OR = 10.02, 95% CI = 7.06-
14.24, p < 0.05; Negative Affect Class OR = 3.88, 95% CI = 3.11-4.83, p < 0.05; 
Externalizing Class OR = 3.39, 95% CI = 2.69-4.28, p < 0.05). Respondents who 
identified as Non-Hispanic Black, Hispanic Multicultural, and Non-Hispanic Other were 
significantly less likely than respondents who identified as Non-Hispanic White to be 
















Table 3.4 Wave 1 - Association Between Demographic and Social Variables with Probability 
of Latent Class Membership 
 Comorbid Class Negative Affect Externalizing 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Sex    
Female REF REF REF 
Male  0.72 (0.63-0.82)* 0.74 (0.66-0.83)* 1.00 (0.87-1.14) 
Age    
18-24 years 10.02 (7.06-14.24)* 3.88 (3.11-4.83)* 3.39 (2.69-4.28)* 
25-34 years 6.00 (4.17-8.64)* 2.39 (1.90-3.01)* 1.81 (1.40-2.33)* 
35-44 years 4.10 (2.83-5.94)* 1.69 (1.32-2.16)* 1.46 (1.11-1.91)* 
45-54 years 3.77 (2.60-5.47)* 1.52 (1.19-1.93)* 1.13 (0.86-1.50) 
55-64 years 2.27 (1.54-3.36)* 1.44 (1.12-1.85)* 0.98 (0.73-1.32) 
65 years and older REF REF REF 
Race    
Non-Hispanic White REF REF REF 
Non-Hispanic Black 0.48 (0.40-0.59)* 0.76 (0.64-0.89)* 0.62 (0.51-0.77)* 
Non-Hispanic Other 0.73 (0.57-0.94)* 0.72 (0.56-0.91)* 0.69 (0.53-0.89)* 
Hispanic Multiracial 0.50 (0.41-0.61)* 0.78 (0.66-0.93)* 0.65 (0.52-0.80)* 
Education    
Less than high school 1.53 (1.05-2.21)* 1.62 (1.22-2.15)* 0.79 (0.57-1.09) 
GED/High school graduate 1.37 (0.98-1.92) 1.42 (1.10-1.83)* 0.80 (0.61-1.05) 
Some college (no degree) 1.79 (1.29-2.47)* 1.36 (1.06-1.75)* 1.08 (0.85-1.37) 
Bachelor’s degree 1.35 (0.94-1.93) 1.16 (0.88-1.53) 1.10 (0.85-1.42) 
Advanced degree REF REF REF 
Income    
Less than $10,000 2.54 (2.03-3.18)* 1.61 (1.32-1.95)* 0.83 (0.65-1.06) 
$10,000- $24,999 2.02 (1.62-2.51)* 1.51 (1.25-1.83)* 0.55 (0.44-0.68) 
$25,000- $49,999 1.45 (1.16-1.81)* 1.11 (0.92-1.33) 0.84 (0.68-1.04) 
$50,000- $99,999 1.00 (0.78-1.27) 0.99 (0.82-1.20) 1.21 (1.00-1.46)* 
$100,000 or more REF REF REF 
Level of satisfaction with social activities and relationships 
Extremely Satisfied REF REF REF 
Very satisfied 1.65 (1.31-2.07)* 1.55 (1.31-1.85)* 1.42 (1.18-1.70)* 
Moderately satisfied 8.15 (6.54-10.15)* 4.53 (3.78-5.43)* 2.66 (2.18-3.26)* 
A little satisfied 34.19 (26.40-44.29)* 11.09 (8.70-14.14)* 3.08 (2.17-4.39)* 
Not at all satisfied 95.87 (66.32-138.58)* 22.62 (15.44-33.16)* 3.67 (1.62-8.31)* 
Note: Low symptom class was the reference level for the outcome.  
* Indicates a p-value < 0.05 
 
Compared to those with an advanced degree, participants with lower education 
levels were significantly more likely to be in the comorbid (Less than High School OR = 
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1.53; Some College/No Degree OR = 1.79) and negative affect (Less than High School 
OR = 1.62; GED/High School Graduate OR = 1.42; Some College/No Degree OR = 
1.36) classes relative to the low symptom class. The associations between education 
level and the externalizing class were not statistically significant. Compared to an 
income of $100,000 or more, those with annual household incomes of $99,999 and 
below were significantly more likely to be in the comorbid (Less than $10,000 OR = 
2.54; $10,000-$24,999 OR = 2.02; $25,000-$49,999 OR = 1.45) and negative affect 
(Less than $10,000 OR = 1.61; $10,000-$24,999 OR = 1.51) classes, compared to the 
low symptom class (Table 3.4).  
A reduction in social satisfaction was associated with membership in comorbid, 
negative affect, and externalizing classes. For example, compared to being extremely 
satisfied, as social satisfaction decreased, the likelihood of being in the comorbid class 
increased (Not at all satisfied OR = 95.87, 95% CI = 66.32-138.58, p < 0.05). Similarly, 
compared to participants who were extremely satisfied, participants who were not at all 
satisfied were about 23 times more likely to be categorized in the negative affect class 
(OR = 22.62, 95% CI = 15.44-33.16, p < 0.05) and almost four time more likely to be in 
the externalizing class (OR = 3.67, 95% CI = 1.62-8.31, p = 0.002). This relationship 
was not detected for the alcohol class. 
Prediction modeling 
 Data generated from the LCA model (i.e., class membership and probability of 
class membership) were exported from Mplus and imported into SAS to determine the 
predictive ability of the latent class on SUD severity. Class membership significantly 
predicted SUD severity (Table 3.5).  
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Table 3.5: Prediction of the probability of class membership and SUD severity 
Latent Class SUD Severity Odds Ratio (95% Confidence Interval) 
Low Symptom Class REF 
Comorbid Class 2.31 (2.07-2.59)* 
Externalizing Class 1.54 (1.38-1.72)* 
Negative Affect Class 1.51 (1.38-1.65)* 
* Indicates a p-value < 0.0001. 
 
Relative to the low symptom class, membership in the comorbid class increased 
the odds of SUD severity by 2.31 times (OR = 2.31, 95% CI = 2.07-2.59, p < 0.0001). 
The externalizing and negative affect classes had similar relationships with SUD 
severity (Externalizing OR = 1.54, 95% CI = 1.38-1.72, p < 0.0001; Negative Affect OR 
= 1.51, 95% CI = 1.38-1.65, p < 0.0001). These estimates were unadjusted since the 
sociodemographic covariates were accounted for in the development of the latent 
classes. 
 
Figure 3.2: Area under the curve comparisons generated from the cumulative ROC 
Curves 
Negative Affect Externalizing Substance Use Class Membership
SUD 0 vs 1,2 0.5063 0.5224 0.5725 0.5093








AREA UNDER THE CURVE COMPARISONS
SUD 0 vs 1,2 SUD 0,1 vs 2
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 Cumulative ROC curves (see Appendix B, Supplemental Figures 3.1-3.8) were 
generated to determine if latent class membership (combining substance use behaviors, 
negative affect, and externalizing symptoms) was a better predictor of specific levels of 
SUD severity compared to any of the indicators that make up the latent class 
separately. Past-month substance use behaviors best predicted SUD severity. For 
example, the area under the curve (AUC; i.e., the degree of separability) for past-month 
substance use to predict low SUD severity versus moderate/high SUD severity was 
0.57 (Figure 3.2). This means that the substance use variables would only be correct in 
predicting SUD severity about 57% of the time. Further, the AUC improved when 
predicting low/moderate SUD severity versus high SUD severity (AUC = 0.6479). 
Therefore, at this threshold (low/moderate vs high SUD severity), the predictive ability 
increased from 57% to 65%. The ability of the latent class to predict SUD severity was 
marginally better than the negative affect and externalizing indicators for the 
low/moderate versus high SUD severity (Class Membership AUC = 0.51; Negative 
Affect AUC = 0.51; Externalizing AUC = 0.47). Therefore, substance use behaviors 
measured alone performed better at predicting SUD severity compared to comorbid 
substance use as reflected in comorbid latent class membership. 
Overall, AUCs ranged from 0.47 (low/moderate SUD severity vs high SUD 
severity level for externalizing) to 0.65 (low/moderate SUD severity vs high SUD 
severity for substance use behaviors) meaning that predictions of SUD severity were 





To our knowledge, this is one of the first studies to use a latent class approach to 
describe comorbidity between substance use behaviors and mental disorder symptoms 
together in a large nationally representative sample of U.S. adults. This study also used 
information from the latent class analysis to predict a health outcome, SUD severity. 
There are three major results from this study. First, a four-class solution (i.e., low 
symptom class, negative affect class, externalizing class, and comorbid class) best 
described the data. These classes also allowed us to understand what symptoms and 
substance use behaviors commonly occur together in this sample, confirming our 
hypothesis that substance use would vary across mental disorder symptoms. For 
example, exclusive cigarette, dual cigarette and e-cigarette, marijuana, and PDNP use 
more commonly occurred in the negative affect class while exclusive e-cigarette and 
alcohol use more commonly occurred with the externalizing class. Second, 
sociodemographic factors were significantly associated with latent class membership 
and social satisfaction was a strong factor associated with the comorbid and negative 
affect classes. Third, latent class membership predicting SUD severity performed 
similarly to a model where the symptoms were grouped separately (i.e., negative affect 
symptoms, externalizing symptoms, and substance use behaviors).  
 
Class prevalences and underestimation 
 The four-class solution was determined to best fit the data for this sample. This is 
consistent with prior latent class results that have identified a four-class solution to be 
most optimal. Salom et al. identified a four-class solution of comorbid polysubstance 
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use and mental health disorders in young adults: low disorder (73.6%); mental health 
and low SUD (10.6%); alcohol, cannabis, and low mental health disorder (12.2%); and 
polysubstance use and moderate mental health disorder (3.5%).12 Other studies have 
also found that four-class solutions are most optimal in their samples with the low 
psychopathology class being the largest group (62.5% to 84.0%) followed by an 
internalizing or negative affect class with some substance use endorsement (i.e., 
alcohol use disorder), an externalizing class with high endorsement of substance use 
problems (i.e., nicotine dependence, alcohol use disorder, and drug use disorder), and 
a comorbid or both internalizing or negative affect/externalizing with high endorsement 
of substance use problems class as the smallest group (1.1% to 4.2%).41,124 Therefore, 
our results confirm and support a four-class solution to best explain substance use and 
mental disorder comorbidity in U.S. adults. 
 Similar to other latent class findings, the low symptom class was most common 
in this sample (72.3%, N=23,571). This suggests that most American adults may 
engage in some substance use (i.e., current CIG or alcohol use) while also experiencing 
some mental disorder symptoms, specifically impulsivity or sleep problems, but 
otherwise have low endorsement of other substance use behaviors and mental disorder 
symptoms. Almost thirty percent (27.7%) of the sample, however, were categorized in 
the other three remaining classes based on higher probabilities of endorsing substance 
use or mental disorder symptom items. These people have the potential to be 
underestimated or not accounted for based on the current classification systems due to 
their subthreshold levels of possible impairment. This presents a missed opportunity to 
identify the comorbid substance use and mental disorder symptoms, and potentially 
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prevent the comorbidity from becoming progressively worse. Therefore, this part of the 
population could benefit from refined detection and possible intervention (e.g., access to 
support or educational materials). Early detection could result in better intervention 
outcomes and better overall mental health outcomes. 
 
Patterns of substance use varies by negative affect and externalizing classes 
Exclusive cigarette, dual cigarette and e-cigarette, marijuana, and PDNP use had 
higher endorsement in the negative affect class. In comparison, exclusive e-cigarette 
and alcohol use had higher endorsement in the externalizing class. These patterns may 
be helpful in identifying people at risk for development of more severe comorbidity in 
public health spaces. The implications of these results are considered below. 
Negative affect class 
Previous work reports that people who engage in conventional cigarette use are 
at an increased risk of negative affect disorders like depression and anxiety.90,92 The 
relationship between negative affect symptoms and dual cigarette and e-cigarette use is 
not as well understood. Our prior analysis (see Chapter 2) showed that the combined 
use of alcohol, cigarette and e-cigarette was significantly associated with high negative 
affect severity while dual cigarette and e-cigarette use was not significantly associated 
with any level of negative affect severity after adjusting for demographic covariates.148 
The LCA results add to our understanding of psychopathology, confirming the 
association between dual cigarette and e-cigarette use with negative affect symptoms, 
especially as this dual use is currently increasing in adults, specifically young adults.83   
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There was higher endorsement for past-month marijuana use in the negative 
affect class compared to the externalizing class. There is a vast literature demonstrating 
the association between marijuana use and negative affect symptoms such as anxiety 
and depression.149–152 Additionally, marijuana use has been increasing at a greater rate 
in women, who are more likely to endorse negative affect symptoms, compared to men 
over the last decade (40% increase for men, 53% increase for women from 2006 to 
2016).153 Therefore, the reason there is greater endorsement of marijuana in the 
negative affect versus the externalizing class may be because women are more likely to 
make up the negative affect class.  
The finding of high endorsement of PDNP in the negative affect class is 
consistent with the literature. Evidence suggests that opioid use, a substance measured 
within PDNP, is associated with PTSD symptoms.154 Other studies have also identified 
that people in SUD treatment for nonmedical use of prescription painkillers like opioids, 
almost half (43%) have a diagnosis or symptoms of anxiety and depression.155  
Externalizing class 
The item response probability for exclusive e-cigarette use was higher for the 
externalizing class compared to the low symptom and negative affect classes. This is 
not supported by our prior analysis (see Chapter 2) where exclusive e-cigarette use was 
not significantly associated with negative affect or externalizing severity using a 
multinomial logistic regression.148 However, e-cigarette and alcohol use together were 
significantly associated with externalizing severity.148 Given that alcohol use is widely 
accepted to be associated with externalizing behaviors,38,117,118 we hypothesized that 
the alcohol use may drive the relationship between e-cigarette and externalizing 
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severity when alcohol was used with e-cigarettes (i.e., dual use). Nevertheless, the 
results from this LCA study support that exclusive e-cigarette use may be more related 
to externalizing symptoms than negative affect. As e-cigarettes continue to increase in 
use,125 it is important to understand how this electronic nicotine delivery system differs 
from conventional cigarette use. Some studies have identified similarities in that both 
deliver nicotine and result in poor health outcomes specifically related to the lungs.125 
However, regarding comorbidity with mental disorder symptoms, e-cigarettes may 
present differently than conventional cigarettes. Alcohol use was also endorsed at a 
greater probability in the externalizing class compared to the negative affect and low 
symptom classes. This is consistent with prior studies that suggest that alcohol use 
contributes to a latent factor of externalizing behaviors.38,117,118 
 
Sociodemographic characteristics and latent class membership 
As age increased, the odds of class membership decreased. This is consistent 
with previous work, where younger people are at greater risk for mental health and 
substance use problems compared to people in older age categories.41 This could 
indicate an increase in substance use initiation which is typical in younger age 
categories.156 This also matches with the age of onset for most mental disorders as 
roughly 50% to 75% of all lifetime mental disorders start by the mid-teens and mid-20s, 
respectively.2 Therefore, broad prevention strategies that address all latent class 
profiles could be helpful in supporting younger people with comorbidity.  
Compared to Non-Hispanic White participants, those in all other race categories 
were less likely to be in any of the latent classes. Another study has also identified the 
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association between race and comorbidity, whereas those who identify as Non-Hispanic 
White are at increased risk of latent class membership compared to individuals in other 
racial/ethnic groups, specifically Non-Hispanic Black and Hispanic Other.41 There are 
many potential reasons why this occurs. First, Non-Hispanic White populations are 
overrepresented in psychopathology and comorbidity research.123 It is also likely that 
diagnoses of comorbidity are optimized for the Non-Hispanic White population rather 
than across all groups. Therefore, it has been more difficult to draw associations with 
other racial/ethnic groups. Second, due to the historical distrust in the U.S. healthcare 
system, people of other racial/ethnic groups may be less likely to participate in research 
and indicate that they participate in substance use behaviors or experience mental 
disorder symptoms.157 However, a likely conclusion that is not an artifact of study 
sampling or potential misclassification could be the strong levels of resiliency in other 
racial/ethnic groups, specifically seen in African Americans or those who identify as 
Black.158 This is known as the black-white mental health paradox and explains that 
Black Americans tend to experience similar or relatively low rates of psychiatric 
disorders compared to Whites despite higher stress exposure, greater material 
hardship, and worse physical health.158 While it is important to support those who 
identify as Non-Hispanic White, it remains important to continue being inclusive of all 
racial/ethnic categories in comorbidity research to develop more consistent results and 
provide the appropriate level of support and targeted prevention efforts. 
Women had higher odds of membership in the comorbid and negative affect 
classes. This is consistent with previous LCA work that has shown that women are 
more likely to be in a comorbid or internalizing/negative affect class.12,41,124 Men, 
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however, were not significantly associated with membership in the externalizing class. 
Men typically have higher rates of alcohol use and endorse more externalizing 
symptoms and disorders. This may due to the robust set of other items included in the 
generation of the latent classes. 
Compared to those at higher levels of socioeconomic status, people at lower 
levels of socioeconomic status had a greater risk of membership in the comorbid and 
negative affect classes. This is consistent with previous studies. For example, a 
longitudinal study of 34,653 noninstitutionalized U.S. adults identified that low levels of 
household income were associated with several lifetime mental disorders and a 
reduction in household income was associated with increased risk of incident mood, 
anxiety or substance use disorders compared to respondents with no change in 
income.159 Additionally, prior work has identified that higher income and education 
levels represent a protective relationship from membership in internalizing or negative 
affect, externalizing, and high psychopathology classes.41  
The magnitudes of the association between social satisfaction and the comorbid 
as well as negative affect classes were very large. Social satisfaction was also 
associated with the externalizing class. Those who were less satisfied with their social 
lives had greater odds of externalizing class membership. Although not incredibly 
precise, the association between social satisfaction and class membership may be a 
place to intervene, as social satisfaction is (1) a more easily modifiable factor compared 
to other demographic characteristics and (2) demonstrates a protective association. For 
example, as people became less satisfied with their social activities and relationships, 
their odds of membership in the comorbid, negative affect, or externalizing classes 
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significantly increased. Therefore, if social satisfaction can improve (i.e., becoming more 
content with one’s activities and relationships with the support of a psychological 
therapist or counselor), there could be a decrease in the risk of belonging to the 
comorbid, negative affect, or externalizing classes. This buffering effect through social 
support has been demonstrated previously160 and could be an opportunity to intervene 
or prevent further development of comorbid or negative affect psychopathology.  
 
Limited ability to predict SUD severity 
The comorbid class had the strongest association with SUD severity when 
predicting SUD severity using class membership in a multinomial logistic regression. 
The comorbid class had greater endorsement of past month substance use behaviors, 
except for alcohol use, and mental disorder symptoms compared to the other classes. 
This finding indicates that people with endorsement of more items at greater rates are 
associated with greater SUD severity. Therefore, we assumed that by grouping 
symptoms together and describing them as they occur using a latent modeling 
approach, we would be better able to predict health outcomes than assessing these 
symptoms separately. However, the cumulative ROC analyses showed that the ability of 
latent class membership to predict SUD severity was no better than the symptoms 
grouped separately (i.e., negative affect symptoms, externalizing symptoms, and 
substance use behaviors). Further, predictions of SUD severity were only correct about 
47-65% of the time.  
The poor ability of latent class membership to predict SUD severity may be due 
to the incongruency between measurement tool used and population assessed. The 
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outcome measure, SUD severity, was created to approximate SUD diagnosis. This tool 
was originally validated in populations which were oversampled with SUD in order to 
appropriately distinguish between SUD and no SUD.28 Therefore, the tool used to 
measure SUD may not perform as well in a sample of people who experience 
subthreshold levels of SUD or other mental disorders. Classes generated from other 
methods like factor mixture modeling131 that can account for heterogeneous groups (i.e., 
SUD and no SUD) may be better in predicting SUD severity. Another reason could be 
due to misclassification bias introduced by the measurement used for negative affect 
and externalizing symptoms, and SUD severity. We could be misclassifying individuals 
by collapsing 2 to 12 months, over a year ago, and never into one reference category to 
compare to the past-month endorsement. Additionally, the negative affect and 
externalizing symptoms were correlated, which may also affect the ability of either items 
to predict SUD severity. Future studies should consider using a factor mixture modeling 
approach to determine comorbidity’s predictive ability of SUD severity. Until then, it may 
be that disorders do better at predicting SUD severity compared to subthreshold or 
symptom-level measures. 
 
Strengths and limitations  
 There are several strengths and limitations to this study. First, this study used 
data from a large, nationally representative sample of U.S. adults allowing for the 
generalizability of these results to the adult, noninstitutionalized population in the U.S. 
However, participants included in this study differed significantly from participants with 
missing data as those included had greater endorsement of substance use, negative 
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affect symptoms, and externalizing symptoms. Therefore, these participants may not 
represent the U.S. adult population. Additionally, these data are cross-sectional and this 
study cannot resolve causal inference. As more waves of data are collected, we will be 
able to assess the stability of this class structure along with changes in class 
membership using longitudinal methods (e.g., latent transition analysis) especially 
considering the more recent changes in substance use over time (e.g., the increase in 
e-cigarette and marijuana use).  
Second, the substance use and mental disorder symptoms measure comorbidity 
within the same time frame (i.e., past month endorsement of substance use as well as 
the negative affect-externalizing symptoms and SUD severity). There is potential 
misclassification due to how the measure was developed by collapsing the 2 to 12 
months, over a year ago, and never response options into one group (coded as 0 vs 
past-month coded as 1). People who endorsed a symptom in the last 2 to 12 months or 
over a year ago differ from people who never endorsed a symptom. Future work could 
consider (1) developing a three-level categorical variable that separates those who 
never endorsed a symptom from those who endorsed a symptom in the last 2 to 12 
months and over a year ago to compare with the past-month level, or (2) maintain the 
original four levels of the item to avoid losing information through dichotomizing or re-
categorizing the variables. Our binary measurement, however, allowed us to model 
current comorbid polysubstance use and negative affect and externalizing symptoms 
while also predicting SUD severity within the same time period. Additionally, by using 
symptom measures, we accommodate and provide a better understanding of 
comorbidity compared to a diagnostic classification system.117 Additionally, it is 
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important to note that although the cut points for SUD severity have acceptable 
reliability, validity, and overlap with DSM-5 SUD criterion in this sample, we may not be 
appropriately treating these variances as a continuous probability. Future research is 
encouraged to evaluate the SUD severity items and consider measurement techniques 
such as the use of quantiles161 to confirm that the categorization of the SUD severity 
variable is appropriate for the population being studied (i.e., based on the distribution of 
population’s responses).  
Third, the assessment of factors associated with class membership is limited to 
the demographic and social factors included in this study. There could be other factors 
associated with comorbidity that were not included and could result in residual 
confounding. Future work should investigate the association of other environmental 
factors on class membership to better understand the influence of additional social 
determinants of health on comorbidity. 
Fourth, we ran an ordinal regression model for the prediction analysis. However, 
the model violated the proportional odds assumption (chi-square = 439.2, p-value < 
0.0001). This means that the relationship between any two pairs of the outcome groups 
(i.e., low vs moderate/high SUD severity and low/moderate vs high SUD severity) was 
not statistically the same. We also ran a multinomial regression model because of the 
assumption violation. However, results from a multinomial regression were consistent 
with the ordinal regression results and, therefore, we presented the ordinal regression 
results in order to be synonymous with results presented from the cumulative ROC 
curves. Nevertheless, predicting SUD severity is a strength. It is an extension to the 
primarily descriptive ability of using an LCA. Further, by utilizing the ROC curves, we 
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were able to identify the ability of latent class membership to predict SUD severity and 
compare that to the substance use behaviors and mental disorder symptoms 
separately.  
Fifth, a LCA model was used to assign participants into comorbidity classes 
using their responses to self-report measures of substance use, negative affect, and 
externalizing symptoms. This approach is considered to be important to discover 
classes based on observed data and characterize participants based on latent class 
membership. LCA was selected to compare results with previous studies that assessed 
for comorbidity and be used in clinical and research settings specifically for risk 
assessment and treatment.41 Further, the interpretability of LCA results (i.e., 
classifications and assigning individuals to groups based on their item endorsement) 
can be easily translated for use in clinical settings by identifying individuals at potential 
risk for increased comorbidity severity based on their current substance use and mental 
disorder symptoms. It is possible that messaging could be developed based on the 
latent classes identified in this study. Results could be shared with policy makers so 
they may allocate more resources toward developing comorbid support in clinical 
spaces. 
Nevertheless, there are several limitations related to the use of the LCA model. 
Specifically, by using categorical data to assign individuals into discrete classes, there 
may be a loss of information that would emerge from a model that accounts for a 
continuous distribution. For example, we observed parallel trends of the item response 
probabilities across the classes. This observation suggests that there could be a 
continuous distribution to these data and that a dimensional presentation, rather than 
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discrete, may be more appropriate in characterizing the comorbidity within the 
population. Therefore, the discrete latent classes generated from the LCA may not 
represent the actual types of individuals in the population.162 Additionally, the conditional 
independence assumption of the LCA model can also be seen as a limitation. 
Conditional independence simplifies the presentation of underlying classes in a 
population based on consistent patterns in the data (i.e., item response probabilities) yet 
it may be an over-simplification or biased representation of the true heterogeneity in the 
population.163 It may not be true that the latent class fully explains the relationship 
between the observed variables. A possible solution to address both major LCA 
limitations is the use of a factor mixture model. The factor mixture model uses a hybrid 
of latent class and factor analysis where the latent variable allows for the classification 
of individuals into groups while the factor models the heterogeneity of the disorder 
within the latent class, relaxing the conditional independence assumption.131 This is 
useful because comorbidity class membership and the range of severity within and 
across classes can be modeled concurrently.164 A factor mixture model estimates a 
factor score for each individual which quantifies the heterogeneity within a class; 
however, there is no model-based classification of individuals because individuals are 
assumed to be from the same homogeneous population.164 Network analysis can also 
assess comorbidity structure without the assumption of conditional independence, and 
is an approach used in Chapter 4.  
Sixth, we could not use the bootstrap likelihood ratio test as an additional 
examination of model fit when accounting for complex sampling design during the LCA. 
LCA includes a bootstrap likelihood ratio test to test for model fit across models with 
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various classes. However, it could not be performed when using weighted data to 
account for complex sampling design. Consequently, we relied on the Lo-Mendell-Rubin 
adjusted likelihood ratio test along with other parsimony metrics to decide on the optimal 
class solution. This is considered a promising and appropriate approach when 
determining the number of classes from an LCA model.165 
Seventh, this is a sample of mainly healthy people and as such, the 
dimensionality of comorbidity may be different here compared to a sample of people 
diagnosed with psychiatric conditions (e.g., those who are institutionalized). This 
approach should be replicated in other samples to confirm or refute the dimensionality 
of comorbidity. Nevertheless, the results from this sample detail the patterns of mental 
disorder symptoms and substance use behaviors in a broader population in order to 
appropriately characterize comorbidity at a population level. This is important because 
substance use and/or mental disorder symptoms that do not result in a diagnosis 
remain pervasive throughout American society.8 Undiagnosed individuals may go 
untreated and untreated mental illness, including SUD, represents $300 billion due to 
losses in productivity annually.166 Therefore, it is important to identify and detail patterns 
of substance use and mental health outcomes throughout the full population in addition 
to those at highest risk for disorders or those who are affected.117131 
 
Conclusions 
 In a nationally representative sample of U.S. adults, four latent classes were 
most optimal at describing mental disorder symptom and substance use comorbidity. 
Negative affect symptoms were commonly seen with exclusive CIG use, dual CIG and 
 113 
EIG use, marijuana, and PDNP use. Externalizing symptoms were commonly seen with 
exclusive ECIG use and alcohol. Social satisfaction may be an important factor to 
consider when intervening on comorbidity. Comorbidity of latent class membership was 
similar to negative affect, externalizing, and substance use behaviors, separately, in 
predicting SUD severity. This may suggest that network psychometrics may be a better 
approach to understanding the predictive ability of comorbidity for other health 






CHAPTER 4: A NETWORK APPROACH TO SUBSTANCE USE, NEGATIVE 




Substance use (e.g., tobacco, alcohol, marijuana, and sedatives [i.e., 
benzodiazepines and barbiturates]) commonly co-occurs with negative affect disorders 
(i.e., behavioral problems that manifest and are maintained within the individual167) such 
as depression and anxiety, and externalizing disorders (i.e., behavioral problems that 
manifest as negative outward behavior acting on the external environment168) like 
attention-deficit hyperactivity disorder (ADHD). These comorbidities are summarized in 
Table 4.1.11,89,91,149–152,169–183   
Many of the most consistent results regarding comorbidity have focused mainly 
on disorder, as seen in Table 4.1. However, other papers have used different substance 
use measures (e.g., initiation, recency of use, quantity of use) and they too have seen 
comorbidity with mental disorders and mental disorder symptoms.151,152,169,178,179,181 
Given the consistency of results in disorder and other use measures, it is worth the 
effort to focus on lower levels of symptomatology and explore the etiology of 










2 A modified version of this chapter was submitted for publication to Addictive Behaviors, Special Issue on 
Networks, Complexity and Addictive Behaviors. 
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Table 4.1: Summary of Previously Reported Comorbidity by Substance 
Substance 
Use Disorder Co-Occurring Substance use Comorbid Mental Health 
Tobacco 
Alcohol Major depressive disorder 
Marijuana Generalized anxiety disorder 
  ADHD 
Alcohol  
Marijuana Anxiety disorders 
Opioids Depressive disorders  
  ADHD 
  Conduct disorder 
Marijuana 
Alcohol use disorder Depression 
Tobacco use disorder Anxiety 
Substance use disorders Conduct disorder 
Sedatives 
Tobacco use disorder Depressive disorders 
Alcohol use disorder Anxiety disorders 
Opioids  





Sedatives Conduct disorder 
 
 To date, it is unclear whether the same patterns of comorbidity identified with 
substances such as conventional cigarettes (CIG), alcohol, and marijuana extend to 
relatively new products including electronic cigarettes (ECIG) and use of prescription 
drugs in a manner not previously prescribed (e.g., sedatives, tranquilizers, and 
painkillers) which have increased in popularity over the past several years.  For 
example, the prevalence of ECIG use has increased from 2.4% in 2012 to 7.6% in 
2018.125 Further, the patterns of some substance use in ECIG users have been reported 
to be similar to that of CIG users. Specifically, ECIG use frequently occurs with alcohol 
use and other substances.87,94,95,97 Similar to ECIG, the prevalence of PDNP (i.e., 
prescription drug use not prescribed, nonmedical use of a prescription drug including 
recreational use) has also been increasing for the last fifteen years with overdose 
deaths involving prescription opioids being four times greater in 2018 than in 1999.184 
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People with SUDs and mental disorders are at a higher risk for nonmedical use of 
prescription opioids.185 Of those in SUD treatment for nonmedical use of prescription 
painkillers, almost half (43%) have a diagnosis or symptoms of anxiety and 
depression.155 Additionally, opioids and sedatives are sometimes combined for 
recreational use, resulting in a higher risk for comorbid mental conditions as well as 
nonfatal and fatal overdoses.186,187 Therefore, as the prevalence of these substances 
increase there has also been increasing evidence for their comorbidity with negative 
affect/externalizing behaviors and other substances. 
 
Patterns of mental health comorbidity focus on diagnoses rather than symptoms 
Most research on the patterns of comorbidity between substance use, 
externalizing, and negative affect behaviors has focused on diagnoses of disorders 
rather than the symptoms underlying these diagnoses.22,39 However, this approach 
neglects the inclusion of people who experience subthreshold levels of impairment and 
results in a potential loss of information when summing symptoms to reach diagnosis.33 
Most substance-related health and social problems occur among individuals who are 
not addicted or have a SUD diagnosis.8 Additionally, many of these symptoms cross 
over diagnostic boundaries.33,188 Consequently, there is a substantial gap in 
understanding the overlap between substance use and mental disorder symptoms. By 
using another measure like past-month substance use, it is possible to capture people 
who use substances with and without a diagnosis of a SUD, allowing for a more robust 
assessment of comorbidity patterns and accounting for overlaps between substance 
use behaviors and mental disorder symptoms. If the focus were to remain solely on 
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diagnosis, there would be no evidence to support people who experience subthreshold 
use and comorbid mental disorder symptoms. Therefore, past-month substance use 
offers an opportunity to study a larger population of people who use substances (i.e., 
those with and without disorder) as well as identify and intervene at the subthreshold 
level to better support individuals experiencing comorbid substance use. 
 
Gender differences in the comorbidity of substance use and mental health  
Much of the substance use and SUD research has largely been conducted in 
men. However, the prevalence of substance use in the U.S. has been increasing in 
women.123 Further, negative affect/externalizing symptoms present differently in men 
and women.2,123 For example, men are more likely to experience externalizing 
disorders, while women are more likely to report negative affect disorders.123,183,189,190 
Furthermore, comorbid psychiatric conditions occur more frequently in women with 
SUDs compared to men.190,191 Consequently, the comorbidity between substance use 
and psychopathology may also vary by gender.  
 
Study goals and hypotheses 
Network analyses of substance use or SUDs have yet to account for comorbid 
mental disorders.34,192 Therefore, the primary goal of this study is to detail a network 
system of past-month substance use as well as a wide range of negative 
affect/externalizing symptoms, and quantify how well a given node can be predicted by 
all other nodes it is connected to in the network using nodewise predictability. A 
secondary goal of this study is to determine whether there are gender differences in the 
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comorbidity network structure. Based on prior literature, we hypothesize that tobacco, 
alcohol, marijuana, and PDNP will connect with negative affect, specifically depression 
and anxiety symptoms, and tobacco, alcohol, and marijuana will connect with 
externalizing symptoms, specifically impulsivity and conduct disorder symptoms. We 
also expect differences in network structure by gender, with men experiencing greater 
connection between substance use and externalizing symptoms and women with 




Wave 1 adult data (N=32,320) from the Population Assessment of Tobacco and 
Health (PATH) study were used.71 These data are cross-sectional and were collected 
between September 2013 and December 2014. PATH is a nationally representative 
longitudinal cohort study of the civilian, non-institutionalized household population of the 
U.S., and participants engaged in all levels of tobacco use ranging from never using 
tobacco to frequent use.  
The weighted response rate among participants was 74.0% for Wave 1.73 
Participants responded to tobacco-specific items including tobacco-use patterns, risk 
perceptions and attitudes towards current and newly emerging tobacco products, 
tobacco initiation, cessation, relapse behaviors, and health outcomes.72 Participants 
also responded to non-tobacco items (e.g., media use, peer and family influences, 




 Participants with missing data on the substance use, negative affect, and 
externalizing measures were not included in the analysis (N= 2,109). Survey 
respondents of the analytic sample endorsed significantly greater substance use 
overall, negative affect symptoms, and externalizing symptoms (except for fighting) 
compared to those not included in the analytic sample. The participants in the analytic 
sample were more likely to be Non-Hispanic white, men, aged 25-54 with higher levels 
of education and annual household income than those who were missing. 
 
Measures 
 Past Month Tobacco and Substance Use. Six substance use categories were 
used in this study: exclusive cigarette, exclusive e-cigarette, dual cigarette and e-
cigarette, alcohol, marijuana, and prescription drugs not prescribed (PDNP) including 
painkillers, sedatives, tranquilizers. The summary of past-month substance use is 
described in Table 4.2. Current dual cigarette and e-cigarette use were identified if the 
respondent indicated they were a current cigarette and current e-cigarette user. Current 
alcohol, marijuana, and PDNP was endorsed if the respondent indicated ever using the 
substance and has used the substance within the past 30 days. Only past month or 
current use of the substances was considered (coded as 1, else = 0) to reduce the 
potential for recall bias and ensure for accurate overlap with negative affect and 
externalizing symptoms occurring in the same time frame. These substance use 
variables were nodes in the networks. 
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Table 4.2: Summary of Past-Month Substance Use and Symptoms of Negative affect 








Ever smoking a cigarette (even one or two puffs), has smoked at 
least 100 or more cigarettes in his or her entire life, and now 
smokes cigarettes every day or some days, while also excluding the 
current use of e-cigarettes 
Exclusive ECIG 
(or ECIG) 
Ever using an e-cigarette (even one or two puffs), ever smoked e-
cigarettes fairly regularly, and now uses e-cigarettes every day or 
some days, while also excluding the current use of cigarettes 
Dual CIG + 
ECIG 
That they were a current cigarette and current e-cigarette user 
Alcohol Ever using alcohol and has used alcohol within the past 30 days 
Marijuana 
Ever using marijuana and has used marijuana within the past 30 
days 
PDNP 
Ever using prescription drugs not prescribed (PDNP) (i.e., 
painkillers, sedatives, and tranquilizers) and has used PDNP within 





The last time you had significant problems with: 
Depressed 
Feeling trapped, lonely, sad, blue, depressed, or hopeless about the 
future 
Sleeping 
Sleep trouble such as bad dreams, sleeping restlessly or falling 
asleep during the day 
Anxious 
Feeling very anxious, nervous, tense, scared, panicked or 
something bad was going to happen 
Distressed/Past 
Becoming very distressed and upset when something reminded you 




The last time you did the following two or more times: 
Lied 
Lied or conned to get things you wanted or to avoid having to do 
something 
Attention Had a hard time paying attention at school, work or home 
Listening Had a hard time listening to instructions at school, work or home 
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Bully Were a bully or threatened other people 
Fights Started physical fights with other people 
Restless Felt restless or the need to run around or climb on things 
Answered Gave answers before the other person finished asking the question 
* The items selected to identify negative affect and externalizing symptoms from the 
GAIN-SS instrument are ordinal and measures people across four times periods: past 
month, 2 to 12 months, over a year ago, and never. Participants indicating that they 
experienced a symptom within the past month were coded as 1. Participants 
indicating that they experienced the symptom 2 to 12 months ago, over a year ago, 
and never were coded as 0. 
 
Past Month Negative Affect and Externalizing Symptoms. Negative affect and 
externalizing symptoms were measured using the Global Appraisal of Individual 
Needs—Short Screener (GAIN-SS).73 The summary of past-month negative affect and 
externalizing symptoms are described in Table 4.2. The items selected to identify 
negative affect and externalizing symptoms from the GAIN-SS instrument are ordinal 
and measures people across four times periods: past month, 2 to 12 months, over a 
year ago, and never. Participants indicating that they experienced a symptom within the 
past month were coded as 1. Participants indicating that they experienced the symptom 
2 to 12 months ago, over a year ago, and never were coded as 0. Only past month or 
current negative affect and externalizing symptoms were considered reducing the 
potential for recall bias and ensure accurate overlap with substance use occurring in the 
same time frame. The negative affect and externalizing symptoms, along with the 
substance use variables, were nodes in the networks. 
Covariates. Networks were stratified by gender to confirm significant differences 
in comorbidity networks by gender. Men and women experience substance use and 
mental disorders differently; therefore, it is important to test these differences by 
stratifying the networks. Previous work shows that women are more likely to experience 
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negative affect symptoms while men are more likely to experience externalizing 
symptoms.41,123 Men also tend to participate in substance use more regularly than 
women and experience substance use problems at twice the rate as females.123 
Therefore, it is important to determine how these comorbidities present by gender.  
  
Statistical Analysis 
Summary Statistics. Summary statistics were generated for the sample using 
PROC SURVEYFREQ in SAS 9.4 to account for complex sampling design. 
Network Analysis. A network model can support a deeper understanding of 
comorbidity because it conceptualizes symptoms as mutually interacting, often 
reciprocally reinforcing elements of a complex network.46 The network approach is 
based on the idea that comorbidities arise from shared symptoms between disorders 
which can capture complexity and individual variation in psychopathology.49 The 
network approach naturally accommodates comorbidities as a central part of its 
theory.50 In the network approach, comorbidity represents causal relationships between 
symptoms in which pathways can bridge symptoms that are part of multiple disorders.46  
Using a network model, symptoms, rather than disorders, are considered within the 
network structure. Rather than the disorder acting as the underlying cause of all 
symptoms, it is the symptoms that mutually interact and set a person into a disordered 
mental health state.  
Within a network model, the symptoms make up a comorbid network structure of 
several symptoms that is specific to the person. This model conceptualizes how 
symptoms of different disorders function together specifically to produce a comorbid 
 123 
disordered state. The network approach explains the co-occurrence of mental disorder 
symptoms, including substance use behaviors, as resulting from direct interactions 
between these symptoms.50 In network analysis, the term interaction is used to explain 
the reciprocal action or influence of symptoms. In the context of network analysis, 
interaction is not used to test whether an effect can be greater than (positive interaction, 
synergism) or less than what we would expect (negative interaction, antagonism).51 
Patterns of symptom-symptom or symptom-behavior interactions can be explained 
using a network structure.45 
An example of the use of a network model is detailed in Figure 4.1 to summarize 
comorbidity of symptoms for SUD and depression. The network model of SUD and 
depression is made of symptoms denoted as nodes (circles) and the associations 
between the symptoms denoted as edges (lines connecting nodes). Every node in a 
network is connected by edges. Edges represent the interactions between the nodes. 
Nodes that directly activate each other (i.e., are associated with one another) are 
connected with an estimated edge, while nodes that do not directly activate each other 
are not. This figure details a directed network where arrows are directed from one node 
to another, indicating that one symptom can lead to the activation of another. 
Depression symptoms (red) are clustered together to the left of the network. SUD 
symptoms (blue) are clustered together to the right of the network. Insomnia and weight 
loss (in purple) are symptoms that occur in both depression and SUD and act as 
bridges between the disorders. The positioning and the distance between the 
symptoms/nodes within the network have implications for the comorbidity structure of 
depression and SUD.   
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Figure 4.1: Network Model of Depression and SUD symptoms. 
 
Overall Network Modeling Strategy. Two sets of network analyses were 
completed to evaluate the connections between substance use behaviors and negative 
affect/externalizing symptoms. The first analysis estimated network models in the entire 
sample and also tested for the consistency of network connections by gender (i.e., 
network comparison tests). The second set of network analyses consisted of model 
evaluation to establish the nodewise metrics (i.e., centrality and predictability), and 
accuracy/stability of the network models as detailed below.  This second set of analyses 

























Network Model Estimation. All networks were estimated using an Ising Model in 
R 3.6.0 using the IsingFit package.193 Ising model selection uses the Extended 
Bayesian Information Criteria (EBIC) to measure model parsimony for moderate sample 
sizes and for a high number of variables by accounting for the number of unknown 
parameters and the complexity of the model space.194–196 Models determined to best 
explain the data using EBIC were interpreted for relevant relationships.193,197 Edges 
between two nodes were estimated at most pairwise, after adjusting for all other 
substance use, negative affect, and externalizing variables.196 Edges were compared 
against each other to determine strength. Networks were visualized using the qgraph 
package.198 Blue edges illustrate positive partial correlations; red edges illustrate 
negative partial correlations. The wider the edge, the stronger the correlation. 
The Ising model contains two node-specific parameters: an interaction parameter 
and a node parameter. The interaction parameter, !!" , represents the strength of the 
interaction between variables j and k. The node parameter, τj, represents the 
autonomous disposition of the variable to take the value of one, regardless of 
neighboring variables. The model estimates these parameters with logistic regressions, 
iteratively, (i.e., one variable is regressed on all others).196 The conditional probability of 
#$ given all other nodes #\$	'( given by: 
 
 Pθ+x#-x$%. = 	
exp	[τ#x# + x# 		∑ β#&x&&∈(\# ]






where 8	 = 	 (8*, 8+, … , 8,) and 8- = 	0	>?	1. The node parameter or intercept is τj , the 
threshold of the variable. The interaction parameter or slope is !!" , the connection 
strength between the relevant nodes.196  
A network approach was conducted to estimate the edges, or connections 
between the nodes (i.e., denoted as lines between the nodes and are called edges) as 
partial correlations among a set of binary items (i.e., current substance use behaviors 
[exclusive cigarette, exclusive e-cigarette, dual cigarette and e-cigarette, alcohol, 
marijuana, and PDNP], four negative affect symptoms, and seven externalizing 
symptoms).34,196,199 
Network Comparisons to Test for Gender Differences. Gender differences across 
networks were evaluated using two approaches. First, visual comparisons using an 
average layout established differences in the magnitude and direction (i.e., positive or 
negative) of edge-weights between nodes. Second, three tests of network invariance 
were used to test significant differences in network models by gender: global strength 
invariance, network structure invariance, and edge strength invariance. 
Global strength invariance. The global strength invariance hypothesis tested 
whether the overall level of connectivity in a network was identical between men and 
women. The global strength invariance hypothesis tests the weighted absolute sum of 
all edges in the networks (i.e., @ or the sum of the unique variance in the network).200 
The null hypothesis specifies that the connectivity for a network in men (A-!* ) and 
women (A-!+ ) are equal: B.:	∑-/*
0 ∑!1--A-!* - = 	∑-/*
0 ∑!1--A-!+ -, where A-!2  is the edge-
weights between nodes ' and $ of network D.  
For all ' < 	$, the distance @ between two networks if defined as:  
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 @+A-!* , A-!+ . = 	 |∑-/*
0 ∑!1-(-A-!* - − -A-!+ -)| (11) 
 
The test of global strength invariance was accomplished through permutation 
testing procedure as implemented in the NetworkComparisonTest package201 to 
statistically assess the difference in global strength by gender. Briefly, permutation 
testing was conducted by repeatedly rearranging the data and calculating the test 
statistic of each permutation. 
 Network structure invariance. A test of the network structure invariance 
hypothesis was conducted to determine whether network structures were identical by 
gender. This test was conducted by comparing the maximum differences in the edge 
weights between all nodes in the networks.200 The null hypothesis that specifies all 
edges are equal is: B.:	H* = H+, where H2 denotes a symmetric I	8	I matrix that 
contains the edge weights of graphical model D. Therefore, gender difference in 
network structure would be detected if any of the edge weights between the nodes are 
determined to be different by gender.  
 The test of network structure invariance computed the maximum difference (J) 
in network edge-weights (A-!2  between nodes ' and $ of network D) by gender. The 
maximum statistic provides the largest value among each element of a vector which 
contains the differences in unique edge weights of networks in men (A-!* ) and women 
(A-!+ ). This is defined as:  
 J+A-!* −	A-!+ . = KL8-!|A-!* −	A-!+ | (12) 
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for ' < 	$ (i.e., the upper triangle of the matrix Ω). This metric functioned as the test 
statistic, and followed the same permutation procedure used to test the global strength 
invariance.   
Edge strength invariance. A test of the edge strength invariance hypothesis was 
conducted to determine if a specific edge between two nodes was equally strong by 
gender. Edge strength is also referred to as the edge weight, quantified as the 
magnitude of an edge. This is the magnitude of association between two nodes. The 
null hypothesis for this test is B.:	A-!* = A-!+ . This was assessed by taking the absolute 
difference in edge strength (A-!) between two nodes ('	LMN	$, O>?	' < $) of interest then 
testing differences between nodes across all other node combinations in the 
networks200: 
 
 P+A-!* 	, A-!+ . = |A-!* −	A-!+ | (13) 
 
 Network Model Evaluation. Once network models were produced, the network 
structure was detailed across four categories: centrality (i.e., the influence of a node in a 
network), nodewise predictability (i.e., how well a given node can be predicted by all 
other nodes it is connected to in the network), model accuracy (i.e., the degree to which 
the model correctly describes the data), and model stability (i.e., the degree to which 
network estimates are expected in other samples). The aggregate evaluation of these 
edge-related metrics provides additional detail regarding how nodes within a network 
connect with one another and the degree to which a given network model is expected to 
consistently explain the data.  
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 Centrality. Three centrality metrics (closeness, betweenness, and node strength) 
were computed for all three networks (full sample, men only, women only) in order to 
detail how nodes (i.e., substance use behaviors and negative affect-externalizing 
symptoms) interact with one another within a network.  
Closeness quantifies how well a node is indirectly connected to other nodes.197 
Closeness is a measure of reach or importance of an individual node, based on the 
number of connections of that node, localized to that node. It considers the indirect ties 
to other nodes in addition to immediate connections. The closeness of a node is the 
reciprocal of the sum of the shortest path distances from the node to all n-1 other 
nodes. The higher closeness centrality, the shorter reach to other symptoms in the 
network meaning the more connected the symptom is to other symptoms in the 
network.  
Betweenness refers to how critical a node is to a network as a bridging node to 
all other nodes in the network. It quantifies the number of times a node act as a bridge 
between the shortest path of two other nodes.197 Betweenness is a measure of 
centrality based on the shortest path length connecting any two nodes. For a given 
node, betweenness is the sum of the fraction of all possible shortest paths that pass 
through that node. The more of these shortest paths that go through a node, the higher 
their betweenness centrality. Betweenness identifies bridges or go-betweens to identify 
other symptoms that may be key players in the comorbidity network.  
The node strength also known as degree of a node is the number of edges that 
touches that node. It quantifies how well a node is directly connected to other nodes.197 
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Nodes that have many edges would be considered to have a high node strength 
because it indicates more connectedness to other nodes.  
All centrality estimates were standardized using z-scores in order to compare the 
metrics across the networks. Additional details for each centrality metric calculated from 




Figure 4.2: Example Network Model 
 
Table 4.3: Calculations, Examples and Interpretations of Node Centrality Metrics 
Derived from Example Network Model 
Metric Calculation Figure Example  Interpretation 
Closeness Reciprocal of the 
sum of the 
shortest path 
distances from 
the given node to 








Values for closeness 
centrality for each node:  
A = 0.75, B = 1.0, C = 1.0, 
and D = 0.75.  
 
Sum of shortest paths for 
node A: 
(A—B) = 1 
(A—C) = 1 
(A—D) = 2 
Total = 4 
 
Closeness for node A is 
calculated: 1/[4/3] = 0.75. 
Nodes B and C have 
the highest 
closeness value 
because they only 
have a shortest path 
of 1 to all other 
nodes in the graph. 
Nodes A and D have 
a shortest path of 2 
to one another. 
 
Betweenness For a given node, 
the sum of the 
fraction of all 
possible shortest 
paths that pass 
Betweenness centrality is 
as follows: A = 0.0, B = 
0.166, C = 0.166, and D = 
0. 
 
Nodes B and C have 
higher betweenness 
centrality compared 
to nodes A and D. 






All possible shortest paths: 
(A—B), (A—C), (A—C—
D), (A—B—D), (C—D), 
(B—D), and (B—C). Only 
the A—D path that 
includes C is counted in 
the calculation of for 
betweenness. 
 
Betweenness for node C 
is = 1/6 = 0.166. 
 
between nodes A 
and D. One must go 
through B and C to 
connect to nodes A 
and D.  
Strength Count of the 
number of edges 
that touches a 
given node. 
Strength 
A = 2 
B = 3 
C = 3 
D = 2 
Nodes B and C have 
the highest strength 
and have greater 
connectedness 
compared to nodes A 
and D. 
 
 Nodewise Predictability. In addition to evaluating network structure as 
summarized above, it is important to also analyze nodewise predictability. The concept 
of predictability complements the interpretation of network structures. Specifically, 
nodewise predictability quantifies how well a given node can be predicted by all the 
other adjacent nodes it is connected to in the network.202 Estimating predictability is 
crucial for three reasons. First, it considers how much of the variance at a given node is 
explained by the edges connected to it. Consequently, an edge that explains 50% of the 
variance of a node will be considered more important than an edge that explains 0.5% 
of the variance of the node. Second, the predictability at one node can provide an 
expectation regarding the extent to which a specific node is influencing another node. 
Therefore, nodewise predictability can produce expectations regarding whether a node 
can be influenced by intervening on the nodes that are connected to it. Third, estimates 
of predictability across nodes indicates whether a network (or portion of the network) is 
influenced by itself through strong interactions between nodes (i.e., high predictability) 
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or whether it is mostly determined by other factors that are not included in the network 
(i.e., low predictability).202 Consequently, interpretation of nodewise predictability can 
yield important insight about the whole network in addition to those related to network 
structure (i.e., centrality). 
Estimation of Predictions in Network Model. Nodewise predictability is estimated 
by computing the mean of the conditional distribution of a specific node given all its 
neighboring nodes.  
 
Figure 4.3: Six-node network to determine nodewise predictability of Node A 
 
For example, in a six-node network (Figure 4.3) consisting of nodes A, B, C, D, E 
and F, an estimated network is produced and the probability of observing a node (A) 














where A is a node measured as a binary variable and k indicates the category, K 
is the number of categories that the node (for a binary node, K = 2). C and D represent 
the nodes adjacent to A. µ& represents the mean of the conditional distribution at node 
A and is estimated as: 
 µ& =	!." +	!5"S +	!6"T (15) 
 
where !5"S and !6"T represent the edge weights of nodes C and D on node A. 
Therefore, the probability of observing a specific value at node A depends on the 
influence of nodes C and D on node A.  
Quantifying Predictability Using Categorical Data. The estimation of nodewise 
predictability for categorical data establishes how close estimated predictabilities at 
each node compared to the observed values in the data. The predictability of a network 
that uses continuous data is estimated as a proportion of the variance for the network 
model that is explained by the predictability measure, measured as: 
 





where YL? is the variance, Z[ is a vector of predictions for Z	as defined in equation 
14, and Z is the vector of observed values in the data. All variables are centered to 
reflect a mean of zero in order to remove the possibility that an intercept from a given 
node can affect the predictability measure. When X+	= 1, a node can be perfectly 
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predicted by its neighboring nodes.  In comparison, when  X+ = 0, a node cannot be 
predicted by all its neighboring nodes in the network. 
 The estimation of nodewise predictability for categorical data differs from that of 
continuous data. In particular, the use of categorical data necessitates the estimation of 
a value of “normalized accuracy” which parallels the estimation of nodewise 
predictability by centering the mean to be equal to zero. Normalized accuracy is 
estimated by removing the marginal effects at each node (i.e., probabilities of the 
categories when ignoring all other variables) to determine how well a given node was 
predicted by all other nodes in the network. The utility of normalized accuracy can be 
exemplified using a hypothetical sample with 100 observations, where ten observations 
have a score of zero and 90 observations with a score of one. The marginal 
probabilities for the node are I0 = 0.1 and I1 = 0.9. Further, if all other nodes in the 
network do not contribute to predicting whether a node has a value of 1 or 0, it is 
possible to predict a value of one for all cases. Subsequently, a 90% correct 
classification would be estimated. However, this is misleading and results in an inflated 
estimate of predictability because nothing can be predicted by all the other nodes. 
Normalized accuracy is estimated to remove the accuracy that occurs from the “trivial” 
prediction from other nodes using marginal of the variable (I1 = 0.9) alone. Therefore, 
normalized accuracy is estimated as the ratio between the additional accuracy due to 





Z −KL8{I., I*, … , I:}
1 − max{I., I*, … , I:}
 (17) 
 
where Z = 	 *,∑-/*
, 	 ∥ (_- = ŷ-), which reflects the proportion of correct predictions 
(accuracy/correct classification). Additionally, I., I*,… I: represent the marginal 
probabilities of the categories for a node where ∥ is the indicator function for the event 
a- =	ab̂-. For binary variables, the marginal probabilities are defined as I. and I* = 1 −
	I..  Therefore, Z,89: indicates how much the node of interest can be predicted by all 
other nodes in the network, beyond what is trivially predicted by the marginal 
distribution. When Z,89: = 0, none of the other nodes contribute to the marginal in 
predicting the node of interest. When Z,89: = 1, all other nodes perfectly predict the 
node of interest.202 
 Interpreting and Visualizing Predictability Using Categorical Data. It is valuable to 
interpret estimates of Z  and Z,89:	via network model visualization as a multi-colored 
ring surrounding a node.  
 
Figure 4.4: Visualizing the Nodewise Predictability of Categorical Data 
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In Figure 4.4, the accuracy of a node from an intercept-only model (i.e., a model 
estimating node predictability without the influence of the other nodes) is represented by 
the orange part of the ring. The red part of the ring reflects the additional accuracy of 
the node that is achieved by all the remaining nodes. The sum of the red and orange 
sections represents Z, or the accuracy of the full model.   Z,89: is the normalized 
accuracy that is estimated as the ratio between the additional accuracy due to the 
remaining nodes in the network and one minus the accuracy of the node alone (white + 
red sections). 
Model estimation to compute nodewise predictability was completed using the 
mgm package.203 The estimated models for the nodewise prediction were the same as 
those estimated using the IsingFit package because the approach was the same: 
neighborhood selection-based method to estimate the binary-valued Ising model.202 The 
predict ( ) function was used to compute the predictability for each node in the network, 
specifying accuracy/correct classification, normalized accuracy, and the accuracy of the 
intercept (marginal) model to visualize the decomposition of total accuracy. 
Accuracy and Stability. Typical parameter estimates in a model provide some 
indication of the degree of uncertainty around the estimate (e.g., standard error or 
confidence intervals). However, such estimates are not automatically generated from a 
network model. Consequently, a preliminary network model cannot provide insight 
regarding the uncertainty of the parameters estimated. Additional calculations of 
accuracy and stability related to the network parameter estimates can be produced to 
establish confidence in the model’s ability to estimate the true value from the data. 
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 Tests of accuracy and stability established confidence in the network model’s 
ability to generate the accurate estimate, allowing for appropriate interpretation of 
results. Therefore, network accuracy and stability tested the inferences about the 
network structure and centrality indices. Accuracy and stability were calculated in three 
steps: (1) estimating the accuracy of estimated edge-weights, by drawing bootstrapped 
confidence intervals, (2) investigating the stability of centrality indices, and (3) testing 
whether edge-weights and centrality estimates for different variables differ from each 
other using a bootstrapped difference test.197  
Edge-weight accuracy (i.e., the accuracy of estimated network connections) was 
assessed by obtaining confidence intervals around the estimated edge-weights using 
non-parametric bootstrapping (bootnet package204).197 Confidence intervals generated 
around the estimated edge-weights identifies the precision of the edge-weight and 
whether the confidence intervals overlap with the bootstrapped confidence intervals of 
other edge-weights. An edge-weight with high accuracy has a narrow confidence 
interval that does not overlap with the confidence interval of other edges. The non-
parametric bootstrapping evaluated whether edge-weights for the variables in the 
network differed from each other in three steps: (1) estimate the difference between the 
bootstrap value of two edge-weights using non-parametric bootstrap, (2) construct 
bootstrapped confidence interval around difference scores, and (3) test the model with 
estimated connections against a model of the null hypothesis to establish whether edge-
weights differed from one another by checking if zero was in the bootstrapped 
confidence interval.197 Results from the edge-weight accuracy test are visualized as a 
plot. 
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Centrality stability refers to the degree to which an estimate of a centrality metric 
(i.e., closeness, betweenness, or strength) is consistent after re-estimating the network 
in other samples with characteristics similar to the study sample. Centrality stability can 
be estimated for each metric separately, and answers the question: “Does the order of 
the centrality indices remain the same after re-estimating the network with a smaller 
sample?”  
The stability of the centrality indices is quantified as a correlation stability 
coefficient (i.e., CS-coefficient). The CS-coefficient represents the maximum proportion 
of observations that can be dropped from the original sample. The higher the CS-
coefficient the greater the stability of the centrality indices. A CS-coefficient should not 
be below 0.25 and preferably above 0.5 for appropriate interpretation of the results. In 
step 2, centrality stability was investigated by using a case-dropping subset bootstrap 
procedure where a centrality metric was obtained for the dataset. Then, networks were 
re-estimated after subsetting the sample to determine if the CS-coefficient for the 
centrality indices retained a correlation of 0.5 in at least 95% of the samples.197 
The estimation of a bootstrapped difference test (nonparametric bootstrap) was 
used to test the degree to which edge and centrality estimates differ from each other 
across variables. A bootstrapped difference test uses the difference between the 
bootstrapped value of one edge weight/centrality and another edge weight/centrality 
using non-parametric bootstrap and constructs a bootstrapped confidence interval 
around difference scores. The bootstrapped difference test identifies whether (1) a 
specific edge (e.g., A—B) is significantly larger than another edge (e.g., A—C) and (2) 
the centrality of node A is significantly larger than the centrality of node B. If the 
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confidence interval generated from the bootstrapped difference test includes zero than 
the two edges or two centrality metrics of interest are considered to not differ 
significantly from each other. This bootstrapped difference test was done for the 
estimated edge-weights and node strength. 
Missingness and Complex Sampling Design. Missing data were removed using 
listwise deletion (N = 2,109). Complex sampling design was not accounted for in the 




32,320 participants were included in the overall sample, and 30,211 participants 
had complete data for all nodes. The sample was 51.9% female and 66.0% Non-
Hispanic White. Age was evenly distributed across the sample. Most of the sample had 
at least a GED or high school education (88.4%) and an annual household income of 
more than $25,000 (65.9%). Past-month alcohol use was most frequently reported 
(52.4%), followed by CIG use (16.6%), and marijuana use (7.1%, Table 4.4). Sleep 
trouble was the most common past-month negative affect symptom reported (26.7%), 
followed by feeling very anxious (16.1%), feeling depressed (13.4%), and becoming 
distressed about the past (12.5%) (Table 4.4). Giving answers before the other person 
finished asking the question was the most common past-month externalizing symptom 
(32.0%), followed by having a hard time paying attention (14.6%) and listening to 
instructions (10.4%).  
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 N (Weighted %) N (Weighted %) N (Weighted %) 
Age*     
   18-24 4609 (13.6) 4495 (12.5) 9110 (13.0) 
   25-34 3232 (18.6) 3103 (16.9) 6337 (17.7) 
   35-44 2448 (16.4) 2478 (16.7) 4930 (16.5) 
   45-54 2428 (18.0) 2409 (17.9) 4846 (17.9) 
   55-64 2039 (16.7) 1929 (16.5) 3971 (16.6) 
   65+ 1547 (16.8) 1558 (19.5) 3110 (18.2) 
Race*    
   Non-Hispanic White 9815 (66.8) 9467 (65.4) 19295 (66.0) 
   Non-Hispanic Black 2129 (11.0) 2364 (11.3) 4496 (11.2) 
   Non-Hispanic Other 1266 (7.8) 1162 (7.3) 2429 (7.5) 
   Hispanic Multiracial 2383 (12.4) 2429 (14.1) 4817 (13.3) 
Education*    
   Less than high school 2287 (12.1) 1938 (11.1) 4233 (11.6) 
   GED/High school graduate 5187 (30.6) 4570 (28.5) 9765 (29.5) 
   Some college (no degree) 5353 (29.6) 5942 (32.4) 11300 (31.0) 
   Bachelor’s degree 2237 (17.6) 2260 (18.1) 4498 (17.8) 
   Advanced degree* 1132 (10.1) 1176 (10.0) 2311 (10.1) 
Annual household income*    
   Less than $10,000 2519 (11.9) 3144 (15.3) 5668 (13.7) 
   $10,000- $24,999 3287 (19.4) 3477 (21.4) 6768 (20.4) 
   $25,000- $49,999 3453 (23.3) 3214 (22.8) 6670 (23.0) 
   $50,000- $99,999 3338 (25.8) 2797 (24.0) 6140 (24.9) 
   $100,000 or more 2220 (19.6) 1692 (16.5) 3914 (18.0) 
Past month tobacco and substance use    
   CIG* 5435 (19.0) 4942 (14.3) 10381 (16.6) 
   ECIG* 299 (1.0) 278 (0.8) 578 (0.9) 
   Dual CIG + ECIG* 533 (1.7) 463 (1.3) 996 (1.5) 
   Alcohol* 9550 (56.3) 8231 (48.8) 17787 (52.4) 
   Marijuana* 2611 (9.1) 1780 (5.3) 4392 (7.1) 
   PDNP * 914 (4.7) 1035 (5.4) 1950 (5.1) 
Past month negative affect symptoms    
   Depressed* 2513 (12.1) 3178 (14.6) 5692 (13.4) 
   Sleeping* 4313 (24.6) 5249 (28.7) 9564 (26.7) 
   Anxious* 2931 (14.0) 3931 (18.0) 6864 (16.1) 
   Distressed/Past* 2459 (11.2) 3143 (13.6) 5605 (12.5) 
Past month externalizing symptoms    
   Lied* 1763 (8.2) 1480 (6.0) 3245 (7.1) 
   Attention* 2712 (13.9) 3114 (15.2) 5831 (14.6) 
   Listening 1976 (10.2) 2148 (10.6) 4128 (10.4) 
   Bully 384 (1.8) 352 (1.6) 737 (1.7) 
   Fights* 258 (0.9) 146 (0.5) 404 (0.7) 
   Restless* 1661 (7.3) 1292 (5.3) 2953 (6.2) 
   Answered* 5459 (30.5) 5937 (33.4) 11399 (32.0) 







Network Comparisons by Gender 
 The range of the magnitudes of the tetrachoric correlations between were similar 
for men and women: substance use and negative affect symptoms rMen = 0.001-0.33, 
rWomen = 0.07-0.30, substance use and externalizing symptoms rMen = 0.01-0.31, rWomen= 
-0.03-0.36, and negative affect and externalizing symptoms rMen = 0.34-0.61, rWomen= 
0.32-0.61 (Table 4.5). This suggested few gender differences between comorbid 
substance use and negative affect/externalizing symptoms. 
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Table 4.5: Tetrachoric correlations for Men (N =16,306) and Women (N =15,980)  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. CIG 1 -0.94* -0.999* 0.03* 0.26* 0.20* 0.20* 0.18* 0.21* 0.21* 0.10* 0.09* 0.12* 0.16* 0.17* 0.07* 0.06* 
2. ECIG -0.94* 1 -0.958* -0.02 0.01* 0.10* 0.08* 0.10* 0.10* 0.08* 0.03 0.09* 0.14* 0.09 -0.03 0.04 0.02 
3. Dual CIG + ECIG -0.999* -0.92* 1 0.06* 0.21* 0.21* 0.12* 0.15* 0.19* 0.15* 0.03 0.17* 0.14* 0.05 0.09 0.09* 0.09* 
4. Alcohol 0.04* 0.01 0.06* 1 0.38* 0.04 0.06* 0.07* 0.07* 0.07* 0.12* 0.12* 0.08* 0.07* 0.08* 0.15* 0.23* 
5. Marijuana 0.27* 0.10* 0.18* 0.32* 1 0.28* 0.30* 0.20* 0.29* 0.30* 0.35* 0.25* 0.22* 0.27* 0.36* 0.26* 0.19* 
6. PDNP 0.21* 0.06 0.21* 0.06* 0.30* 1 0.32* 0.33* 0.34* 0.34* 0.26* 0.25* 0.26* 0.19* 0.28* 0.17* 0.18* 
7. Depressed 0.16* 0.001 0.16* 0.07* 0.25* 0.28* 1 0.70* 0.79* 0.75* 0.49* 0.58* 0.54* 0.45* 0.44* 0.46* 0.32* 
8. Sleeping 0.12* 0.05 0.16* 0.10* 0.17* 0.32* 0.71* 1 0.73* 0.66* 0.42* 0.56* 0.54* 0.35* 0.36* 0.46* 0.35* 
9. Anxious 0.16* 0.01 0.20* 0.06* 0.22* 0.33* 0.79* 0.74* 1 0.79* 0.49* 0.61* 0.58* 0.45* 0.47* 0.50* 0.37* 
10. Distressed/Past 0.18* 0.05 0.22* 0.07* 0.26* 0.32* 0.77* 0.69* 0.81* 1 0.54* 0.57* 0.55* 0.46* 0.47* 0.49* 0.35* 
11. Lied 0.07* 0.11* 0.12* 0.19* 0.30* 0.26* 0.50* 0.43* 0.53* 0.56* 1 0.53* 0.52* 0.52* 0.51* 0.40* 0.38* 
12. Attention 0.03* 0.07* 0.17* 0.15* 0.23* 0.22* 0.58* 0.55* 0.61* 0.59* 0.57* 1 0.91* 0.47* 0.34* 0.52* 0.48* 
13. Listening 0.07* 0.01 0.16* 0.07* 0.21* 0.23* 0.57* 0.55* 0.61* 0.59* 0.53* 0.91* 1 0.48* 0.38* 0.51* 0.47* 
14. Bully 0.17* 0.07 0.14* 0.12* 0.27* 0.26* 0.45* 0.43* 0.53* 0.53* 0.54* 0.48* 0.50* 1 0.66* 0.38* 0.33* 
15. Fights 0.17* 0.07 0.11* 0.05 0.31* 0.30* 0.36* 0.35* 0.42* 0.46* 0.46* 0.36* 0.40* 0.73* 1 0.46* 0.28* 
16. Restless 0.06* 0.03 0.15* 0.11* 0.26* 0.16* 0.45* 0.43* 0.49* 0.47* 0.45* 0.53* 0.51* 0.45* 0.46* 1 0.49* 
17. Answered 0.01 0.05 0.13* 0.22* 0.20* 0.14* 0.34* 0.36* 0.40* 0.39* 0.44* 0.49* 0.45* 0.42* 0.31* 0.52* 1 
* Significant association at p < 0.05 level. 
Note: Correlations for women are on the top diagonal. Correlations for men are on the bottom diagonal. 
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The average layouts between networks for men and women did not indicate 
substantial differences by gender (Figure 4.5). The tobacco cluster was also quite 
similar for both men and women. The edge weight between “Bully” and “Fights” was 
thicker (i.e., greater) in the male network compared to the female network. Some nodes 
had more or fewer edges, depending on the network. The following nodes had more 
edges in women: PDNP, feeling depressed, feeling anxious, attention difficulties, 
fighting, and restlessness. The following nodes had more edges in men: CIG, alcohol, 
feeling distressed about the past, lying, listening difficulties, and giving answers before 
person finished asking the question. 
 
 
Figure 4.5 Network Structure by Gender 
 
 The edge-weights (EW) were significantly different (p < 0.05) between men and 
women for eight edges: (1) alcohol—marijuana (EWMen = 0.87, EWWomen = 1.08), (2) 
alcohol—sleeping problems (EWMen = 0.08, EWWomen = 0), (3) marijuana—feeling 
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anxious (EWMen = 0, EWWomen = 0.15), (4) ECIG—lying (EWMen = 0.25, EWWomen = 0), (5) 
alcohol—lying (EWMen = 0.31, EWWomen = 0), (6) alcohol—attention difficulties (EWMen = 
0.25, EWWomen = 0), (7) lying—attention difficulties (EWMen = 0.86, EWWomen = 0.56), 
alcohol—listening difficulties (EWMen = -0.11, EWWomen = 0). 
Despite some node-specific relationships that differed by gender, the overall 
structure of the networks (maximum difference = 1.33, p-value = 0.32) and the global 
strength (Men = 53.4, Women = 50.9, p-value = 0.46) did not significantly differ between 
men and women. Therefore, the overall structure and connectivity was not different 
across men and women, and we focus detailing overall network results for men and 
women together first, then we subsequently provide information for men and women 
separately to further detail these networks.  
 
Overall Network 
The overall network consisted of 17 nodes (Figure 4.6). The network had 94 non-
zero edges out of 136 possible edges (density=0.691), indicating that 69.1% of possible 
connections were identified in the network. The figure below shows the estimated 
network structure of 6 substance use behaviors (in green), 4 negative affect symptoms 
(in blue), and 7 externalizing symptoms (in yellow). The network structure is an Ising 
model, which is a network of partial correlation coefficients. Especially strong 
connections emerged between the tobacco use nodes, between “Attention” and 
“Listening”, and “Fights” and “Bully”. The negative affect symptoms were positioned 
between the substance use behaviors and externalizing symptoms, with many of the 




Figure 4.6: Overall Network of Substance Use, Negative Affect and Externalizing 
Comorbidity 
 
The assessment of the accuracy of estimated network connections demonstrated 
that many edge-weights significantly differ from one-another (Appendix C, Supplemental 
Figure 4.1). Results from the edge-weights significant difference test for the overall 
sample network can be found in Appendix C, Supplemental Figure 4.2. Tobacco 
products were negatively associated with one another (CIG—ECIG = -4.74 [95% CI = -
5.50; -3.98], dual CIG + ECIG—CIG = -4.60 [95% CI = -5.82; -3.39], dual CIG + ECIG—
ECIG = -2.66 [95% CI = -4.11; -1.21]) (Appendix C, Supplemental Table 4.1).  
Externalizing symptoms also demonstrated strong connections with one another. 
For example, attention difficulties had the strongest connection with listening difficulties 
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(EW = 3.47, 95% CI = 3.36; 3.58). Bullying was positively associated with fighting (EW = 
2.40, 95% CI = 2.10; 2.70).  
The connections between PDNP were strongest with negative affect symptoms. 
Specifically, the connections with the largest magnitudes were PDNP—sleeping 
problems (EW = 0.53, 95% CI = 0.40; 0.66), PDNP—feeling anxious (EW=0.31, 95% CI 
= 0.17; 0.46), and PDNP—feeling distressed about the past (EW = 0.31, 95% CI = 0.16; 
0.45).  
The connections between marijuana, alcohol, and PDNP use were strongest with 
externalizing symptoms. Specifically, the connections with the largest magnitudes were 
marijuana—lying (EW = 0.60, 95% CI = 0.49; 0.70), marijuana—fighting (EW = 0.54, 
95% CI = 0.27; 0.81), alcohol—answered (EW = 0.48, 95% CI = 0.42; 0.53), 
marijuana—restlessness (EW = 0.37, 95% CI = 0.26; 0.49) and PDNP—fighting (EW = 
0.36, 95% CI = 0.001; 0.72).  
The investigation of the stability of centrality indices demonstrated that closeness 
(CS coefficient = 0.517) and strength (CS coefficient = 0.594) were stable enough for 
interpretation. The betweenness CS coefficient (0.206), however, was too low to 
interpret for the overall network (Appendix C, Supplemental Figure 4.3). Significant 
differences between node strength were also tested and are displayed in Appendix C, 
Supplemental Figure 4.4.  
The centrality metrics are provided in the Table 4.6, and also depicted as z-
scores in Appendix C, Supplemental Figure 4.5. “CIG” has the greatest strength in the 
network (strength = 2.39), followed by “Dual CIG + ECIG” (strength = 1.47), “ECIG” 
(strength = 0.92), and “Anxious” (strength = 0.38). Nodes with the greatest closeness 
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centrality include “Lied” (closeness = 2.34), “Marijuana” (closeness = 1.46), “Fights” 
(closeness = 1.24), and “Bully” (closeness = 0.75). Alcohol was lowest for strength, and 
ECIG was lowest for closeness. Both are seen on the periphery of the network. 
Table 4.6. Node Centrality Indices for the Overall 
Sample 
 Strength Closeness 
CIG 2.39 -1.00 
ECIG 0.92 -1.51 
Dual CIG + ECIG 1.47 -0.59 
Alcohol -2.01 -1.07 
Marijuana -0.18 1.46 
PDNP -1.02 -0.41 
Depressed -0.35 -0.59 
Sleeping -0.21 0.05 
Anxious 0.38 -0.08 
Distressed/Past 0.27 0.13 
Lied -0.11 2.34 
Attention 0.70 0.49 
Listening -0.25 -0.68 
Bully -0.18 0.75 
Fights -0.51 1.24 
Restless -0.54 -0.003 
Answered -0.78 -0.53 
 
Men-Only Network 
The men-only network consisted of 17 nodes (N = 15,268) visualized in Figure 
4.7. The network had 85 non-zero edges out of 136 possible edges. Figure 4.7 shows 
the estimated network structure of 6 substance use behaviors (in green), 4 negative 
affect symptoms (in blue), and 7 externalizing symptoms (in yellow). The network 
structure is an Ising model, which is a network of partial correlation coefficients. Similar 
connections emerged between the tobacco use nodes, between “Attention” and 




Figure 4.7: Men-Only Network of Substance Use, Negative Affect and 
Externalizing Comorbidity 
 
The assessment of the accuracy of estimated network connections demonstrated 
that many edge-weights significantly differed from one-another (Appendix C, 
Supplemental Figure 4.6). Results from the edge-weights significant difference test for 
the overall sample network can be found in Appendix C, Supplemental Figure 4.7. 
Especially strong connections emerged among “Dual CIG + ECIG” and “CIG” (edge 
weight = -5.31), “CIG” and “ECIG” (edge weight = -4.16), “Dual CIG + ECIG” and “ECIG” 
(edge weight = -1.55), “Attention” and “Listening” (edge weight = 3.45), and “Bully” and 
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“Fights” (edge weight = 2.59). Other connections were absent like “Exclusive CIG” and 
“Sleeping” (edge weight = 0) (Appendix C, Supplemental Table 4.2). 
The investigation of the stability of centrality indices demonstrated that strength 
(CS coefficient = 0.517) was stable enough for interpretation. Closeness (CS coefficient 
= 0.361) was lower than the preferred 0.50, but higher than 0.25. Closeness metrics 
should be interpreted with caution. The betweenness CS coefficient (0.128), however, 
was too low to interpret for the men-only network (Appendix C, Supplemental Figure 
4.8). Significant differences between node strength were also tested and are displayed 
in Appendix C, Supplemental Figure 4.9. 
 The centrality metrics are provided in the Table 4.7, and also depicted as z-
scores in Appendix C, Supplemental Figure 4.10. “CIG” had the greatest strength in the 
network (strength = 2.62), followed by “Dual CIG + ECIG” (strength = 1.16), “Anxious” 
(strength = 0.71), and “Attention” (strength = 0.67). Nodes with the greatest closeness 
centrality included “Distressed/Past” (closeness = 1.62), “Lied” (closeness = 1.57), and 
“Bully” (closeness = 1.15). Alcohol was lowest for all centrality metrics. 
Table 4.7: Node Centrality Indices for the Men-Only 
Sample 
 Strength Closeness 
CIG 2.62 -0.27 
ECIG 0.07 -1.77 
Dual CIG + ECIG 1.26 0.0004 
Alcohol -1.87 -1.91 
Marijuana -0.32 0.46 
PDNP -1.19 -0.55 
Depressed -0.39 -0.31 
Sleeping -0.37 0.27 
Anxious 0.71 0.59 
Distressed/Past 0.56 1.62 
Lied 0.11 1.57 
Attention 0.67 -0.01 
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Listening -0.09 -0.76 
Bully -0.08 1.15 
Fights -0.49 0.65 
Restless -0.55 0.09 
Answered -0.66 -0.81 
 
Women-Only Network 
The women-only network consisted of 17 nodes (N = 14,925) visualized in Figure 
4.8. The network had 84 non-zero edges out of 136 possible edges. Figure 4.8 shows 
the estimated network structure of 6 substance use behaviors (in green), 4 negative 
affect symptoms (in blue), and 7 externalizing symptoms (in yellow). The network 
structure is an Ising model, which is a network of partial correlation coefficients. Similar 
connections emerged between the tobacco use nodes, between “Attention” and 
“Listening.”  
 




The assessment of the accuracy of estimated network connections suggested 
that many edge-weights significantly differed from one-another (Appendix C, 
Supplemental Figure 4.11). Results from the edge-weights significant difference test for 
the overall sample network can be found in Appendix C, Supplemental Figure 4.12. 
Especially strong connections emerged among “Dual CIG + ECIG” and “CIG” (edge 
weight = -3.98), “CIG” and “ECIG” (edge weight = -3.48), “Dual CIG + ECIG” and “ECIG” 
(edge weight = -1.96), “Attention” and “Listening” (edge weight = 3.49), and “Bully” and 
“Fights” (edge weight = 2.04). Other connections were absent like “CIG” and “Alcohol” 
(edge weight = 0) (Appendix C, Supplemental Table 4.3). 
Closeness (CS coefficient = 0.439) and strength (CS coefficient = 0.361) were 
lower than the preferred 0.50, but higher than 0.25. Closeness and strength metrics 
should be interpreted with caution. The betweenness CS coefficient (0.128), however, 
was too low to interpret for the women-only network (Appendix C, Supplemental Figure 
4.13). Significant differences between node strength were also tested and are displayed 
in Appendix C, Supplemental Figure 4.14. 
The centrality metrics are provided in Table 4.8, and also depicted as z-scores in 
Appendix C, Supplemental Figure 4.15. “CIG” had the greatest strength in the network 
(strength = 1.91), followed by “Dual CIG + ECIG” (strength = 1.35), “Attention” (strength 
= 1.13), and “Anxious” (strength = 1.03). Nodes with the greatest closeness centrality 
included “Lied” (closeness = 2.25), “Anxious” (closeness = 1.13), and “Marijuana” 
(closeness = 0.95). Alcohol was lowest for strength, and PDNP was lowest for 
closeness. Both are seen on the periphery of the network. 
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Table 4.8: Node Centrality Indices for the Women-
Only Sample 
 Strength Closeness 
CIG 1.91 -0.34 
ECIG 0.17 -1.34 
Dual CIG + ECIG 1.35 0.38 
Alcohol -2.27 -0.94 
Marijuana 0.08 0.95 
PDNP -1.11 -1.42 
Depressed -0.13 0.41 
Sleeping -0.29 0.01 
Anxious 1.03 1.13 
Distressed/Past 0.37 0.63 
Lied 0.02 2.25 
Attention 1.13 0.31 
Listening -0.05 -0.56 
Bully -0.48 -0.12 
Fights -0.23 0.76 
Restless -0.57 -0.97 
Answered -0.95 -1.15 
 
Nodewise Predictability 
 Nodewise predictability results are summarized in Table 4.9 and are graphically 
depicted in Figure 4.9. The predictability measures accuracy/correct classification and 
normalized accuracy. The accuracy of the intercept (marginal) model was also used to 
estimate the decomposition of the total accuracy in the intercept model (Table 4.9, 
Accuracy of Intercept column, orange) and the contribution of other variables (Table 4.9, 
Correct Classification – Accuracy of Intercept Model column). Figure 4.9 visualizes the 
results from Table 4.9. The colors in the ring around the node indicate the accuracy of 
the intercept model (orange) and the total accuracy (orange plus red). The normalized 
accuracy is the ratio red/ (red + white). 
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CIG 0.687 0.037 0.675 0.012 
ECIG 0.982 0.000 0.982 0 
Dual CIG + ECIG 0.969 0.000 0.969 0 
Alcohol 0.590 0.041 0.572 0.018 
Marijuana 0.861 0.011 0.859 0.002 
PDNP 0.938 0.001 0.938 0 
Depressed 0.878 0.312 0.823 0.055 
Sleeping 0.808 0.357 0.701 0.107 
Anxious 0.876 0.422 0.785 0.091 
Distressed/Past 0.883 0.330 0.825 0.058 
Lied 0.904 0.048 0.899 0.005 
Attention 0.908 0.498 0.817 0.091 
Listening 0.914 0.332 0.871 0.043 
Bully 0.977 0.024 0.976 0.001 
Fights 0.987 -0.027 0.987 0 
Restless 0.909 0.009 0.908 0.001 
Answered 0.707 0.186 0.640 0.067 
 
Results from the CIG node are detailed as an example by which to interpret 
results. The normalized accuracy (i.e., estimate of nodewise predictability for use with 
categorical variables) was 0.037. The normalized accuracy was computed by taking the 
ratio of the contribution from other variables (0.012) to the contribution from other 
variables (0.012) plus one minus the total accuracy: 0.012/0.012 + 0.313 = 0.037. 
Therefore, 3.7% of the CIG node could be predicted by all other nodes in the network. 
Further, the total accuracy of the CIG node was 68.7% (0.675 + 0.012 = 0.687). 
Therefore, most of accuracy of the CIG node (67.5%) was due to contributions of this 
node specifically. Since the other variables do not strongly contribute to the 
predictability of CIG, it is expected that successful intervention on past-month CIG use 
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specifically could potentially address use by 68.7%. In contrast, intervention for other 
behaviors related to past-month CIG use is likely to influence this behavior by 3.7%. 
Results for the CIG node are compared against the Anxious node, where a 
greater proportion of the predictability was due to other nodes. The normalized accuracy 
of the Anxious node was 0.422 meaning that 42.2% of the Anxious node could be 
predicted by all other nodes in the network. Furthermore, the total accuracy of the 
Anxious node was 87.6%, meaning that the majority of accuracy of the Anxious node 
(42.2%) was due to contributions of other nodes in the network, not the Anxious node 
specifically (45.4%). Unlike the CIG node, successful intervention on other nodes 
connected to the Anxious node could potentially address this symptom by 87.6%. 
 
Figure 4.9: Mixed Graphical Model Estimated on the Data. Green edges indicate 
positive relationships and red edges indicate negative relationships. The orange part of 
the ring indicates the accuracy of the intercept model. The red part of the ring is the 
additional accuracy achieved by all remaining variables. The sum of both orange and 
red is the accuracy of the full model A. The normalized accuracy Anorm is the ratio 
between the additional accuracy due to the remaining variables (red) and one minus the 
accuracy of the intercept model (white + red). 
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 Nodes with greater strength and greater magnitudes in edge-weights were 
predicted better (e.g., Dual CIG + ECIG and Attention) than nodes with fewer or weaker 
edges (e.g., Alcohol). Alcohol (0.590), CIG (0.687), and Answered (0.707), and had the 
lowest total accuracy in the network whereas Fights (0.987), ECIG (0.982), and Bully 
(0.977) had the highest total accuracy. Interestingly, the predictability of fights, ECIG, 
and Bully had no contribution from the other variables (correct classification = 0 or near 
0). Other nodes also had a correct classification of 0 (i.e., Dual CIG + ECIG and PDNP) 
meaning that other nodes in the network did not predict the node at hand beyond the 
intercept model. Additional accuracy due to the remaining variables contributed to the 
predictive ability of the negative affect items as well as Attention, Listening, and 
Answered externalizing items (denoted by the red portion of the ring).  
The average predictability as estimated across the accuracy/correct classification 
column for all nodes was 0.85, indicating that 85% of the variance of the network was 
explained by the nodes in the network. Therefore, the network was largely determined 
by itself through strong mutual interactions between nodes. Intervention on any of these 
nodes would likely result in a decrease of a neighboring symptom, especially for nodes 
with higher contribution from other variables in the network. 
 
DISCUSSION 
 To our knowledge, this is one of the first studies to investigate a comorbidity 
network including substance use behaviors and a wide range of mental disorder 
symptoms in a large sample of U.S. adults. There were two major results from this 
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study. First, networks for men and women did not significantly differ in structure and 
connectivity, although there were significant differences by gender between specific 
nodes. Second, the overall network structure and edge-weights confirmed the 
connections of substance use behaviors, negative affect symptoms, and externalizing 
symptoms in the network. Yet, there were edges that crossed the construct boundaries 
(i.e., substance use, negative affect, externalizing), identifying connections across these 
three constructs. Furthermore, high predictability of all nodes indicated the network was 
largely determined by itself through strong mutual interactions between nodes. These 
results suggest that symptom connections, including substance use, (1) do not 
significantly differ between men and women, and (2) connect based on construct with 
some overlap. 
 
No gender differences between overall networks but some gender-specific differences 
between nodes 
There were no significant gender differences for the overall comorbidity 
networks. This was inconsistent with our hypothesis based on expectations developed 
in the prior literature.123,190 In general, these studies report a higher prevalence of 
alcohol, tobacco, illicit substance use, and externalizing problems in men and greater 
negative affect symptoms and comorbidity in women.123,183,189,190 Differences in the 
network structures may be due to the measurement of past-month substance use and 
mental health symptom endorsement rather than diagnosis. There were gender 
differences in higher severity due to use of aggregate sum scores. However, this 
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difference was not present in a comorbidity network of people experiencing 
subthreshold levels of use or symptoms.205,206  
Some gender-specific differences were discovered between nodes. These are 
detailed below: 
(1) Alcohol—marijuana (EWMen = 0.87, EWWomen = 1.08): One would likely expect 
that this connection between alcohol and marijuana would have a larger 
magnitude for men, especially given that men experience more substance use 
and externalizing behaviors.123,183,189,190 However, as men have a higher 
prevalence of marijuana use, women have demonstrated a greater increase in 
use over time.153 From 2006-2016, the rate of marijuana use increased 40% for 
men (from 8.1% to 11.3%), and 63% for women (from 4.1% to 6.7%).153 Data 
also suggest that women have a faster development of cannabis use disorder 
with poorer outcomes compared to men.153 Therefore, the alcohol—marijuana 
connection may be a greater connection of interest in women, but should also not 
be discounted in men. 
(2) Alcohol—sleeping problems (EWMen = 0.08, EWWomen = 0): There was a small 
positive connection between alcohol use and sleeping problems for men where 
there was no edge present for women, indicating that alcohol use was associated 
with sleeping problems in men. The relationship between alcohol use and sleep 
disturbances is well established.207 A recent study conducted in the United 
Kingdom identified that men who maintained a heavy volume of drinking over 
three decades, had unstable consumption patterns, and sustained hazardous 
drinking had worse sleep profiles compared to men without these problems while 
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results for women were mixed.208 This relationship is consistent with the literature 
and should continue to be a relationship of interest in comorbidity research. 
(3) Marijuana—feeling anxious (EWMen = 0, EWWomen = 0.15): Women have 
demonstrated a greater increase in marijuana use over time compared to men, 
although men have a higher prevalence of marijuana use.153 Women with 
cannabis use disorder are more likely to experience anxiety and depression 
compared to men with cannabis use disorder.153 This relationship is consistent 
with prior work and underscores the importance of marijuana use and anxiety 
problems in women. 
(4) ECIG—lying (EWMen = 0.25, EWWomen = 0): Men reported more ECIG use and 
lying behaviors compared to women. This is consistent with research that has 
established women reporting less substance use, including e-cigarettes, and 
externalizing behaviors compared to men.123,183,189,190,209 Additionally, this 
significantly different edge demonstrates that this connection is not present in 
women where other positive connections exist for the lying node (e.g., attention 
difficulties—lying). This relationship may be of more importance in men versus 
women. 
(5) Alcohol—lying (EWMen = 0.31, EWWomen = 0) and Alcohol—attention 
difficulties (EWMen = 0.25, EWWomen = 0): Men consistently drink more alcohol 
and have a higher likelihood of alcohol use disorders compared to women.210–212 
Similarly, men experience more externalizing symptoms than women.123,183,189,190 
The relationship between with alcohol and externalizing symptoms is in line with 
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prior research and these results confirm the importance of this relationship, 
especially with lying and attention difficulties, in men. 
(6) Lying—attention difficulties (EWMen = 0.86, EWWomen = 0.56): Lying and 
attention difficulties are externalizing behaviors that are associated with each 
other in both men and women. The association between attention difficulties, 
commonly seen with ADHD, and emotional dysregulation is well recognized.213 
Emotional dysregulation encompasses emotional expressions and experiences 
that are context-inappropriate, which is clinically expressed as irritability.213 
Those with irritability can react to the external stimuli in ways that are overly 
angry and aggressive214; however, the connection between attention difficulties 
and lying is not well understood. This connection should be investigated further, 
especially in men as we see a stronger magnitude of association compared to 
women. 
(7) Alcohol—listening difficulties (EWMen = -0.11, EWWomen = 0): The relationship 
between alcohol and listening difficulties is not as well understood compared to 
other externalizing symptoms identified with alcohol use. Listening difficulties can 
be classified as an inattention ADHD symptom.2 The comorbidity between ADHD 
and alcohol has been identified14,15,215 yet our results reflect a negative 
relationship between listening difficulties and alcohol for men and no relationship 
for women. This may be because the inattention ADHD symptom may be less 
likely to be associated with alcohol use compared to the hyperactivity/impulsivity 
ADHD symptoms.216 However, results are mixed.216–219 Further work is needed to 
better understand this relationship by gender. 
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Overall network connections with negative affect and externalizing symptoms varies by 
substance 
 The largest edge-weight between any tobacco product and a negative affect or 
externalizing symptom was found between dual use of CIG and ECIG and feeling 
anxious. Furthermore, out of all potential connections with negative affect and 
externalizing symptoms, ECIG was only connected to sleeping problems. Previous 
studies of adolescents and young adults found ECIG use was associated with ADHD, 
PTSD, anxiety and other SUDs.94,95,97 More research is needed to confirm the 
relationship between ECIG and mental health symptoms in adults. It is possible that 
these differences in results are due to the measurement of tobacco use. It is rare for 
studies to exclude ECIG use from CIG use and vice versa, which misclassifies the 
relationships between CIG and ECIG use to be more strongly associated than reality. 
Consequently, the study of this association may be important to consider in future 
research.  
PDNP was connected to negative affect and externalizing symptoms with the 
strongest connection found with sleeping problems, followed by fighting, feeling 
anxious, and becoming distressed about the past. These results confirm previous work 
which identified nonmedical prescription drug disorders with externalizing behaviors220 
as well as negative affect behaviors, specifically opioids with PTSD symptoms.154  
Marijuana had a relatively strong connection between two externalizing 
symptoms (i.e., lying and fighting). These connections with conduct disorder specific 
symptoms confirm and reinforce the association with marijuana use as stronger than 
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with previously identified negative affect symptoms (i.e., anxiety and depression).149–152 
Although these connections were not as strong as those within the construct, they exist 
and demonstrate the overlapping nature among these symptoms and behaviors. 
Alcohol was connected to the impulsivity item which is consistent with previous 
alcohol focused literature demonstrating an association between highly impulsive 
behaviors and alcohol use.221 A bidirectional relationship has been identified in that 
impulsivity significantly increases the risk for initiation, continuation, and excessive 
alcohol use and can also result from acute intoxication and long-term alcohol abuse. 221 
These results confirm this association specifically with a past month measure of alcohol 
use and through the externalizing symptom of giving an answer before a question is 
finished being asked. 
Finally, several weaker and negative connections remain across substances and 
negative affect/externalizing symptoms although there were some strong connections 
across constructs, which is supported by the prior literature.89,149,169–173 These broad, 
though weaker connections emphasize the complexity of the comorbidity across 
substance use and negative affect/externalizing disorders. 
 
Node Centrality and Predictability 
 Strength and closeness were the only centrality metrics stable enough to 
interpret for the overall, men, and women networks. Exclusive CIG use and dual CIG 
and ECIG use were the two nodes with the largest strength in all three networks. This 
means that these two types of tobacco use had the most connections to other nodes in 
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these networks. This may be due to the oversampling of tobacco users in the PATH 
data or due to tobacco use being common across the other behaviors.  
 Lying, acting as a bully, physical fighting, feeling anxious, feeling distressed 
about the past, and marijuana use were the nodes with the highest closeness centrality 
for the three networks. Based on these results, we could consider lying, acting as a 
bully, and physical fighting as more important externalizing nodes in the comorbidity 
structure compared to the others given their stronger measure of indirect ties to other 
nodes in the network. Similarly, we could assume that feeling anxious and feeling 
distressed about the past may be a more important negative affect node in the 
comorbidity structure as it has a closer measure of reach compared to the other 
negative affect symptoms. Marijuana use could also be considered an important 
substance use node in the comorbidity structure based on its high closeness centrality. 
 Nodes with more and stronger edges had higher node predictability compared to 
other nodes in the network with lower strength. The overall high predictability of all 
nodes in the network, however, has implications for potential intervention. Since, on 
average, 85% of the variance of a node was explained by its neighbors, then one could 
intervene on one of these symptoms which could affect the entire network. The negative 
affect variables had the highest predictability contributed from other nodes in the 
network. Therefore, if we wanted to reduce anxiousness, the network model suggests 
intervening on the variables that are closely connected to the anxious node: sleep 
problems, feeling depressed, and feeling distressed about the past. Nodewise 
predictability tells us we might reduce anxiousness by approximately 87.6% (total 
 163 
accuracy) if we were to intervene on sleep problems, feeling depressed, and feeling 
distressed about the past. 
 The node with the overall lowest centrality in all networks was past month alcohol 
use. This is consistently low across all networks, perhaps because in the way alcohol 
was measured in this study. Past month alcohol use is not indicative of severity or 
problematic alcohol use. Therefore, people who indicated past month alcohol use were 
not likely to also indicate other substance use behaviors and mental disorder symptoms, 
as demonstrated by the low strength and closeness. More severe measures of 
problematic alcohol use, however, may perform differently in a comorbidity network. 
Future work should consider other measures of alcohol use in determining comorbidity 
structure of substance use behaviors and mental disorder symptoms.  
 
Strengths and limitations  
These results should be evaluated in light of the following limitations. First, 
conclusions that are drawn from this study are not indicative of severe psychopathology 
or SUD because it uses a population-based sample and data from subthreshold 
behaviors. Therefore, we cannot draw conclusions about disorders. Nevertheless, the 
purpose of this project was to better understand how the wide range of behaviors and 
symptoms interact in a typical sample of adults. Second, the items included in the 
networks were dichotomized either from combining multiple measures as seen in the 
substance use items or from collapsing the ordinal negative affect/externalizing items. 
This strategy results in a loss of information, but allows for easier interpretation of the 
results, especially since all items overlap regarding time (i.e., past-month endorsement). 
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Additionally, the items included in the network analysis represent three separate 
constructs (i.e., substance use, negative affect problems, and externalizing problems) 
and this presents a potential limitation regarding nodewise predictability because these 
constructs are correlated. This could result in edge-weights indicating how similar the 
variables are and do not necessarily reflect mutual influence. Therefore, further 
investigation in the nodewise predictability of these items is warranted. Future analyses 
could include three categorical items that represent the constructs and then test for 
nodewise predictability. Third, these models did not adjust for the influence of other 
sociodemographic variables. Therefore, there may be some residual confounding. 
Fourth, these data are cross-sectional. We cannot draw any causal inferences from 
these networks. Future research is encouraged to study these networks over time. Fifth, 
networks can only be estimated with complete data. Approximately 2,109 participants 
were missing data on all seventeen items and not included in the estimation of the 
overall network. There may be potential for social desirability or misclassification biases 
in that the people with missing information on these items did not want to endorse their 
substance use or mental disorder symptoms. 
A strength of this project includes the use of accuracy, stability and comparison tests 
to ensure that the inferences made by these study results were appropriate.  
 
Conclusions 
Results emphasized many weak connections throughout the substance use and 
negative affect/externalizing network and identified a few important connections for 
future study. In particular, PDNP was most strongly associated with negative affect 
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while marijuana, alcohol and PDNP use were most strongly associated with 
externalizing. Future work should replicate these analyses in other large samples, 
including additional nodes of importance and/or sociodemographic factors that may play 
a role in the comorbidity structure and assess the stability of these networks over time. 
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CHAPTER 5: PRELIMINARY PATTERNS OF SUBSTANCE USE AND MENTAL 




 Comorbidity of substance use and mental health problems are more common 
than exclusive substance use or mental health problems only.67 Comorbidity has been 
detected consistently across age groups, and studies within a specific age group have 
demonstrated different results. For example, younger age groups are at a greater risk of 
experiencing substance use and mental health comorbidity compared to older age 
groups.41,222 It is unclear, however, whether patterns of comorbidity in adults change 
over time.  
 
Substance use comorbidity over time 
 Several longitudinal studies identifying co-occurring substance use over time 
have focused primarily on youth and young adults. These studies have discovered a 
similar result in that substance use behaviors are relatively stable over time; however, if 
there is a change in behavior, it usually moves from less severe to more severe (e.g., 
alcohol only to using multiple substances simultaneously [polysubstance use]). 
Generally, early substance use (e.g., alcohol and illicit substances) in adolescents is 
strongly associated with later substance use disorder (SUD) development.223 
Longitudinal association studies in youth have demonstrated that ever tobacco use 
predicts subsequent substance use224 while others have identified heavy alcohol use 
predicting marijuana use during college.225,226 A latent transition analysis of adolescents 
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identified three substance use groups (mild alcohol use, alcohol and moderate 
marijuana use, and polysubstance use). Overall, adolescents generally remained in the 
same group over time; however, when they did transition, adolescents were most likely 
to move to a more harmful substance use status.227 Another longitudinal analysis of 
vocational students (16 to 20 years) in Germany found a similar result. Approximately, 
10% of alcohol users at baseline transitioned to polysubstance use of alcohol, 
cigarettes, and marijuana at 18-month follow up.52 It is unclear whether this stability and 
potential transition to more harmful substance use continues in adulthood. 
 
Mental health comorbidity over time 
 Compared to co-occurring substance use, more is understood about co-occurring 
mental health conditions in adults. There is evidence that less severe mental disorders 
precede more severe disorders.2 Certain mental health conditions can increase the risk 
of development of future mental health conditions. For example, chronicity of depressive 
symptoms increases the likelihood of anxiety and substance use disorders.2,55,56 
Epidemiologic studies have provided evidence for both continuity and change of mental 
disorder comorbidity.67–69 Overall, the highest stability rates are documented in low 
psychopathology and externalizing classes, whereas the internalizing or negative affect 
and highly comorbid classes are moderately stable. Furthermore, results from a latent 
transition analysis of a nationally representative sample demonstrated that internalizing 
or negative affect presentations progressed toward remission, while comorbid and 
externalizing presentations was notably symptomatic across time.67  
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Substance use and mental health comorbidity over time 
 Less, however, is understood about the stability of substance use and mental 
disorder comorbidity in adults over time. To date, comorbidity studies have reported that 
(1) externalizing problems (e.g., ADHD, ODD, CD) in youth precede substance use in 
both boys and girls whereas (2) substance use (e.g., alcohol and marijuana) in youth 
predict internalizing or negative affect disorders in adulthood specifically for women.57–61 
A systematic review and meta-analysis of prospective cohort studies suggests a 
positive association between anxiety and later alcohol use disorders.228 More 
longitudinal approaches to assessing the comorbidity structure over time is needed. 
These studies will help to better understand the progression or regression of symptoms 
or behaviors in adults, and identify how to better support individuals experiencing 
comorbidity. 
 
Study goals and hypotheses 
 The primary goal of this study is to perform a preliminary assessment of the 
substance use and mental disorder symptom comorbidity patterns across three years of 
data (2013-2016) using both latent class and network analyses. The secondary goal of 
this study is to describe the similarities and differences in the patterns of comorbidity 
across LCA and network analyses. Based on the current understanding of substance 
use and mental disorder symptoms over time, we hypothesize that overall adult 
comorbidity patterns will not significantly differ across time. However, we expect minor 






The Population Assessment of Tobacco and Health (PATH) study is a nationally 
representative longitudinal cohort study of the civilian, non-institutionalized household 
population of the U.S., and participants engaged in all levels of tobacco use ranging 
from never using tobacco to frequent use.72 Three waves of data were included in this 
study. 
Wave 1. Wave 1 adult data (N=32,320) are cross-sectional and were collected 
between September 2013 and December 2014. The weighted response rate among 
participants was 74.0% for Wave 1.73 This interview rate is conditional on completion of 
the Wave 1 screener. 
Wave 2. Wave 2 adult data (N=28,362) were collected between October 2014 
and October 2015. The weighted response rate among participants was 83.2% and is 
conditional on Wave 1 participation.71 
Wave 3. Wave 3 adult data (N=28,148) were collected between October 2015 
and October 2016. The weighted response rate among participants was 78.4% and is 
conditional on Wave 1 participation.71 
Study Representativeness. New participants introduced at Waves 2 or 3 were 
excluded. This includes youth that “aged up” into the adult questionnaires. Therefore, 
we included the same adults from Wave 1 through Wave 3 resulting in Wave 2 N = 
26,444 and Wave 3 N = 26,239.  
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Participants with missing data on the substance use, negative affect, and 
externalizing measures were not included in the analysis (NWave1= 2,109, NWave2= 852, 
NWave3= 880). Survey respondents of the analytic sample endorsed significantly greater 
substance use overall, negative affect symptoms, and externalizing symptoms (except 
for fighting in Waves 1-3 and bullying in Waves 2-3) compared to those not included in 
the analytic sample. The participants in the analytic sample were more likely to be Non-
Hispanic white, men, aged 25-54 with higher levels of education and annual household 
income than those who were missing. 
 
Measures 
Past Month Tobacco and Substance Use. Six substance use categories were used 
in this study: exclusive cigarette, exclusive e-cigarette, dual cigarette and e-cigarette, 
alcohol, marijuana, and prescription drugs not prescribed (PDNP) including painkillers, 
sedatives, tranquilizers. Only past month or current use of the substances was 
considered (coded as 1, else = 0) to reduce the potential for recall bias and ensure for 
accurate overlap with negative affect and externalizing symptoms occurring in the same 
time frame. 
Past Month Negative Affect and Externalizing Symptoms. Negative affect and 
externalizing symptoms were measured using the Global Appraisal of Individual 
Needs—Short Screener (GAIN-SS).73 Four questions were used to measure negative 
affect symptoms that asked the last time you had significant problems with:  
(1) “feeling trapped, lonely, sad, blue, depressed, or hopeless about the future,” 
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(2)  “sleep trouble- such as bad dreams, sleeping restlessly or falling asleep during 
the day,”  
(3) “feeling very anxious, nervous, tense, scared, panicked or something bad was 
going to happen,” and  
(4) “becoming very distressed and upset when something reminded you of the past.”  
 
Externalizing symptoms were also measured using the GAIN-SS. Seven questions were 
used to assess externalizing symptoms. Items asked the last time you did the following 
two or more times:  
(1) “lied or conned to get things you wanted or to avoid having to do something,”  
(2) “had a hard time paying attention at school, work or home,”  
(3) “had a hard time listening to instructions at school, work or home,”  
(4) “were a bully or threatened other people,”  
(5) “started physical fights with other people,”  
(6) “felt restless or the need to run around or climb on things” and  
(7) “gave answers before the other person finished asking the question.”  
 
The items selected to identify negative affect and externalizing symptoms from the 
GAIN-SS instrument are ordinal and measures people across four times periods: past 
month, 2 to 12 months, over a year ago, and never. Participants indicating that they 
experienced a symptom within the past month were coded as 1. Participants indicating 
that they experienced the symptom 2 to 12 months ago, over a year ago, and never 
were coded as 0. Only past month or current negative affect and externalizing 
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symptoms were considered reducing the potential for recall bias and ensure accurate 
overlap with substance use occurring in the same time frame. 
Covariates. Sex, age, race, education, annual household income, and level of 
satisfaction with social activities and relationships were included as covariates in the 
generation of latent class models for Waves 1, 2, and 3. Sex was a binary variable with 
one level representing male and the other level representing female. Age, measured in 
PATH as a seven-level categorical variable, was re-categorized to have a uniform 
distribution with six levels (18-24, 25-34, 35-44, 45-54, 55-64, and 65 years or older). 
Race/ethnicity was measured as a four-level categorical race variable and included 
information from a separate variable that accounted for Hispanic ethnicity (Non-Hispanic 
White, Non-Hispanic Black, Non-Hispanic Other, and Hispanic Multicultural). Education, 
measured in PATH as a six-level categorical variable, was re-categorized as a five-level 
categorical variable with a uniform distribution [less than high school, GED/high school 
graduate, some college (no degree) or Associate’s degree, Bachelor’s degree, and 
Advanced degree]. Annual household income was measured as a five-level categorical 
variable: less than $10,000, $10,000 to $24,999, $25,000 to $49,999, $50,000 to 
$99,999, and $100,000 or more. 
 Level of satisfaction with social activities and relationships was measured as a 
five-level categorical variable: extremely satisfied, very satisfied, moderately satisfied, a 
little satisfied, and not at all satisfied. 
These covariates were included as auxiliary variables to predict the probability of 
class membership. Covariates were not included or adjusted for in the development of 




Summary Statistics. Data management and summary statistics for the three 
waves were done in SAS 9.4. Data were then exported from SAS and imported into 
Mplus to conduct the LCA. Results from the LCA were then imported back into SAS to 
evaluate the pairwise comparisons. The original data generated in SAS were also 
imported into R to estimate the network structures. 
 
Latent Class Comparisons 
Latent Class Analysis. Latent class analysis (LCA) is a type of mixture modeling 
used to identify unobserved heterogeneity in a population and find meaningful groups of 
people that are similar based on their responses to measured items.70,141 The observed 
items (i.e., six substance use behaviors, four negative affect symptoms, and seven 
externalizing symptoms) are independent of each other given an individual’s response 
on the latent variable meaning that the latent variable (i.e., comorbidity class) explains 
why the observed items are related to one another.130 LCA accounts for the observed 
covariation between substance use and mental disorder symptoms and offers objective 
indices of class classification accuracy that are not available in traditional cluster 
analysis methods.132 
Two parameters are estimated in the LCA model: item probability parameters 
and class probability parameters. Item probability parameters represent the probability 
of endorsing an item conditional on latent class membership. It can also be referred to 
as the item response probabilities or conditional item probabilities. Class probability 
 174 
parameters reflect the probability that a person in a given latent class has of endorsing 
the specific item. The class probability parameter specifies the prevalence of each class 
in the population or the relative frequency of class membership. Therefore, a LCA 
estimates the probability of being in a latent class conditional on the probability of 
endorsing a measured item.70 More detail on LCA is provided in the methods section of 
Chapter 3. 
Model Selection. A four-class solution was determined to be most optimal in the 
LCA for Wave 1 (Chapter 3). Therefore, only a four-class solution was generated for 
Waves 2 and 3 for comparison.  Lo-Mendell-Rubin adjusted likelihood ratio test (LMRT), 
Akaike information criteria (AIC), Bayesian information criteria (BIC), sample-size 
adjusted BIC, and entropy were tested to show model fit and parsimony. More detail on 
these fit and parsimony tests are provided in the methods section of Chapter 3. A 
smaller AIC and BIC, a larger entropy, and statistically significant results from the LMRT 
are conditions that determine a more optimal class solution.  
Multinomial Logistic Regression. Multinomial regression was used to determine 
whether any covariates were significantly associated with membership of a latent 
class.142 Multinomial regression was conducted using the three-step method (R3STEP) 
via the AUXILIARY statement in Mplus. This approach was used in order for the latent 
class model and the latent class predictor model to be obtained automatically142 rather 
than introducing potential bias by performing a multinomial regression after the latent 
class models were selected. More detail of the multinomial logistic regression procedure 
is provided in the methods section of Chapter 3. 
 175 
Latent Class Analysis Comparisons. Class probability parameters, item response 
probability parameters, transition patterns and results from the multinomial logistic 
regression were compared across the three waves. Differences in class and item 
response probability parameters were compared. Transition patterns were identified to 
determine the stability of movement among the classes across the waves. Odds ratios 
from the multinomial logistic regression were discussed.  
Handling Missingness and Complex Sampling Design. Data management, 
summary statistics, and transition tables for latent class comparisons were performed in 
SAS 9.4. All LCA was conducted in MPlus. Missing data were removed (NWave 1 = 256, 
NWave 2 = 166, NWave 3 = 198). Complex sampling design was accounted for in SAS 9.4 
using PROC SURVEYFREQ (to generate summary statistics), and in Mplus using the 
WEIGHT option.  
 
Network Comparisons 
Network Analysis. Patterns of associations or interactions between substance 
use behaviors and mental disorder symptoms can be encoded in a network structure.45 
Measured symptoms and behaviors (i.e., substance use behaviors and negative affect 
and externalizing symptoms) are represented as nodes. Nodes are connected by 
edges. Edges represent the interactions between the nodes. Nodes that directly activate 
each other (i.e., demonstrate an association) are connected while nodes that do not 
directly activate each other are not. Three networks were generated for comparison, 
one for each wave. The resulting networks produced patterns of symptom-symptom or 
symptom-substance use interactions.45  
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Network Model Estimation. All networks were estimated using an Ising Model in 
R 3.6.0 (IsingFit package193) to estimate the associations between the nodes (i.e., 
edges) as partial correlations among a set of binary items (i.e., current substance use 
behaviors [exclusive cigarette, exclusive e-cigarette, dual cigarette and e-cigarette, 
alcohol, marijuana, and PDNP], four negative affect symptoms, and seven externalizing 
symptoms).34,196,199 Ising model selection uses the Extended Bayesian Information 
Criteria (EBIC) to measure model parsimony for moderate sample sizes and for a high 
number of variables by accounting for the number of unknown parameters and the 
complexity of the model space.194–196 Models determined to best explain the data using 
EBIC were interpreted for relevant relationships.193,197 Edges between two nodes were 
estimated at most pairwise, after adjusting for all other substance use, negative affect, 
and externalizing variables.196 Edges were compared against each other to determine 
strength. Networks were visualized using the qgraph R package.198 Blue edges illustrate 
positive partial correlations; red edges illustrate negative partial correlations. The wider 
the edge, the stronger the correlation. 
The Ising model contains two node-specific parameters: the interaction 
parameter and the node parameter. Details on how these parameters were calculated 
are provided in the methods section of Chapter 4.  
Network Comparisons to Test for Differences by Wave. Differences by wave 
were evaluated using two approaches. First, visual comparisons using an average 
layout established differences in the magnitude and direction (i.e., positive or negative) 
of edge-weights between nodes. Second, three tests of network invariance were used 
to test significant differences in network models by wave. Greater detail of the three 
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tests of network invariance is provided in the methods section of Chapter 4. These tests 
were done in a pairwise fashion in the following order: Wave 1 was compared to Wave 
2, Wave 2 was compared to Wave 3, and Wave 1 was compared to Wave 3.  
The global strength invariance hypothesis tested whether the overall level of 
connectivity in a network was identical between the waves. The global strength 
invariance hypothesis tests the weighted absolute sum of all edges in the networks or 
the sum of the unique variance in the network.200  
 A test of the network structure invariance hypothesis determined whether 
network structures were identical by wave by comparing the maximum differences in the 
edge-weights between all nodes in the networks.200 
Edge strength invariance hypothesis was tested to determine if a specific edge 
between two nodes was equally strong between the waves. Edge strength is also 
referred to as the edge weight, quantified as the magnitude of an edge. This is the 
magnitude of association between two nodes.200  
Handling Missingness and Complex Sampling Design. Participants with missing 
data were removed using listwise deletion (NWave 1 = 2,109, NWave 2 = 852, NWave 3 = 880). 





The overall sample size decreased from Wave 1 (N=32,320) to Wave 3 
(N=26,239) as shown in Table 5.1. Women (51.9 to 52.1%) and those who identified as 
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Non-Hispanic White (65.8 to 66.0%) made up the majority of the samples across the 
waves. Age was evenly distributed. Most of the samples had at least a GED or high 
school education, an annual household income of more than $25,000, and were at least 
moderately satisfied with their social activities and relationships. 
 Endorsement of past month substance use and mental disorder symptoms 
remained stable across the waves. Alcohol was the most commonly reported past 
month substance used (52.4% to 54.4%), followed by CIG (16.6%) and marijuana (7.1% 
to 9.7%). Sleep problems were the most commonly reported past month negative affect 
symptom (25.4% to 27.0%) followed by feeling anxious (16.0% to 16.5%). Giving 
answers before the other person finished asking the question was the most common 
past month externalizing symptom (28.5% to 32.0%), followed by having a hard time 













Table 5.1: Characteristics of the Samples by Wave 












Sex    
   Male 16306 (48.1) 13067 (47.9) 12830 (47.9) 
   Female 15980 (51.9) 13354 (52.1) 13386 (52.1) 
Age    
   18-24 9110 (13.0) 6259 (11.1) 6546 (10.8) 
   25-34 6337 (17.7) 5674 (17.8) 5824 (17.8) 
   35-44 4930 (16.5) 4200 (16.8) 3971 (16.4) 
   45-54 4846 (17.9) 4030 (17.5) 3804 (17.5) 
   55-64 3971 (16.6) 3507 (17.3) 3389 (17.5) 
   65+ 3110 (18.2) 2770 (19.5) 2703 (20.0) 
Race    
   Non-Hispanic White 19295 (66.0) 15757 (65.9) 15368 (65.8) 
   Non-Hispanic Black 4496 (11.2) 3774 (11.2) 3808 (11.2) 
   Non-Hispanic Other 2429 (7.5) 1948 (7.7) 1946 (7.6) 
   Hispanic Multiracial 4817 (13.3) 3949 (13.4) 4067 (13.5) 
Education    
   Less than high school 4233 (11.6) 3159 (10.9) 3101 (10.8) 
   GED/High school graduate 9765 (29.5) 7516 (27.8) 7591 (27.8) 
   Some college (no degree) 11300 (31.0) 9567 (32.3) 9416 (32.0) 
   Bachelor’s degree 4498 (17.8) 3971 (18.4) 3944 (18.7) 
   Advanced degree 2311 (10.1) 2106 (10.6) 2074 (10.8) 
Annual household income    
   Less than $10,000 5668 (13.7) 4358 (12.3) 4192 (11.4) 
   $10,000- $24,999 6768 (20.4) 5598 (19.9) 5384 (19.1) 
   $25,000- $49,999 6670 (23.0) 5665 (22.9) 5672 (22.9) 
   $50,000- $99,999 6140 (24.9) 5415 (26.2) 5546 (26.8) 
   $100,000 or more 3914 (18.0) 3519 (18.7) 3658 (19.8) 
Satisfaction with social activities and relationships       
   Extremely satisfied 6942 (22.3) 5285 (20.9) 5630 (21.4) 
   Very satisfied 13742 (46.1) 11295 (46.8) 10578 (44.6) 
   Moderately satisfied 8157 (23.7) 7015 (24.2) 6895 (24.6) 
   A little satisfied 2376 (5.6) 1975 (5.8) 2119 (6.6) 
   Not at all satisfied 1001 (2.3) 812 (2.3) 939 (2.7) 
Past month tobacco and substance use       
   CIG 10381 (16.6) 8373 (16.6) 7904 (16.6) 
   ECIG 578 (0.9) 593 (1.2) 703 (1.5) 
   Dual CIG + ECIG 996 (1.5) 1069 (2.0) 938 (1.8) 
   Alcohol 17787 (52.4) 15312 (54.4) 14749 (53.9) 
   Marijuana 4392 (7.1) 4363 (8.9) 4630 (9.7) 
   PDNP  1950 (5.1) 1707 (5.4) 1737 (5.8) 
Past month negative affect symptoms       
   Depressed 5692 (13.4) 4639 (13.6) 4421 (13.2) 
   Sleeping 9564 (26.7) 7745 (27.0) 7152 (25.4) 
   Anxious 6864 (16.1) 5602 (16.5) 5433 (16.0) 
   Distressed/Past 5605 (12.5) 4577 (13.1) 4493 (12.7) 
Past month externalizing symptoms       
   Lied 3245 (7.1) 2399 (6.6) 2360 (6.4) 
   Attention 5831 (14.6) 4818 (15.3) 4798 (15.4) 
   Listening 4128 (10.4) 3480 (11.3) 3478 (11.3) 
   Bully 737 (1.7) 635 (1.7) 641 (1.7) 
   Fights 404 (0.7) 331 (0.7) 336 (0.7) 
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   Restless 2953 (6.2) 2125 (5.9) 2112 (5.6) 
   Answered 11399 (32.0) 8390 (29.8) 8033 (28.5) 
 
 
Latent Class Comparisons 
Four class solution 
 The four-class model was selected for interpretation in Wave 1 because (1) the 
AIC, BIC, and sample-size adjusted BIC were smallest for the four-class solution 
compared to the three- and two- class solutions, and (2) the LMRT was statistically 
significant, rejecting the five-class model when compared to the four-class model. A 
four-class solution was also selected for Waves 2 and 3 to compare latent classes 
across waves (Table 5.2). 
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Table 5.2: Model Parsimony and Fit Statistics for Five-Class Solution by Wave 
 
AIC BIC Sample-Size Adjusted BIC Entropy Ho LL LMRT p-value LC 1 LC 2 LC 3 LC 4 

























Class probability  
 The four classes were labeled based on the characteristics of the item response 
probabilities of the specific class. The low symptom class was most common across the 
three waves and gradually decreased from Wave 1 to Wave 3 (NWave 1 = 23,571, 72.9%; 
NWave 2 = 18,922, 71.6%; NWave 3 = 17,176, 65.5%). The comorbid class was the least 
common across the three waves and gradually increased from Wave 1 to Wave 3 
(NWave 1 = 1,960, 6.1%; NWave 2 = 1,727, 6.5%; NWave 3 = 2,140, 8.2%), seen in Table 5.3. 
 















 N (Weighted %) N (Weighted %) N (Weighted %) N (Weighted %) N (Weighted %) N (Weighted %) 
Wave 1 1960 (6.1%) -- 2691 (8.3%) 23571 (72.9%) 4098 (12.7%) -- 
Wave 2 1727 (6.5%) -- 2316 (8.8%) 18922 (71.6%) 3478 (13.2%) -- 
Wave 3 2140 (8.2%) 5400 (20.6%) -- 17176 (65.5%) -- 1524 (5.8%) 
 
The externalizing and negative affect classes remained stable at Waves 1 and 2. 
At Wave 3, however, the classes changed in composition. Rather than externalizing and 
negative affect classes, low comorbid and substance use classes emerged.  
 
Item response probabilities  
 Figures 5.1 – 5.3 display the item-probability plots for the four-class solution for 
Waves 1, 2, and 3. Tables 5.4 – 5.6 presents the corresponding conditional probability 
or item response probability values for the four comorbidity classes for Waves 1, 2, and 
3. There are seventeen items (six substance use, four negative affect, and seven 
externalizing items) along the x-axis of each plot. The y-axis represents the probability 
of endorsing a given item. The four lines, called profiles, correspond to the four classes 
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in the LCA solution and the values are the conditional item probabilities for each of the 
seventeen items across the four classes. 
The comorbid and the low symptom classes were the most extreme classes that 
consistently emerged across the three waves. The comorbid class, overall, had high 
probability of endorsing most items while the low symptom class generally had low 
probability of endorsing all items except for endorsing past 30-day alcohol use. 
Similar profiles emerged across Waves 1 and 2, particularly for the negative 
affect and externalizing classes. The negative affect class had high item response 
probabilities on the four negative affect items: feeling depressed (40.2% to 45.5%), 
sleeping problems (63.5% to 67.0%), feeling anxious (57.3% to 58.3%), and feeling 
distressed about the past (37.7% to 42.3%). The externalizing class had high item 
response probabilities on the seven externalizing items: lying (13.8% to 17.9%), 
attention problems (75.7% to 78.0%), listening problems (55.3% to 56.9%), bullying 
(2.8% to 3.4%), getting into physical fights (0.7% to 1.0%), restlessness (15.9% to 
16.9%), and giving an answer before a question is finished being asked (62.9% to 
65.3%). 
In Wave 3, a low comorbid and substance use class emerged. The low comorbid 
class resembled the comorbid class with similar peaks yet overall lower item 
endorsement compared to the comorbid class. This was specifically noticeable for the 
negative affect and externalizing symptoms where the item response probabilities were 
second highest relative to the comorbid class for all negative affect and externalizing 
items except for getting into physical fights. The substance use class had higher item 
response endorsement for cigarette (43.1%), alcohol (76.1%), and marijuana (69.9%) 
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use compared to all other classes. Item response probabilities were also high for e-
cigarette use (2.9%), dual cigarette and e-cigarette use (3.4%), and PDNP (7.9%). 
 
 






































































































WAVE 1 - 4 CLASS SOLUTION
Comorbid N=1960 (6.1%) Externalizing N=2691 (8.3%)
Low Symptom N=23571 (72.9%) Negative Affect N=4098 (12.7%)
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CIG 34.20% 12.90% 13.60% 26.20% 
ECIG 1.90% 1.30% 0.70% 1.00% 
Dual CIG + ECIG 4.60% 1.60% 1.00% 2.50% 
Alcohol 57.80% 64.40% 49.60% 56.40% 
Marijuana 21.00% 10.30% 4.30% 13.20% 
PDNP 17.70% 5.20% 2.90% 10.50% 
Depressed 79.20% 10.50% 1.60% 45.50% 
Sleeping 90.30% 40.10% 11.30% 67.00% 
Anxious 92.40% 14.50% 1.40% 57.30% 
Distressed/Past 80.10% 8.20% 1.10% 42.30% 
Lied 39.40% 17.90% 1.50% 13.50% 
Attention 91.20% 75.70% 1.00% 8.90% 
Listening 74.30% 55.30% 0.50% 2.70% 
Bully 13.60% 3.40% 0.20% 3.00% 
Fights 5.60% 0.70% 0.00% 2.00% 
Restless 34.70% 15.90% 1.50% 11.30% 








Figure 5.2: Wave 2 - Four-Class Solution of Substance Use Behaviors and Mental 
Disorder Symptoms 
 














CIG 30.10% 12.80% 14.20% 24.10% 
ECIG 2.20% 1.70% 1.00% 1.60% 
Dual CIG + ECIG 6.00% 2.00% 1.40% 3.10% 
Alcohol 59.70% 65.80% 52.00% 55.70% 
Marijuana 22.30% 11.60% 5.90% 14.50% 
PDNP 16.00% 5.80% 3.50% 9.10% 
Depressed 81.60% 10.60% 1.50% 40.20% 
Sleeping 90.30% 44.70% 10.40% 63.50% 
Anxious 91.40% 17.00% 0.00% 58.30% 
Distressed/Past 84.60% 9.80% 1.30% 37.70% 
Lied 41.30% 13.80% 1.20% 11.50% 
Attention 92.60% 78.00% 0.90% 7.20% 
Listening 78.10% 56.90% 0.50% 2.20% 
Bully 13.30% 2.80% 0.20% 2.50% 
Fights 5.90% 1.00% 0.10% 1.10% 
Restless 33.90% 16.90% 1.30% 7.50% 


















































































WAVE 2 - 4 CLASS SOLUTION
Comorbid N=1727 (6.5%) Externalizing N=2316 (8.8%)
Low Symptom N=18922 (71.6%) Negative Affect N=3478 (13.2%)
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Figure 5.3: Wave 3 - Four-Class Solution of Substance Use Behaviors and Mental 
Disorder Symptoms 
 














CIG 35.20% 13.50% 11.70% 43.10% 
ECIG 3.30% 1.60% 1.00% 2.90% 
Dual CIG + ECIG 5.00% 2.10% 1.10% 3.40% 
Alcohol 58.00% 59.90% 48.30% 76.10% 
Marijuana 26.00% 8.90% 0.00% 69.90% 
PDNP 16.20% 8.30% 3.20% 7.90% 
Depressed 81.90% 24.50% 1.10% 3.30% 
Sleeping 89.50% 49.60% 9.50% 11.70% 
Anxious 93.20% 31.70% 1.30% 4.70% 
Distressed/Past 84.50% 21.80% 0.80% 3.80% 
Lied 38.10% 11.90% 0.50% 3.90% 
Attention 70.80% 40.30% 0.50% 1.60% 
Listening 59.60% 28.30% 0.00% 0.00% 
Bully 12.60% 2.30% 0.10% 0.90% 
Fights 6.30% 0.60% 0.00% 0.70% 
Restless 30.90% 10.70% 0.40% 4.30% 














































































WAVE 3 - 4 CLASS SOLUTION
Comorbid N=2140 (8.2%) Low Comorbid N=5400 (20.6%)
Low Symptom N=17176 (65.5%) Substance Use N=1524 (5.8%)
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Transitions based on cross-sectional results 
 Individuals in the sample were assigned to one of the four classes based on the 
LCA posterior probabilities. This was done for Waves 1, 2, and 3 and class membership 
information was merged across the waves to create cross-classification tables. The 
tables were used to describe individual movement among the comorbidity classes over 
time. Table 5.7 includes cross tabulations for three transition points (i.e., Wave 1 to 
Wave 2, Wave 2 to Wave 3, and Wave 1 to Wave 3). To read the Table 5.7, start with 
the preceding wave first and look to where people move to the subsequent wave. 
Interpret the proportion forward whereas 9.5% of individuals in the negative affect class 
at Wave 1 transitioned to the comorbidity class at Wave 2. It is not appropriate, 
however, to interpret this proportion backwards (i.e., 9.5% of those in the comorbid 
class at Wave 2 were in the negative affect class at Wave 1). 
Table 5.7: Transition Tables based on Cross-Sectional LCA Results (%) 
  W2 W3 
W1 COM EXT LS NA   W2 COM L COM LS SU  
COM 8.6% 9.2% 65.4% 16.8% 100% COM 7.6% 21.5% 64.3% 6.6% 100% 
EXT 9.5% 10.2% 64.3% 15.9% 100% EXT 7.8% 20.2% 65.0% 6.1% 100% 
LS 9.5% 8.9% 65.1% 16.2% 100% LS 8.4% 20.5% 65.3% 5.8% 100% 
NA 9.8% 10.0% 62.3% 15.0% 100% NA 8.2% 20.7% 64.9% 6.1% 100% 
  W3             
W1 COM L COM LS SU              
COM 8.2% 21.0% 64.9% 6.0% 100%             
EXT 7.1% 20.2% 66.8% 5.9% 100%             
LS 8.7% 20.2% 65.0% 6.1% 100%             
NA 7.6% 22.6% 64.2% 5.6% 100%             
W1 = Wave 1, W2 = Wave 2, W3 = Wave 3, COM = comorbidity class, NA = negative affect class, EXT 
= externalizing class, LS = low symptom class, L COM = low comorbid, SU = substance use 
 
 
The values shaded in grey are values that describe stability in membership 
status. For example, 8.6% of individuals who were in the comorbidity class in Wave 1 
remained in the comorbidity class in Wave 2. The values that are not shaded describe 
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movement among the classes. For example, of the individuals who were in the 
comorbid class in Wave 1, 16.8% transitioned into the negative affect class in Wave 2. 
The low symptom class was the most stable class for all transitions (62.3% to 66.8%). 
From Wave 1 to Wave 2, the negative affect class was second to the low symptom 
class in stability (15.0%) followed by the externalizing class (10.2%).   
 As seen in all three transition tables, overall, when individuals transitioned, they 
typically to transitioned into the low symptom class (62.3% to 66.8%). The second most 
common transition was to the low comorbid class (20.2% to 22.6%) from Wave 2 to 
Wave 3 and Wave 1 to Wave 3. 
 
Sociodemographic characteristics 
 In Waves 1 and 2, males were significantly less likely than females to be 
classified in the comorbid and negative affect classes relative to the low symptom class, 
seen in Tables 5.8 – 5.10. In Wave 3, this relationship between sex and probability of 
latent class membership extended to the low comorbid class where men were less likely 
to be classified in the low comorbid class (OR = 0.79, 95% CI = 0.70-0.89), Table 5.10. 
However, males were more likely than females to be classified in the substance use 
class relative to the low symptom class in Wave 3 (OR = 1.98, 95% CI = 1.73-2.27), 
Table 5.10. 
 For all waves, a trend emerged for age across all classes: as age increased, the 
odds of class membership decreased for all classes relative to the low symptom class. 
Therefore, the youngest age group (18-24 years) had the highest odds of class 
membership compared to the oldest age group (65 years and older), relative to the low 
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symptom class (Tables 5.8 – 5.10). In Waves 1 and 2, the relationship between age and 
probability of latent class membership was largest in magnitude for the comorbid class. 
In Wave 3, the magnitude of association between age and the comorbid class (18-24 
years ORWave3 = 13.99, 95% CI = 9.83-19.90) was smaller than the substance use class 
(18-24 years ORWave3 = 30.75, 95% CI = 18.99-49.81), Table 5.10. 
 Respondents who identified as Non-Hispanic Black, Hispanic Multicultural, and 
Non-Hispanic Other were significantly less likely than respondents who identified as 
Non-Hispanic White to be classified in any of the classes relative to the low symptom 
class across all waves except for the relationship between Non-Hispanic Black and the 
substance use class in Wave 3 (OR = 1.10, 95% CI = 0.93-1.29). 
 Generally, all education levels relative to having an advanced degree increased 
one’s odds for membership in the comorbid classes for all waves, negative affect 
classes for Waves 1 and 2, and the substance use class for Wave 3, relative to the low 
symptom class across all three waves. The opposite relationship emerged between 
education and the externalizing classes for Waves 1 and 2, and the low comorbid class 
for Wave 3. Relative the having an advanced degree, generally all education levels 
demonstrated a protective effect for membership in the externalizing classes, especially 
in Wave 2 (Tables 5.8 – 5.9). The same relationship between education and latent class 
membership emerged between income and latent class membership except for the low 
comorbid class in Wave 3. Yet, these associations were not statistically significant (Less 
than $10,000 ORWave3 = 1.20, 95% CI = 0.94-1.53; $10,000-$24,999 ORWave3 = 1.14, 
95% CI = 0.93-1.39; $25,000-$49,999 ORWave3 = 1.07, 95% CI = 0.89-1.28; $50,000-
$99,999 ORWave3 = 1.01, 95% CI = 0.85-1.19), Table 5.10.  
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Compared to being extremely satisfied, as social satisfaction decreased, the 
likelihood of being in the comorbid (Not at all satisfied ORWave1 = 95.87, 95% CI = 66.32-
138.58; Not at all satisfied ORWave2 = 83.35, 95% CI = 54.05-128.53; Not at all satisfied 
ORWave3 = 88.94, 95% CI = 58.93-134.24), negative affect (Not at all satisfied ORWave1 = 
22.62, 95% CI = 15.44-33.16; Not at all satisfied ORWave2 = 18.34, 95% CI = 11.66-
28.84), externalizing (Not at all satisfied ORWave1 = 3.67, 95% CI = 1.62-8.31; Not at all 
satisfied ORWave2 = 6.31, 95% CI = 3.12-12.78), low comorbid (Not at all satisfied 
ORWave3 = 8.78, 95% CI = 5.47-14.12), and substance use (Not at all satisfied ORWave3 = 
4.21, 95% CI = 2.40-7.41) classes significantly increased. A dose-response relationship 
was identified with each level decrease of social satisfaction for every latent class 























Table 5.8: Wave 1 - Association Between Demographic and Social Variables on Probability of Latent Class 
Membership* 
 Comorbid Class Externalizing Class Negative Affect Class 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Sex    
Female REF REF REF 
Male  0.72 (0.63-0.82) 1.00 (0.87-1.14) 0.74 (0.66-0.83) 
Age    
18-24 years 10.02 (7.06-14.24) 3.39 (2.69-4.28) 3.88 (3.11-4.83) 
25-34 years 6.00 (4.17-8.64) 1.81 (1.40-2.33) 2.39 (1.90-3.01) 
35-44 years 4.10 (2.83-5.94) 1.46 (1.11-1.91) 1.69 (1.32-2.16) 
45-54 years 3.77 (2.60-5.47) 1.13 (0.86-1.50) 1.52 (1.19-1.93) 
55-64 years 2.27 (1.54-3.36) 0.98 (0.73-1.32) 1.44 (1.12-1.85) 
65 years + REF REF REF 
Race    
Non-Hispanic White REF REF REF 
Non-Hispanic Black 0.48 (0.40-0.59) 0.62 (0.51-0.77) 0.76 (0.64-0.89) 
Non-Hispanic Other 0.73 (0.57-0.94) 0.69 (0.53-0.89) 0.72 (0.56-0.91) 
Hispanic Multiracial 0.50 (0.41-0.61) 0.65 (0.52-0.80) 0.78 (0.66-0.93) 
Education    
Less than high school 1.53 (1.05-2.21) 0.79 (0.57-1.09) 1.62 (1.22-2.15) 
GED/High school graduate 1.37 (0.98-1.92) 0.80 (0.61-1.05) 1.42 (1.10-1.83) 
Some college (no degree) 1.79 (1.29-2.47) 1.08 (0.85-1.37) 1.36 (1.06-1.75) 
Bachelor’s degree 1.35 (0.94-1.93) 1.10 (0.85-1.42) 1.16 (0.88-1.53) 
Advanced degree REF REF REF 
Income    
Less than $10,000 2.54 (2.03-3.18) 0.83 (0.65-1.06) 1.61 (1.32-1.95) 
$10,000- $24,999 2.02 (1.62-2.51) 0.55 (0.44-0.68) 1.51 (1.25-1.83) 
$25,000- $49,999 1.45 (1.16-1.81) 0.84 (0.68-1.04) 1.11 (0.92-1.33) 
$50,000- $99,999 1.00 (0.78-1.27) 1.21 (1.00-1.46) 0.99 (0.82-1.20) 
$100,000 or more REF REF REF 
Level of satisfaction with social activities and relationships  
Extremely satisfied REF REF REF 
Very satisfied 1.65 (1.31-2.07) 1.42 (1.18-1.70) 1.55 (1.31-1.85) 
Moderately satisfied 8.15 (6.54-10.15) 2.66 (2.18-3.26) 4.53 (3.78-5.43) 
A little satisfied 34.19 (26.4-44.29) 3.08 (2.17-4.39) 11.09 (8.70-14.14) 
Not at all satisfied 95.87 (66.32-138.58) 3.67 (1.62-8.31) 22.62 (15.44-33.16) 











Table 5.9: Wave 2 - Association Between Demographic and Social Variables on Probability of Latent 
Class Membership* 
 Comorbid Class Externalizing Class Negative Affect Class 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Sex    
Female REF REF REF 
Male  0.57 (0.49-0.66) 1.01 (0.87-1.17) 0.70 (0.62-0.79) 
Age    
18-24 years 8.17 (5.73-11.64) 2.75 (2.09-3.62) 2.59 (2.09-3.22) 
25-34 years 5.48 (3.79-7.92) 2.29 (1.73-3.04) 1.88 (1.49-2.36) 
35-44 years 4.39 (3.01-6.39) 1.97 (1.48-2.63) 1.40 (1.11-1.78) 
45-54 years 3.60 (2.46-5.28) 1.30 (0.96-1.77) 1.44 (1.14-1.82) 
55-64 years 2.33 (1.56-3.49) 1.17 (0.85-1.62) 1.31 (1.03-1.68) 
65 years + REF REF REF 
Race    
Non-Hispanic White REF REF REF 
Non-Hispanic Black 0.43 (0.35-0.53) 0.51 (0.39-0.65) 0.81 (0.69-0.95) 
Non-Hispanic Other 0.80 (0.59-1.09) 0.58 (0.43-0.77) 0.74 (0.55-0.99) 
Hispanic Multiracial 0.62 (0.50-0.78) 0.53 (0.41-0.69) 0.73 (0.61-0.88) 
Education    
Less than high school 1.28 (0.86-1.90) 0.51 (0.34-0.77) 1.42 (1.04-1.94) 
GED/High school graduate 1.26 (0.89-1.78) 0.62 (0.47-0.82) 1.40 (1.07-1.85) 
Some college (no degree) 1.58 (1.14-2.21) 0.94 (0.73-1.19) 1.48 (1.13-1.93) 
Bachelor’s degree 1.08 (0.74-1.59) 0.91 (0.71-1.17) 1.06 (0.79-1.41) 
Advanced degree REF REF REF 
Income    
Less than $10,000 2.14 (1.66-2.76) 0.78 (0.57-1.07) 1.63 (1.31-2.04) 
$10,000- $24,999 1.87 (1.46-2.39) 0.89 (0.69-1.15) 1.52 (1.23-1.87) 
$25,000- $49,999 1.29 (1.01-1.65) 0.98 (0.79-1.22) 1.18 (0.97-1.44) 
$50,000- $99,999 1.01 (0.78-1.30) 0.90 (0.73-1.10) 0.90 (0.73-1.10) 
$100,000 or more REF REF REF 
Level of satisfaction with social activities and relationships  
Extremely satisfied REF REF REF 
Very satisfied 1.79 (1.35-2.35) 1.60 (1.3-1.97) 1.69 (1.4-2.03) 
Moderately satisfied 8.36 (6.4-10.91) 3.24 (2.59-4.05) 4.07 (3.35-4.94) 
A little satisfied 33.21 (24.27-45.45) 4.47 (3.05-6.54) 10.9 (8.35-14.23) 
Not at all satisfied 83.35 (54.05-128.53) 6.31 (3.12-12.78) 18.34 (11.66-28.84) 








Table 5.10: Wave 3 - Association Between Demographic and Social Variables on Probability of Latent 
Class Membership* 
 Comorbid Class Low Comorbid Class Substance Use Class 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Sex    
Female REF REF REF 
Male  0.78 (0.68-0.91) 0.79 (0.70-0.89) 1.98 (1.73-2.27) 
Age    
18-24 years 13.99 (9.83-19.90) 3.23 (2.66-3.94) 30.75 (18.99-49.81) 
25-34 years 8.31 (5.81-11.90) 2.00 (1.64-2.45) 17.64 (10.87-28.62) 
35-44 years 5.49 (3.80-7.94) 1.45 (1.18-1.80) 11.45 (6.99-18.76) 
45-54 years 4.15 (2.87-6.00) 1.26 (1.02-1.56) 7.46 (4.53-12.30) 
55-64 years 2.16 (1.48-3.15) 1.27 (1.03-1.57) 6.39 (3.81-10.69) 
65 years + REF REF REF 
Race    
Non-Hispanic White REF REF REF 
Non-Hispanic Black 0.45 (0.37-0.56) 0.61 (0.52-0.73) 1.10 (0.93-1.29) 
Non-Hispanic Other 0.76 (0.57-1.01) 0.68 (0.53-0.86) 0.61 (0.47-0.80) 
Hispanic Multiracial 0.57 (0.46-0.71) 0.61 (0.51-0.73) 0.54 (0.45-0.66) 
Education    
Less than high school 1.64 (1.12-2.40) 0.76 (0.57-0.99) 2.08 (1.38-3.13) 
GED/High school graduate 1.34 (0.94-1.89) 0.81 (0.65-1.01) 2.34 (1.60-3.43) 
Some college (no degree) 1.68 (1.20-2.34) 1.04 (0.85-1.27) 2.25 (1.55-3.26) 
Bachelor’s degree 0.98 (0.68-1.42) 0.89 (0.72-1.11) 1.62 (1.10-2.38) 
Advanced degree REF REF REF 
Income    
Less than $10,000 2.87 (2.20-3.76) 1.20 (0.94-1.53) 2.35 (1.84-2.99) 
$10,000- $24,999 2.19 (1.70-2.81) 1.14 (0.93-1.39) 1.94 (1.55-2.43) 
$25,000- $49,999 1.43 (1.12-1.83) 1.07 (0.89-1.28) 1.42 (1.14-1.76) 
$50,000- $99,999 1.12 (0.86-1.45) 1.01 (0.85-1.19) 1.07 (0.85-1.34) 
$100,000 or more REF REF REF 
Level of satisfaction with social activities and relationships  
Extremely satisfied REF REF REF 
Very satisfied 1.92 (1.51-2.46) 1.56 (1.32-1.85) 1.23 (1.04-1.44) 
Moderately satisfied 7.52 (5.98-9.45) 3.50 (2.91-4.20) 1.92 (1.59-2.30) 
A little satisfied 36.74 (27.49-49.11) 7.17 (5.43-9.47) 2.51 (1.86-3.39) 
Not at all satisfied 88.94 (58.93-134.24) 8.78 (5.47-14.12) 4.21 (2.40-7.41) 











The Wave 1 network consisted of 17 nodes (Figure 5.4). The network had 94 
non-zero edges out of 136 possible edges (density=0.691), indicating that 69.1% of 
possible connections were identified in the network. The network structure is an Ising 
model, which is a network of partial correlation coefficients. Especially strong 
connections emerged between the tobacco use nodes, between “Attention” and 
“Listening”, and “Fights” and “Bully”. The negative affect symptoms were positioned 
between the substance use behaviors and externalizing symptoms, with many of the 
nodes lying on the periphery of the network. Edge-weights are shown in the Appendix D 
(Supplemental Table 5.1). 
 
 




The Wave 2 network consisted of 17 nodes and had 84 non-zero edges out of 
136 possible edges (density = 0.618), indicating that 61.8% of possible connections 
were identified in the network (Figure 5.5). The network structure is an Ising model, 
which is a network of partial correlation coefficients. Similar to Wave 1, strong 
connections emerged between the tobacco use nodes, between “Attention” and 
“Listening”, and “Fights” and “Bully”. The nodes were clustering based on their 
respective groups rather than the negative affect symptoms lying between the 
substance use behaviors and negative affect symptoms, as seen in the Wave 1 
network. Edge-weights are shown in the Appendix D (Supplemental Table 5.2). 
 






The Wave 3 network consisted of 17 nodes and had 95 non-zero edges out of 
136 possible edges (density = 0.699), indicating that 69.9% of possible connections 
were identified in the network (Figure 5.6). The network structure is an Ising model, 
which is a network of partial correlation coefficients. Similar to Waves 1 and 2, strong 
connections emerged between the tobacco use nodes, between “Attention” and 
“Listening”, and “Fights” and “Bully”. Edge-weights are shown in the Appendix D 
(Supplemental Table 5.3). 
 





Wave 1 vs Wave 2 Comparison 
 There were not too many noticeable differences when visually comparing the 
Wave 1 and Wave 2 networks (Figure 5.7). The direction of the edges (e.g., positive or 
negative) was the same in both networks. The edge-weight between “Bully” and “Fights” 
appears larger in Wave 2 compared to Wave 1. Some nodes had more or fewer 
connections, depending on the network. For example, alcohol had six connections in 
the Wave 1 network versus only three connections in the Wave 2 network. 
 
Figure 5.7: Visual Comparison of Wave 1 and Wave 2 Networks 
 
 Nine edges (edge-weights = EW) were significantly different (p < 0.05) between 
Wave 1 and Wave 2 (Table 5.11). Overall, these edges increased in magnitude from 
Wave 1 to Wave 2 except for the connections between sleeping problems—restless 
(EWWave 1= 0.37, EWWave 2 = 0.09), marijuana—PDNP (EWWave 1= 0.62, EWWave 2 = 0.37), 
and CIG—sleeping problems (EWWave 1= 0.16, EWWave 2 = 0). Some connections existed 
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in one wave where it did not in another: CIG—sleeping (EWWave 1= 0.16, EWWave 2 = 0) 
and  ECIG—distressed about the past (EWWave 1= 0, EWWave 2 = 0.42).   
 
Table 5.11: Significant Edge Differences between Wave 1 and Wave 2 
Node 1 Node 2 W1 Edge W2 Edge P-value 
CIG Marijuana 0.78 0.91 0.01 
Marijuana PDNP 0.62 0.37 0.01 
CIG Sleeping 0.16 0 0.04 
ECIG Distressed/Past  0 0.42 0.03 
Anxious Lied 0.25 0.46 0.03 
Distressed/Past Listening 0.20 0.46 0.01 
Attention Listening  3.47 3.72 0.02 
Bully Fights  2.40 2.80 0.04 
Sleeping Restless 0.37 0.09 0.01 
 
 Despite some node-specific relationships that differed by wave, the overall 
structure of the networks (maximum difference = 1.56, p-value = 0.23) and the global 
strength (Wave 1 = 56.0, Wave 2 = 59.3, p-value = 0.27) did not significantly differ 
between Wave 1 and Wave 2. Therefore, the overall structure and connectivity was not 
different between Wave 1 and Wave 2. 
 
Wave 2 vs Wave 3 Comparison 
There were fewer differences between Waves 2 and 3 versus Waves 1 and 2 
when visually comparing the networks (Figure 5.8). The direction of the edges was the 
same in both networks. The magnitudes of the edge-weight appear very similar 
between Waves 2 and 3. Some nodes had more or fewer connections depending on the 
network. For example, marijuana had eight connections in the Wave 2 network versus 




Figure 5.8: Visual Comparison of Wave 2 and Wave 3 Networks 
 
 Nine edges were significantly different (p < 0.05) between Wave 2 and Wave 3 
(Table 5.12). Five edges increased in magnitude from Wave 2 to Wave 3: Dual CIG + 
ECIG—listening difficulties (EWWave 2= 0, EWWave 3 = 0.22), listening difficulties—fighting 
(EWWave 2= 0, EWWave 3 = 0.40), feeling depressed—restlessness (EWWave 2= 0.14, 
EWWave 3 = 0.44), alcohol—answered (EWWave 2= 0.44, EWWave 3 = 0.55), and bullying—
answered (EWWave 2= 0.38, EWWave 3 = 0.65). The remaining four edges decreased in 





Table 5.12: Significant Edge Differences between Wave 2 and Wave 3 
Node 1 Node 2 W2 Edge W3 Edge P-value 
ECIG Distressed/Past 0.42 0 0.03 
Dual CIG + ECIG Listening 0 0.22 0.02 
Marijuana Listening 0 -0.2 0.02 
Listening Fights 0  0.4 0.02 
CIG Restless 0  -0.29 0.02 
Depressed Restless 0.14 0.44 0.02 
Distressed/Past Restless 0.43 0.23 0.04 
Alcohol Answered 0.44 0.55 0.03 
Bully Answered 0.38 0.65 0.05 
 
Despite the nine node-specific relationships that differed by wave, the overall 
structure of the networks (maximum difference = 1.32, p-value = 0.23) and the global 
strength (Wave 2 = 59.3, Wave 3 = 60.0, p-value = 0.75) did not significantly differ 
between Wave 2 and Wave 3. Therefore, the overall structure and connectivity was not 
different between Wave 2 and Wave 3. 
 
Wave 1 vs Wave 3 Comparison 
 There were few noticeable differences when visually comparing the Wave 1 and 
Wave 3 networks (Figure 5.9). The direction of the edges (e.g., positive or negative) 
was the same in both networks. The edge-weight between “Bully” and “Fights” appears 





Figure 5.9: Visual Comparison of Wave 1 and Wave 3 Networks 
 
Twenty-two edges were significantly different (p < 0.05) between Wave 1 and 
Wave 3 (Table 5.13). Half of these edges increased in magnitude, specifically CIG—
marijuana (EWWave 1= 0.78, EWWave 3 = 0.93), anxious—distressed about the past 
(EWWave 1= 1.63, EWWave 3 = 1.77), and attention difficulties—listening difficulties 









Table 5.13: Significant Edge Differences between Wave 1 and Wave 3 
Node 1 Node 2 W1 Edge W3 Edge P-value 
CIG Alcohol  0 -0.07 0.01 
CIG Marijuana 0.78 0.93 0.01 
Marijuana PDNP 0.62 0.32 0.01 
Alcohol Depressed 0  -0.09 0.03 
CIG Sleeping 0.16 0 0.04 
ECIG Sleeping 0.22 0 0.04 
PDNP Distressed/Past 0.31 0.08 0.04 
Anxious Distressed/Past 1.63 1.77 0.05 
Alcohol Lied 0.2 0 0.01 
Marijuana Lied 0.6 0.39 0.02 
Sleeping Lied 0.11 0.3 0.03 
Sleeping Attention 0.53 0.69 0.04 
Dual CIG + ECIG Listening 0 0.22 0.04 
Marijuana Listening 0 -0.2 0.02 
Distressed/Past Listening  0.2 0.4 0.05 
Attention Listening  3.47 3.66 0.03 
Listening Fights 0 0.4 0.03 
Bully Fights 2.40 2.88 0.03 
CIG Restless -0.09 -0.29 0.04 
Depressed  Restless 0.19 0.44 0.01 
Sleeping Restless 0.37 0.14 0.02 
Listening Answered 0.34 0.48 0.05 
 
 Global strength did not significantly differ between Wave 1 and Wave 3 (Wave 1 
= 56.0, Wave 3 = 60.0, p-value = 0.24). There was not a significant difference in the 
maximum difference in edge weights between Waves 1 and 3 (maximum difference = 
0.82, p-value = 0.60). Therefore, the overall structure and connectivity was not different 
between Wave 1 and Wave 3. 
 
Wave 1, Wave 2, and Wave 3 Network 
The network including Waves 1, 2, and 3 consisted of 51 nodes (Figure 5.10). 
The network had 233 non-zero edges out of 1275 possible edges (density=0.183), 
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indicating that 18.3% of possible connections were identified in the network. The 
network structure is an Ising model, which is a network of partial correlation coefficients. 
Edge-weights within a respective wave reduced in magnitude. For example, the edge-
weight between cigarette and e-cigarette for the Wave 1 only network was -4.74 and the 
edge-weight in the network with three waves is -2.28. Edge-weights are shown in the 
Appendix D (Supplemental Table 5.4-5.6). 
 
Figure 5.10: Visualization of the Wave 1, Wave 2, and Wave 3 Network 
 
Nodes clustered by wave with very little overlap. Only two edges connected from 
Wave 1 to Wave 2: distressed about the past from Wave 1—dual cigarette and e-
cigarette from Wave 2 (EW = 0.05, tetrachoric correlation = 0.02, p-value = 0.30), and 
lying from Wave 1—PDNP from Wave 2 (EW = -0.14, tetrachoric correlation = -0.02, p-
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value = 0.31). One edge connected from Wave 1 to Wave 3: marijuana from Wave 1—
feeling depressed from Wave 3 (EW = -0.07, tetrachoric correlation = -0.03, p-value = 
0.02). No edges connected from Wave 2 to Wave 3. All other tetrachoric correlations 
between waves were zero or near zero and were not statistically significant. 
 
DISCUSSION 
This is one of the first studies to use results from latent class and network 
analyses to preliminarily assess whether comorbidity between substance use behaviors 
and mental disorder symptoms changes over time in adults. There were three major 
results from this study. First, both latent class profiles and network analyses suggested 
that the comorbidity structure remained stable over time. Second, results from the latent 
class comparisons demonstrated that for people that did transition to another class, 
these transitions moved from a more severe class to a less severe or low symptom 
class. Third, the edge strength invariance test suggested stronger connections among 
the substance use behaviors and mental health symptoms from preceding to 
subsequent waves.  
 
Overall stability in latent profiles with transitions to low symptom class 
 Similar latent profiles emerged across the three waves in the cross-sectional 
review of the four-class solution specifically where the low symptom class was largest 
(65.5% to 72.9%) and the comorbid class was smallest (6.1% to 8.2%). These 
consistencies also emerged in the multinomial regression analyses to determine which 
sociodemographic factors were significantly associated with class membership. These 
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results support previous work that have established a stability in substance use and 
mental disorder comorbidity over time67–69 and are generally consistent with youth and 
young adult studies.227  
 The largest difference was seen in Wave 3 where low comorbid and substance 
use classes emerged rather than the externalizing and negative affect classes from 
Waves 1 and 2. There are two potential reasons for this difference. First, it could be the 
case that a four-class solution is not most optimal in Wave 3. Results from the entropy 
and the Lo-Mendell-Rubin tests did not support the selection of a four-class solution as 
most optimal. Yet, a four-class solution was selected in order to easily compare the 
latent classes from Wave 3 to the latent classes from Waves 1 and 2. Another reason 
could be that the composition of the latent classes shifted meaning that the comorbidity 
profile changed from Wave 2 to Wave 3. However, this is not a probable reason 
because the same people are included at each wave and a shift in their comorbidity 
profiles is unlikely to occur over the course of a year. 
 The low symptom class was the most stable over the transition periods. Our 
results suggest that there was a greater transition from the original class (i.e., 
comorbidity, negative affect, externalizing, low comorbid or substance use) to the low 
symptom class compared to stability from the preceding to the subsequent waves. This 
is inconsistent with substance use comorbidity research in adolescents, as they have 
identified transitions from less to more severe substance use behaviors.12,223,226,227 
However, results are consistent with prior mental disorder comorbidity literature that 
explains both a continuity and a change.67,227 This transition may indicate that the 
individual is receiving the resources and support necessary to remit to a less severe 
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class. This could also result from characterizing symptom or behavior patterns rather 
than diagnoses. Past month endorsement of a symptom or behavior may be more 
flexible to transition compared to a diagnosis. A true longitudinal assessment like a 
latent transition analysis is needed to confirm these transitions over time. 
 
No difference in network structure over time but an increase in association between 
symptoms and behaviors 
 There was no significant difference in overall structure and connectivity between 
any pairwise network comparison. This finding supports the stability discovered in the 
cross-sectional assessments of the latent classes. However, there were significant 
differences in edge weights between the waves. These differences (1) occurred within 
constructs (e.g., between two substance use behaviors) and across constructs (e.g., 
between a substance use behavior and negative affect symptom), and (2) generally 
demonstrated an increase in magnitude from the preceding wave to the subsequent 
wave. These discoveries enforce that the comorbidity structure was not dynamic, and 
that connections were becoming stronger across a three-year time period. 
There are many reasons why connections may increase across time. This could 
be due to biological factors (i.e., onset of new disorder symptoms) or time-varying 
changes (i.e., age or an increase in education and income). Another important 
consideration, however, is the change in substance use and mental health conditions 
due to cultural or environmental shifts. For example, there is potential for greater access 
to and use of electronic cigarettes as new electronic nicotine delivery systems are 
developed. Marijuana is also becoming more widely available in the United States 
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because of changes in policies either decriminalizing or legalizing recreational use. 
Other worldly events (e.g., the COVID-19 pandemic) may give rise to an increase in 
substance use behaviors and mental health problems.32 The biological, time-varying, 
cultural and environmental shifts have the potential to increase the connections of 
substance use behaviors and mental disorder symptoms over time. 
The network with all three waves of data was very sparse, and interesting 
connections were not found between nodes in different waves. The data were merged 
by an individual’s identification number; however, time was not accounted for in the 
network model, meaning that this was not a true longitudinal analysis. Additionally, the 
nodes in these networks only capture past month endorsement of substance use 
behaviors and mental disorder symptoms. Therefore, it is unlikely that there would be 
connections detected between the waves because nodes within a respective wave 
represent a different time. Prior work has identified comorbid longitudinal relationships 
by using diagnostic level measures after one year68 and three years67 from data 
collected at baseline. Relationships have also been identified between depressive 
symptoms (measured as the frequency of depressive symptoms within one week using 
the Center for Epidemiologic Studies Depression Scale [CES-D]) and past month as 
well as past year major depressive disorder diagnosis over seven years of data 
collection.229 However, these studies did not utilize a network approach. There are 
longitudinal network models for panel data in development that should be leveraged to 
more accurately account for the longitudinal nature of these data and explore possible 
connections over time.  
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Complementary latent class and network results  
Both analyses support stability in the comorbidity structures over time. The 
preliminary assessments of comorbidity patterns of both approaches complement the 
major results that (1) the comorbidity structure exists and remains relatively stable over 
time, (2) if a transition occurs in the comorbidity profile, it is likely to move from more to 
less severe, and (3) connections among the substance use behaviors and mental 
disorder symptoms may be growing larger from preceding to subsequent wave. 
 
Strengths and limitations 
 Results from this study should be interpreted with consideration of the following 
limitations. First, these data were collected between 2013-2016. Three years is likely 
not a long enough time frame to detect significant changes in comorbidity. Although 
there were considerable cultural and environmental changes during this time (like the 
increase and influx of e-cigarette availability and products, respectively, as well as 
changes in marijuana legislation across the U.S.), we recommend a more updated 
longitudinal assessment of the comorbidity structure especially in light of the COVID-19 
pandemic. Second, the approaches used in this study were preliminary assessments of 
the comorbidity patterns in a nationally representative sample of adults. A latent 
transition analysis was not conducted. Additionally, we did not evaluate the differences 
in item response patterns due the overwhelming nature of possible combinations (i.e., 
seventeen items across three time periods). A true longitudinal assessment (i.e., latent 
transition analysis) is needed to ensure optimal class solution across the waves and 
confirm the transitions found in this study. Third, the ability to perform a longitudinal 
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network analysis for panel data is currently limited. This method is in the early stages of 
development; therefore, we were limited to pairwise network comparisons. Researchers 
should consider using this new approach (i.e., cross-lagged network models) to 
investigate the comorbidity structure in future analyses. Fourth, PATH participants who 
did not start the study at Wave 1 were not included in our study. This decreased the 
sample size; however, we could account for any cohort effects by excluding them from 
the study. Furthermore, participants included in the analyses differed significantly from 
participants that were excluded due to missing data. Consequently, these results may 
not be generalizable to the U.S. adult population. Fifth, the network models did not 
adjust for the influence of other sociodemographic variables were not included in these 
analyses. Therefore, there may be some residual confounding. Sixth, accuracy and 
stability test for Waves 2 and 3 were not conducted; therefore, network results should 
be interpreted with caution. 
 
Conclusions 
 This is the first study to use complementary statistical methods, latent class and 
network analysis, to evaluate substance use behavior and mental disorder symptom 
comorbidity patterns in adults over time. These results suggest that the comorbidity 
structure exists and remains stable. Furthermore, the connections between these 
behaviors and symptoms are possibly becoming stronger. Therefore, investment of 
time, money, and other resources are encouraged to support those experiencing 
comorbidity as they are unlikely to change in adulthood. It is important to target and 
maintain interventions based on comorbidity structures because the structure is not 
 211 
changing in composition, but is changing in strength. There is a need to support people 























CHAPTER 6: DISCUSSION 
 
To date, current approaches to detection and prevention of comorbid SUD have 
been limited by a focus on SUD exclusively even though substance use often co-occurs 
across multiple substances and is often comorbid with mental disorders. This 
dissertation sought to address the following knowledge gaps: (1) current SUD research 
suffers from the unidimensional approach that does not account for comorbidity; (2) 
patterns of comorbidity are not the same, although current knowledge is based on 
homogeneous samples; and (3) it is unclear whether patterns of comorbidity remain 
stable or changes. Therefore, the goal of this dissertation was to characterize the 
comorbidity between substance use, including tobacco use, and mental disorder 
symptoms measured as negative affect and externalizing symptoms in a population-
based sample by: preliminarily assessing comorbidity using multinomial regression 
between lifetime negative affect severity, externalizing severity and nicotine 
dependence, and current use of tobacco (cigarettes and e-cigarettes) and alcohol 
(Chapter 2); identifying latent classes of comorbid substance use as well as negative 
affect and externalizing symptoms and their ability to predict SUD severity (Chapter 3); 
detailing substance use, negative affect, and externalizing symptom networks and 
testing for differences in the network structure and connectivity by gender (Chapter 4); 
and using pairwise comparisons from the LCA and network results to address stability 
or movement of comorbidity structures over three waves of data (Chapter 5). 
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Confirmation of the comorbidity structure in U.S. adults prompts a multidimensional 
approach to substance use and mental disorders 
 Results from Chapters 3 and 4 distinguished different comorbidity groups and 
identified how the substance use and mental disorder symptoms connected with each 
other, respectively. These results confirm a robust comorbidity structure in U.S. adults 
by characterizing seventeen substance use behaviors and mental disorder symptoms 
into groups and identifying specific connections. The LCA results suggest that 
approximately 21% of the sample made up the negative affect or externalizing classes 
at Waves 1 and 2, and about 26% made up the low comorbid or substance use classes 
at Wave 3. These individuals reflect a subpopulation with possible subthreshold levels 
of impairment that may not be identified with current classification systems of substance 
use and mental disorders. Network analysis results confirm that connections between 
behaviors and symptoms overlap and cut across constructs (i.e., diagnostic 
boundaries). Furthermore, these results identified comorbidity patterns, not singular 
disorder in the population. This provides reason to reconsider our current 
unidimensional approach to substance use and mental disorder comorbidity because 
the prevalence of potential subthreshold level comorbidity in the population is 
happening at a greater rate than the high comorbidity class (21-26% vs 6-8%).  These 
results support inclusion and regular study of additional substance use behaviors and 
mental disorder symptoms at subthreshold levels. The robust comorbidity structure can 
provide insight into the overall wellbeing of an individual. Dissertation results have the 
potential to increase comorbidity awareness in clinicians and further help clinicians to 
better target comorbidity because specific aspects of substance use and mental 
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disorder symptoms that are more likely to occur with each other were identified. Future 
studies could build upon these findings and explore how this comorbidity awareness 
can be applied to clinical settings. In the future, comorbidity research done in the clinical 
space could be translated to encourage increased communication about substance use 
behaviors and mental disorder symptoms with clinicians and their clients to consider 
comorbidity during health screenings, and support those affected with multiple 
conditions more efficiently. 
 
Substance use varied by mental disorder symptoms suggesting different comorbidity 
profiles  
Analysis of the Population Assessment of Tobacco and Health Study provided a 
unique opportunity to study patterns of comorbidity across multiple tobacco products 
(i.e., electronic- and conventional- cigarette use) in addition to substance use and 
mental health comorbidity. A relatively novel tobacco product, e-cigarettes, was 
included in the study while also accounting for the dual use of conventional cigarettes 
and e-cigarettes rather than simply classifying any tobacco use through a measure of 
nicotine dependence or considering conventional cigarette use only. Dual users 
represent a novel and distinct class of tobacco users that must be accounted for, 
especially when exploring comorbidity.230 This approach (1) allowed for a more detailed 
investigation into how tobacco products present and connect with comorbid substance 
use behaviors and mental disorder symptoms, and (2) limited the potential 
misclassification bias introduced when dual users are not classified outside of 
conventional or e-cigarette use.  
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Results from Chapters 3 and 4 indicated that conventional cigarette use and dual 
use of conventional cigarettes and e-cigarettes were associated with negative affect 
symptoms, while the exclusive use of e-cigarettes was associated with externalizing 
symptoms. This result differs from a prior study from Conway et al. (2017) that reported 
e-cigarette use to have a larger magnitude of association with negative 
affect/internalizing severity compared to externalizing symptoms.73 This difference is 
likely due to the classification of tobacco product use. The Conway et al. paper 
measured current e-cigarette use without excluding conventional cigarette use. 
Nevertheless, dual use of e-cigarette and cigarette use is increasing in the U.S.83 and 
about 16% of current smokers were also current e-cigarette users in 2014.85 
Additionally, results in Chapter 2 identified patterns of association with mental disorder 
symptoms varied by dual use and exclusive use. The results from this dissertation 
encourage the study of three separate classes of tobacco products (i.e., exclusive 
conventional cigarette use, exclusive e-cigarette use, and dual use of conventional and 
e-cigarettes) in order to provide a clearer understanding of comorbidity profiles related 
to substance use behaviors and mental disorder symptoms in U.S. adults.  
Chapter 2 determined that the associations between psychopathology (negative 
affect vs. externalizing severity) varied by different combinations of alcohol, 
conventional cigarette and e-cigarette use. Negative affect severity was associated with 
cigarette and alcohol use together as well as alcohol-exclusive use, while externalizing 
severity was associated with e-cigarette and alcohol use together. These results confirm 
that associations between negative affect and externalizing severity varies by different 
combinations of alcohol, cigarette, and e-cigarette use. 
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Chapter 3 results built on those of Chapter 2 by including a more robust set of 
substance use and mental disorder symptom variables (i.e., adding marijuana, 
prescription drugs not prescribed [PDNP], four negative affect symptoms, and seven 
externalizing symptoms) and extending past multinomial regression by using a latent 
class analysis approach to detail the patterns of specific substance use behaviors that 
have different relationships with mental disorder symptoms. Specifically, exclusive 
cigarette use, dual cigarette and e-cigarette use, marijuana use, and PDNP were 
associated with a negative affect class. In contrast, exclusive e-cigarette and alcohol 
use were associated with an externalizing class. Results from Chapter 3 confirmed the 
relationship between conventional cigarette use and negative affect identified in Chapter 
2, and provided more clarity on the relationships between dual cigarette and e-cigarette 
use and negative affect as well as exclusive e-cigarette use and alcohol use with 
externalizing symptoms. 
Chapter 4 complemented the results from Chapter 3 by identifying the 
magnitudes of specific connections between a unique pair of variables. PDNP, 
marijuana use, dual use of cigarette and e-cigarette, and conventional cigarette use had 
strong connections with negative affect symptoms. PDNP use was most strongly 
associated with negative affect symptoms. Marijuana and alcohol use were most 
strongly associated with externalizing symptoms. Results from the nodewise 
predictability analysis identified which nodes were most important in influencing the 
other nodes in the network, an important discovery regarding intervention.  
 It is often thought that interventions can be best developed using longitudinal 
data. However, the use and incorporation of marginal effects in models have been 
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utilized more frequently in health systems research to establish expectations related to 
interventions, particularly for cross-sectional data.231 An underappreciated result from 
network models are the estimates of nodewise predictability, which are produced using 
marginal effects. The nodewise predictability results discussed in Chapter 4 provided a 
quantitative understanding into how effective intervention could be as well as guidance 
on how to intervene on substance use behaviors and mental disorder symptoms (i.e., 
through a specific node of interest or neighboring nodes). Most of the nodes in the 
model had a small normalized accuracy, meaning that most of the accuracy or 
predictability of these nodes in the network were due to the contribution of the node in 
question specifically rather than through the contribution of other nodes. The negative 
affect symptoms, attention problems, listening problems, and impulsivity had larger 
normalized accuracy in that the accuracy of these symptoms had larger contributions by 
other nodes in the network. Therefore, intervention on any of the nodes would likely 
influence any other behavior or symptom in the network since the network was largely 
determined by itself through strong mutual interactions between nodes. 
These results could help to inform future research in clinical spaces to target 
specific behaviors and symptom combinations. This type of research could identify a 
potential opportunity for clinicians and their patients/clients to have an open 
conversation about substance use behaviors that may influence their mental health and 
vice versa. A clinician could consider alternative approaches for someone with 
comorbidity versus someone affected with a single condition. For example, if a person 
were to present with co-occurring dual cigarette and e-cigarette use, a clinician could 
consider asking questions about the person’s co-occurring negative affect symptoms. 
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The alternative can happen as well: if a person were to present with negative affect 
symptoms (i.e., feeling depressed, feeling anxious, experiencing sleeping problems, 
and/or feeling distressed about the past), a clinician could ask questions about the 
person’s co-occurring tobacco use, specifically conventional cigarette use or the 
combination of cigarettes and e-cigarettes together.  
 
Sociodemographic characteristics were associated with comorbidity 
 The results in Chapters 3, 4, and 5 were consistent with previous work, 
particularly as it applies to gender.2,41,123 For instance, compared to men, women had 
greater odds of membership in the comorbid, low comorbid, and negative affect latent 
classes (Chapters 3 and 5). Compared to women, men had greater odds of 
membership in the substance use latent class (Chapter 5). Results from Chapter 4 
expanded the gender difference literature related to comorbidity by identifying specific 
connections between comorbid substance use and mental disorder symptoms by 
gender. Specifically, alcohol use and sleeping problems, exclusive e-cigarette use and 
lying, alcohol use and lying, and alcohol use and attention difficulties were all stronger 
for men than they were for women.  
Chapters 3 and 5 emphasized the importance of age on comorbidity. Participants 
of any age category (i.e., 18-24 years, 25-34 years, 35-44 years, 45-54 years, and 55-
64 years) compared to those ages 65 and older, had greater odds of latent class 
membership for all classes. The magnitude of the association gradually decreased as 
age increased. This is consistent with previous work where younger people are at 
greater risk for mental health and substance use problems compared to people in older 
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age categories.41 This matches the age of substance use initiation which typically 
occurs in younger age categories, and age of onset for most mental disorders as 
roughly 50% to 75% of all lifetime mental disorders start by the mid-teens and mid-20s, 
respectively.2,154 Therefore, strategies targeting younger ages, specifically those 
between the ages of 18-24 years, could be helpful in reducing comorbidity in younger 
ages and possibly prevent comorbidity as age increases. 
Chapters 3 and 5 highlighted the role of race/ethnicity on comorbidity and 
encourage additional study in this area. For example, participants who described 
themselves as belonging to non-White racial categories (i.e., Non-Hispanic Black, Non-
Hispanic Other, Hispanic Multiracial) were less likely to be in any of the following latent 
classes compared to those who categorized themselves as Non-Hispanic White:  
comorbid, externalizing, negative affect, low comorbid, and substance use classes. This 
result does support other findings typically identified in the Black-White mental health 
paradox.158 This paradox has generally supported the idea that Black Americans 
experience similar or relatively low rates of psychiatric disorders compared to Whites 
despite higher stress exposure, greater material hardship, and worse physical health.158 
Previous work exploring the Black-White mental health paradox has focused on single 
psychiatric conditions158 and these results identify that this paradox is also present for 
comorbidity. 
Chapters 3 and 5 identified the role of education and income in comorbidity. In 
general, low education and income were positively associated with membership in the 
comorbid, negative affect, and substance use latent classes. However, a negative 
relationship was discovered with low education and income and the externalizing class 
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in Waves 1 and 2, and the low comorbid class in Wave 3. Prior work has identified that 
higher education and income levels represent a protective relationship from 
membership in internalizing or negative affect, externalizing, and high psychopathology 
classes.41 Therefore, our result of low education and income being less likely to occur 
with externalizing and low comorbid classes is different than what has previously been 
identified. Future research should continue to include socioeconomic status variables in 
the assessment of comorbidity to further clarify this association. 
A social support variable was included in Chapters 3 and 5 because the 
relationship between social support and substance use behaviors/disorders (1) is well-
established in youth, but results are mixed, and (2) may be a potential modifiable factor 
to use as part of intervention strategies to address substance use and mental disorder 
symptom comorbidity. This variable also provided insight into how an individual’s 
interpersonal relationships were associated with comorbidity as previous research has 
only focused on a single outcome (e.g., substance use only).232,233 The associations 
between social satisfaction and latent class membership reflected a potential dose-
response relationship where a decrease in social satisfaction significantly increased 
odds of class membership. This represents a very interesting opportunity for potential 
intervention because social satisfaction is an easier factor to influence or change 
compared to the other demographic factors included in the analysis (i.e., sex, age, race, 
education, and income). Specifically, the probability of class membership in comorbid, 
negative affect, low comorbid, or substance use classes could decrease if social 
satisfaction can be improved by increasing satisfaction with activities and relationships. 
Epidemiologic and community-based participatory research studies have identified the 
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benefit of improving social support and relationships to reduce the likelihood of 
developing mental health and substance use problems.234–239 Consequently, social 
satisfaction should be considered and implemented for public health prevention 
strategies related to substance use and mental disorder symptom comorbidity, 
supporting and expanding community-wide efforts to develop and increase social 
satisfaction.   
 
Comorbidity structure remained stable with transition to lower severity groups but 
identification of stronger connections across three data points 
 Results from Chapter 5 confirmed prior research regarding substance use and 
mental disorder symptom comorbidity67,69: the behaviors were stable across three 
years. Both the LCA and network analyses showed that the overall comorbidity profiles 
and network structures were consistent across waves. Further, evaluation of the 
possible latent class transitions among the waves identified that people more commonly 
transitioned from more severe class to a less severe class. However, stronger 
connections were discovered in subsequent waves when specifically testing for 
significant differences in edge-weights of substance use and mental disorder symptom 
connections between the waves. Consequently, the connections between these 
behaviors and symptoms may become stronger over time. Investment of time, money, 
and other resources early in adulthood are encouraged to support those experiencing 
comorbidity as the co-occurring behaviors and symptoms are likely to become more 
severe in adulthood.  
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Latent class analysis and network analysis produce complementary results 
 Although LCA and network approaches are different and follow different 
conceptual frameworks, results from both arrived at similar conclusions described in 
Table 6.1. Both LCA and network analysis identified relationships between (1) exclusive 
cigarette, dual cigarette and e-cigarette, marijuana, and PDNP with negative affect 
symptoms, and (2) alcohol with externalizing symptoms. 
Table 6.1: Associations between substance use and mental disorder symptoms 
identified through LCA and/or network analysis 
Past Month Substance Use Past Month Mental Disorder Symptom LCA 
Network 
Analysis 
Exclusive cigarette Negative affect Yes Yes 
Dual cigarette and e-cigarette  Negative affect Yes Yes 
Marijuana Negative affect Yes Yes Externalizing  Yes 
PDNP Negative affect Yes Yes 
Exclusive e-cigarette Externalizing Yes  
Alcohol Externalizing Yes Yes 
  
Latent class analysis was best at distinguishing different comorbidity in the population 
while also accounting for the potential influence of sociodemographic factors compared 
to the network analysis. Although the latent class analysis was unsuccessful at using 
latent class membership to predict SUD severity, a strong relationship between class 
membership and SUD severity was detected. This confirms and underscores the 
importance of the relationship between comorbidity and SUD severity.  
Network analysis was best at demonstrating the total number of connections 
between substance use behaviors and mental disorder symptoms compared to the 
LCA, while also showing which behaviors/symptoms were most influential in the 
comorbidity network. These results identify important comorbid substance use 
behaviors and mental disorder symptoms, informing a more targeted approach to 
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comorbidity. There were no significant differences in network structure or connectivity 
by gender, but specific connections were different and these differences were 
consistent with other literature.2,153,209,240–243  
These approaches complement each other because they fill the gaps of the other 
approach. Latent class results identified heterogeneous groups in the population which 
helped to inform which items were likely to happen with each other. Network analysis 
results provided information regarding the strength of associations between two nodes. 
For example, alcohol use had relatively high item response probabilities across all 
classes, but was highest in the externalizing class. Network analysis results identified 
that alcohol use was more strongly associated with the impulsivity externalizing 
symptom compared to other externalizing symptoms. In addition to identifying which 
substance use behaviors or mental disorder symptoms likely occur with one another, 
network analysis complements the latent class results by identifying the magnitude of 
the associations. Latent variable and network approaches should continue to be used in 
comorbidity studies to further explore the comorbidity structure in other populations 
including additional substance use behaviors and mental disorder symptoms. 
 
Future considerations to address dissertation limitations  
Symptom-level data (i.e., past month endorsement of substance use and 
experiencing negative affect/externalizing symptoms) were used in these analyses to 
address research gaps identified in Chapter 1. A strength of using symptom-level data 
was that it limited recall bias and accurately accounted for comorbidity overlap (i.e., 
comorbidity occurring within the same time frame). However, it did not identify 
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problematic or severe comorbidity. This limitation was obvious in two places in the 
dissertation. First, the poor ability to predict SUD severity using latent class membership 
in Chapter 3 may have been because of the past-month measurement. Second, past-
month alcohol use was not necessarily indicative of problematic or harmful alcohol use. 
This point was acknowledged specifically in Chapters 4 and 5 regarding why the alcohol 
node was not well centralized or connected to others in the network. These points 
should be considered when interpreting results from this dissertation. 
 Results estimated in this dissertation may be subject to bias due to missing data. 
The sample was large and missing data did not influence the statistical power of the 
models tested. However, the missing data may have represented a misclassification 
bias in two ways. First, participants with missing data were significantly different than 
those included in the analyses. Those included in the analyses were more likely to 
endorse substance use, negative affect symptoms, and externalizing symptoms 
compared to those who were missing. Also, the analytic sample were more likely to be 
Non-Hispanic white, men, aged 25-54 years with higher levels of education and annual 
household income than those who were missing. Consequently, these results may not 
be generalizable to the U.S. adult population. Second, there was an expectation for 
social desirability bias to play a role in the missing data, meaning that participants might 
be less likely to endorse their true substance use behaviors and negative 
affect/externalizing symptoms because of the stigmatization surrounding these 
measures. This effect is expected to underestimate the study results. Although those 
included in the analysis were more likely to endorse substance use behaviors and 
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mental disorder symptoms, social desirability may still be at play and should be 
considered when interpreting results. 
Other statistical approaches are encouraged as the comorbidity research 
continues to develop. First, the use of LCA was limited by the conditional independence 
assumption and its inability to account for heterogeneous groups within the population 
(i.e., SUD and no SUD). Consequently, factor mixture modeling (FMM)131 is suggested 
to address this limitation. Unlike LCA, FMM does not operate under the conditional 
independence assumption, meaning that it is not the latent class only that truly defines 
why the classes emerge as they do. FMM may also better account for the people with 
and without SUD in the sample and, therefore, has the potential to create latent classes 
that better predict SUD severity. 
Second, the comorbidity structure using LCA and network analysis was assessed 
separately without the ability to account for both the variance that is unique to pairs of 
variables (network approach) and the variance that is shared across all variables (LCA 
approach). Therefore, a hybrid latent class and network model, also referred to as 
residual network modeling244, should be a method considered in future work. The hybrid 
latent class and network model allows for the estimation of structural equation modeling 
(like LCA) without the assumption of conditional independence, and the estimation of a 
network structure, while considering the fact that the covariance between items may be 
partly due to latent factors.244 This approach may further detail the etiology of 
comorbidity. 
Finally, preliminary assessments of the comorbidity patterns over time were done 
by assessing the latent class and network structure cross-sectionally at three separate 
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time periods. However, a true longitudinal analysis to test whether the stability or 
changes were statistically significant over time was not performed. Latent transition 
analysis70,226 is a necessary next analysis to confirm the suspected trends discovered in 
Chapter 5. A time-series network model245 should also be considered to similarly 
estimate the comorbidity network structure over time. This method for panel data is in 
development, but early results suggest it could be the network equivalent to a latent 
transition analysis.245 
 
Implications of dissertation results and final conclusions 
In summary, there are three specific results from the dissertation that could apply 
to public health practice. First, identification of specific substance use and mental 
disorder symptom connections can be a useful starting point in discussing comorbidity. 
Past-month PDNP was consistently identified to be strongly associated with negative 
affect symptoms while alcohol use was consistently identified to be strongly associated 
with externalizing symptoms. Therefore, building awareness of co-occurring negative 
affect and externalizing symptoms in individuals who are engaged in these past month 
substance use behaviors is an appropriate strategy in approaching the comorbidity 
conversation and future comorbidity research particularly in clinical spaces. 
Second, the nodewise predictability results showed strong mutual interactions 
between all nodes. This implies that interventions on any of the six substance use 
behaviors, four negative affect symptoms, and seven externalizing symptoms would 
likely result in a change in the comorbidity network. Nodes with a greater proportion of 
predictability due to other nodes (i.e., negative affect items, attention difficulties, 
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listening difficulties, and impulsivity) may be important to target due to their influence of 
other nodes in the network. However, targeting one specific behavior or symptom may 
not be the most effective strategy specifically given the pairwise comparison results that 
show a stability in the comorbidity profile. Therefore, it is likely that interventions might 
be most effective when targeting multiple behaviors and symptoms together. 
Last, sociodemographic variables can be helpful in identifying potential risk for 
specific comorbidity profiles. For example, a young woman between the ages of 18-24 
years with a lower education level or income is at potential risk for membership in the 
comorbid or negative affect classes. This demographic information could be used in 
public health practice to offer services or programs to people who may likely fit into this 
risk profile. Studies have identified the use of individual characteristics to create risk 
profiles in machine learning algorithms to predict substance use disorder treatment 
success.246–248 Risk profiles have been generated and used in community and clinical 
settings to effectively target interventions.249,250 Additionally, the dose-response 
relationship identified with social satisfaction and comorbidity represents a unique 
opportunity to encourage overall social support and healthy interpersonal relationships, 
especially when providing mental health and substance use services. Some studies 
have identified that social support interventions (e.g., support group involvement and 
utilizing family/friend support in a community-based substance abuse program) resulted 
in reduced substance use.251–253 Improving social satisfaction could result in reduced 
substance use and may be extended to reducing comorbidity. 
Characterizations of the comorbidity structure provide more information on how 
to approach substance use and mental disorders. Using a large sample of U.S. adults, 
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this study identified specific combinations of substance use behaviors and mental 
disorder symptoms, determined which sociodemographic factors play a role in specific 
comorbidity profiles, and assessed the patterns of comorbidity among three waves of 
data. These results support the need to approach substance use and mental disorders 
from a more holistic perspective, taking comorbidity into account to better support the 
overall wellbeing of the individual. The results can inform robust and targeted prevention 
strategies to effectively mitigate the substantial burden and societal costs of comorbidity 
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Variable AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) 
Negative Affect 
Severity (ref=low) 
        
Moderate  REF 0.91 (0.51-1.63) 0.73 (0.39-1.38) 1.11 (0.74-1.67) 0.78 (0.45-1.38) 0.92 (0.61-1.40) 1.19 (0.81-1.75) 0.75 (0.48-1.18) 
High  REF 0.67 (0.40-1.11) 0.78 (0.44-1.38) 0.84 (0.56-1.27) 0.65 (0.38-1.10) 0.71 (0.46-1.10) 0.86 (0.57-1.28) 0.65 (0.43-1.01) 
Externalizing Severity 
(ref=low) 
        
Moderate REF 0.82 (0.48-1.39) 1.61 (0.92-2.82) 0.99 (0.66-1.51) 0.62 (0.34-1.10) 0.65 (0.44-0.97) 1.14 (0.73-1.77) 0.70 (0.46-1.08) 
High  REF 0.69 (0.41-1.17) 1.66 (0.94-2.94) 0.86 (0.57-1.28) 0.65 (0.35-1.18) 0.49 (0.33-0.74) 0.98 (0.64-1.49) 0.56 (0.36-0.87) 
Nicotine Dependence         
REF 1.02 (1.01-1.03) 0.94 (0.93-0.95) 0.99 (0.98-1.00) 0.95 (0.93-0.96) 1.00 (0.99-1.00) 0.92 (0.91-0.93) 0.94 (0.94-0.95) 
Negative Affect 
Severity (ref=low) 
        
Moderate  1.10 (0.62-1.96) REF 0.81 (0.46-1.43) 1.22 (0.81-1.82) 0.86 (0.44-1.69) 1.01 (0.68-1.50) 1.30 (0.87-1.96) 0.83 (0.51-1.35) 
High  1.50 (0.90-2.48) REF 1.17 (0.67-2.02) 1.26 (0.88-1.81) 0.97 (0.58-1.64) 1.06 (0.75-1.51) 1.28 (0.90-1.83) 0.98 (0.65-1.47) 
Externalizing Severity 
(ref=low) 
        
Moderate 1.23 (0.72-2.08) REF 1.97 (1.11-3.50) 1.22 (0.84-1.78) 0.75 (0.46-1.25) 0.80 (0.56-1.14) 1.39 (0.93-2.09) 0.86 (0.57-1.30) 
High  1.46 (0.86-2.47) REF 2.42 (1.32-4.44) 1.24 (0.87-1.78) 0.94 (0.53-1.68) 0.72 (0.50-1.03) 1.42 (0.95-2.12) 0.82 (0.54-1.23) 
Nicotine Dependence         
0.98 (0.98-0.99) REF 0.93 (0.92-0.94) 0.97 (0.97-0.98) 0.93 (0.92-0.94) 0.98 (0.98-0.99) 0.91 (0.90-0.91) 0.93 (0.92-0.94) 
Negative Affect 
Severity (ref=low) 
        
Moderate  1.36 (0.72-2.57) 1.24 (0.70-2.19) REF 1.51 (0.97-2.35) 1.07 (0.56-2.06) 1.26 (0.79-1.99) 1.62 (1.03-2.55) 1.03 (0.64-1.64) 
High  1.29 (0.72-2.28) 0.86 (0.50-1.49) REF 1.08 (0.73-1.61) 0.84 (0.46-1.52) 0.91 (0.61-1.36) 1.10 (0.73-1.65) 0.84 (0.55-1.28) 
Externalizing Severity 
(ref=low) 
        
Moderate 0.62 (0.35-1.09) 0.51 (0.29-0.90) REF 0.62 (0.42-0.91) 0.38 (0.23-0.63) 0.40 (0.28-0.59) 0.71 (0.47-1.06) 0.44 (0.29-0.66) 
High  0.60 (0.34-1.06) 0.41 (0.23-0.76) REF 0.51 (0.34-0.78) 0.39 (0.22-0.68) 0.30 (0.19-0.46) 0.59 (0.38-0.91) 0.34 (0.21-0.55) 
Nicotine Dependence         
1.06 (1.05-1.07) 1.08 (1.06-1.09) REF 1.05 (1.04-1.06) 1.00 (0.99-1.02) 1.06 (1.05-1.07) 0.97 (0.96-0.99) 1.00 (0.99-1.01) 
Negative Affect 
Severity (ref=low) 
        
Moderate  0.90 (0.60-1.36) 0.82 (0.55-1.23) 0.66 (0.43-1.03) REF 0.71 (0.44-1.15) 0.83 (0.71-0.98) 1.07 (0.92-1.26) 0.68 (0.57-0.82) 
High  1.19 (0.79-1.80) 0.79 (0.55-1.14) 0.93 (0.62-1.38) REF 0.77 (0.49-1.23) 0.84 (0.73-0.97) 1.02 (0.85-1.22) 0.78 (0.62-0.97) 
Externalizing Severity 
(ref=low) 
        
Moderate 1.01 (0.66-1.53) 0.82 (0.56-1.20) 1.62 (1.10-2.39) REF 0.62 (0.41-0.94) 0.65 (0.58-0.74) 1.14 (0.97-1.36) 0.71 (0.58-0.86) 
High  1.17 (0.78-1.76) 0.80 (0.56-1.15) 1.95 (1.28-2.95) REF 0.76 (0.47-1.22) 0.58 (0.51-0.66) 1.14 (0.94-1.39) 0.66 (0.52-0.82) 
Nicotine Dependence         
1.01 (1.01-1.02) 1.03 (1.02-1.03) 0.95 (0.94-0.96) REF 0.96 (0.95-0.97) 1.01 (1.01-1.01) 0.93 (0.93-0.93) 0.95 (0.95-0.96) 
Bolded values indicate estimate significant a p < 0.05 
Each model adjusts for sex, age, race, education, and annual household income. 
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Supplemental Table 2.1 CONTINUED:  Model 2 - Presentation of Different Reference Levels for Current Substance Use Outcome (Including Nicotine Dependence) (n = 15,947, Weighted 

















Variable AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) 
Negative Affect 
Severity (ref=low) 
        
Moderate  1.28 (0.73-2.24) 1.16 (0.59-2.28) 0.94 (0.49-1.80) 1.41 (0.87-2.29) REF 1.18 (0.72-1.91) 1.51 (0.95-2.42) 0.96 (0.60-1.55) 
High  1.54 (0.91-2.61) 1.03 (0.61-1.72) 1.20 (0.66-2.18) 1.29 (0.81-2.06) REF 1.09 (0.69-1.71) 1.32 (0.84-2.05) 1.00 (0.63-1.61) 
Externalizing Severity 
(ref=low) 
        
Moderate 1.63 (0.91-2.91) 1.33 (0.80-2.19) 2.62 (1.59-4.31) 1.62 (1.06-2.46) REF 1.06 (0.71-1.58) 1.85 (1.21-2.83) 1.14 (0.73-1.79) 
High  1.55 (0.85-2.83) 1.06 (0.60-1.90) 2.57 (1.47-4.51) 1.32 (0.82-2.14) REF 0.76 (0.47-1.24) 1.51 (0.93-2.47) 0.87 (0.51-1.46) 
Nicotine Dependence         
1.06 (1.05-1.07) 1.08 (1.06-1.09) 1.00 (0.99-1.01) 1.05 (1.04-1.06) REF 1.06 (1.05-1.07) 0.97 (0.96-0.98) 1.00 (0.99-1.01) 
Negative Affect 
Severity (ref=low) 
        
Moderate  1.09 (0.72-1.65) 0.99 (0.67-1.47) 0.80 (0.50-1.26) 1.20 (1.03-1.41) 0.85 (0.52-1.38) REF 1.29 (1.07-1.55) 0.82 (0.65-1.04) 
High  1.41 (0.91-2.19) 0.94 (0.66-1.34) 1.10 (0.74-1.64) 1.19 (1.03-1.38) 0.92 (0.58-1.45) REF 1.21 (1.00-1.46) 0.92 (0.73-1.17) 
Externalizing Severity 
(ref=low) 
        
Moderate 1.54 (1.03-2.29) 1.26 (0.88-1.80) 2.47 (1.68-3.64) 1.53 (1.35-1.73) 0.95 (0.63-1.41) REF 1.75 (1.45-2.10) 1.08 (0.89-1.32) 
High  2.03 (1.36-3.02) 1.39 (0.97-2.00) 3.37 (2.18-5.21) 1.73 (1.53-1.97) 1.31 (0.81-2.13) REF 1.98 (1.62-2.42) 1.13 (0.90-1.43) 
Nicotine Dependence         
1.00 (1.00-1.01) 1.02 (1.01-1.03) 0.95 (0.94-0.95) 0.99 (0.99-0.99) 0.95 (0.94-0.96) REF 0.92 (0.92-0.93) 0.95 (0.94-0.95) 
Negative Affect 
Severity (ref=low) 
        
Moderate  0.84 (0.57-1.24) 0.77 (0.51-1.15) 0.62 (0.39-0.98) 0.93 (0.80-1.09) 0.66 (0.41-1.06) 0.78 (0.64-0.94) REF 0.64 (0.51-0.79) 
High  1.17 (0.78-1.75) 0.78 (0.55-1.11) 0.91 (0.61-1.36) 0.98 (0.82-1.18) 0.76 (0.49-1.19) 0.83 (0.69-1.00) REF 0.76 (0.61-0.96) 
Externalizing Severity 
(ref=low) 
        
Moderate 0.88 (0.56-1.37) 0.72 (0.48-1.08) 1.42 (0.94-2.13) 0.87 (0.74-1.03) 0.54 (0.35-0.83) 0.57 (0.48-0.69) REF 0.62 (0.51-0.75) 
High  1.02 (0.67-1.55) 0.70 (0.47-1.05) 1.70 (1.10-2.63) 0.88 (0.72-1.06) 0.66 (0.41-1.08) 0.51 (0.41-0.62) REF 0.57 (0.45-0.73) 
Nicotine Dependence         
1.09 (1.08-1.10) 1.11 (1.10-1.11) 1.03 (1.02-1.04) 1.08 (1.07-1.08) 1.03 (1.02-1.04) 1.09 (1.08-1.09) REF 1.03 (1.02-1.03) 
Negative Affect 
Severity (ref=low) 
        
Moderate  1.33 (0.85-2.07) 1.21 (0.74-1.97) 0.97 (0.61-1.56) 1.47 (1.22-1.77) 1.04 (0.64-1.68) 1.22 (0.96-1.55) 1.58 (1.27-1.96) REF 
High  1.53 (1.00-2.36) 1.02 (0.68-1.53) 1.19 (0.78-1.81) 1.29 (1.03-1.61) 1.00 (0.62-1.60) 1.08 (0.85-1.38) 1.31 (1.05-1.64) REF 
Externalizing Severity 
(ref=low) 
        
Moderate 1.42 (0.93-2.17) 1.16 (0.77-1.74) 2.29 (1.53-3.43) 1.41 (1.16-1.72) 0.87 (0.56-1.37) 0.92 (0.76-1.13) 1.62 (1.33-1.97) REF 
High  1.79 (1.15-2.78) 1.23 (0.82-1.85) 2.97 (1.84-4.81) 1.53 (1.21-1.92) 1.16 (0.69-1.95) 0.88 (0.70-1.11) 1.75 (1.38-2.22) REF 
Nicotine Dependence         
1.06 (1.05-1.07) 1.08 (1.07-1.09) 1.00 (0.99-1.01) 1.05 (1.04-1.05) 1.00 (0.99-1.01) 1.06 (1.05-1.06) 0.97 (0.97-0.98) REF 
Bolded values indicate estimate significant a p < 0.05 
Each model adjusts for sex, age, race, education, and annual household income. 
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Supplemental Figure 3.1: Cumulative ROC Curve for Substance Use: SUD 0 vs 1,2 
 
 










Supplemental Figure 3.3: Cumulative ROC Curve for Class Membership: SUD 0 vs 1,2 
 
 




Supplemental Figure 3.5: Cumulative ROC Curve for Negative Affect: SUD 0 vs 1,2 
 
 





Supplemental Figure 3.7: Cumulative ROC Curve for Externalizing: SUD 0 vs 1,2 
 
 









APPENDIX C: CHAPTER 4 
 
 
Supplemental Figure 4.1: Results from Edge-Weight Accuracy Test for the Overall 
Sample Network 
 
The assessment of the accuracy of estimated network connections demonstrated that 
many edge-weights significantly differ from one-another. Supplemental Figure 1 shows 
the bootstrapped confidence intervals of estimated edge-weights for the estimated 
overall network. The red line indicates the sample values and the gray area represent 
the bootstrapped confidence intervals. Each horizontal line represents one edge of the 
network, ordered from the edge with the highest edge-weight to the edge with the 
lowest edge-weight. The y-axis labels have been removed to avoid cluttering. There 
were narrow bootstrapped confidence intervals (narrowest 95% CI = -0.013; 0.013 for 
alcohol—fighting; widest 95% CI = -4.112; -1.211 for ECIG—dual CIG + ECIG) around 








Supplemental Figure 4.2: Results from the Edge-Weights Significant Difference Test for 
the Overall Sample Network 
 
To test for significant difference between edges, a confidence interval was constructed 
on the difference of two edges and the test was deemed significant if zero was not in 
this confidence interval (represented as a black square in the grid). Supplemental 
Figure 2 shows the bootstrapped difference test (alpha = 0.05) between edges weights 
that were non-zero in the estimated network. Gray boxes indicate edges that do not 
differ significantly from one-another and black boxes represent edges that do differ 
significantly from one-another. Colored boxes correspond to the direction of the edge’s 
magnitude (i.e., the negative “Dual CIG + ECIG” and “CIG” edge is red, the positive 
















Supplemental Table 4.1: Edge Matrix for the Overall Sample 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. CIG 0                 
2. ECIG -4.74 0                
3. Dual CIG + ECIG -4.6 -2.66 0               
4. Alcohol 0 0 0 0              
5. Marijuana 0.78 0.62 0.83 1 0             
6. PDNP 0.54 0.43 0.78 0 0.62 0            
7. Depressed 0.12 0 0 0 0.28 0.11 0           
8. Sleeping 0.16 0.22 0.15 0.04 0 0.53 1.16 0          
9. Anxious 0.17 0 0.27 0 0 0.31 1.5 1.39 0         
10. Distressed/Past 0.24 0 0.25 0 0.17 0.31 1.25 0.77 1.63 0        
11. Lied -0.1 0 -0.14 0.2 0.6 0.21 0.35 0.11 0.25 0.71 0       
12. Attention -0.22 0 0.15 0.18 0.13 0 0.47 0.53 0.49 0.36 0.71 0      
13. Listening 0 0 0 0 0 0 0.13 0.33 0.36 0.2 0.35 3.47 0     
14. Bully 0.23 0 0 0 0.13 0 0.23 0 0.44 0.39 0.91 0.25 0.42 0    
15. Fights 0 0 0 0 0.54 0.36 0 0 0 0.45 0.76 0 0 2.4 0   
16. Restless -0.09 0 0 0.11 0.37 0 0.19 0.37 0.37 0.29 0.33 0.53 0.4 0.3 0.92 0  







Supplemental Figure 4.3: Results from Centrality Stability Test for the Overall Sample 
Network 
 
Supplemental Figure 4.3 shows the average correlations between centrality indices of 
networks samples with persons dropped from the original sample to establish the 
stability in the centrality indices. Lines represent the means of the centrality indices and 












































Supplemental Figure 4.4: Results from the Centrality (Node Strength) Significant 
Difference Test for the Overall Sample Network 
 
Significant differences between node strength were also tested. Supplemental Figure 
4.4 shows the bootstrapped difference tests (alpha = 0.05) between node strength of 
the 17 nodes. Gray boxes indicate nodes that did not differ significantly from one-
another and black boxes represent nodes that do differ significantly from one-another 
(e.g., the node strength of sleeping is significantly different from the node strength of 


































































Supplemental Figure 4.5: Strength and Closeness Centrality Indices as Z-scores for the 



































Supplemental Figure 4.6: Results from Edge-Weight Accuracy Test for the Men-Only 
Network 
 
The assessment of the accuracy of estimated network connections demonstrated that 
many edge-weights significantly differ from one-another. Supplemental Figure 4.6 
shows the bootstrapped confidence intervals of estimated edge-weights for the 
estimated overall network. The red line indicates the sample values and the gray area 
represent the bootstrapped confidence intervals. Each horizontal line represents one 
edge of the network, ordered from the edge with the highest edge-weight to the edge 















Supplemental Figure 4.7: Results from the Edge-Weights Significant Difference Test for 
the Men-Only Network 
 
Supplemental Figure 4.7 shows the bootstrapped difference test (alpha = 0.05) between 
edges weights that were non-zero in the estimated network. Gray boxes indicate edges 
that do not differ significantly from one-another and black boxes represent edges that do 
differ significantly from one-another. Colored boxes correspond to the color of the edge 
(i.e., the negative “Dual CIG + ECIG” and “CIG” edge is red, the positive “Attention” and 













Supplemental Table 4.2: Edge Matrix for the Men-Only Sample 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. CIG 0                 
2. ECIG -4.16 0                
3. Dual CIG + ECIG -5.31 -1.55 0               
4. Alcohol 0 0 0 0              
5. Marijuana 0.81 0.48 0.76 0.87 0             
6. PDNP 0.52 0 0.74 0 0.66 0            
7. Depressed 0.11 0 0 0 0.22 0 0           
8. Sleeping 0 0 0 0.08 0 0.47 1.16 0          
9. Anxious 0.16 0 0.2 -0.08 0 0.34 1.51 1.39 0         
10. Distressed/Past 0.27 0 0.44 0 0.16 0.27 1.28 0.84 1.69 0        
11. Lied -0.14 0.25 0 0.31 0.47 0.29 0.32 0.07 0.37 0.71 0       
12. Attention -0.25 0 0 0.25 0.12 0 0.38 0.5 0.4 0.35 0.86 0      
13. Listening 0 0 0 -0.11 0 0 0.26 0.34 0.46 0.18 0.27 3.45 0     
14. Bully 0.28 0 0 0 0.11 0 0 0 0.58 0.42 0.88 0 0.38 0    
15. Fights 0 0 0 0 0.4 0.34 0 0 0 0.46 0.58 0 0 2.59 0   
16. Restless 0 0 0 0 0.35 0 0.18 0.29 0.41 0.19 0.4 0.55 0.39 0.36 0.82 0  




Supplemental Figure 4.8: Results from Centrality Stability Test for the Men-Only 
Network 
 
Supplemental Figure 4.8 shows the average correlations between centrality indices of 
networks samples with persons dropped from the original sample to establish the 













































Supplemental Figure 4.9: Results from the Centrality (Node Strength) Significant 
Difference Test for the Men-Only Network 
 
Significant differences between node strength were also tested. Supplemental Figure 
4.9 shows the bootstrapped difference tests (alpha = 0.05) between node strength of 
the 17 nodes. Gray boxes indicate nodes that do not differ significantly from one-
another and black boxes represent nodes that do differ significantly from one-another 
(e.g., the node strength of restless is significantly different from the node strength of 
































































Supplemental Figure 4.10: Strength and Closeness Centrality Indices as Z-scores for 
the Men-Only Network 
 
Supplemental Figure 4.10 shows the men-only network’s corresponding centrality 




































Supplemental Figure 4.11: Results from Edge-Weight Accuracy Test for the Women-
Only Network 
 
The assessment of the accuracy of estimated network connections demonstrated that 
many edge-weights significantly differ from one-another. Supplemental Figure 4.11 
shows the bootstrapped confidence intervals of estimated edge-weights for the 
estimated overall network. The red line indicates the sample values and the gray area 
represent the bootstrapped confidence intervals. Each horizontal line represents one 
edge of the network, ordered from the edge with the highest edge-weight to the edge 














Supplemental Figure 4.12: Results from the Edge-Weights Significant Difference Test 
for the Women-Only Network 
 
Supplemental Figure 4.12 shows the bootstrapped difference test (alpha = 0.05) 
between edges weights that were non-zero in the estimated network. Gray boxes 
indicate edges that do not differ significantly from one-another and black boxes 
represent edges that do differ significantly from one-another. Colored boxes correspond 
to the color of the edge (i.e., the negative “Dual CIG + ECIG” and “CIG” edge is red, the 
















Supplemental Table 4.3: Edge Matrix for the Women-Only Sample 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. CIG 0                 
2. ECIG -3.48 0                
3. Dual CIG + ECIG -3.98 -1.96 0 
              
4. Alcohol 0 0 0 0              
5. Marijuana 0.7 0.51 0.91 1.08 0             
6. PDNP 0.48 0.36 0.73 0 0.57 0            
7. Depressed 0.09 0 0 0 0.32 0.15 0           
8. Sleeping 0.2 0 0 0 0 0.47 1.08 0          
9. Anxious 0.21 0 0.43 0 0.15 0.3 1.48 1.37 0         
10. Distressed/Past 0.21 0 0 0 0.18 0.31 1.21 0.68 1.57 0        
11. Lied 0 0 -0.26 0 0.69 0.12 0.37 0.12 0.19 0.74 0       
12. Attention -0.16 0 0.28 0 0.14 0 0.52 0.52 0.54 0.36 0.56 0      
13. Listening 0 0 0 0 0 0 0 0.29 0.28 0.21 0.43 3.49 0     
14. Bully 0 0 0 0 0 0 0.36 0 0.32 0.3 0.91 0.33 0.42 0    
15. Fights 0 0 0 0 0.59 0.29 0 0 0.47 0.43 0.91 0 0 2.04 0   
16. Restless -0.11 0 0 0.14 0.26 0 0.17 0.41 0.39 0.4 0.17 0.53 0.38 0.14 0.82 0  






Supplemental Figure 4.13: Results from Centrality Stability Test for the Women-Only 
Network 
 
Supplemental Figure 4.13 shows the average correlations between centrality indices of 
networks samples with persons dropped from the original sample to establish the 













































Supplemental Figure 4.14. Results from the Centrality (Node Strength) Significant 
Difference Test for the Women-Only Network 
 
Significant differences between node strength were also tested. Supplemental Figure 
4.14 shows the bootstrapped difference tests (alpha = 0.05) between node strength of 
the 17 nodes. Gray boxes indicate nodes that do not differ significantly from one-
another and black boxes represent nodes that do differ significantly from one-another 
(e.g., the node strength of lied is significantly different from the node strength of alcohol 
































































Supplemental Figure 4.15: Strength and Closeness Centrality as Z-scores for the 
Women-Only Network 
 
Supplemental Figure 4.15 shows the women-only network’s corresponding strength and 
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Supplemental Table 5.1: Edge Matrix for the Wave 1 Sample 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. CIG 0                 
2. ECIG -4.74 0                
3. Dual CIG + ECIG -4.6 -2.66 0               
4. Alcohol 0 0 0 0              
5. Marijuana 0.78 0.62 0.83 1 0             
6. PDNP 0.54 0.43 0.78 0 0.62 0            
7. Depressed 0.12 0 0 0 0.28 0.11 0           
8. Sleeping 0.16 0.22 0.15 0.04 0 0.53 1.16 0          
9. Anxious 0.17 0 0.27 0 0 0.31 1.5 1.39 0         
10. Distressed/Past 0.24 0 0.25 0 0.17 0.31 1.25 0.77 1.63 0        
11. Lied -0.1 0 -0.14 0.2 0.6 0.21 0.35 0.11 0.25 0.71 0       
12. Attention -0.22 0 0.15 0.18 0.13 0 0.47 0.53 0.49 0.36 0.71 0      
13. Listening 0 0 0 0 0 0 0.13 0.33 0.36 0.2 0.35 3.47 0     
14. Bully 0.23 0 0 0 0.13 0 0.23 0 0.44 0.39 0.91 0.25 0.42 0    
15. Fights 0 0 0 0 0.54 0.36 0 0 0 0.45 0.76 0 0 2.4 0   
16. Restless -0.09 0 0 0.11 0.37 0 0.19 0.37 0.37 0.29 0.33 0.53 0.4 0.3 0.92 0  
17. Answered -0.05 0 0.1 0.48 0.11 0.07 0 0.35 0.27 0.17 0.59 0.69 0.34 0.48 0 1.1 0 
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Supplemental Table 5.2: Edge Matrix for the Wave 2 Sample 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. CIG 0                 
2. ECIG -5.41 0                
3. Dual CIG + ECIG -6.17 -3.76 0               
4. Alcohol 0 0 0 0              
5. Marijuana 0.91 0.68 1.01 0.91 0             
6. PDNP 0.6 0.55 0.78 0 0.37 0            
7. Depressed 0.06 0 0 0 0.27 0.12 0           
8. Sleeping 0 0 0 0 0 0.44 1.19 0          
9. Anxious 0.25 0 0.34 0 0.07 0.24 1.51 1.4 0         
10. Distressed/Past 0.33 0.42 0.42 0 0.12 0.17 1.25 0.8 1.72 0        
11. Lied 0 0 0 0 0.54 0.27 0.27 0.08 0.46 0.83 0       
12. Attention -0.16 0 0 0.15 0.09 0 0.51 0.67 0.55 0.25 0.66 0      
13. Listening 0 0 0 0 0 0 0.02 0.31 0.26 0.46 0.35 3.72 0     
14. Bully 0.31 0 0.3 0 0 0 0.23 0 0.29 0.47 0.97 0 0.63 0    
15. Fights 0 0 0 0 0 0 0 0 0 0.58 0.68 0 0 2.8 0   
16. Restless 0 0 0 0 0.48 0 0.14 0.09 0.33 0.43 0.21 0.67 0.42 0.44 0.89 0  
17. Answered -0.13 0.08 0 0.44 0.05 0.22 0.04 0.45 0.28 0.12 0.52 0.69 0.37 0.38 0 1.24 0 
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Supplemental Table 5.3: Edge Matrix for the Wave 3 Sample 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. CIG 0                 
2. ECIG -4.73 0                
3. Dual CIG + ECIG -5.42 -2.44 0               
4. Alcohol -0.07 0 0 0              
5. Marijuana 0.93 0.88 0.99 0.93 0             
6. PDNP 0.58 0.32 0.81 0 0.32 0            
7. Depressed 0.07 0 0 -0.09 0.28 0 0           
8. Sleeping 0 0 0 0.07 -0.09 0.52 1.19 0          
9. Anxious 0.26 0 0.13 0 0.16 0.36 1.59 1.41 0         
10. Distressed/Past 0.32 0 0.46 -0.1 0.12 0.08 1.37 0.76 1.77 0        
11. Lied 0 0 0 0 0.39 0.11 0.19 0.3 0.34 0.88 0       
12. Attention -0.17 0 0 0.13 0.17 0 0.54 0.69 0.53 0.34 0.68 0      
13. Listening 0 0.2 0.22 0 -0.2 0 0.19 0.27 0.31 0.4 0.42 3.66 0     
14. Bully 0.18 0 0 0 0.16 0 0.35 0 0.32 0.56 0.74 0.2 0.4 0    
15. Fights 0.47 0 0 0 0.36 0 0.27 0 0 0.56 1.02 0 0.4 2.88 0   
16. Restless -0.29 0 0 0.07 0.45 0 0.44 0.14 0.41 0.23 0.22 0.63 0.35 0.36 1.12 0  


























































CIG 0.00 -2.28 -2.82 0.00 0.68 0.43 0.00 0.08 0.19 0.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 













0.68 0.50 0.68 0.95 0.00 0.59 0.22 0.00 0.00 0.23 0.55 0.11 0.00 0.00 0.47 0.27 0.07 
W1 

















0.17 0.00 0.30 0.00 0.23 0.24 1.26 0.79 1.59 0.00 0.65 0.36 0.18 0.39 0.29 0.28 0.16 
W1 








0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.34 0.30 0.18 0.37 3.36 0.00 0.48 0.00 0.41 0.34 
W1 
Bully 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.00 0.39 0.39 0.95 0.22 0.48 0.00 2.30 0.24 0.27 
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W1 








0.00 0.00 0.00 0.42 0.07 0.00 0.00 0.32 0.26 0.16 0.55 0.67 0.34 0.27 0.00 0.98 0.00 
W2 
CIG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 













0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 

















0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 









0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Bully 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 








0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 
CIG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 













0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 

















0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 









0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 
Bully 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 







































































CIG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 













0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 

















0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 








0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Bully 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
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W1 








0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
CIG 0.00 -2.58 -3.18 0.00 0.82 0.48 0.00 0.00 0.16 0.31 0.00 -0.09 0.00 0.00 0.00 -0.03 0.00 
W2 













0.82 0.51 0.90 0.86 0.00 0.31 0.28 0.00 0.00 0.12 0.53 0.10 0.00 0.00 0.00 0.46 0.00 
W2 

















0.31 0.37 0.40 0.00 0.12 0.00 1.23 0.77 1.74 0.00 0.81 0.18 0.55 0.56 0.50 0.40 0.10 
W2 









0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.16 0.55 0.31 3.69 0.00 0.59 0.00 0.40 0.38 
W2 
Bully 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.56 0.93 0.00 0.59 0.00 2.65 0.49 0.20 
W2 








0.00 0.00 0.00 0.39 0.00 0.09 0.00 0.43 0.17 0.10 0.51 0.65 0.38 0.20 0.00 1.21 0.00 
W3 
CIG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 













0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 

















0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 









0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 
Bully 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 







































































CIG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 




ECIG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Alcoh
ol 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Mariju
ana 0.00 0.00 0.00 0.00 0.00 0.00 -0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
PDNP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Depre
ssed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Sleepi
ng 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Anxio




Past 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Lied 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Attent
ion 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Listen
ing 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Bully 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
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W1 
Fights 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Restl
ess 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W1 
Answ
ered 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
CIG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 




ECIG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Alcoh
ol 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Mariju
ana 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
PDNP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Depre
ssed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Sleepi
ng 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Anxio




Past 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Lied 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Attent




ing 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Bully 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Fights 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Restl
ess 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W2 
Answ
ered 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 
CIG 0.00 -2.79 -3.00 -0.04 0.84 0.51 0.00 0.00 0.19 0.27 0.00 -0.06 0.00 0.00 0.29 -0.14 0.00 
W3 




ECIG -3.00 -1.33 0.00 0.00 0.79 0.75 0.00 0.00 0.00 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
W3 
Alcoh
ol -0.04 0.00 0.00 0.00 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.00 0.00 0.00 0.00 0.51 
W3 
Mariju
ana 0.84 0.75 0.79 0.85 0.00 0.28 0.20 0.00 0.11 0.09 0.38 0.07 0.00 0.11 0.21 0.38 0.09 
W3 
PDNP 0.51 0.22 0.75 0.00 0.28 0.00 0.00 0.50 0.31 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.05 
W3 
Depre
ssed 0.00 0.00 0.00 0.00 0.20 0.00 0.00 1.19 1.59 1.37 0.17 0.47 0.16 0.25 0.13 0.43 0.00 
W3 
Sleepi
ng 0.00 0.00 0.00 0.00 0.00 0.50 1.19 0.00 1.38 0.73 0.24 0.69 0.21 0.00 0.00 0.00 0.41 
W3 
Anxio




Past 0.27 0.00 0.30 0.00 0.09 0.09 1.37 0.73 1.72 0.00 0.89 0.32 0.38 0.54 0.48 0.27 0.15 
W3 




ion -0.06 0.00 0.00 0.08 0.07 0.00 0.47 0.69 0.52 0.32 0.65 0.00 3.63 0.00 0.00 0.67 0.66 
W3 
Listen
ing 0.00 0.00 0.00 0.00 0.00 0.00 0.16 0.21 0.35 0.38 0.41 3.63 0.00 0.23 0.22 0.27 0.42 
W3 
Bully 0.00 0.00 0.00 0.00 0.11 0.00 0.25 0.00 0.29 0.54 0.80 0.00 0.23 0.00 2.98 0.37 0.56 
W3 
Fights 0.29 0.00 0.00 0.00 0.21 0.00 0.13 0.00 0.00 0.48 0.96 0.00 0.22 2.98 0.00 1.06 0.00 
W3 
Restl
ess -0.14 0.00 0.00 0.00 0.38 0.00 0.43 0.00 0.36 0.27 0.19 0.67 0.27 0.37 1.06 0.00 1.17 
W3 
Answ
ered 0.00 0.00 0.00 0.51 0.09 0.05 0.00 0.41 0.32 0.15 0.51 0.66 0.42 0.56 0.00 1.17 0.00 
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SAS File name: LCA W1 4132021 
 
*In the ICPSR_36498 folder, select DS1001 and open the data file (36498-1001-Data) which is 
a SAS Cport Transport file. Once this is open, formats are in, and can begin data management; 
 







 *Current User Cigarette; 
 *R01_AC1002: Ever smoked a cigarette, even one or two puffs; 
 *R01_AC1005: Number of cigarettes smoked in your entire life; 
 *R01_AC1003: Now smoke cigarettes; 
  
 if R01_AC1002 = 1 AND R01_AC1005=6 AND R01_AC1003 in (1 2) then acur_cig = 1; 
 else if R01_AC1002 = 2 OR R01_AC1003=3 OR (R01_AC1003 in (1,2,.) AND R01_AC1005 in 
(1,2,3,4,5)) then acur_cig=0; 
 else if R01_AC1002 = . OR R01_AC1003=. OR R01_AC1005=. then acur_cig = .; 
 
 *Current E-cigarette user; 
 *R01_AE1002: Ever used an e-cigarette, even one or two times; 
 *R01_AE1100: Ever smoked e-cigarettes fairly regularly; 
 *R01_AE1003: Now use e-cigarettes; 
 
 if R01_AE1002 = 1 AND R01_AE1100=1 AND R01_AE1003 in (1,2) then acur_ecig = 1; 
 else if R01_AE1001=2 OR R01_AE1002 = 2 OR R01_AE1003 = 3 OR (R01_AE1003 in (1,2,.) AND 
R01_AE1100 = 2) then acur_ecig=0; 
 else if R01_AE1002 = . OR R01_AE1001=. OR R01_AE1003 = . OR R01_AE1100 = . then acur_ecig 
= .; 
 
 ***NOT USING FOR LCA************ 
 ******************************** 
 *Current Traditional cigar user; 
 
 *if R01_AG9003 = 1 AND R01_AG1100TC=1 AND R01_AG1003TC in (1,2) then acur_cigr = 1; 
 *else if R01_AG1001=2 OR R01_AG9002_01 = 2 OR R01_AG9003= 2 OR R01_AG1003TC= 3 OR 
(R01_AG1003TC in 
 *(1,2,.) AND R01_AG1100TC = 2) THEN acur_cigr = 0;  
 *ELSE IF R01_AG1001 = . OR R01_AG9003 = . OR R01_AG1100TC = . OR R01_AG1003TC = . OR 
R01_AG9002_01 = . THEN 
 *acur_cigr = .; 
 
 *Current Cigarillo user; 
 
 *IF R01_AG9004=1 AND (R01_AG9009_01=1 OR R01_AG9009_03=1) AND R01_AG1100CG = 1 AND 
R01_AG1003CG in 
 (1, 2) THEN acur_cigrlo= 1;  
 *ELSE IF R01_AG9004= 2 OR R01_AG1001=2 OR R01_AG9002_02 = 2 OR R01_AG1003CG=3 OR 
R01_AG1100CG=2 OR (R01_AG9009_01=2 AND R01_AG9009_03=2) OR ((R01_AG9009_01=1 
 *OR R01_AG9009_03=1) AND R01_AG1100CG= 2 AND R01_AG1003CG=.) OR ((R01_AG9009_01=1 OR 
 *R01_AG9009_03=1) AND R01_AG1100CG=. AND R01_AG1003CG= 3) THEN acur_cigrlo= 0; 
 *ELSE IF R01_AG1001 = . OR R01_AG9004 = . OR R01_AG9009_03 = . OR R01_AG9009_01 = . OR 
 R01_AG1100CG = . OR R01_AG1003CG = . OR R01_AG9002_02 = . THEN acur_cigrlo = .; 
 
 *Current Filtered Cigar user; 
 
 *IF R01_AG9004=1 AND R01_AG9009_02=1 AND R01_AG1100FC = 1 AND R01_AG1003FC in (1, 2) THEN 
 acur_filcigr= 1;  
 *ELSE IF R01_AG9004= 2 OR R01_AG1001=2 OR R01_AG9002_02 = 2 OR R01_AG1003FC=3 OR 
R01_AG1100FC=2 OR R01_AG9009_02=2  
 OR (R01_AG9009_02=1 AND R01_AG1100FC= 2 AND R01_AG1003FC=.) OR (R01_AG9009_02=1 AND 
R01_AG1100FC=. AND 
 R01_AG1003FC= 3) THEN acur_filcigr=0;  
 *ELSE IF R01_AG9004 = . OR R01_AG9009_02 =. OR R01_AG1100FC = . OR R01_AG1003FC = . OR 
R01_AG1001 = . OR R01_AG9002_02 = . THEN 
 *acur_filcigr = .; 
 
 *Current Use Any Cigar/Cigarillo; 
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 *IF (acur_cigr = 1 OR acur_cigrlo = 1 OR acur_filcigr = 1) THEN acur_fullcigr = 1;  
 *ELSE IF (acur_cigr = 0 AND acur_cigrlo = 0 AND acur_filcigr= 0) THEN acur_fullcigr = 0; 
 *ELSE IF acur_cigr = . OR acur_cigrlo = . OR acur_filcigr = . THEN acur_fullcigr = .; 
 
 *Current Pipe user; 
 
 *IF R01_AP1002 = 1 AND R01_AP1100=1 AND R01_AP1003 in (1,2) THEN acur_pipe= 1;  
 *ELSE IF R01_AP1001=2 OR R01_AP1002= 2 OR R01_AP1003= 3 OR (R01_AP1003 in (1,2,.) AND 
R01_AP1100 = 2) 
 THEN acur_pipe=0;  
 *ELSE IF R01_AP1001 = . OR R01_AP1002 = . OR R01_AP1003 = . OR R01_AP1100 = . THEN 
acur_pipe= .; 
 
 *Current Hookah User; 
 
 *IF R01_AH1002 = 1 AND R01_AH1100=1 AND R01_AH1003 in (1, 2) THEN acur_hook= 1;  
 *ELSE IF R01_AH1001=2 OR R01_AH1002= 2 OR R01_AH1003= 3 OR (R01_AH1003 in (1,2,.) AND 
R01_AH1100 = 2) 
 *THEN acur_hook=0;  
 *ELSE IF R01_AH1002=. OR R01_AH1001=. OR R01_AH1003=. OR R01_AH1100=. 
 *THEN acur_hook=.; 
 
 *Current User Smokeless; 
 
 *IF (R01_AS1002_02=1 OR R01_AU1003 in (1,2)) AND R01_AS1100SM = 1 AND R01_AS1003SM in (1, 
2) THEN acur_smls= 1;  
 *ELSE IF R01_AS1001=2 OR R01_AS1002_03=1 OR (R01_AS1002_02=2 AND R01_AU1003 in 
 (2,3,.)) OR R01_AS1003SM= 3 OR (R01_AS1003SM in (1,2,.) AND R01_AS1100SM = 2) THEN 
acur_smls=0; 
 *ELSE IF R01_AS1002_02 = . OR R01_AU1003 = . OR R01_AS1100SM = . OR 
 R01_AS1003SM = . OR R01_AS1001 = . THEN acur_smls = .; 
 
 *Current User Snus; 
 
 *IF R01_AS1002_01=1 AND R01_AU1003 in (2, 3) AND R01_AS1100SU= 1 AND R01_AS1003SU in 
(1,2) THEN acur_snus= 1;  
 *ELSE IF R01_AS1001=2 OR R01_AS1002_03=1 OR (R01_AS1002_01=2 AND R01_AS1002_02=1) 
 OR (R01_AS1002_01=1 AND R01_AU1003=1) OR (R01_AU1003 in (2,3) AND R01_AS1003SU= 3) OR 
(R01_AU1003 in (2,3) AND 
 R01_AS1003SU in (1,2,.) AND R01_AS1100SU = 2) THEN acur_snus= 0;  
 *ELSE IF R01_AS1002_01 = . OR R01_AS1002_02 = . OR R01_AS1002_03 = . OR R01_AU1003 = . OR 
R01_AS1100SU = . OR R01_AS1003SU =.  
 *OR R01_AS1001 = . THEN acur_snus=.; 
 
 *Current Use Any Smokeless/Snus; 
  
 *IF (acur_smls = 1 OR acur_snus = 1) THEN acur_fullsmkls = 1;  
 *ELSE IF (acur_smls = 0 AND acur_snus = 0) THEN acur_fullsmkls = 0; 
 *ELSE IF acur_smls = . OR acur_snus = . THEN acur_fullsmkls = .; 
 
 *Current User Dissolvable; 
 
 *IF R01_AD1002 = 1 AND R01_AD1100=1 AND R01_AD1003 in (1,2) THEN acur_diss= 1;  
 *ELSE IF R01_AD1001=2 OR R01_AD1002= 2 OR R01_AD1003= 3 OR (R01_AD1003 in (1,2,.) AND 
R01_AD1100 = 2) THEN acur_diss=0;  
 *ELSE IF R01_AD1001 = . OR R01_AD1002 = . OR R01_AD1003 = . OR R01_AD1100 = . THEN 




 NEW SUBSTANCES ADDED; 
 
 *Current Use Alcohol; 
 *R01_AX0084 is ever used alcohol 
 *R01_AX0073 is how long since last used alcohol and 1 is within the past 30 days; 
 if R01_AX0084 = 1 AND R01_AX0073 = 1 then acur_alc=1; 
 else if R01_AX0084 = 2 OR R01_AX0073 in (2,3) then acur_alc=0; 
 else if R01_AX0084= . OR R01_AX0073= . then acur_alc=.; 
 
 *Current User Marijuana; 
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 *R01_AX0085 is ever used marijuana - look at measures spreadsheet in oral dis proposal 
folder; 
 *R01_AX0078 is how long since last used marijuana and 1 is within the past 30 days; 
 if R01_AX0078 = 1 then acur_marijuana=1; 
 else if R01_AX0078 in (-1,2,3) then acur_marijuana=0; 
 else if R01_AX0078= . then acur_marijuana=.; 
 
 *Current User Ritalin or Adderall (prescription drugs not prescribed to you); 
 *R01_AX0089_01 is ever used ritalin or adderal 
 *R01_AX0081_01 is how long since last used ritalin or adderall and 1 is within the past 
30 days; 
 *if R01_AX0089_01 = 1 AND R01_AX0081_01 = 1 then acur_ritadder=1; 
 *else if R01_AX0089_01 = 2 OR R01_AX0081_01 in (2,3) then acur_ritadder=0; 
 *else if R01_AX0089_01 = . OR R01_AX0081_01= . then acur_ritadder=.; 
 
 *Current User Painkillers, Sedatives, or Tranquilizers (prescription drugs not prescribed 
to you); 
 *R01_AX0089_02 is ever used painkillers 
 *R01_AX0081_02 is how long since last used painkillers and 1 is within the past 30 days; 
 if R01_AX0089_02 = 1 AND R01_AX0081_02 = 1 then acur_painkiller=1; 
 else if R01_AX0089_02 = 2 OR R01_AX0081_02 in (2,3) then acur_painkiller=0; 
 else if R01_AX0089_02 = . OR R01_AX0081_02= . then acur_painkiller=.; 
 
 *Current User Cocaine or Crack 
 *R01_AX0220_01 is ever used cocaine or crack 
 *R01_AX0081_03 is how long since last used cocaine or crack and 1 is within the past 30 
days; 
 *if R01_AX0220_01 = 1 AND R01_AX0081_03 = 1 then acur_cocaine=1; 
 *else if R01_AX0220_01 = 2 OR R01_AX0081_03 in (2,3) then acur_cocaine=0; 
 *else if R01_AX0220_01 = . OR R01_AX0081_03= . then acur_cocaine=.; 
 
 *Curent User Meth or Speed 
 *R01_AX0220_02 is ever used meth or speed 
 *R01_AX0081_04 is how long since last used meth or speed and 1 is within the past 30 
days; 
 *if R01_AX0220_02 = 1 AND R01_AX0081_04 = 1 then acur_meth=1; 
 *else if R01_AX0220_02 = 2 OR R01_AX0081_04 in (2,3) then acur_meth=0; 
 *else if R01_AX0220_02 = . OR R01_AX0081_04= . then acur_meth=.; 
 
 
 *Current User Heroin, Inhalents, Solvents, Hallucinogens 
 *R01_AX0220_03 is ever used heroin, inhalents, solvents, hallucinogens 
 *R01_AX0081_05 is how long since last used heroin.... and 1 is within the past 30 days; 
 *if R01_AX0220_03 = 1 AND R01_AX0081_05 = 1 then acur_heroinplus=1; 
 *else if R01_AX0220_03 = 2 OR R01_AX0081_05 in (2,3) then acur_heroinplus=0; 




*R01R_A_RACECAT3: DERIVED - Race from the interview (3 levels): 1 = white alone, 2 = black alone, 
3 = other; 
*R01R_A_HISP: DERIVED - Hispanic origin from the interview (2 levels): 1 = hispanic, 2 = not 
hispanic; 
NUMRACES = 0 ;  
if R01R_A_RACECAT3 = 1 then NUMRACES = NUMRACES + 1 ;  
if R01R_A_RACECAT3 = 2 then NUMRACES= NUMRACES + 1 ;  
if R01R_A_RACECAT3 = 3 then NUMRACES = NUMRACES + 1 ;  
if R01R_A_HISP = 1 then NUMRACES = NUMRACES + 1; 
if (NUMRACES = 1 and R01R_A_RACECAT3 = 1 AND R01R_A_HISP=2) then R01R_A_ETHRACECAT7= 1 ; *NH 
White; 
if (NUMRACES = 1 and R01R_A_RACECAT3 = 2 AND R01R_A_HISP=2) then R01R_A_ETHRACECAT7= 2 ; *NH AA; 
if (NUMRACES = 1 and R01R_A_RACECAT3 = 3 AND R01R_A_HISP=2) then R01R_A_ETHRACECAT7= 3 ; *NH 
Other;  
if (NUMRACES = 1 and R01R_A_HISP=1) then R01R_A_ETHRACECAT7= 4; *Hispanic Only;  
if (NUMRACES > 1 and R01R_A_HISP=2) then R01R_A_ETHRACECAT7= 5; *NH Multiracial; 
if (NUMRACES > 1 and R01R_A_HISP=1) then R01R_A_ETHRACECAT7= 6; *Hispanic Multiracial; 
ELSE IF R01R_A_HISP=. OR R01R_A_RACECAT3 = . THEN R01R_A_ETHRACECAT7=.;  
 
*AGE; 
if R01R_A_AGECAT7=1 then age=1; *18-24; 
else if R01R_A_AGECAT7=2 then age=2; *25-34; 
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else if R01R_A_AGECAT7=3 then age=3; *35-44; 
else if R01R_A_AGECAT7=4 then age=4; *45-54; 
else if R01R_A_AGECAT7=5 then age=5; *55-64; 




if R01R_A_AM0018=1 then education=1; *less than high school; 
else if R01R_A_AM0018 in (2 3) then education=2; *GED/high school graduate; 
else if R01R_A_AM0018=4 then education=3; *Some college (no degree) or associates degree; 
else if R01R_A_AM0018=5 then education=4; *Bachelor's degree; 
else if R01R_A_AM0018=6 then education=5; *Advanced degree; 
else education=.; 
 




*R01_AX0161: Last time you had significant problems with: feeling very trapped, lonely, sad, 
blue,  
depressed or hopeless about the future; 
if R01_AX0161 in (2, 3, 4) then depressed=0; 
else if R01_AX0161 in (1) then depressed=1; 
else if R01_AX0161 = . then depressed= .; 
 
*R01_AX0162: Last time you had significant problems with: Sleep trouble - such as bad 
dreams, sleeping restlessly or falling asleep during the day; 
if R01_AX0162 in (2, 3, 4) then sleeping=0; 
else if R01_AX0162 in (1) then sleeping=1; 
else if R01_AX0162 = . then sleeping=.; 
 
*R01_AX0163: Last time you had significant problems with: feeling very anxious, nervous, tense,  
panicked or like something bad was going to happen; 
if R01_AX0163 in (2, 3, 4) then anxious=0; 
else if R01_AX0163 in (1) then anxious=1; 
else if R01_AX0163 = . then anxious=.; 
 
*R01_AX0164: Last time you had significant problems with: Becoming very distressed and 
upset when something reminded you of the past; 
if R01_AX0164 in (2, 3, 4) then ptsd=0; 
else if R01_AX0164 in (1) then ptsd=1; 




*R01_AX0165: Last time you lied or conned to get something; 
if R01_AX0165 in (2, 3, 4) then lied=0; 
else if R01_AX0165 in (1) then lied=1; 
else if R01_AX0165 = . then lied=.; 
 
*R01_AX0166: Last time you did the following two or more times:  
had a hard time paying attention at school, work or home; 
if R01_AX0166 in (2, 3, 4) then attention=0; 
else if R01_AX0166 in (1) then attention=1; 
else if R01_AX0166 = . then attention=.; 
 
*R01_AX0167: Last time you did the following two or more times: had a hard 
time listening to instructions at school, work or home; 
if R01_AX0167 in (2, 3, 4) then listening=0; 
else if R01_AX0167 in (1) then listening=1; 
else if R01_AX0167 = . then listening= .; 
 
*R01_AX0168: Last time you did the following two or more times:  
were a bully or threatened other people; 
if R01_AX0168 in (2, 3, 4) then bully=0; 
else if R01_AX0168 in (1) then bully=1; 
else if R01_AX0168 = . then bully= .; 
 
*R01_AX0169: Last time you did the following two or more times:  
started physical fights with other people; 
if R01_AX0169 in (2, 3, 4) then fights=0; 
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else if R01_AX0169 in (1) then fights=1; 
else if R01_AX0169 = . then fights= .; 
 
*R01_AX0250: Last time felt restless/need to climb on things; 
if R01_AX0250 in (2, 3, 4) then restless=0; 
if R01_AX0250 in (1) then restless=1; 
else if R01_AX0250 = . then restless=.; 
 
*R01_AX0251: Last time gave answers before question was finished; 
if R01_AX0251 in (2, 3, 4) then answered=0; 
if R01_AX0251 in (1) then answered=1; 
else if R01_AX0251 = . then answered=.; 
 
******SUBSTANCE USE DISORDERS**********; 
 
*R01_AX0170: Last time used alcohol/drugs weekly or more often; 
if R01_AX0170 in (2, 3, 4) then weeklyuse=0; 
if R01_AX0170 in (1) then weeklyuse=1; 
else if R01_AX0170 = . then weeklyuse=.; 
 
*R01_AX0171: Last time spent a lot of time getting alcohol/drugs; 
if R01_AX0171 in (2, 3, 4) then timegetting=0; 
if R01_AX0171 in (1) then timegetting=1; 
else if R01_AX0171 = . then timegetting=.; 
 
*R01_AX0193: Last time you spent a lot of time using or recovering from alcohol or other drugs; 
if R01_AX0193 in (2, 3, 4) then timeusing=0; 
if R01_AX0193 in (1) then timeusing=1; 
else if R01_AX0193 = . then timeusing=.; 
 
*R01_AX0172: Last time that you kept using alcohol or other drugs even though it was causing 
social problems, leading to fights, or getting you into trouble with other people; 
if R01_AX0172 in (2, 3, 4) then socialprob=0; 
if R01_AX0172 in (1) then socialprob=1; 
else if R01_AX0172 = . then socialprob=.; 
 
*R01_AX0173: Last time that your use of alcohol or other drugs reduced your involvement in 
activities at work, school, home or social events; 
if R01_AX0173 in (2, 3, 4) then reducedact=0; 
if R01_AX0173 in (1) then reducedact=1; 
else if R01_AX0173 = . then reducedact=.; 
 
*R01_AX0174: Last time that you had withdrawal problems such as shaky hands, throwing up, 
having trouble sitting still or sleeping; 
if R01_AX0174 in (2, 3, 4) then withdraw=0; 
if R01_AX0174 in (1) then withdraw=1; 
else if R01_AX0174 = . then withdraw=.; 
 
*R01_AX0194: Use of alcohol/drugs to avoid withdrawal; 
if R01_AX0194 in (2, 3, 4) then usetoavoid=0; 
if R01_AX0194 in (1) then usetoavoid=1; 
else if R01_AX0194 = . then usetoavoid=.; 
 
*ALL PAST 30 DAY; 
sud_score = sum(weeklyuse, timegetting, timeusing, socialprob, reducedact, withdraw, usetoavoid); 
 
*OLD; 
*SUD is 3 levels- no/low, moderate, and high; 
*if sud_score in (0,1) then sud=0; 
*if sud_score in (2,3) then sud=1; 
*if sud_score in (4,5,6,7) then sud=2; 
*if sud_score = . then sud=.; 
 
*NEW = 1/16/20; 
*SUD is 3 levels- no/low, moderate, and high; 
if sud_score in (0) then sud=0; 
if sud_score in (1,2) then sud=1; 
if sud_score in (3,4,5,6,7) then sud=2; 
if sud_score = . then sud=.; 
 
*Dichotomize by 0 = no/low, 1 = moderate/high; 
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*if sud in (0) then sudbin1=0; 
*if sud in (1, 2) then sudbin1=1; 
*if sud = . then sudbin1 = .; 
 
*Dichotomize by 0 = no/low/moderate, 1 = high; 
*if sud in (0,1) then sudbin2=0; 
*if sud in (2) then sudbin2=1; 
*if sud = . then sudbin2 = .; 
 
 
*R01_AX0170 + R01_AX0171 + R01_AX0172 + R01_AX0173 + R01_AX0174 + R01_AX0193 + R01_AX0194; 
*Last time used alcohol/drugs weekly or more often; 
*if R01_AX0170 = 1 then sudcon1=3; 
*if R01_AX0170 = 2 then sudcon1=2; 
*if R01_AX0170 = 3 then sudcon1=1; 
*if R01_AX0170 = 4 then sudcon1=0; 
*else if R01_AX0170 = . then sudcon1=.; 
*Last time spent a lot of time getting alcohol/drugs; 
*if R01_AX0171 = 1 then sudcon2=3; 
*if R01_AX0171 = 2 then sudcon2=2; 
*if R01_AX0171 = 3 then sudcon2=1; 
*if R01_AX0171 = 4 then sudcon2=0; 
*else if R01_AX0171 = . then sudcon2=.; 
*Last time spent a lot of time using or recovering; 
*if R01_AX0172 = 1 then sudcon3=3; 
*if R01_AX0172 = 2 then sudcon3=2; 
*if R01_AX0172 = 3 then sudcon3=1; 
*if R01_AX0172 = 4 then sudcon3=0; 
*else if R01_AX0172 = . then sudcon3=.; 
*Last time alcohol/drugs causing social problems; 
*if R01_AX0173 = 1 then sudcon4=3; 
*if R01_AX0173 = 2 then sudcon4=2; 
*if R01_AX0173 = 3 then sudcon4=1; 
*if R01_AX0173 = 4 then sudcon4=0; 
*else if R01_AX0173 = . then sudcon4=.; 
*Reduced involvement with activities; 
*if R01_AX0174 = 1 then sudcon5=3; 
*if R01_AX0174 = 2 then sudcon5=2; 
*if R01_AX0174 = 3 then sudcon5=1; 
*if R01_AX0174 = 4 then sudcon5=0; 
*else if R01_AX0174 = . then sudcon5=.; 
*Withdrawal problems; 
*if R01_AX0193 = 1 then sudcon6=3; 
*if R01_AX0193 = 2 then sudcon6=2; 
*if R01_AX0193 = 3 then sudcon6=1; 
*if R01_AX0193 = 4 then sudcon6=0; 
*else if R01_AX0193 = . then sudcon6=.; 
*Use of alcohol/drugs to avoid withdrawal; 
*if R01_AX0194 = 1 then sudcon7=3; 
*if R01_AX0194 = 2 then sudcon7=2; 
*if R01_AX0194 = 3 then sudcon7=1; 
*if R01_AX0194 = 4 then sudcon7=0; 
*else if R01_AX0194 = . then sudcon7=.; 
 
*sudconscore = sum(sudcon1, sudcon2, sudcon3, sudcon4, sudcon5, sudcon6, sudcon7); 
 
 
*****DUMMY CODING FOR THE COVARIATES******; 
 
IF R01R_A_SEX=1 THEN SEXMALE_1=1; 
ELSE SEXMALE_1=0; 
 
IF R01R_A_SEX=2 THEN SEXFEMALE_2=1; 
ELSE SEXFEMALE_2=0; 
 
IF age=1 THEN AGE1824_1=1; 
ELSE AGE1824_1=0; 
 




IF age=3 THEN AGE3544_3=1; 
ELSE AGE3544_3=0; 
 
IF age=4 THEN AGE4554_4=1; 
ELSE AGE4554_4=0; 
 
IF age=5 THEN AGE5564_5=1; 
ELSE AGE5564_5=0; 
 
IF age=6 THEN AGE65_6=1; 
ELSE AGE65_6=0; 
 
IF R01R_A_ETHRACECAT7=1 THEN RACEWH_1=1; 
ELSE RACEWH_1=0; 
 
IF R01R_A_ETHRACECAT7=2 THEN RACEBL_2=1; 
ELSE RACEBL_2=0; 
 
IF R01R_A_ETHRACECAT7=3 THEN RACEOT_3=1; 
ELSE RACEOT_3=0; 
 
IF R01R_A_ETHRACECAT7=6 THEN RACEHI_6=1; 
ELSE RACEHI_6=0; 
 
IF education=1 THEN EDU_1=1; 
ELSE EDU_1=0; 
 
IF education=2 THEN EDU_2=1; 
ELSE EDU_2=0; 
 
IF education=3 THEN EDU_3=1; 
ELSE EDU_3=0; 
 
IF education=4 THEN EDU_4=1; 
ELSE EDU_4=0; 
 
IF education=5 THEN EDU_5=1; 
ELSE EDU_5=0; 
 
IF R01R_A_AM0030=1 THEN INC_1=1; 
ELSE INC_1=0; 
 
IF R01R_A_AM0030=2 THEN INC_2=1; 
ELSE INC_2=0; 
 
IF R01R_A_AM0030=3 THEN INC_3=1; 
ELSE INC_3=0; 
 
IF R01R_A_AM0030=4 THEN INC_4=1; 
ELSE INC_4=0; 
 
IF R01R_A_AM0030=5 THEN INC_5=1; 
ELSE INC_5=0; 
 
*extremely satisfied =1; 
IF R01_AX0092=1 THEN SOC_1=1; 
ELSE SOC_1=0; 
 
IF R01_AX0092=2 THEN SOC_2=1; 
ELSE SOC_2=0; 
 
IF R01_AX0092=3 THEN SOC_3=1; 
ELSE SOC_3=0; 
 
IF R01_AX0092=4 THEN SOC_4=1; 
ELSE SOC_4=0; 
 
*not at all satisfied =5; 





 array change _numeric_; 
 do over change; 
 if change=-97777 then change=.; 
 else if change=-99999 then change=.; 
 else if change=-99988 then change=.; 
 else if change=-99977 then change=.; 
 else if change=-99955 then change=.; 
 else if change=-99911 then change=.; 
 else if change=-9 then change=.; 
 else if change=-8 then change=.; 
 else if change=-7 then change=.; 
 else if change=-1 then change=.; 












proc freq data=lca.w1; 
table  R01R_A_SEX*SEXMALE_1 
  R01R_A_SEX*SEXFEMALE_2 
  age*AGE1824_1 
  age*AGE2534_2 
  age*AGE3544_3 
  age*AGE4554_4 
  age*AGE5564_5 
  age*AGE65_6 
  R01R_A_ETHRACECAT7*RACEWH_1 
  R01R_A_ETHRACECAT7*RACEBL_2 
  R01R_A_ETHRACECAT7*RACEOT_3 
  R01R_A_ETHRACECAT7*RACEHI_6 
  education*EDU_1 
  education*EDU_2 
  education*EDU_3 
  education*EDU_4 
  education*EDU_5 
  R01R_A_AM0030*INC_1 
  R01R_A_AM0030*INC_2 
  R01R_A_AM0030*INC_3 
  R01R_A_AM0030*INC_4 
  R01R_A_AM0030*INC_5 
  R01_AX0092*SOC_1 
  R01_AX0092*SOC_2 
  R01_AX0092*SOC_3 
  R01_AX0092*SOC_4 
  R01_AX0092*SOC_5; 
run; 
 
*check cig and ecig; 














*first do multinomial - 4 levels; 
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if acur_cig=0 and acur_ecig=0 then acur_dual=0; 
else if acur_cig=1 and acur_ecig=0 then acur_dual=1; 
else if acur_cig=0 and acur_ecig=1 then acur_dual=2; 










*then do the dummies; 
data lca.w1july20b; 
set lca.w1july20; 
if acur_dual = 1 then acur_cignew=1; 
else acur_cignew=0; 
if acur_dual = 2 then acur_ecignew=1; 
else acur_ecignew=0; 











*confirm marijuana is good; 






*check all substances; 
proc freq data=lca.w1; 










proc freq data=lca.w1; 
table acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller  
   R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030  R01_AX0092 
      depressed sleeping anxious ptsd 
   lied attention listening bully fights restless answered 
      weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid 





*Identify all variable want to keep; 
 
*Now limit to the main variables that we want to keep; 
data LCA.W1mplus; 
set LCA.W1 (keep = caseid personid R01_A_PWGT 
    acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller  
     R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030  
R01_AX0092 
     SEXMALE_1 SEXFEMALE_2  
        AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
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     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud ); 
*rename missings; 
array change _numeric_; 
do over change; 





proc contents data=LCA.W1mplus; 
run; 
 
*Maybe later- add weights back in; 
proc surveyfreq data=LCA.W1 varmethod=BRR (fay=0.3);  
table  
acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller  
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030 
R01_AX0092 
depressed sleeping anxious ptsd 













proc freq data=LCA.W1; 
table acur_painkiller*acur_cig/chisq oddsratio plcorr; 
run; 
 
proc freq data=LCA.W1; 




proc freq data=LCA.W1; 




proc freq data=LCA.W1; 




proc print data=LCA.W1; 
var SOC_5 depressed; 
run; 
 
proc freq data=LCA.W1; 




*current use - conventional cigarette prevalence; 













*July 2 2020 re-run with new exclusive CC, exclusive EC, and dual variables; 
data LCA.W1mplusJuly2020; 
set LCA.w1july20b (keep = caseid personid R01_A_PWGT 
     acur_cignew acur_ecignew acur_dualnew 
     acur_alc acur_marijuana acur_painkiller  
     R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030  
R01_AX0092 
     SEXMALE_1 SEXFEMALE_2  
        AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud ); 
*rename missings; 
array change _numeric_; 
do over change; 














set LCA.w1july20b (keep = caseid personid R01_A_PWGT 
     acur_cignew acur_ecignew acur_dualnew 
     acur_alc acur_marijuana acur_painkiller  
     R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030  
R01_AX0092 
     SEXMALE_1 SEXFEMALE_2  
        AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud  
        R01_A_PWGT1 - R01_A_PWGT100); 
     run; 
*rename missings; 
*array change _numeric_; 
*do over change; 










proc surveyfreq data= LCA.W1mplusJuly2020weights varmethod=BRR (fay=0.3); 
table acur_marijuana /row chisq(secondorder); 
weight R01_A_PWGT; 





proc surveyfreq data= LCA.W1mplusJuly2020weights varmethod=BRR (fay=0.3); 
table acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller  
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030 
R01_AX0092 
depressed sleeping anxious ptsd 












proc surveyfreq data= LCA.W1 varmethod=BRR (fay=0.3); 
table acur_marijuana  
/row chisq(secondorder); 
weight R01_A_PWGT; 





*confirm marijuana is good; 











proc mi data=lca.w1july20b seed=14832 nimpute=0 simple; 
var acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller  
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030 
R01_AX0092 
depressed sleeping anxious ptsd 









set LCA.w1july20b (keep = caseid personid R01_A_PWGT 
     acur_cignew acur_ecignew acur_dualnew 
     acur_alc acur_marijuana acur_painkiller  
     R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030  
R01_AX0092 
     SEXMALE_1 SEXFEMALE_2  
        AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
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     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud  
        R01_A_PWGT1 - R01_A_PWGT100); 
*rename missings; 
array change _numeric_; 
do over change; 




proc surveyfreq data=lca.W1mplusJuly2020weights4132021 varmethod=BRR (fay=0.3); 
table  acur_cignew acur_ecignew acur_dualnew 
     acur_alc acur_marijuana acur_painkiller  
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
/row chisq(secondorder); 
weight R01_A_PWGT; 





*export lca.W1mplusJuly2020weights4132021   
1 - run lca in mplus 
*need to rerun the summary stats for wave 1 from this data set = 
LCA.W1mplusJuly2020weights4132021;!!! 
2 - take results import into sas for prediction 






***Missing vs nonmissing for W1; 





if (acur_cignew=.) or (acur_ecignew=.) or (acur_dualnew=.) or (acur_alc=.) or 
(acur_marijuana=.) or (acur_painkiller=.) or  
(R01R_A_SEX=.)  or (age=.) or (R01R_A_ETHRACECAT7=.) or (education=.) or (R01R_A_AM0030=.) or 
(R01_AX0092=.) or 
(depressed=.) or (sleeping=.) or (anxious=.) or (ptsd=.) or 
(lied=.) or (attention=.) or (listening=.) or (bully=.) or (fights=.) or 
(restless=.) or (answered=.) or 






proc freq data=lca.w1missingtest; 
table compare; 
run; 
*complete data/analytic sample (compare = 1) = 24039; 
*missing (compare = 0) = 8281; 
 
******************************** 
*compare missing and nonmissing; 
*look at column percent; 




*sig different: analytic sample engages in more cig use , chi sq = <.0001; 
 
proc freq data=lca.w1missingtest; 
table acur_ecignew*compare/chisq; 
run; 
*sig different: analytic sample engages in more ecig use , chi sq = 0.002; 
 
proc freq data=lca.w1missingtest; 
table acur_dualnew*compare/chisq; 
run; 
*sig different: analytic sample engages in more dual use , chi sq = <.0001; 
 
proc freq data=lca.w1missingtest; 
table acur_alc*compare/chisq; 
run; 
*sig different: analytic sample engages in more alcohol use , chi sq = <.0001; 
 
proc freq data=lca.w1missingtest; 
table acur_marijuana*compare/chisq; 
run; 
*sig different: analytic sample engages in more, chi sq =<.0001; 
 
proc freq data=lca.w1missingtest; 
table acur_painkiller*compare/chisq; 
run; 
*sig different: analytic sample engages in more, chi sq=<.0001; 
 
*demos; 
proc freq data=lca.w1missingtest; 
table R01R_A_SEX*compare 
      age*compare 
      R01R_A_ETHRACECAT7*compare 
      education*compare 
      R01R_A_AM0030*compare 
      R01_AX0092*compare/chisq; 
run; 
*sig difference sex: more males, less women in analytic sample; 
*sig difference by age: more in categories 2, 3, 4 (25-54) in analytic sample; 
*sig difference by race: more white, less other cats in analytic sample; 
*sig difference by edu: higher edu levels in analytic sample; 
*sig difference by income: higher income levels in analytic sample; 
*sig difference by social: missing had more extremely and very satisfied; 
 
*internalizing; 
proc freq data=lca.w1missingtest; 
table depressed*compare 
      sleeping*compare 
      anxious*compare 
      ptsd*compare/chisq; 
run; 
*sig diff for all: analytic sample has higher endorsement of all 4 symptoms; 
 
*externalizing; 
proc freq data=lca.w1missingtest; 
table lied*compare 
      attention*compare 
      listening*compare 
      bully*compare 
      fights*compare 
      restless*compare 
      answered*compare/chisq; 
run; 




proc freq data=lca.w1missingtest; 
table sud*compare/chisq; 
run; 
*sig diff: analytic sample has higher endorsement of moderate and high sud severity; 
ods pdf close; 
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MPLUS File name: WAVE 1 RUN 4132021 4 CLASS 
 
TITLE: WAVE 1 MODEL 4-13-2021 with weights added and new tobacco variables : fixing the missing; 
     DATA: FILE IS newwave4132021editnoheader.csv; 
     VARIABLE: NAMES ARE CASEID PERSONID weight 
           acur_cignew acur_ecignew acur_dualnew 
            acur_alc acur_marijuana acur_painkiller  
           R01R_A_ETHRACECAT7 age education 
           depressed sleeping anxious ptsd  
           lied attention listening bully fights restless answered  
           weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid  
            sud  
           SEXMALE_1 SEXFEMALE_2  
           AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6  
           RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6  
           EDU_1 EDU_2 EDU_3 EDU_4 EDU_5  
           INC_1 INC_2 INC_3 INC_4 INC_5  
           SOC_1 SOC_2 SOC_3 SOC_4 SOC_5; 
        USEVARIABLES = acur_cignew acur_ecignew acur_dualnew 
                  acur_alc acur_marijuana acur_painkiller 
               depressed sleeping anxious ptsd  
               lied attention listening bully fights restless answered; 
        IDVARIABLE = CASEID; 
        MISSING ARE ALL (-99999); 
        CLASSES = c(4); 
        CATEGORICAL = acur_cignew acur_ecignew acur_dualnew 
                 acur_alc acur_marijuana acur_painkiller 
               depressed sleeping anxious ptsd  
               lied attention listening bully fights restless answered; 
        AUXILIARY = SEXMALE_1 (R3STEP) 
                    AGE1824_1 (R3STEP) AGE2534_2 (R3STEP) AGE3544_3 (R3STEP) 
                    AGE4554_4 (R3STEP) AGE5564_5 (R3STEP) 
                    RACEBL_2 (R3STEP) RACEOT_3 (R3STEP) RACEHI_6 (R3STEP) 
                    EDU_1 (R3STEP) EDU_2 (R3STEP) EDU_3(R3STEP) 
                   EDU_4 (R3STEP) INC_1 (R3STEP) INC_2 (R3STEP) 
                    INC_3 (R3STEP) INC_4 (R3STEP) 
                 SOC_2 (R3STEP) SOC_3 (R3STEP) SOC_4 (R3STEP) SOC_5 (R3STEP); 
      WEIGHT is weight; 
      ANALYSIS: TYPE = MIXTURE; 
                  STARTS = 100 10; 
                  OPTSEED = 991329; 
                  LRTSTARTS = 0 0 150 40; 
      SAVEDATA: file is w14class4132021.csv; 
               save = Cprob; 




SAS File name: Wave 1 4 class prediction 4142021 
 
*Prediction Model - Wave 1 4 Class Solution; 
*Data into Mplus is from LCA W1 4132021 (newwave4132021editnoheader.csv); 
*MPLUS Output = wave 1 run 4132021 4 class; 
*CSV = = w14class4132021; 
 





ACUR_CIG       ACUR_ECI       ACUR_DUA      ACUR_ALC       ACUR_MAR       ACUR_PAI        
DEPRESS        SLEEPING       ANXIOUS       PTSD            
LIED           ATTENTIO       LISTENING     BULLY          FIGHTS         RESTLESS       ANSWERED        
SEXMALE_        
AGE1824_        
    AGE2534_        
    AGE3544_        
    AGE4554_        
    AGE5564_        
    RACEBL_2        
    RACEOT_3        
    RACEHI_6        
    EDU_1           
    EDU_2           
    EDU_3          
    EDU_4           
    INC_1          
    INC_2          
    INC_3          
    INC_4          
    SOC_2          
    SOC_3           
    SOC_4           
    SOC_5           
    CPROB1         
    CPROB2         
    CPROB3          
    CPROB4         
    C               
    WEIGHT         
    CASEID; 
datalines; 








libname pred "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\Wave 1 Prediction 4142021"; 
 




proc surveyfreq data=pred.w14classprob4142021; 
table ACUR_MAR/row chisq(secondorder); 
weight weight; 
run; 
*the weighted freqs match with the mplus output; 
 
*now need to merge sud into the dataset using idvariable to get sud outcome in same dataset; 




libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Data Management"; 
 





merge pred.w14classprob4142021 LCA.W1mplusJuly2020weights4132021; 
by caseid; 
array change _numeric_; 
 304 
do over change; 








proc contents data=pred.w14classprobmerge; 
run; 
 
proc surveyfreq data=pred.w14classprobmerge; 




















proc surveylogistic data=pred.w14classprobmerge; 
class c (ref='3')/param=ref; 
model sud (descending) = c/ link=glogit; 





*Trying ordinal regression; 
proc surveylogistic data=pred.w14classprobmerge; 
class c (ref='3')/param=ref order=internal; 
model sud (descending) = c/lackfit; 




*use lackfit to test get pvalue for prop odds assumption; 
proc logistic data=pred.w14classprobmerge; 
class c (ref='3')/param=ref order=internal; 
model sud (descending) = c/lackfit; 
*output predprobs=(I) out=pred.probs72220; 
weight weight; 
run; 
ods pdf close; 
 
libname cb "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp"; 
 




    /* Compile supporting macros */ 
    %IF       %UPCASE(&_macComp)= YES %THEN %DO ; 
        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\words_MAC.sas"          ; 
        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\00_preCheck_MAC.sas"    ; 
        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\01_dataPre_MAC.sas"     ; 
        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\02_cr3_1Logit_MAC.sas"  ; 
        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\03_cr3_2ROC_MAC.sas"    ; 
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        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\04_cut3Base_MAC.sas"    ; 
        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\05_cut3Parmx_MAC.sas"   ; 
        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\06_parmx95_MAC.sas"     ; 
        %INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\07_cr3Results_MAC.sas"  ; 
    %END ; 
 
    %GLOBAL _poTitle _fileSfx ; 
 
    /* For portrait with 10pt font */ 
    OPTIONS LINESIZE= 95 
            PAGESIZE= 54 
    ; 
    OPTIONS FORMCHAR='|----|+|---+=|-/\<>*'; 
    ODS ESCAPECHAR= "^" ; 
 
    /* Check ternary ordinal outcome encoding is compatible with macro */ 
    %preCheck ; 
 
    %IF &_yOK EQ PASS %THEN %DO ; 
        %IF       %UPCASE(&_propOdds)= PO %THEN %DO ; 
            %LET _poTitle= %STR(Proportional Odds) ; 
            %LET _fileSfx= &_YOUT._&_XPRED._PO  ; 
        %END ; 
        %ELSE %IF %UPCASE(&_propOdds)= NPO %THEN %DO ; 
            %LET _poTitle= %STR(Non-Proportional Odds) ; 
            %LET _fileSfx= &_YOUT._&_XPRED._NPO ; 
        %END ; 
 
        /* Discard previous temporary datasets */ 
        PROC DATASETS LIBRARY= WORK NOLIST NOPRINT ; 
            DELETE  _inDsn _cutParmx _parmx95 ; 
        RUN ; QUIT ; 
 
        /* Discard previous permanent output datasets */ 
        PROC DATASETS LIBRARY= &_LIBNM NOLIST NOPRINT ; 
            DELETE  PARMS4VAR_&_fileSfx 
                    COVB_&_fileSfx 
                    CUMLOGPARM_&_fileSfx 
                    CUMLOGTABLE_&_fileSfx 
                    CUMLOGPRED_&_fileSfx 
                    ASSOC_&_fileSfx 
                    ROC_&_fileSfx 
                    AUC_&_fileSfx 
                    CUTBASE_&_fileSfx 
                    CUTPARMX_&_fileSfx 
                    CUMROC3_&_fileSfx 
            ; 
        RUN ; QUIT ; 
 
        /*  MACRO MODE 
            1:  Complete procedure: analysis, criteria and parametric cutpoint calculation, 
reporting 
            2:  Analysis and criteria and parametric cutpoint calculation only 
            3:  Reporting only: requires 1 or 2 to have been run previously */ 
        %IF &_macMode= 1 OR &_macMode= 2 %THEN %DO ; 
            %dataPre ; 
            %cr3_1Logit ; 
            %cr3_2ROC ; 
            %cut3Base ; 
            %cut3Parmx ; %parmx95 ; 
        %END ; 
 
        %IF &_macMode= 1 OR &_macMode= 3 
            %THEN %cr3Results(CUTPARMX CUTBASE) ; 
 
        /* Clean up */ 
        %IF %upCase(&_debug0)= NO 
            AND 
            (&_macMode= 1 OR &_macMode= 2) 
            %THEN %DO ; 
                PROC DATASETS library= WORK NOLIST NOPRINT ; 
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                    DELETE  _inDsn _cutParmx _parmx95 ; 
                RUN ; QUIT ; 
            %END ; 
    %END ; 
%MEND cumRoc3 ; 
 
 
*Create dataset for class and SUD to run the cum ROC; 
data cb.macrotestclass4142021; 
set pred.w14classprobmerge (keep = sud c); 
run; 
 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF; 
    /* Macro debugging: ENABLED */ 
    OPTIONS MLOGIC MPRINT SYMBOLGEN ; 
    %cumRoc3(sud,c,SUD,%STR(BESTD8.3),macrotestclass4142021, 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
 
        2019_DEMO,_macMode=1,_macComp=YES, 
        _outCntnts=YES,_outRtf=NO) ; 
    /* Macro debugging: DISABLED */ 
    OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ; 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF CLOSE; 
 
 
*Create internal score; 
data pred.internalscore; 
set pred.w14classprobmerge;  
*create our continuous internalizing "predictive variable"; 
int_score = sum (depressed, sleeping, anxious, ptsd); 
run; 
 





*Create dataset for internalizing and SUD to run the cum ROC; 
data cb.macrotestintscore4142021; 
set pred.internalscore (keep = sud int_score); 
run; 
 
proc contents data=cb.macrotestintscore4142021; 
run; 
 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF; 
    /* Macro debugging: ENABLED */ 
    OPTIONS MLOGIC MPRINT SYMBOLGEN ; 
    %cumRoc3(sud,int_score,SUD,%STR(BESTD8.3),macrotestintscore4142021, 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
 
        2019_DEMO,_macMode=1,_macComp=YES, 
        _outCntnts=YES,_outRtf=NO) ; 
    /* Macro debugging: DISABLED */ 
    OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ; 
*ODS HTML Close ; *ODS HTML ; 




*Create external score; 
data pred.externalscore; 
set pred.w14classprobmerge;  
*create our continuous  "predictive variable"; 
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ext_score = sum (lied, attention, listening, bully, fights, restless, answered); 
run; 
 





*Create dataset for externalizing and SUD to run the cum ROC; 
data cb.macrotestextscore4142021; 
set pred.externalscore (keep = sud ext_score); 
run; 
 
proc contents data=cb.macrotestextscore4142021; 
run; 
 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF; 
    /* Macro debugging: ENABLED */ 
    OPTIONS MLOGIC MPRINT SYMBOLGEN ; 
    %cumRoc3(sud,ext_score,SUD,%STR(BESTD8.3),macrotestextscore4142021, 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
 
        2019_DEMO,_macMode=1,_macComp=YES, 
        _outCntnts=YES,_outRtf=NO) ; 
    /* Macro debugging: DISABLED */ 
    OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ; 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF CLOSE; 
 
 





*Create substance use score; 
data pred.subsscore; 
set pred.w14classprobmerge;  
*create our continuous  "predictive variable"; 









*Create dataset for substance use and SUD to run the cum ROC; 
data cb.macrotestsubsscore4142021; 
set pred.subsscore (keep = sud subs_score); 
run; 
 
proc contents data=cb.macrotestsubsscore4142021; 
run; 
 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF; 
    /* Macro debugging: ENABLED */ 
    OPTIONS MLOGIC MPRINT SYMBOLGEN ; 
    %cumRoc3(sud,subs_score,SUD,%STR(BESTD8.3),macrotestsubsscore4142021, 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
 
        2019_DEMO,_macMode=1,_macComp=YES, 
        _outCntnts=YES,_outRtf=NO) ; 
    /* Macro debugging: DISABLED */ 
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    OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ; 
*ODS HTML Close ; *ODS HTML ; 












set pred.probs72220 (keep = sud IP_2); 
run; 
 
*move the dataset into cb; 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF; 
    /* Macro debugging: ENABLED */ 
    OPTIONS MLOGIC MPRINT SYMBOLGEN ; 
    %cumRoc3(sud,IP_2,SUD,%STR(BESTD8.3),macroip2, 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
 
        2019_DEMO,_macMode=1,_macComp=YES, 
        _outCntnts=YES,_outRtf=NO) ; 
    /* Macro debugging: DISABLED */ 
    OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ; 
*ODS HTML Close ; *ODS HTML ; 





set pred.probs72220 (keep = sud IP_1); 
run; 
 
*move the dataset into cb; 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF; 
    /* Macro debugging: ENABLED */ 
    OPTIONS MLOGIC MPRINT SYMBOLGEN ; 
    %cumRoc3(sud,IP_1,SUD,%STR(BESTD8.3),macroip1, 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
 
        2019_DEMO,_macMode=1,_macComp=YES, 
        _outCntnts=YES,_outRtf=NO) ; 
    /* Macro debugging: DISABLED */ 
    OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ; 
*ODS HTML Close ; *ODS HTML ; 





set pred.probs72220 (keep = sud IP_0); 
run; 
 
*move the dataset into cb; 
*ODS HTML Close ; *ODS HTML ; 
ODS PDF; 
    /* Macro debugging: ENABLED */ 
    OPTIONS MLOGIC MPRINT SYMBOLGEN ; 
    %cumRoc3(sud,IP_0,SUD,%STR(BESTD8.3),macroip0, 
        %STR(C:\Users\blondinoct\Documents\LCA), 
        %STR(C:\Users\blondinoct\Documents\LCA), 
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        %STR(C:\Users\blondinoct\Documents\LCA), 
 
        2019_DEMO,_macMode=1,_macComp=YES, 
        _outCntnts=YES,_outRtf=NO) ; 
    /* Macro debugging: DISABLED */ 
    OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ; 
*ODS HTML Close ; *ODS HTML ; 




SAS File name: Network W1 4142021 
 
****SA 2 - Network Analysis 
****Making datasets for overall Wave 1 then by sex 
****NEW!!!! APRIL 14 2021; 
 
 
libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Data Management"; 
 
 




set LCA.W1mplusJuly2020weights4132021 (keep = R01R_A_SEX CASEID PERSONID 
     acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana 
acur_painkiller  
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered); 
 array change _numeric_; 
do over change; 




proc contents data=lca.newwave1fornet442021; 
run; 
 
proc freq data=lca.newwave1fornet442021; 
table R01R_A_SEX ; 
run; 
 
proc freq data=lca.newwave1fornet442021; 
table R01R_A_SEX  
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller  
     depressed sleeping anxious ptsd 




libname net "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\Network Wave 1 Data Management"; 
 
*OVERALL WAVE 1; 
data net.overallwave14142021; 
set lca.newwave1fornet442021 (keep =  
     acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana 
acur_painkiller  
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered); 




*male wave 1; 
data net.malesubset4142021; 
set lca.newwave1fornet442021; 




proc contents data=net.malesubset4142021; 
run; 
 
*use this one; 
data net.malewave14142021; 
set net.malesubset4142021(keep = acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana 
acur_painkiller  
     depressed sleeping anxious ptsd 







*female wave 1; 
data net.femalesubset4142021; 
set lca.newwave1fornet442021; 
if R01R_A_SEX="2" then output; 
run; 
 
proc contents data=net.femalesubset4142021; 
run; 
 
*use this one; 
data net.femalewave14142021; 
set net.femalesubset4142021(keep = acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana 
acur_painkiller  
     depressed sleeping anxious ptsd 









proc contents data=net.overallwave14142021; 
run; 
 
proc corr data=net.overallwave14142021; 
var ACUR_CIGNEW  ACUR_ECIGNEW ACUR_DUALNEW ACUR_ALC ACUR_MARIJUANA
 ACUR_PAINKILLER  
DEPRESSED SLEEPING ANXIOUS  PTSD  














































































ACUR_CIGNEW*ANXIOUS   
ACUR_ECIGNEW*ANXIOUS   
ACUR_DUALNEW*ANXIOUS   
ACUR_ALC*ANXIOUS   






















proc freq data=net.overallwave14142021; 
































ACUR_ALC*FIGHTS   





















































































**correlations by sex; 
 
ods pdf; 
**male - su; 































**male - su and int; 
















ACUR_CIGNEW*ANXIOUS   
ACUR_ECIGNEW*ANXIOUS   
ACUR_DUALNEW*ANXIOUS   
ACUR_ALC*ANXIOUS   






















**male - su and ext; 
proc freq data=net.malewave14142021; 

































ACUR_ALC*FIGHTS   




















*male int and ext; 


































































**female - su; 






























**female - su and int; 

















ACUR_CIGNEW*ANXIOUS   
ACUR_ECIGNEW*ANXIOUS   
ACUR_DUALNEW*ANXIOUS   
ACUR_ALC*ANXIOUS   






















**female - su and ext; 
proc freq data=net.femalewave14142021; 

































ACUR_ALC*FIGHTS   




















*female int and ext; 





























































ods pdf close; 
      
*tobacco; 








ods pdf close; 
 
 
R File name: New W1, M, W Network Analysis 4142021 
 




# Starting with Overall Wave 1 Sample  # 
######################################## 
 





























#rename variables so they look nice on the network 
names(overall)[names(overall) == "ACUR_CIG"] <- "CIG" 
names(overall)[names(overall) == "ACUR_ECI"] <- "ECIG" 
names(overall)[names(overall) == "ACUR_DUA"] <- "Dual CIG + ECIG" 
names(overall)[names(overall) == "ACUR_ALC"] <- "Alcohol" 
names(overall)[names(overall) == "ACUR_MAR"] <- "Marijuana" 
names(overall)[names(overall) == "ACUR_PAI"] <- "PDNP" 
names(overall)[names(overall) == "DEPRESS"] <- "Depressed" 
names(overall)[names(overall) == "SLEEPING"] <- "Sleeping" 
names(overall)[names(overall) == "ANXIOUS"] <- "Anxious" 
names(overall)[names(overall) == "PTSD"] <- "Distressed/Past" 
names(overall)[names(overall) == "LIED"] <- "Lied" 
names(overall)[names(overall) == "ATTENTIO"] <- "Attention" 
names(overall)[names(overall) == "LISTENING"] <- "Listening" 
names(overall)[names(overall) == "BULLY"] <- "Bully" 
names(overall)[names(overall) == "FIGHTS"] <- "Fights" 
names(overall)[names(overall) == "RESTLESS"] <- "Restless" 












OverallNetworkIF <-estimateNetwork(overall, default="IsingFit", missing="listwise") 
#try a network with spring layout 







Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana",  "PDNP",        
          "Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",        
          "Attention" , "Listening" , "Bully" ,"Fights"  , "Restless",    
          "Answered") 
 
Traits <- rep(c( 
  'Substance Use', 
  'Negative Affect', 







#     layout="spring", 
#     cut=0, 
#     theme="colorblind", 
#     groups=Traits, 
#     labels=Names, 
     #nodeNames=Names, 
#     edge.color="black", 
#     label.scale.equal=TRUE, 
#     label.cex= 1.2, 





     layout="spring", 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     labels=Names, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 3.0, 
     legend.cex = 0.4) 
 
     #title= "Overall Wave 1 Sample") 
 
#edges 





#write(OverallNetworkIF$graph, file="OverallEdges.csv", sep=" ") 
 
####################################################################### 
#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS          # 
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (OverallNetworkIF) # 
####################################################################### 
 
#First, test accuracy of connections by obtaining confidence interval around 






#Perform a non-parametric bootstrap on the estimated network, and 
#plot the confidence intervals of the edge-weights 
OverallBoot <- bootnet(OverallNetworkIF, nCores=8) 
#note that the default is not listed here but in the notes, they are 
plot(OverallBoot, order="sample") 
plot(OverallBoot, order="sample", plot="interval", split0=TRUE, labels=FALSE) 
plot(OverallBoot, order="sample", labels=FALSE) 
plot(OverallBoot, order="sample", plot="interval", split0=TRUE) 
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#plot bootstrapped edge CIs 
plot(OverallBoot, labels=FALSE, order="sample") 
#plot significant differences (alpha=0.05) of edges 
plot(OverallBoot, "edge", plot="difference", onlyNonZero = TRUE, 
     order="sample") 
 
 
#removing edges (setting them to 0) based on significance alpha=0.05 
# Threshold network: 






#print on PDF so you can read which edge and how many times 
#make sure dimensions are quite long 
#was it included in the bootstrap 
Overall_Ising_threshold <- bootThreshold(OverallBoot, alpha=0.01) 
Overall_Ising_threshold$results 
 
L<- averageLayout(OverallNetworkIF, Overall_Ising_threshold) 
layout(t(1:2)) 
plot(OverallNetworkIF, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 1.2, 
     legend.cex = 0.4, 
     title="Ising Fit Overall Sample") 
plot(Overall_Ising_threshold, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 1.2, 
     legend.cex = 0.4, 






Edges <- OverallNetworkIF$graph 
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print(Edges) 
write(Edges, file="OverallEdges.csv", sep=" ") 
 
OverallSigDifEdge <- summary(OverallBoot) 
write(OverallSigDifEdge, file="OverallSigDifEdge.csv", sep=" ") 
 
#Second, investigate stability of centrality indices by case-dropping subset bootstrap 
#and get the CS-coefficient 
 
 
#Perform a case-drop bootstrap on the network, and plot the stability 
#of centrality indices. Remember that the default values have now changes 
#and do not automatically include stability estimates of 'closeness' 
#and 'betweenness'. If you do wish to inspect these, you must include 
#statistics = c("strength", "closeness", "betweenness") 
OverallBoot2 <- bootnet(OverallNetworkIF, nCores=8, type="case", 
                        statistics=c("strength", "closeness", "betweenness")) 
plot(OverallBoot2, statistics = c("strength", "closeness", "betweenness")) 
 
 
plot(OverallBoot2, statistics = c("strength", "closeness")) 
 
 
plot(OverallBoot2, statistics = c("strength", "closeness", "betweenness"), 
     CIstyle="quantiles") 
 
differenceTest(OverallBoot2, "ACUR_CIG", "ACUR_ECIG", "strength") 
 
 
#Give the CS-coefficient of the three centrality indices, and explain how 
#this measure can be interpreted 
corStability(OverallBoot2) 
#CS-coefficient for  
#betweenness= 0.206 (below 0.25- not good) - should not interpret betweenness values because CS 
coefficient is not stable 
#closeness= 0.517 this is ok 
#strength= 0.594 this is good, above 0.5 
 
centralityPlot(OverallNetworkIF, include=c("Strength", "Closeness","Betweenness")) 










#Third, test whether network connections (step1) and centrality metrics (step2) 
#for different variables significantly differ from each other using bootstrapped difference test 
#can do the edge weight difference test and the centrality difference test 
 
plot(OverallBoot, "edge", plot="difference", onlyNonZero = TRUE, order="sample", labels=FALSE) 
 
differenceTest(OverallBoot, 3, 17, "strength") 
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differenceTest(OverallBoot, 1, 1, "strength") 
plot(OverallBoot, "strength") 
#plot(OverallBoot, statistics = c("betweenness", "closeness", "strength"), plot = 
#       "difference") 


















#rename variables so they look nice on the network 
names(male)[names(male) == "ACUR_CIG"] <- "CIG" 
names(male)[names(male) == "ACUR_ECI"] <- "ECIG" 
names(male)[names(male) == "ACUR_DUA"] <- "Dual CIG + ECIG" 
names(male)[names(male) == "ACUR_ALC"] <- "Alcohol" 
names(male)[names(male) == "ACUR_MAR"] <- "Marijuana" 
names(male)[names(male) == "ACUR_PAI"] <- "PDNP" 
names(male)[names(male) == "DEPRESS"] <- "Depressed" 
names(male)[names(male) == "SLEEPING"] <- "Sleeping" 
names(male)[names(male) == "ANXIOUS"] <- "Anxious" 
names(male)[names(male) == "PTSD"] <- "PTSD" 
names(male)[names(male) == "LIED"] <- "Lied" 
names(male)[names(male) == "ATTENTIO"] <- "Attention" 
names(male)[names(male) == "LISTENING"] <- "Listening" 
names(male)[names(male) == "BULLY"] <- "Bully" 
names(male)[names(male) == "FIGHTS"] <- "Fights" 
names(male)[names(male) == "RESTLESS"] <- "Restless" 





MaleNetworkIF <-estimateNetwork(male, default="IsingFit", missing="listwise") 
#try a network with spring layout 






Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana",  "PDNP",        
          "Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",        
          "Attention" , "Listening" , "Bully" ,"Fights"  , "Restless",    
          "Answered") 
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Traits <- rep(c( 
  'Substance Use', 
  'Internalizing', 





     layout="spring", 
     cut=0, 
     theme="colorblind", 
     #title="Wave 1 - Men Only", 
     groups=Traits, 
     labels=Names, 
     #nodeNames=Names, 
     label.scale.equal=TRUE, 
     label.cex= 4, 












#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS          # 
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (MaleNetworkIF)    # 
####################################################################### 
library(bootnet) 
#Network <- estimateNetwork(bfiData, default="ggmModSelect", 
#                           stepwise=FALSE, corMethod="cor") 
#plot(Network) 
 
#Perform a non-parametric bootstrap on the estimated network, and 
#plot the confidence intervals of the edge-weights 
MaleBoot1 <- bootnet(MaleNetworkIF, nCores=8) 
#note that the default is not listed here but in the notes, they are 
plot(MaleBoot1, order="sample") 
plot(MaleBoot1, order="sample", plot="interval", split0=TRUE) 
#print on PDF so you can read which edge and how many times 
#make sure dimensions are quite long 
#was it included in the bootstrap 
plot(MaleBoot1, order="sample", labels=FALSE) 
 
#Perform a case-drop bootstrap on the network, and plot the stability 
#of centrality indices. Remember that the default values have now changes 
#and do not automatically include stability estimates of 'closeness' 
#and 'betweenness'. If you do wish to inspect these, you must include 
#statistics = c("strength", "closeness", "betweenness") 
MaleBoot2 <- bootnet(MaleNetworkIF, nCores=8, type="case", 
                 statistics=c("strength", "closeness", "betweenness")) 
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plot(MaleBoot2, statistics = c("strength", "closeness", "betweenness")) 
 
#Give the CS-coefficient of the three centrality indices, and explain how 
#this measure can be interpreted 
corStability(MaleBoot2) 
#CS-coefficient for  
#betweenness= 0.128 (below 0.25- not good) 
#closeness= 0.361  (don't think this is good but check) 
#strength= 0.517 this is good, before 0.5 
 
centralityPlot(MaleNetworkIF) 
centralityPlot(MaleNetworkIF, include=c("Strength", "Closeness","Betweenness")) 
 






#plot significant differences (alpha=0.05) of edges 
plot(MaleBoot1, "edge", plot="difference", onlyNonZero = TRUE, 
     order="sample", labels=FALSE) 


















#rename variables so they look nice on the network 
names(female)[names(female) == "ACUR_CIG"] <- "CIG" 
names(female)[names(female) == "ACUR_ECI"] <- "ECIG" 
names(female)[names(female) == "ACUR_DUA"] <- "Dual CIG + ECIG" 
names(female)[names(female) == "ACUR_ALC"] <- "Alcohol" 
names(female)[names(female) == "ACUR_MAR"] <- "Marijuana" 
names(female)[names(female) == "ACUR_PAI"] <- "PDNP" 
names(female)[names(female) == "DEPRESS"] <- "Depressed" 
names(female)[names(female) == "SLEEPING"] <- "Sleeping" 
names(female)[names(female) == "ANXIOUS"] <- "Anxious" 
names(female)[names(female) == "PTSD"] <- "PTSD" 
names(female)[names(female) == "LIED"] <- "Lied" 
names(female)[names(female) == "ATTENTIO"] <- "Attention" 
names(female)[names(female) == "LISTENING"] <- "Listening" 
names(female)[names(female) == "BULLY"] <- "Bully" 
names(female)[names(female) == "FIGHTS"] <- "Fights" 
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names(female)[names(female) == "RESTLESS"] <- "Restless" 





FemaleNetworkIF <-estimateNetwork(female, default="IsingFit", missing="listwise") 
#try a network with spring layout 







Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana",  "PDNP",        
          "Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",        
          "Attention" , "Listening" , "Bully" ,"Fights"  , "Restless",    
          "Answered") 
 
Traits <- rep(c( 
  'Substance Use', 
  'Internalizing', 





     layout="spring", 
     cut=0, 
     theme="colorblind", 
     #title="Wave 1 - Women Only", 
     groups=Traits, 
     labels=Names, 
     #nodeNames=Names, 
     label.scale.equal=TRUE, 
     label.cex= 4, 











#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS          # 
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (FemaleNetworkIF)    # 
####################################################################### 
library(bootnet) 
#Network <- estimateNetwork(bfiData, default="ggmModSelect", 




#Perform a non-parametric bootstrap on the estimated network, and 
#plot the confidence intervals of the edge-weights 
FemaleBoot1 <- bootnet(FemaleNetworkIF, nCores=8) 
#note that the default is not listed here but in the notes, they are 
plot(FemaleBoot1, order="sample", labels=FALSE) 
plot(FemaleBoot1, order="sample", plot="interval", split0=TRUE) 
#print on PDF so you can read which edge and how many times 
#make sure dimensions are quite long 
#was it included in the bootstrap 
 
#Perform a case-drop bootstrap on the network, and plot the stability 
#of centrality indices. Remember that the default values have now changes 
#and do not automatically include stability estimates of 'closeness' 
#and 'betweenness'. If you do wish to inspect these, you must include 
#statistics = c("strength", "closeness", "betweenness") 
FemaleBoot2 <- bootnet(FemaleNetworkIF, nCores=8, type="case", 
                       statistics=c("strength", "closeness", "betweenness")) 
plot(FemaleBoot2, statistics = c("strength", "closeness", "betweenness")) 
 
#Give the CS-coefficient of the three centrality indices, and explain how 
#this measure can be interpreted 
corStability(FemaleBoot2) 
#CS-coefficient for  
#betweenness= 0.128 (below 0.25- not good) 
#closeness= 0.439 (don't think this is good but check) 
#strength= 0.361 not good - all below 0.5 so not good 
 
centralityPlot(FemaleNetworkIF) 









#plot significant differences (alpha=0.05) of edges 
plot(FemaleBoot1, "edge", plot="difference", onlyNonZero = TRUE, 
     order="sample", labels=FALSE) 













Max<- max(abs(c(getWmat(MaleNetworkIF), getWmat(FemaleNetworkIF)))) 
layout(t(1:2)) 
plot(MaleNetworkIF, layout=L, title="Men", maximum=Max) 
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Max<- max(abs(c(getWmat(MaleNetworkIF), getWmat(FemaleNetworkIF)))) 
layout(t(1:2)) 
plot(MaleNetworkIF, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     labels=Names, 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex=4.0, 
     legend.cex = 0.4, 
     legend=FALSE, 
     title= "Men", 
     maximum=Max) 
plot(FemaleNetworkIF, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     labels=Names, 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 
     legend = FALSE, 
     title= "Women", 
     maximum=Max) 
 
MaleW1Edges <- MaleNetworkIF$graph 
write.csv(MaleW1Edges, file="Male_W1_Edges.csv") 
 








#perform NCT and interpret results 
NCTres<- NCT(MaleNetworkIF, FemaleNetworkIF, test.edges=TRUE, 
             it=100) 
 




#global strength values of individual networks 
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NCTres$glstrinv.sep 
#53.41989 vs 50.94101 
 
#Difference in global strength p-value 
NCTres$glstrinv.pval 
#0.4554455 - so not significantly different from one another in regard to global strength 
 




#Maximum difference in edge weights 
NCTres$nwinv.pval 
#0.3168317 - so not significantly different from one another in regard to number of edge weights 
 
#Which edges significantly differ? 
NCTres$einv.pvals[which(NCTres$einv.pvals[,3]<0.05),] 
#            Var1           Var2    p-value 
#72        acur_alc acur_marijuana 0.01980198 
#123       acur_alc       sleeping 0.00990099 
#141 acur_marijuana        anxious 0.02970297 
#172   acur_ecignew           lied 0.03960396 
#174       acur_alc           lied 0.00990099 
#191       acur_alc      attention 0.01980198 
#198           lied      attention 0.03960396 




#NCTresCen<- NCT(MaleNetworkIF, FemaleNetworkIF, test.centrality=TRUE, centrality=c("strength"), 














#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS          # 
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (OverallNetworkIF) # 
####################################################################### 
 
#First, test accuracy of connections by obtaining confidence interval around 




#Network <- estimateNetwork(bfiData, default="ggmModSelect", 




#Perform a non-parametric bootstrap on the estimated network, and 
#plot the confidence intervals of the edge-weights 
OverallBoot <- bootnet(OverallNetworkIF, nCores=8) 
#note that the default is not listed here but in the notes, they are 
plot(OverallBoot, order="sample") 
plot(OverallBoot, order="sample", plot="interval", split0=TRUE, labels=FALSE) 
plot(OverallBoot, order="sample", labels=FALSE) 





#plot bootstrapped edge CIs 
plot(OverallBoot, labels=FALSE, order="sample") 
#plot significant differences (alpha=0.05) of edges 
plot(OverallBoot, "edge", plot="difference", onlyNonZero = TRUE, 
     order="sample") 
 
 
#removing edges (setting them to 0) based on significance alpha=0.05 
# Threshold network: 






#print on PDF so you can read which edge and how many times 
#make sure dimensions are quite long 
#was it included in the bootstrap 
Overall_Ising_threshold <- bootThreshold(OverallBoot, alpha=0.01) 
Overall_Ising_threshold$results 
 
L<- averageLayout(OverallNetworkIF, Overall_Ising_threshold) 
layout(t(1:2)) 
plot(OverallNetworkIF, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 1.2, 
     legend.cex = 0.4, 
     title="Ising Fit Overall Sample") 
plot(Overall_Ising_threshold, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 1.2, 
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     legend.cex = 0.4, 








#Second, investigate stability of centrality indices by case-dropping subset bootstrap 
#and get the CS-coefficient 
 
 
#Perform a case-drop bootstrap on the network, and plot the stability 
#of centrality indices. Remember that the default values have now changes 
#and do not automatically include stability estimates of 'closeness' 
#and 'betweenness'. If you do wish to inspect these, you must include 
#statistics = c("strength", "closeness", "betweenness") 
OverallBoot2 <- bootnet(OverallNetworkIF, nCores=8, type="case", 
                        statistics=c("strength", "closeness", "betweenness")) 
plot(OverallBoot2, statistics = c("strength", "closeness", "betweenness")) 
 
 
plot(OverallBoot2, statistics = c("strength", "closeness")) 
 
 
plot(OverallBoot2, statistics = c("strength", "closeness", "betweenness"), 
     CIstyle="quantiles") 
 
differenceTest(OverallBoot2, "ACUR_CIG", "ACUR_ECIG", "strength") 
 
 
#Give the CS-coefficient of the three centrality indices, and explain how 
#this measure can be interpreted 
corStability(OverallBoot2) 
#CS-coefficient for  
#betweenness= 0.128 (below 0.25- not good) - should not interpret betweenness values because CS 
coefficient is not stable 
#closeness= 0.594 this is ok 
#strength= 0.594 this is good, above 0.5 
 
centralityPlot(OverallNetworkIF, include=c("Strength", "Closeness","Betweenness")) 










#Third, test whether network connections (step1) and centrality metrics (step2) 
#for different variables significantly differ from each other using bootstrapped difference test 
#can do the edge weight difference test and the centrality difference test 
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plot(OverallBoot, "edge", plot="difference", onlyNonZero = TRUE, order="sample", labels=FALSE) 
 
differenceTest(OverallBoot, 3, 17, "strength") 
differenceTest(OverallBoot, 1, 1, "strength") 
plot(OverallBoot, "strength") 
#plot(OverallBoot, statistics = c("betweenness", "closeness", "strength"), plot = 
#       "difference") 





























#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS          # 
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (MaleNetworkIF)    # 
####################################################################### 
library(bootnet) 
#Network <- estimateNetwork(bfiData, default="ggmModSelect", 
#                           stepwise=FALSE, corMethod="cor") 
#plot(Network) 
 
#Perform a non-parametric bootstrap on the estimated network, and 
#plot the confidence intervals of the edge-weights 
Boot1 <- bootnet(MaleNetworkIF, nCores=8) 
#note that the default is not listed here but in the notes, they are 
plot(Boot1, order="sample") 
plot(Boot1, order="sample", plot="interval", split0=TRUE) 
#print on PDF so you can read which edge and how many times 
#make sure dimensions are quite long 
#was it included in the bootstrap 
plot(Boot1, order="sample", labels=FALSE) 
 
#Perform a case-drop bootstrap on the network, and plot the stability 
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#of centrality indices. Remember that the default values have now changes 
#and do not automatically include stability estimates of 'closeness' 
#and 'betweenness'. If you do wish to inspect these, you must include 
#statistics = c("strength", "closeness", "betweenness") 
Boot2 <- bootnet(MaleNetworkIF, nCores=8, type="case", 
                 statistics=c("strength", "closeness", "betweenness")) 
plot(Boot2, statistics = c("strength", "closeness", "betweenness")) 
 
#Give the CS-coefficient of the three centrality indices, and explain how 
#this measure can be interpreted 
corStability(Boot2) 
#CS-coefficient for  
#betweenness= 0.128 (below 0.25- not good) 
#closeness= 0.283 (don't think this is good but check) 
#strength= 0.517 this is good, before 0.5 
 
centralityPlot(MaleNetworkIF) 
centralityPlot(MaleNetworkIF, include=c("Strength", "Closeness","Betweenness")) 
 





#plot significant differences (alpha=0.05) of edges 
plot(Boot1, "edge", plot="difference", onlyNonZero = TRUE, 
     order="sample", labels=FALSE) 








#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS          # 
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (FemaleNetworkIF)    # 
####################################################################### 
library(bootnet) 
#Network <- estimateNetwork(bfiData, default="ggmModSelect", 
#                           stepwise=FALSE, corMethod="cor") 
#plot(Network) 
 
#Perform a non-parametric bootstrap on the estimated network, and 
#plot the confidence intervals of the edge-weights 
FemaleBoot1 <- bootnet(FemaleNetworkIF, nCores=8) 
#note that the default is not listed here but in the notes, they are 
plot(FemaleBoot1, order="sample", labels=FALSE) 
plot(FemaleBoot1, order="sample", plot="interval", split0=TRUE) 
#print on PDF so you can read which edge and how many times 
#make sure dimensions are quite long 
#was it included in the bootstrap 
 
#Perform a case-drop bootstrap on the network, and plot the stability 
#of centrality indices. Remember that the default values have now changes 
#and do not automatically include stability estimates of 'closeness' 
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#and 'betweenness'. If you do wish to inspect these, you must include 
#statistics = c("strength", "closeness", "betweenness") 
FemaleBoot2 <- bootnet(FemaleNetworkIF, nCores=8, type="case", 
                       statistics=c("strength", "closeness", "betweenness")) 
plot(FemaleBoot2, statistics = c("strength", "closeness", "betweenness")) 
 
#Give the CS-coefficient of the three centrality indices, and explain how 
#this measure can be interpreted 
corStability(FemaleBoot2) 
#CS-coefficient for  
#betweenness= 0.05 (below 0.25- not good) 
#closeness= 0.05 (don't think this is good but check) 
#strength= 0.439 not good 
 
centralityPlot(FemaleNetworkIF) 









#plot significant differences (alpha=0.05) of edges 
plot(FemaleBoot1, "edge", plot="difference", onlyNonZero = TRUE, 
     order="sample", labels=FALSE) 




R File name: Nodewise Predictability 4162021 
 
#Nodewise predictability 4162021 
 









#rename variables so they look nice on the network 
names(overall)[names(overall) == "acur_cignew"] <- "CIG" 
names(overall)[names(overall) == "acur_ecignew"] <- "ECIG" 
names(overall)[names(overall) == "acur_dualnew"] <- "Dual CIG + ECIG" 
names(overall)[names(overall) == "acur_alc"] <- "Alcohol" 
names(overall)[names(overall) == "acur_marijuana"] <- "Marijuana" 
names(overall)[names(overall) == "acur_painkiller"] <- "PDNP" 
names(overall)[names(overall) == "depressed"] <- "Depressed" 
names(overall)[names(overall) == "sleeping"] <- "Sleeping" 
names(overall)[names(overall) == "anxious"] <- "Anxious" 
names(overall)[names(overall) == "ptsd"] <- "PTSD" 
names(overall)[names(overall) == "lied"] <- "Lied" 
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names(overall)[names(overall) == "attention"] <- "Attention" 
names(overall)[names(overall) == "listening"] <- "Listening" 
names(overall)[names(overall) == "bully"] <- "Bully" 
names(overall)[names(overall) == "fights"] <- "Fights" 
names(overall)[names(overall) == "restless"] <- "Restless" 











#delete obs with missing data 
overall_complete_cases <- overall[complete.cases(overall),] 
 
#make into matrix 
overall_matrix <- data.matrix(overall_complete_cases) 
 
 
OverallNetworkMGM <- mgm (data = overall_matrix,  
                          type =  c("c", "c","c","c","c","c","c","c","c","c", 
                                    "c","c","c","c","c","c","c"), 
                          level = c(2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 
                                    2, 2, 2), 
                          ruleReg = "OR", 
                          k = 2, 






Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana",  "PDNP",        
          "Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",        
          "Attention" , "Listening" , "Bully" ,"Fights"  , "Restless",    
          "Answered") 
 
Traits <- rep(c( 
  'Substance Use', 
  'Negative Affect', 
  'Externalizing' 
), times=c(6,4,7)) 
 
#this won't run... 
plot(OverallNetworkMGM, 
     layout="spring", 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     minimum=0, 
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     label.scale.equal=TRUE, 
     label.cex= 2.0, 
     legend.cex = 0.6, 









predModel <- predict(OverallNetworkMGM, overall_matrix, 




#created a columb list with CCmarg values 
error_list_me <- list () 
for(i in 1:17) error_list_me[[i]] <- predModel$errors[i,4] 
error_list_me 
 
#created the beyond marg values 
#beyondmarg_me <- predModel$errors[1:17,2]-predModel$errors[1:17,4] 
#beyondmarg_me 
 
#need to combine ccmarg values with beyond marg values in 2 columns, 1 list 
 
beyondmarg_list_me <- list () 




#for (i in 1:17) error_list_me[[i]] <- c(predModel$errors[4], beyondmarg_me) 
#new_error_list_me  <- c(error_list_me, beyondmarg_list_me) 
#new_error_list_me 
 
new_error_list_me <- Map(c, error_list_me, beyondmarg_list_me) 
new_error_list_me 
 
color_list_me <- list () 




#error_list_CC <- list() 
#for (i in 1:17) error_list_CC[[i]] <- predModel$errors[i,2] 
 
#error_list_NCC <- list() 
#for (i in 1:17) error_list_NCC[[i]] <- predModel$errors[i,3] 
 
#error_list_CCmarg <- list() 
#for (i in 1:17) error_list_CCmarg[[i]] <- predModel$errors[i,4] 
 
#color_list <- list () 

















OGpred <- qgraph(OverallNetworkMGM$pairwise$wadj, pie = new_error_list_me, 
                 layout="spring", labels = Names, 
                 theme="colorblind", 
                 groups=Traits, 
                 pieColor = color_list_me,     
                 label.scale.equal=TRUE, 
                 label.cex= 4.0, 
                 legend.cex = 0.4, 
                 edge.color = OverallNetworkMGM$pairwise$edgecolor, 
                 curveAll = TRUE, curveDefault = .6, 




SAS File name: READ in W1 4 CLASS 4142021 
 
*Read in W1; 
*MPLUS Output = wave 1 run 4132021 4 class; 
*CSV = = w14class4132021; 
 





W1_ACUR_CIG       W1_ACUR_ECI       W1_ACUR_DUA      W1_ACUR_ALC       W1_ACUR_MAR       
W1_ACUR_PAI        
W1_DEPRESS        W1_SLEEPING       W1_ANXIOUS       W1_PTSD            
W1_LIED           W1_ATTENTIO       W1_LISTENING     W1_BULLY          W1_FIGHTS         
W1_RESTLESS       W1_ANSWERED        
W1_SEXMALE_        
W1_AGE1824_        
    W1_AGE2534_        
    W1_AGE3544_        
    W1_AGE4554_        
    W1_AGE5564_        
    W1_RACEBL_2        
    W1_RACEOT_3        
    W1_RACEHI_6        
    W1_EDU_1           
    W1_EDU_2           
    W1_EDU_3          
    W1_EDU_4           
    W1_INC_1          
    W1_INC_2          
    W1_INC_3          
    W1_INC_4          
    W1_SOC_2          
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    W1_SOC_3           
    W1_SOC_4           
    W1_SOC_5           
    W1_CPROB1         
    W1_CPROB2         
    W1_CPROB3          
    W1_CPROB4         
    W1_C               
    W1_WEIGHT         
    CASEID; 
datalines; 




SAS File name: LCA W2 
 
*In the ICPSR_36498 folder, select DS2001 and open the data file (36498-2001-Data) which is 
a SAS Cport Transport file. Once this is open, formats are in, and can begin data management; 
 







 *Current User Cigarette; 
 *R02_AC1002_12M: In past 12 months, smoked a cigarette, even one or two puffs; 
 *R02_AC1005: Number of cigarettes smoked in your entire life; 
 *R02_AC1003: Now smoke cigarettes; 
  
  
 *if R02_AC1002_12M = 1 AND R02_AC1005=6 AND R02_AC1003 in (1 2) then acur_cig = 1; 
 *else if R02_AC1002_12M = 2 OR R02_AC1003=3 OR (R02_AC1003 in (1,2,.) AND R02_AC1005 in 
(1,2,3,4,5)) then acur_cig=0; 
 *else if R02_AC1002_12M = . OR R02_AC1003=. OR R02_AC1005=. then acur_cig = .; 
 
 if R02R_A_CUR_ESTD_CIGS=1 then acur_cig=1; 
 else if R02R_A_CUR_ESTD_CIGS=2 then acur_cig=0; 
 else if R02R_A_CUR_ESTD_CIGS=. then acur_cig=.; 
 
 *Current E-cigarette user; 
 *R02_AO9035_01: Ever used the following electronic nicotine product: E-cigarette; 
 *R02_AE1100: Ever used e-cigarettes fairly regularly; 
 *R02_AO1003C: Now use e-cigarettes; 
 
 *if R02_AO9035_01 = 1 AND R02_AE1100=1 AND R02_AO1003C in (1,2) then acur_ecig = 1; 
 *else if R02_AO9035_01=2 OR R02_AE1100 = 2 OR R02_AO1003C = 3 OR (R02_AE1100 in (1,2,.) 
AND R02_AO1003C = 2) then acur_ecig=0; 
 *else if R02_AO9035_01 = . OR R02_AE1100=. OR R02_AO1003C = . OR R02_AE1100 = . then 
acur_ecig = .; 
 
 if R02R_A_CUR_ESTD_ECIG=1 then acur_ecig=1; 
 else if R02R_A_CUR_ESTD_ECIG=2 then acur_ecig=0; 
 else if R02R_A_CUR_ESTD_ECIG=. then acur_ecig=.; 
 
 ***NOT USING FOR LCA************ 
 ******************************** 
 *Current Traditional cigar user 
 
 if R02_AG9003 = 1 AND R02_AG1100TC=1 AND R02_AG1003TC in (1,2) then acur_cigr = 1 
 else if R02_AG1001=2 OR R02_AG9002_01 = 2 OR R02_AG9003= 2 OR R02_AG1003TC= 3 OR 
(R02_AG1003TC in 
 (1,2,.) AND R02_AG1100TC = 2) THEN acur_cigr = 0 
 ELSE IF R02_AG1001 = . OR R02_AG9003 = . OR R02_AG1100TC = . OR R02_AG1003TC = . OR 
R02_AG9002_01 = . THEN 
 acur_cigr = .; 
 
 *Current Cigarillo user 
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 IF R02_AG9004=1 AND (R02_AG9009_01=1 OR R02_AG9009_03=1) AND R02_AG1100CG = 1 AND 
R02_AG1003CG in 
 (1, 2) THEN acur_cigrlo= 1 
 ELSE IF R02_AG9004= 2 OR R02_AG1001=2 OR R02_AG9002_02 = 2 OR R02_AG1003CG=3 OR 
R02_AG1100CG=2 OR (R02_AG9009_01=2 AND R02_AG9009_03=2) OR ((R02_AG9009_01=1 
 OR R02_AG9009_03=1) AND R02_AG1100CG= 2 AND R02_AG1003CG=.) OR ((R02_AG9009_01=1 OR 
 R02_AG9009_03=1) AND R02_AG1100CG=. AND R02_AG1003CG= 3) THEN acur_cigrlo= 0 
 ELSE IF R02_AG1001 = . OR R02_AG9004 = . OR R02_AG9009_03 = . OR R02_AG9009_01 = . OR 
 R02_AG1100CG = . OR R02_AG1003CG = . OR R02_AG9002_02 = . THEN acur_cigrlo = .; 
 
 *Current Filtered Cigar user 
 
 IF R02_AG9004=1 AND R02_AG9009_02=1 AND R02_AG1100FC = 1 AND R02_AG1003FC in (1, 2) THEN 
 acur_filcigr= 1 
 ELSE IF R02_AG9004= 2 OR R02_AG1001=2 OR R02_AG9002_02 = 2 OR R02_AG1003FC=3 OR 
R02_AG1100FC=2 OR R02_AG9009_02=2  
 OR (R02_AG9009_02=1 AND R02_AG1100FC= 2 AND R02_AG1003FC=.) OR (R02_AG9009_02=1 AND 
R02_AG1100FC=. AND 
 R02_AG1003FC= 3) THEN acur_filcigr=0 
 ELSE IF R02_AG9004 = . OR R02_AG9009_02 =. OR R02_AG1100FC = . OR R02_AG1003FC = . OR 
R02_AG1001 = . OR R02_AG9002_02 = . THEN 
 acur_filcigr = .; 
 
 *Current Use Any Cigar/Cigarillo 
  
 IF (acur_cigr = 1 OR acur_cigrlo = 1 OR acur_filcigr = 1) THEN acur_fullcigr = 1 
 ELSE IF (acur_cigr = 0 AND acur_cigrlo = 0 AND acur_filcigr= 0) THEN acur_fullcigr = 0 
 ELSE IF acur_cigr = . OR acur_cigrlo = . OR acur_filcigr = . THEN acur_fullcigr = .; 
 
 *Current Pipe user 
 
 IF R01_AP1002 = 1 AND R01_AP1100=1 AND R01_AP1003 in (1,2) THEN acur_pipe= 1 
 ELSE IF R01_AP1001=2 OR R01_AP1002= 2 OR R01_AP1003= 3 OR (R01_AP1003 in (1,2,.) AND 
R01_AP1100 = 2) 
 THEN acur_pipe=0 
 ELSE IF R01_AP1001 = . OR R01_AP1002 = . OR R01_AP1003 = . OR R01_AP1100 = . THEN 
acur_pipe= .; 
 
 *Current Hookah User 
 
 IF R02_AH1002 = 1 AND R02_AH1100=1 AND R02_AH1003 in (1, 2) THEN acur_hook= 1 
 ELSE IF R02_AH1001=2 OR R02_AH1002= 2 OR R02_AH1003= 3 OR (R02_AH1003 in (1,2,.) AND 
R02_AH1100 = 2) 
 THEN acur_hook=0 
 ELSE IF R02_AH1002=. OR R02_AH1001=. OR R02_AH1003=. OR R02_AH1100=. 
 THEN acur_hook=.; 
 
 *Current User Smokeless 
 
 IF (R02_AS1002_02=1 OR R02_AU1003 in (1,2)) AND R02_AS1100SM = 1 AND R02_AS1003SM in (1, 
2) THEN acur_smls= 1 
 ELSE IF R02_AS1001=2 OR R02_AS1002_03=1 OR (R02_AS1002_02=2 AND R02_AU1003 in 
 (2,3,.)) OR R02_AS1003SM= 3 OR (R02_AS1003SM in (1,2,.) AND R02_AS1100SM = 2) THEN 
acur_smls=0 
 ELSE IF R02_AS1002_02 = . OR R02_AU1003 = . OR R02_AS1100SM = . OR 
 R02_AS1003SM = . OR R02_AS1001 = . THEN acur_smls = .; 
 
 *Current User Snus 
 
 IF R02_AS1002_01=1 AND R02_AU1003 in (2, 3) AND R02_AS1100SU= 1 AND R02_AS1003SU in (1,2) 
THEN acur_snus= 1 
 ELSE IF R02_AS1001=2 OR R02_AS1002_03=1 OR (R02_AS1002_01=2 AND R02_AS1002_02=1) 
 OR (R02_AS1002_01=1 AND R02_AU1003=1) OR (R02_AU1003 in (2,3) AND R02_AS1003SU= 3) OR 
(R02_AU1003 in (2,3) AND 
 R02_AS1003SU in (1,2,.) AND R02_AS1100SU = 2) THEN acur_snus= 0 
 ELSE IF R02_AS1002_01 = . OR R02_AS1002_02 = . OR R02_AS1002_03 = . OR R02_AU1003 = . OR 
R02_AS1100SU = . OR R02_AS1003SU =.  
 OR R02_AS1001 = . THEN acur_snus=.; 
 
 *Current Use Any Smokeless/Snus 
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 IF (acur_smls = 1 OR acur_snus = 1) THEN acur_fullsmkls = 1 
 ELSE IF (acur_smls = 0 AND acur_snus = 0) THEN acur_fullsmkls = 0 
 ELSE IF acur_smls = . OR acur_snus = . THEN acur_fullsmkls = .; 
 
 *Current User Dissolvable 
 
 IF R02_AD1002 = 1 AND R02_AD1100=1 AND R02_AD1003 in (1,2) THEN acur_diss= 1 
 ELSE IF R02_AD1001=2 OR R02_AD1002= 2 OR R02_AD1003= 3 OR (R02_AD1003 in (1,2,.) AND 
R02_AD1100 = 2) THEN acur_diss=0 
 ELSE IF R02_AD1001 = . OR R02_AD1002 = . OR R02_AD1003 = . OR R02_AD1100 = . THEN 






 NEW SUBSTANCES ADDED; 
 
 *Current Use Alcohol; 
 *R02_AX0084_12M: In past 12 months, used alcohol, including small tastes or sips 
 *R02_AX0673: In past 30 days, used alcohol; 
 if R02_AX0084_12M = 1 AND R02_AX0673 = 1 then acur_alc=1; 
 else if R02_AX0084_12M = 2 OR R02_AX0673 = 2 then acur_alc=0; 
 else if R02_AX0084_12M= . OR R02_AX0673= . then acur_alc=.; 
 
 *Current User Marijuana; 
 *R02_AX0085_12M: In past 12 months, used marijuana, hash, THC, grass, pot or weed; 
 *R02_AX0675: In past 30 days, used marijuana, hash, THC, grass, pot or weed; 
 if R02_AX0675 = 1 then acur_marijuana=1; 
 else if  R02_AX0675 in (2  -1) then acur_marijuana=0; 
 else if R02_AX0675= . then acur_marijuana=.; 
 
 *Current User Ritalin or Adderall (prescription drugs not prescribed to you); 
 *R02_AX0089_12M_01: In past 12 months, used prescription drugs not prescribed to you: 
Ritalin or Adderall; 
 *R02_AX0676_01: In past 30 days, used: Ritalin or Adderall; 
 *if R02_AX0089_12M_01 = 1 AND R02_AX0676_01 = 1 then acur_ritadder=1; 
 *else if R02_AX0089_12M_01 = 2 OR R02_AX0676_01 = 2 then acur_ritadder=0; 
 *else if R02_AX0089_12M_01 = . OR R02_AX0676_01= . then acur_ritadder=.; 
 
 *Current User Painkillers, Sedatives, or Tranquilizers (prescription drugs not prescribed 
to you); 
 *R02_AX0089_12M_02: In past 12 months, used prescription drugs not prescribed to you: 
Painkillers, sedatives or tranquilizers; 
 *R02_AX0676_02: In past 30 days, used: Painkillers, sedatives or tranquilizers; 
 if R02_AX0089_12M_02= 1 AND R02_AX0676_02 = 1 then acur_painkiller=1; 
 else if R02_AX0089_12M_02 = 2 OR R02_AX0676_02 = 2 then acur_painkiller=0; 
 else if R02_AX0089_12M_02 = . OR R02_AX0676_02= . then acur_painkiller=.; 
 
 *Current User Cocaine or Crack 
 *R02_AX0220_12M_01: In past 12 months, used substance: Cocaine or crack; 
 *R02_AX0676_03: In past 30 days, used: Cocaine or crack; 
 *if R02_AX0220_12M_01 = 1 AND R02_AX0676_03 = 1 then acur_cocaine=1; 
 *else if R02_AX0220_12M_01 = 2 OR R02_AX0676_03 = 2 then acur_cocaine=0; 
 *else if R02_AX0220_12M_01 = . OR R02_AX0676_03= . then acur_cocaine=.; 
 
 *Curent User Meth or Speed 
 *R02_AX0220_12M_02: In past 12 months, used substance: Stimulants like methamphetamine or 
speed; 
 *R02_AX0676_04: In past 30 days, used Stimulants like methamphetamine or speed; 
 *if R02_AX0220_12M_02 = 1 AND R02_AX0676_04 = 1 then acur_meth=1; 
 *else if R02_AX0220_12M_02 = 2 OR R02_AX0676_04= 2 then acur_meth=0; 
 *else if R02_AX0220_12M_02 = . OR R02_AX0676_04= . then acur_meth=.; 
 
 
 *Current User Heroin, Inhalents, Solvents, Hallucinogens 
 *R02_AX0220_12M_03: In past 12 months, used substance: Any other drugs like heroin, 
inhalants, solvents or hallucinogens; 
 *R02_AX0676_05: In past 30 days, used: Any other drugs like heroin, inhalants, solvents 
or hallucinogens; 
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 *if R02_AX0220_12M_03 = 1 AND R02_AX0676_05 = 1 then acur_heroinplus=1; 
 *else if R02_AX0220_12M_03 = 2 OR R02_AX0676_05 = 2 then acur_heroinplus=0; 
 *else if R02_AX0220_12M_03 = . OR R02_AX0676_05 = . then acur_heroinplus=.; 
 
 
*Create new variables; 
********************** 
********************** 
NEED TO COME BACK AND 
ADD SUBSTANCE USE VARS 
AND SUICIDE QUESTIONS 




*R02R_A_RACECAT3: DERIVED - Race from the interview (3 levels): 1 = white alone, 2 = black alone, 
3 = other; 
*R02R_A_HISP: DERIVED - Wave 2 Adult Hispanic Origin (2 levels): 1 = hispanic, 2 = not hispanic; 
NUMRACES = 0 ;  
if R02R_A_RACECAT3 = 1 then NUMRACES = NUMRACES + 1 ;  
if R02R_A_RACECAT3 = 2 then NUMRACES= NUMRACES + 1 ;  
if R02R_A_RACECAT3 = 3 then NUMRACES = NUMRACES + 1 ;  
if R02R_A_HISP = 1 then NUMRACES = NUMRACES + 1; 
if (NUMRACES = 1 and R02R_A_RACECAT3 = 1 AND R02R_A_HISP=2) then R02R_A_ETHRACECAT7= 1 ; *NH 
White; 
if (NUMRACES = 1 and R02R_A_RACECAT3 = 2 AND R02R_A_HISP=2) then R02R_A_ETHRACECAT7= 2 ; *NH AA; 
if (NUMRACES = 1 and R02R_A_RACECAT3 = 3 AND R02R_A_HISP=2) then R02R_A_ETHRACECAT7= 3 ; *NH 
Other;  
if (NUMRACES = 1 and R02R_A_HISP=1) then R02R_A_ETHRACECAT7= 4; *Hispanic Only;  
if (NUMRACES > 1 and R02R_A_HISP=2) then R02R_A_ETHRACECAT7= 5; *NH Multiracial; 
if (NUMRACES > 1 and R02R_A_HISP=1) then R02R_A_ETHRACECAT7= 6; *Hispanic Multiracial; 
ELSE IF R02R_A_HISP=. OR R02R_A_RACECAT3 = . THEN R02R_A_ETHRACECAT7=.;  
 
*AGE; 
*R02R_A_AGECAT7: DERIVED - Age range when interviewed (7 levels); 
if R02R_A_AGECAT7=1 then age=1; *18-24; 
else if R02R_A_AGECAT7=2 then age=2; *25-34; 
else if R02R_A_AGECAT7=3 then age=3; *35-44; 
else if R02R_A_AGECAT7=4 then age=4; *45-54; 
else if R02R_A_AGECAT7=5 then age=5; *55-64; 




*R02R_A_AM0018: DERIVED - Highest grade or level of school completed (6 levels); 
if R02R_A_AM0018=1 then education=1; *less than high school; 
else if R02R_A_AM0018 in (2 3) then education=2; *GED/high school graduate; 
else if R02R_A_AM0018=4 then education=3; *Some college (no degree) or associates degree; 
else if R02R_A_AM0018=5 then education=4; *Bachelor's degree; 
else if R02R_A_AM0018=6 then education=5; *Advanced degree; 
else education=.; 
 




*R02_AX0161: Last time you had significant problems with: Feeling very trapped, lonely, sad, 
blue, depressed or hopeless about the future; 
if R02_AX0161 in (2, 3, 4) then depressed=0; 
else if R02_AX0161 in (1) then depressed=1; 
else if R02_AX0161 = . then depressed= .; 
 
*R02_AX0162: Last time you had significant problems with: Sleep trouble - such as bad 
dreams, sleeping restlessly or falling asleep during the day; 
if R02_AX0162 in (2, 3, 4) then sleeping=0; 
else if R02_AX0162 in (1) then sleeping=1; 
else if R02_AX0162 = . then sleeping=.; 
 
*R02_AX0163: Last time you had significant problems with: Feeling very anxious, nervous, 
tense, scared, panicked or like something bad was going to happen; 
if R02_AX0163 in (2, 3, 4) then anxious=0; 
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else if R02_AX0163 in (1) then anxious=1; 
else if R02_AX0163 = . then anxious=.; 
 
*R02_AX0164: Last time you had significant problems with: Becoming very distressed and 
upset when something reminded you of the past; 
if R02_AX0164 in (2, 3, 4) then ptsd=0; 
else if R02_AX0164 in (1) then ptsd=1; 




*R02_AX0165: Last time you did the following two or more times: Lied or conned to get things 
you wanted or to avoid having to do something; 
if R02_AX0165 in (2, 3, 4) then lied=0; 
else if R02_AX0165 in (1) then lied=1; 
else if R02_AX0165 = . then lied=.; 
 
*R02_AX0166: Last time you did the following two or more times: Had a hard time paying 
attention at school, work or home; 
if R02_AX0166 in (2, 3, 4) then attention=0; 
else if R02_AX0166 in (1) then attention=1; 
else if R02_AX0166 = . then attention=.; 
 
*R02_AX0167: Last time you did the following two or more times: Had a hard time listening to 
instructions at school, work or home; 
if R02_AX0167 in (2, 3, 4) then listening=0; 
else if R02_AX0167 in (1) then listening=1; 
else if R02_AX0167 = . then listening= .; 
 
*R02_AX0168: Last time you did the following two or more times: Were a bully or threatened 
other people; 
if R02_AX0168 in (2, 3, 4) then bully=0; 
else if R02_AX0168 in (1) then bully=1; 
else if R02_AX0168 = . then bully= .; 
 
*R02_AX0169: Last time you did the following two or more times: Started physical fights with 
other people; 
if R02_AX0169 in (2, 3, 4) then fights=0; 
else if R02_AX0169 in (1) then fights=1; 
else if R02_AX0169 = . then fights= .; 
 
*R02_AX0250: Last time you did the following two or more times: Felt restless or the need to 
run around or climb on things; 
if R02_AX0250 in (2, 3, 4) then restless=0; 
if R02_AX0250 in (1) then restless=1; 
else if R02_AX0250 = . then restless=.; 
 
*R02_AX0251: Last time you did the following two or more times: Gave answers before the 
other person finished asking the question; 
if R02_AX0251 in (2, 3, 4) then answered=0; 
if R02_AX0251 in (1) then answered=1; 
else if R02_AX0251 = . then answered=.; 
 
******SUBSTANCE USE DISORDERS**********; 
 
*R02_AX0170: Last time that you used alcohol or other drugs weekly or more often; 
if R02_AX0170 in (2, 3, 4) then weeklyuse=0; 
if R02_AX0170 in (1) then weeklyuse=1; 
else if R02_AX0170 = . then weeklyuse=.; 
 
*R02_AX0171: Last time that you spent a lot of time getting alcohol or other drugs; 
if R02_AX0171 in (2, 3, 4) then timegetting=0; 
if R02_AX0171 in (1) then timegetting=1; 
else if R02_AX0171 = . then timegetting=.; 
 
*R02_AX0193: Last time you spent a lot of time using or recovering from alcohol or other drugs; 
if R02_AX0193 in (2, 3, 4) then timeusing=0; 
if R02_AX0193 in (1) then timeusing=1; 
else if R02_AX0193 = . then timeusing=.; 
 
*R02_AX0172: Last time that you kept using alcohol or other drugs even though it was causing 
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social problems, leading to fights, or getting you into trouble with other people; 
if R02_AX0172 in (2, 3, 4) then socialprob=0; 
if R02_AX0172 in (1) then socialprob=1; 
else if R02_AX0172 = . then socialprob=.; 
 
*R02_AX0173: Last time that your use of alcohol or other drugs reduced your involvement in 
activities at work, school, home or social events; 
if R02_AX0173 in (2, 3, 4) then reducedact=0; 
if R02_AX0173 in (1) then reducedact=1; 
else if R02_AX0173 = . then reducedact=.; 
 
*R02_AX0174: Last time that you had withdrawal problems such as shaky hands, throwing up, 
having trouble sitting still or sleeping; 
if R02_AX0174 in (2, 3, 4) then withdraw=0; 
if R02_AX0174 in (1) then withdraw=1; 
else if R02_AX0174 = . then withdraw=.; 
 
*R02_AX0194: Last time you used any alcohol or other drugs to stop being sick or avoid 
withdrawal problems; 
if R02_AX0194 in (2, 3, 4) then usetoavoid=0; 
if R02_AX0194 in (1) then usetoavoid=1; 
else if R02_AX0194 = . then usetoavoid=.; 
 
*ALL PAST 30 DAY; 
sud_score = sum(weeklyuse, timegetting, timeusing, socialprob, reducedact, withdraw, usetoavoid); 
 
*OLD 
*SUD is 3 levels- no/low, moderate, and high; 
*if sud_score in (0,1) then sud=0; 
*if sud_score in (2,3) then sud=1; 
*if sud_score in (4,5,6,7) then sud=2; 
*if sud_score = . then sud=.; 
 
*NEW = 1/16/20; 
*SUD is 3 levels- no/low, moderate, and high; 
if sud_score in (0) then sud=0; 
if sud_score in (1,2) then sud=1; 
if sud_score in (3,4,5,6,7) then sud=2; 
if sud_score = . then sud=.; 
 
*Dichotomize by 0 = no/low, 1 = moderate/high; 
*if sud in (0) then sudbin1=0; 
*if sud in (1, 2) then sudbin1=1; 
*if sud = . then sudbin1 = .; 
 
*Dichotomize by 0 = no/low/moderate, 1 = high; 
*if sud in (0,1) then sudbin2=0; 
*if sud in (2) then sudbin2=1; 
*if sud = . then sudbin2 = .; 
 
 
*****DUMMY CODING FOR THE COVARIATES******; 
 
IF R02R_A_SEX=1 THEN SEXMALE_1=1; 
ELSE SEXMALE_1=0; 
 
IF R02R_A_SEX=2 THEN SEXFEMALE_2=1; 
ELSE SEXFEMALE_2=0; 
 
IF age=1 THEN AGE1824_1=1; 
ELSE AGE1824_1=0; 
 
IF age=2 THEN AGE2534_2=1; 
ELSE AGE2534_2=0; 
 
IF age=3 THEN AGE3544_3=1; 
ELSE AGE3544_3=0; 
 




IF age=5 THEN AGE5564_5=1; 
ELSE AGE5564_5=0; 
 
IF age=6 THEN AGE65_6=1; 
ELSE AGE65_6=0; 
 
IF R02R_A_ETHRACECAT7=1 THEN RACEWH_1=1; 
ELSE RACEWH_1=0; 
 
IF R02R_A_ETHRACECAT7=2 THEN RACEBL_2=1; 
ELSE RACEBL_2=0; 
 
IF R02R_A_ETHRACECAT7=3 THEN RACEOT_3=1; 
ELSE RACEOT_3=0; 
 
IF R02R_A_ETHRACECAT7=6 THEN RACEHI_6=1; 
ELSE RACEHI_6=0; 
 
IF education=1 THEN EDU_1=1; 
ELSE EDU_1=0; 
 
IF education=2 THEN EDU_2=1; 
ELSE EDU_2=0; 
 
IF education=3 THEN EDU_3=1; 
ELSE EDU_3=0; 
 
IF education=4 THEN EDU_4=1; 
ELSE EDU_4=0; 
 
IF education=5 THEN EDU_5=1; 
ELSE EDU_5=0; 
 
IF R02R_A_AM0030=1 THEN INC_1=1; 
ELSE INC_1=0; 
 
IF R02R_A_AM0030=2 THEN INC_2=1; 
ELSE INC_2=0; 
 
IF R02R_A_AM0030=3 THEN INC_3=1; 
ELSE INC_3=0; 
 
IF R02R_A_AM0030=4 THEN INC_4=1; 
ELSE INC_4=0; 
 
IF R02R_A_AM0030=5 THEN INC_5=1; 
ELSE INC_5=0; 
 
*extremely satisfied =1; 
IF R02_AX0092=1 THEN SOC_1=1; 
ELSE SOC_1=0; 
 
IF R02_AX0092=2 THEN SOC_2=1; 
ELSE SOC_2=0; 
 
IF R02_AX0092=3 THEN SOC_3=1; 
ELSE SOC_3=0; 
 
IF R02_AX0092=4 THEN SOC_4=1; 
ELSE SOC_4=0; 
 
*not at all satisfied =5; 





 array change _numeric_; 
 do over change; 
 if change=-97777 then change=.; 
 else if change=-99999 then change=.; 
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 else if change=-99988 then change=.; 
 else if change=-99977 then change=.; 
 else if change=-99955 then change=.; 
 else if change=-99911 then change=.; 
 else if change=-9 then change=.; 
 else if change=-8 then change=.; 
 else if change=-7 then change=.; 
 else if change=-1 then change=.; 








proc freq data=lca.w2; 




proc freq data=lca.w2; 
table R02R_A_SEX*SEXMALE_1 
  R02R_A_SEX*SEXFEMALE_2 
  age*AGE1824_1 
  age*AGE2534_2 
  age*AGE3544_3 
  age*AGE4554_4 
  age*AGE5564_5 
  age*AGE65_6 
  R02R_A_ETHRACECAT7*RACEWH_1 
  R02R_A_ETHRACECAT7*RACEBL_2 
  R02R_A_ETHRACECAT7*RACEOT_3 
  R02R_A_ETHRACECAT7*RACEHI_6 
  education*EDU_1 
  education*EDU_2 
  education*EDU_3 
  education*EDU_4 
  education*EDU_5 
  R02R_A_AM0030*INC_1 
  R02R_A_AM0030*INC_2 
  R02R_A_AM0030*INC_3 
  R02R_A_AM0030*INC_4 
  R02R_A_AM0030*INC_5 
  R02_AX0092*SOC_1 
  R02_AX0092*SOC_2 
  R02_AX0092*SOC_3 
  R02_AX0092*SOC_4 




proc freq data=lca.w2; 
table R02R_A_CUR_ESTD_CIGS*acur_cig 
      R02R_A_CUR_ESTD_ECIG*acur_ecig; 
run; 
*derived variables have info from wave 1 so use these not the ones I created; 
 
*check other subs; 
proc freq data=lca.w2; 
table acur_alc acur_marijuana acur_painkiller;; 
run; 
*marijuana is still weird; 
 
*check sud; 





proc freq data=lca.w2; 
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table  depressed sleeping anxious ptsd 
        lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid 
  sud; 
run; 
 
*only select people from wave 1; 

















*Identify all variable want to keep; 
proc freq data=lca.w2contadult; 
table  
acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller  
     R02R_A_SEX age R02R_A_ETHRACECAT7 education R02R_A_AM0030 
R02_AX0092 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud; 
     run; 
 
 
*Now limit to the main variables that we want to keep; 
data LCA.w2mpluscontadult; 
set LCA.w2contadult (keep = caseid personid acur_cig acur_ecig acur_alc acur_marijuana 
acur_painkiller  
     R02R_A_SEX age R02R_A_ETHRACECAT7 education R02R_A_AM0030 
R02_AX0092 
     SEXMALE_1 SEXFEMALE_2  
     AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud); 
*rename missings; 
array change _numeric_; 
do over change; 















***Missing vs nonmissing for W2; 
***using contadultc data because it has new tobacco vars; 
proc contents data=lca.w2contadultc; 
run; 
 
proc freq data=lca.w2contadultc; 
table acur_cignew acur_ecignew acur_dualnew  






if (acur_cignew=.) or (acur_ecignew=.) or (acur_dualnew=.) or (acur_alc=.) or 
(acur_marijuana=.) or (acur_painkiller=.) or  
(R02R_A_SEX=.)  or (age=.) or (R02R_A_ETHRACECAT7=.) or (education=.) or (R02R_A_AM0030=.) or 
(R02_AX0092=.) or 
(depressed=.) or (sleeping=.) or (anxious=.) or (ptsd=.) or 
(lied=.) or (attention=.) or (listening=.) or (bully=.) or (fights=.) or 
(restless=.) or (answered=.) or 






proc freq data=lca.w2missingtest; 
table compare; 
run; 
*complete data/analytic sample (compare = 1) = 21508; 
*missing (compare = 0) = 4936; 
 
******************************** 
*compare missing and nonmissing; 
*look at column percent; 
 
*subs; 
proc freq data=lca.w2missingtest; 
table acur_cignew*compare 
      acur_ecignew*compare 
      acur_dualnew*compare 
      acur_alc*compare 
      acur_marijuana*compare 
      acur_painkiller*compare/chisq; 
run; 
*sig diff for all: analytic sample has higher endorsement of all subs; 
 
*demos; 
proc freq data=lca.w2missingtest; 
table R02R_A_SEX*compare 
      age*compare 
      R02R_A_ETHRACECAT7*compare 
      education*compare 
      R02R_A_AM0030*compare 
      R02_AX0092*compare/chisq; 
run; 
*sig difference sex: more males, less women in analytic sample; 
*sig difference by age: more in categories 2, 3, 4 (25-54) in analytic sample; 
*sig difference by race: more white, less other cats in analytic sample; 
*sig difference by edu: higher edu levels in analytic sample; 
*sig difference by income: higher income levels in analytic sample; 




proc freq data=lca.w2missingtest; 
table depressed*compare 
      sleeping*compare 
      anxious*compare 
      ptsd*compare/chisq; 
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run; 
*sig diff for all: analytic sample has higher endorsement of all 4 symptoms; 
 
*externalizing; 
proc freq data=lca.w2missingtest; 
table lied*compare 
      attention*compare 
      listening*compare 
      bully*compare 
      fights*compare 
      restless*compare 
      answered*compare/chisq; 
run; 
*sig diff for all except bully and fights: all others - analytic sample has higher endorsement of 
the other 5 symptoms; 
*no sig diff for bully or fights; 
 
*sud; 
proc freq data=lca.w2missingtest; 
table sud*compare/chisq; 
run; 
*sig diff: analytic sample has higher endorsement of moderate and high sud severity; 
ods pdf close; 
 
 
MPLUS File name: w2 4 class 4142021 
 
   TITLE: WAVE 2 MODEL 4 CLASS -- APRIL 14 2021; 
         DATA: FILE IS w2dataformplus232021_noheader.csv; 
         VARIABLE: NAMES ARE CASEID PERSONID weight 
               acur_cignew acur_ecignew acur_dualnew 
                  acur_alc acur_marijuana acur_painkiller  
               R02R_A_ETHRACECAT7 age education 
               depressed sleeping anxious ptsd  
               lied attention listening bully fights restless answered  
               weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid  
                sud  
               SEXMALE_1 SEXFEMALE_2  
               AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6  
               RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6  
               EDU_1 EDU_2 EDU_3 EDU_4 EDU_5  
               INC_1 INC_2 INC_3 INC_4 INC_5  
               SOC_1 SOC_2 SOC_3 SOC_4 SOC_5; 
            USEVARIABLES = acur_cignew acur_ecignew acur_dualnew 
                      acur_alc acur_marijuana acur_painkiller 
                   depressed sleeping anxious ptsd  
                   lied attention listening bully fights restless answered; 
            IDVARIABLE = CASEID; 
            MISSING ARE ALL (-99999); 
            CLASSES = c(4); 
            CATEGORICAL = acur_cignew acur_ecignew acur_dualnew 
                      acur_alc acur_marijuana acur_painkiller 
                   depressed sleeping anxious ptsd  
                   lied attention listening bully fights restless answered; 
            AUXILIARY = SEXMALE_1 (R3STEP) 
                        AGE1824_1 (R3STEP) AGE2534_2 (R3STEP) AGE3544_3 (R3STEP) 
                        AGE4554_4 (R3STEP) AGE5564_5 (R3STEP) 
                        RACEBL_2 (R3STEP) RACEOT_3 (R3STEP) RACEHI_6 (R3STEP) 
                        EDU_1 (R3STEP) EDU_2 (R3STEP) EDU_3(R3STEP) 
                     EDU_4 (R3STEP) INC_1 (R3STEP) INC_2 (R3STEP) 
                        INC_3 (R3STEP) INC_4 (R3STEP) 
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                     SOC_2 (R3STEP) SOC_3 (R3STEP) SOC_4 (R3STEP) SOC_5 (R3STEP); 
          WEIGHT is weight; 
          ANALYSIS: TYPE = MIXTURE; 
                      STARTS = 100 10; 
                      OPTSEED = 991329; 
                      LRTSTARTS = 0 0 150 40; 
          SAVEDATA: file is w24classweight414.csv; 
                    save = Cprob; 
          OUTPUT: TECH1 TECH8 TECH10 TECH11 TECH14; 
 
 
SAS File name: Read in W2 4 CLASS 4142021 
 
*WAVE 2 4 CLASS SOLUTION - import to compare with W1 and W3; 
*MPLUS OUTPUT = w2 4 class 4142021; 
*CSV = w24classweight414; 
 





 W2_ACUR_CIG        
    W2_ACUR_ECI        
    W2_ACUR_DUA       
    W2_ACUR_ALC        
    W2_ACUR_MAR       
    W2_ACUR_PAI       
    W2_DEPRESS        
    W2_SLEEPING       
    W2_ANXIOUS         
    W2_PTSD           
    W2_LIED           
    W2_ATTENTIO        
    W2_LISTENIN        
    W2_BULLY           
    W2_FIGHTS         
    W2_RESTLESS        
    W2_ANSWERED        
    W2_SEXMALE_        
    W2_AGE1824_        
    W2_AGE2534_        
    W2_AGE3544_        
    W2_AGE4554_        
    W2_AGE5564_       
    W2_RACEBL_2        
    W2_RACEOT_3        
    W2_RACEHI_6      
    W2_EDU_1           
    W2_EDU_2          
    W2_EDU_3           
    W2_EDU_4           
    W2_INC_1           
    W2_INC_2          
    W2_INC_3           
    W2_INC_4           
    W2_SOC_2           
    W2_SOC_3           
    W2_SOC_4           
    W2_SOC_5           
    W2_CPROB1          
    W2_CPROB2          
    W2_CPROB3          
    W2_CPROB4          
    W2_C               
    W2_WEIGHT          
    CASEID; 
datalines; 
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SAS File name: LCA W3 
 
*In the ICPSR_36498 folder, select DS3001 and open the data file (36498-3001-Data) which is 
a SAS Cport Transport file. Once this is open, formats are in, and can begin data management; 
 







 *Current User Cigarette; 
 *R03_AC1002_12M: In past 12 months, smoked a cigarette, even one or two puffs; 
 *R03_AC1005: Number of cigarettes smoked in your entire life; 
 *R03_AC1003: Now smoke cigarettes; 
  
 *if R03_AC1002_12M = 1 AND R03_AC1005=6 AND R03_AC1003 in (1 2) then acur_cig = 1; 
 *else if R03_AC1002_12M = 2 OR R03_AC1003=3 OR (R03_AC1003 in (1,2,.) AND R03_AC1005 in 
(1,2,3,4,5)) then acur_cig=0; 
 *else if R03_AC1002_12M = . OR R03_AC1003=. OR R03_AC1005=. then acur_cig = .; 
 
 if R03R_A_CUR_ESTD_CIGS=1 then acur_cig=1; 
 else if R03R_A_CUR_ESTD_CIGS=2 then acur_cig=0; 
 else if R03R_A_CUR_ESTD_CIGS=. then acur_cig=.; 
 
 *Current E-cigarette user; 
 *R03_AV1002_12M: Ever used the following electronic nicotine product: E-cigarette; 
 *R03_AV1100: Ever used e-cigarettes fairly regularly; 
 *R03_AV1003EC: Now use e-cigarettes; 
 
 *if R03_AV1002_12M = 1 AND R03_AV1100=1 AND R03_AV1003EC in (1,2) then acur_ecig = 1; 
 *else if R03_AV1002_12M=2 OR R03_AV1100 = 2 OR R03_AV1003EC = 3 OR (R03_AV1100 in (1,2,.) 
AND R03_AV1003EC = 2) then acur_ecig=0; 
 *else if R03_AV1002_12M= . OR R03_AV1100=. OR R03_AV1003EC = . OR R03_AV1100 = . then 
acur_ecig = .; 
 
 if R03R_A_CUR_ESTD_EPRODS=1 then acur_ecig=1; 
 else if R03R_A_CUR_ESTD_EPRODS=2 then acur_ecig=0; 
 else if R03R_A_CUR_ESTD_EPRODS=. then acur_ecig=.; 
 
 *Current Use Alcohol; 
 *R03_AX0084_12M: In past 12 months, used alcohol, including small tastes or sips 
 *R03_AX0673: In past 30 days, used alcohol; 
 
 if R03_AX0084_12M = 1 AND R03_AX0673 = 1 then acur_alc=1; 
 else if R03_AX0084_12M = 2 OR R03_AX0673 = 2 then acur_alc=0; 
 else if R03_AX0084_12M = . OR R03_AX0673 = . then acur_alc=.; 
 
 *Current User Marijuana; 
 *R03_AX0085_12M: In past 12 months, used marijuana, hash, THC, grass, pot or weed; 
 *R03_AX0675: In past 30 days, used marijuana, hash, THC, grass, pot or weed; 
 
 if R03_AX0675 = 1 then acur_marijuana=1; 
 else if R03_AX0675 in (-1, 2) then acur_marijuana=0; 
 else if R03_AX0675 = . then acur_marijuana=.; 
 
 *Current User Painkillers, Sedatives, or Tranquilizers (prescription drugs not prescribed 
to you); 
 *R03_AX0089_12M_02: In past 12 months, used prescription drugs not prescribed to you: 
Painkillers, sedatives or tranquilizers; 
 *R03_AX0676_02: In past 30 days, used: Painkillers, sedatives or tranquilizers; 
 
 if R03_AX0089_12M_02 = 1 AND R03_AX0676_02 = 1 then acur_painkiller=1; 
 else if R03_AX0089_12M_02 = 2 OR R03_AX0676_02 = 2 then acur_painkiller=0; 





*R03R_A_RACECAT3: DERIVED - Race from the interview (3 levels): 1 = white alone, 2 = black alone, 
3 = other; 
*R03R_A_HISP: DERIVED - Wave 2 Adult Hispanic Origin (2 levels): 1 = hispanic, 2 = not hispanic; 
NUMRACES = 0 ;  
if R03R_A_RACECAT3 = 1 then NUMRACES = NUMRACES + 1 ;  
if R03R_A_RACECAT3 = 2 then NUMRACES= NUMRACES + 1 ;  
if R03R_A_RACECAT3 = 3 then NUMRACES = NUMRACES + 1 ;  
if R03R_A_HISP = 1 then NUMRACES = NUMRACES + 1; 
if (NUMRACES = 1 and R03R_A_RACECAT3 = 1 AND R03R_A_HISP=2) then R03R_A_ETHRACECAT7= 1 ; *NH 
White; 
if (NUMRACES = 1 and R03R_A_RACECAT3 = 2 AND R03R_A_HISP=2) then R03R_A_ETHRACECAT7= 2 ; *NH AA; 
if (NUMRACES = 1 and R03R_A_RACECAT3 = 3 AND R03R_A_HISP=2) then R03R_A_ETHRACECAT7= 3 ; *NH 
Other;  
if (NUMRACES = 1 and R03R_A_HISP=1) then R03R_A_ETHRACECAT7= 4; *Hispanic Only;  
if (NUMRACES > 1 and R03R_A_HISP=2) then R03R_A_ETHRACECAT7= 5; *NH Multiracial; 
if (NUMRACES > 1 and R03R_A_HISP=1) then R03R_A_ETHRACECAT7= 6; *Hispanic Multiracial; 
ELSE IF R03R_A_HISP=. OR R03R_A_RACECAT3 = . THEN R03R_A_ETHRACECAT7=.;  
 
*AGE; 
*R03R_A_AGECAT7: DERIVED - Age range when interviewed (7 levels); 
if R03R_A_AGECAT7=1 then age=1; *18-24; 
else if R03R_A_AGECAT7=2 then age=2; *25-34; 
else if R03R_A_AGECAT7=3 then age=3; *35-44; 
else if R03R_A_AGECAT7=4 then age=4; *45-54; 
else if R03R_A_AGECAT7=5 then age=5; *55-64; 




*R03R_A_AM0018: DERIVED - Highest grade or level of school completed (6 levels); 
if R03R_A_AM0018=1 then education=1; *less than high school; 
else if R03R_A_AM0018 in (2 3) then education=2; *GED/high school graduate; 
else if R03R_A_AM0018=4 then education=3; *Some college (no degree) or associates degree; 
else if R03R_A_AM0018=5 then education=4; *Bachelor's degree; 





*R03_AX0161: Last time you had significant problems with: Feeling very trapped, lonely, sad, 
blue, depressed or hopeless about the future; 
if R03_AX0161 in (2, 3, 4) then depressed=0; 
else if R03_AX0161 in (1) then depressed=1; 
else if R03_AX0161 = . then depressed= .; 
 
*R03_AX0162: Last time you had significant problems with: Sleep trouble - such as bad 
dreams, sleeping restlessly or falling asleep during the day; 
if R03_AX0162 in (2, 3, 4) then sleeping=0; 
else if R03_AX0162 in (1) then sleeping=1; 
else if R03_AX0162 = . then sleeping=.; 
 
*R03_AX0163: Last time you had significant problems with: Feeling very anxious, nervous, 
tense, scared, panicked or like something bad was going to happen; 
if R03_AX0163 in (2, 3, 4) then anxious=0; 
else if R03_AX0163 in (1) then anxious=1; 
else if R03_AX0163 = . then anxious=.; 
 
*R03_AX0164: Last time you had significant problems with: Becoming very distressed and 
upset when something reminded you of the past; 
if R03_AX0164 in (2, 3, 4) then ptsd=0; 
else if R03_AX0164 in (1) then ptsd=1; 





*R03_AX0165: Last time you did the following two or more times: Lied or conned to get things 
you wanted or to avoid having to do something; 
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if R03_AX0165 in (2, 3, 4) then lied=0; 
else if R03_AX0165 in (1) then lied=1; 
else if R03_AX0165 = . then lied=.; 
 
*R03_AX0166: Last time you did the following two or more times: Had a hard time paying 
attention at school, work or home; 
if R03_AX0166 in (2, 3, 4) then attention=0; 
else if R03_AX0166 in (1) then attention=1; 
else if R03_AX0166 = . then attention=.; 
 
*R03_AX0167: Last time you did the following two or more times: Had a hard time listening to 
instructions at school, work or home; 
if R03_AX0167 in (2, 3, 4) then listening=0; 
else if R03_AX0167 in (1) then listening=1; 
else if R03_AX0167 = . then listening= .; 
 
*R03_AX0168: Last time you did the following two or more times: Were a bully or threatened 
other people; 
if R03_AX0168 in (2, 3, 4) then bully=0; 
else if R03_AX0168 in (1) then bully=1; 
else if R03_AX0168 = . then bully= .; 
 
*R03_AX0169: Last time you did the following two or more times: Started physical fights with 
other people; 
if R03_AX0169 in (2, 3, 4) then fights=0; 
else if R03_AX0169 in (1) then fights=1; 
else if R03_AX0169 = . then fights= .; 
 
*R03_AX0250: Last time you did the following two or more times: Felt restless or the need to 
run around or climb on things; 
if R03_AX0250 in (2, 3, 4) then restless=0; 
if R03_AX0250 in (1) then restless=1; 
else if R03_AX0250 = . then restless=.; 
 
*R03_AX0251: Last time you did the following two or more times: Gave answers before the 
other person finished asking the question; 
if R03_AX0251 in (2, 3, 4) then answered=0; 
if R03_AX0251 in (1) then answered=1; 
else if R03_AX0251 = . then answered=.; 
 
 
******SUBSTANCE USE DISORDERS**********; 
 
*R03_AX0170: Last time that you used alcohol or other drugs weekly or more often; 
if R03_AX0170 in (2, 3, 4) then weeklyuse=0; 
if R03_AX0170 in (1) then weeklyuse=1; 
else if R03_AX0170 = . then weeklyuse=.; 
 
*R03_AX0171: Last time that you spent a lot of time getting alcohol or other drugs; 
if R03_AX0171 in (2, 3, 4) then timegetting=0; 
if R03_AX0171 in (1) then timegetting=1; 
else if R03_AX0171 = . then timegetting=.; 
 
*R03_AX0193: Last time you spent a lot of time using or recovering from alcohol or other drugs; 
if R03_AX0193 in (2, 3, 4) then timeusing=0; 
if R03_AX0193 in (1) then timeusing=1; 
else if R03_AX0193 = . then timeusing=.; 
 
*R03_AX0172: Last time that you kept using alcohol or other drugs even though it was causing 
social problems, leading to fights, or getting you into trouble with other people; 
if R03_AX0172 in (2, 3, 4) then socialprob=0; 
if R03_AX0172 in (1) then socialprob=1; 
else if R03_AX0172 = . then socialprob=.; 
 
*R03_AX0173: Last time that your use of alcohol or other drugs reduced your involvement in 
activities at work, school, home or social events; 
if R03_AX0173 in (2, 3, 4) then reducedact=0; 
if R03_AX0173 in (1) then reducedact=1; 
else if R03_AX0173 = . then reducedact=.; 
 
*R03_AX0174: Last time that you had withdrawal problems such as shaky hands, throwing up, 
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having trouble sitting still or sleeping; 
if R03_AX0174 in (2, 3, 4) then withdraw=0; 
if R03_AX0174 in (1) then withdraw=1; 
else if R03_AX0174 = . then withdraw=.; 
 
*R03_AX0194: Last time you used any alcohol or other drugs to stop being sick or avoid 
withdrawal problems; 
if R03_AX0194 in (2, 3, 4) then usetoavoid=0; 
if R03_AX0194 in (1) then usetoavoid=1; 
else if R03_AX0194 = . then usetoavoid=.; 
 
*ALL PAST 30 DAY; 
sud_score = sum(weeklyuse, timegetting, timeusing, socialprob, reducedact, withdraw, usetoavoid); 
 
*SUD is 3 levels- no/low, moderate, and high; 
if sud_score in (0) then sud=0; 
if sud_score in (1,2) then sud=1; 
if sud_score in (3,4,5,6,7) then sud=2; 
if sud_score = . then sud=.; 
 
*****DUMMY CODING FOR THE COVARIATES******; 
 
IF R03R_A_SEX=1 THEN SEXMALE_1=1; 
ELSE SEXMALE_1=0; 
 
IF R03R_A_SEX=2 THEN SEXFEMALE_2=1; 
ELSE SEXFEMALE_2=0; 
 
IF age=1 THEN AGE1824_1=1; 
ELSE AGE1824_1=0; 
 
IF age=2 THEN AGE2534_2=1; 
ELSE AGE2534_2=0; 
 
IF age=3 THEN AGE3544_3=1; 
ELSE AGE3544_3=0; 
 
IF age=4 THEN AGE4554_4=1; 
ELSE AGE4554_4=0; 
 
IF age=5 THEN AGE5564_5=1; 
ELSE AGE5564_5=0; 
 
IF age=6 THEN AGE65_6=1; 
ELSE AGE65_6=0; 
 
IF R03R_A_ETHRACECAT7=1 THEN RACEWH_1=1; 
ELSE RACEWH_1=0; 
 
IF R03R_A_ETHRACECAT7=2 THEN RACEBL_2=1; 
ELSE RACEBL_2=0; 
 
IF R03R_A_ETHRACECAT7=3 THEN RACEOT_3=1; 
ELSE RACEOT_3=0; 
 
IF R03R_A_ETHRACECAT7=6 THEN RACEHI_6=1; 
ELSE RACEHI_6=0; 
 
IF education=1 THEN EDU_1=1; 
ELSE EDU_1=0; 
 
IF education=2 THEN EDU_2=1; 
ELSE EDU_2=0; 
 
IF education=3 THEN EDU_3=1; 
ELSE EDU_3=0; 
 
IF education=4 THEN EDU_4=1; 
ELSE EDU_4=0; 
 




IF R03R_A_AM0030=1 THEN INC_1=1; 
ELSE INC_1=0; 
 
IF R03R_A_AM0030=2 THEN INC_2=1; 
ELSE INC_2=0; 
 
IF R03R_A_AM0030=3 THEN INC_3=1; 
ELSE INC_3=0; 
 
IF R03R_A_AM0030=4 THEN INC_4=1; 
ELSE INC_4=0; 
 
IF R03R_A_AM0030=5 THEN INC_5=1; 
ELSE INC_5=0; 
 
*extremely satisfied =1; 
IF R03_AX0092=1 THEN SOC_1=1; 
ELSE SOC_1=0; 
 
IF R03_AX0092=2 THEN SOC_2=1; 
ELSE SOC_2=0; 
 
IF R03_AX0092=3 THEN SOC_3=1; 
ELSE SOC_3=0; 
 
IF R03_AX0092=4 THEN SOC_4=1; 
ELSE SOC_4=0; 
 
*not at all satisfied =5; 




 array change _numeric_; 
 do over change; 
 if change=-97777 then change=.; 
 else if change=-99999 then change=.; 
 else if change=-99988 then change=.; 
 else if change=-99977 then change=.; 
 else if change=-99955 then change=.; 
 else if change=-99911 then change=.; 
 else if change=-9 then change=.; 
 else if change=-8 then change=.; 
 else if change=-7 then change=.; 
 else if change=-1 then change=.; 







*********confirming recodes worked; 
 
*check dummies; 
proc freq data=lca.w3; 
table R03R_A_SEX*SEXMALE_1 
  R03R_A_SEX*SEXFEMALE_2 
  age*AGE1824_1 
  age*AGE2534_2 
  age*AGE3544_3 
  age*AGE4554_4 
  age*AGE5564_5 
  age*AGE65_6 
  R03R_A_ETHRACECAT7*RACEWH_1 
  R03R_A_ETHRACECAT7*RACEBL_2 
  R03R_A_ETHRACECAT7*RACEOT_3 
  R03R_A_ETHRACECAT7*RACEHI_6 
  education*EDU_1 
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  education*EDU_2 
  education*EDU_3 
  education*EDU_4 
  education*EDU_5 
  R03R_A_AM0030*INC_1 
  R03R_A_AM0030*INC_2 
  R03R_A_AM0030*INC_3 
  R03R_A_AM0030*INC_4 
  R03R_A_AM0030*INC_5 
  R03_AX0092*SOC_1 
  R03_AX0092*SOC_2 
  R03_AX0092*SOC_3 
  R03_AX0092*SOC_4 









proc freq data=lca.w3; 
table  acur_alc acur_marijuana acur_painkiller 
  depressed sleeping anxious ptsd 
  lied attention listening bully fights restless answered 
  weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid 
  sud; 
run; 
 
proc freq data=lca.w3; 
table R03R_A_CUR_ESTD_CIGS*acur_cig 
      R03R_A_CUR_ESTD_EPRODS*acur_ecig; 
run; 
 
proc freq data=lca.w3; 
table acur_alc acur_marijuana acur_painkiller; 
run; 
*marijuana is weird again for past 30 day--  
because R03_AX0675 is either smoked traditional cigar, cigarillo, or filtered cigar with 
marijuana in the past 12 months 
OR 
have you used marijuana in the past 12 months; 
 
 
*only select people from wave 1 and wave 2; 













proc freq data=lca.w3contadult; 
table acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller  
   R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 R03_AX0092 
   depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     sud; 




*Identify all variable want to keep; 
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*Now limit to the main variables that we want to keep; 
data LCA.W3mpluscontadult; 
set LCA.W3contadult (keep = caseid personid acur_cig acur_ecig acur_alc acur_marijuana 
acur_painkiller  
     R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 
R03_AX0092 
     SEXMALE_1 SEXFEMALE_2  
                 AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud); 
*rename missings; 
array change _numeric_; 
do over change; 













***Missing vs nonmissing for W3; 
***using contadultc data because it has new tobacco vars; 
proc contents data=lca.w3contadultc; 
run; 
 
proc freq data=lca.w3contadultc; 
table acur_cignew acur_ecignew acur_dualnew  






if (acur_cignew=.) or (acur_ecignew=.) or (acur_dualnew=.) or (acur_alc=.) or 
(acur_marijuana=.) or (acur_painkiller=.) or  
(R03R_A_SEX=.)  or (age=.) or (R03R_A_ETHRACECAT7=.) or (education=.) or (R03R_A_AM0030=.) or 
(R03_AX0092=.) or 
(depressed=.) or (sleeping=.) or (anxious=.) or (ptsd=.) or 
(lied=.) or (attention=.) or (listening=.) or (bully=.) or (fights=.) or 
(restless=.) or (answered=.) or 






proc freq data=lca.w3missingtest; 
table compare; 
run; 
*complete data/analytic sample (compare = 1) = 21628; 
*missing (compare = 0) = 4611; 
 
******************************** 
*compare missing and nonmissing; 
*look at column percent; 
 
*subs; 
proc freq data=lca.w3missingtest; 
 358 
table acur_cignew*compare 
      acur_ecignew*compare 
      acur_dualnew*compare 
      acur_alc*compare 
      acur_marijuana*compare 
      acur_painkiller*compare/chisq; 
run; 
*sig diff for all: analytic sample has higher endorsement of all subs; 
 
*demos; 
proc freq data=lca.w3missingtest; 
table R03R_A_SEX*compare 
      age*compare 
      R03R_A_ETHRACECAT7*compare 
      education*compare 
      R03R_A_AM0030*compare 
      R03_AX0092*compare/chisq; 
run; 
*sig difference sex: more males, less women in analytic sample; 
*sig difference by age: more in categories 2, 3, 4 (25-54) in analytic sample; 
*sig difference by race: more white, less other cats in analytic sample; 
*sig difference by edu: higher edu levels in analytic sample; 
*sig difference by income: higher income levels in analytic sample; 
*sig difference by social: missing had more extremely and also not at all satisfied; 
 
*internalizing; 
proc freq data=lca.w3missingtest; 
table depressed*compare 
      sleeping*compare 
      anxious*compare 
      ptsd*compare/chisq; 
run; 
*sig diff for all: analytic sample has higher endorsement of all 4 symptoms; 
 
*externalizing; 
proc freq data=lca.w3missingtest; 
table lied*compare 
      attention*compare 
      listening*compare 
      bully*compare 
      fights*compare 
      restless*compare 
      answered*compare/chisq; 
run; 
*sig diff for all except bully and fights: all others - analytic sample has higher endorsement of 
the other 5 symptoms; 
*no sig diff for bully or fights; 
 
*sud; 
proc freq data=lca.w3missingtest; 
table sud*compare/chisq; 
run; 
*sig diff: analytic sample has higher endorsement of moderate and high sud severity; 





MPLUS File name: w3 4 class 4142021 
 
TITLE: WAVE 3 MODEL 4 CLASS -- APRIL 14 2021; 
         DATA: FILE IS w3dataformplus332021_noheader.csv; 
         VARIABLE: NAMES ARE CASEID PERSONID weight 
               acur_cignew acur_ecignew acur_dualnew 
                  acur_alc acur_marijuana acur_painkiller  
               R03R_A_ETHRACECAT7 age education 
               depressed sleeping anxious ptsd  
               lied attention listening bully fights restless answered  
 359 
               weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid  
                sud  
               SEXMALE_1 SEXFEMALE_2  
               AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6  
               RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6  
               EDU_1 EDU_2 EDU_3 EDU_4 EDU_5  
               INC_1 INC_2 INC_3 INC_4 INC_5  
               SOC_1 SOC_2 SOC_3 SOC_4 SOC_5; 
            USEVARIABLES = acur_cignew acur_ecignew acur_dualnew 
                      acur_alc acur_marijuana acur_painkiller 
                   depressed sleeping anxious ptsd  
                   lied attention listening bully fights restless answered; 
            IDVARIABLE = CASEID; 
            MISSING ARE ALL (-99999); 
            CLASSES = c(5); 
            CATEGORICAL = acur_cignew acur_ecignew acur_dualnew 
                     acur_alc acur_marijuana acur_painkiller 
                   depressed sleeping anxious ptsd  
                   lied attention listening bully fights restless answered; 
            AUXILIARY = SEXMALE_1 (R3STEP) 
                        AGE1824_1 (R3STEP) AGE2534_2 (R3STEP) AGE3544_3 (R3STEP) 
                        AGE4554_4 (R3STEP) AGE5564_5 (R3STEP) 
                        RACEBL_2 (R3STEP) RACEOT_3 (R3STEP) RACEHI_6 (R3STEP) 
                        EDU_1 (R3STEP) EDU_2 (R3STEP) EDU_3(R3STEP) 
                       EDU_4 (R3STEP) INC_1 (R3STEP) INC_2 (R3STEP) 
                        INC_3 (R3STEP) INC_4 (R3STEP) 
                     SOC_2 (R3STEP) SOC_3 (R3STEP) SOC_4 (R3STEP) SOC_5 (R3STEP); 
          WEIGHT is weight; 
          ANALYSIS: TYPE = MIXTURE; 
                      STARTS = 100 10; 
                      OPTSEED = 991329; 
                      LRTSTARTS = 0 0 150 40; 
          SAVEDATA: file is w34classweight414.csv; 
                   save = Cprob; 






SAS File name: Read in W3 4 CLASS 4142021 
 
*WAVE 3 4 CLASS SOLUTION - import to compare with W1 and W2; 
*MPLUS OUTPUT = w3 4 class 4152021; 
*CSV = w34classweight415; 
 





   W3_ACUR_CIG        
    W3_ACUR_ECI      
    W3_ACUR_DUA        
    W3_ACUR_ALC        
    W3_ACUR_MAR        
    W3_ACUR_PAI        
    W3_DEPRESS       
    W3_SLEEPING       
    W3_ANXIOUS       
 360 
    W3_PTSD           
    W3_LIED            
    W3_ATTENTIO       
    W3_LISTENIN      
    W3_BULLY           
    W3_FIGHTS        
    W3_RESTLESS        
    W3_ANSWERED       
    W3_SEXMALE_        
    W3_AGE1824_        
    W3_AGE2534_       
    W3_AGE3544_        
    W3_AGE4554_        
    W3_AGE5564_        
    W3_RACEBL_2        
    W3_RACEOT_3        
    W3_RACEHI_6        
    W3_EDU_1           
    W3_EDU_2           
    W3_EDU_3           
    W3_EDU_4           
    W3_INC_1          
    W3_INC_2           
    W3_INC_3           
    W3_INC_4           
    W3_SOC_2          
    W3_SOC_3          
    W3_SOC_4           
    W3_SOC_5           
    W3_CPROB1         
    W3_CPROB2          
    W3_CPROB3          
    W3_CPROB4         
    W3_C               
    W3_WEIGHT          
    CASEID; 
datalines; 




SAS File name: LCA Comparisons, Transition Tables 4142021 
 
*Merge the datasets to look at transition tables; 
 
libname aim3 "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\LCA Wave 2 and 3 - 4 class - 
4142021"; 
 
*start by checking freqs; 
 
*Wave 1; 
proc surveyfreq data=aim3.w14classprob4142021; 
table  
W1_ACUR_CIG      W1_ACUR_ECI       W1_ACUR_DUA       W1_ACUR_ALC       W1_ACUR_MAR       
W1_ACUR_PAI        
W1_DEPRESS       W1_SLEEPING       W1_ANXIOUS        W1_PTSD            
W1_LIED          W1_ATTENTIO       W1_LISTENING      W1_BULLY          W1_FIGHTS         





proc surveyfreq data=aim3.w24classprob4142021; 
table       
W2_ACUR_CIG      W2_ACUR_ECI      W2_ACUR_DUA       W2_ACUR_ALC       W2_ACUR_MAR       
W2_ACUR_PAI        
W2_DEPRESS       W2_SLEEPING      W2_ANXIOUS        W2_PTSD          
W2_LIED          W2_ATTENTIO      W2_LISTENIN      W2_BULLY        W2_FIGHTS      W2_RESTLESS       






proc surveyfreq data=aim3.W34classprob4152021; 
table  
W3_ACUR_CIG      W3_ACUR_ECI      W3_ACUR_DUA       W3_ACUR_ALC     W3_ACUR_MAR    W3_ACUR_PAI        
W3_DEPRESS       W3_SLEEPING      W3_ANXIOUS        W3_PTSD          
W3_LIED          W3_ATTENTIO      W3_LISTENIN      W3_BULLY        W3_FIGHTS      W3_RESTLESS       
W3_ANSWERED        




proc surveyfreq data=aim3.W34classprob4152021; 
table  
w3_C      




*then sort by caseid; 












********************need to add in R03_A_AWGT to use when running weighted transition tables; 





(keep = caseid R03_A_AWGT); 
run; 








merge aim3.w14classprob4142021 aim3.w24classprob4142021 aim3.W34classprob4152021 
aim3.w3allweights; 
by caseid; 
*array change _numeric_; 
*do over change; 




proc contents data=aim3.master; 
run; 
 
proc print data=aim3.master (obs=20); 
run; 
 
*make transition tables; 
 
ods pdf; 
*W1 vs W2; 





*W2 vs W3; 




*W1 vs W3; 
proc freq data=aim3.master; 
table w1_c*w3_c; 
run; 
ods pdf close; 
 
 
*make transition tables - with wave 3 all weights; 
 
ods pdf; 
*W1 vs W2; 
proc surveyfreq data=aim3.master; 
table w1_c*w2_c 




*W2 vs W3; 
proc surveyfreq data=aim3.master; 
table w2_c*w3_c 




*W1 vs W3; 
proc surveyfreq data=aim3.master; 
table w1_c*w3_c 
/ row chisq (secondorder); 
weight R03_A_AWGT; 
run; 




*Try to get item response pattern for each comorbidity class for each wave; 







*tetrachoric correlations by wave; 
*4/28/2021; 
ods pdf; 
proc contents data=aim3.master; 
run; 
 
******W1 VS W2; 









































































































































W1_SLEEPING*W2_ACUR_CIG   






















































W1_PTSD*W2_ANSWERED   
 
  








































































































































ods pdf close; 
 
   
ods pdf; 
******W1 VS W3; 









































































































































W1_SLEEPING*W3_ACUR_CIG   






















































W1_PTSD*W3_ANSWERED   
 
  












































































































































******W2 VS W3; 









































































































































W2_SLEEPING*W3_ACUR_CIG   





















































W2_PTSD*W3_ANSWERED   
 
  












































































































































SAS File name: Making W2 and W3 for Network Comparisons 
 
****SA 3 - Network Comparisons for W1 vs W2 vs W3 
****W1 already generated for SA2 (can be found in PNASS\\Data Management\\CSVs to use in 
R\\overallwave1.csv) 
****Making datasets for SA3 including overall W2 and W3 
    Need to make dual CC + EC variables for W2 and W3 
    Keep only adults who have continued from W1 (contadult datasets) 
    Change . to -99999 
    Export as CSV to R 
    ONLY KEEPING 17 NODES FOR NETWORK COMPARISON SECTION OF SA 3 




*Starting with Wave 2 
********************* 
 377 
 Pull most recent version of W2 data created in LCA W2 SAS Program (lca.w2contadult) 
 Need to download formats for W2; 
libname LCA "C:\Users\blondinoct\Documents\LCA\Wave 2\Data Management"; 
 
proc contents data=lca.w2contadult; 
run; 
 




*first do multinomial - 4 levels; 
if acur_cig=0 and acur_ecig=0 then acur_dual=0; 
else if acur_cig=1 and acur_ecig=0 then acur_dual=1; 
else if acur_cig=0 and acur_ecig=1 then acur_dual=2; 










*then do the dummies; 
data lca.w2contadultc; 
set lca.w2contadultb; 
if acur_dual = 1 then acur_cignew=1; 
else acur_cignew=0; 
if acur_dual = 2 then acur_ecignew=1; 
else acur_ecignew=0; 











*confirm marijuana is good; 





**SUMMARY STATS FOR WAVE 2; 
proc surveyfreq data= LCA.w2contadultc varmethod=BRR (fay=0.3); 
table acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller  
 R02R_A_SEX age R02R_A_ETHRACECAT7 education R02R_A_AM0030 R02_AX0092 
depressed sleeping anxious ptsd 










**data kept to run LCA again then compare; 
data LCA.w2contadultd; 
set LCA.w2contadultc (keep = caseid personid R02_A_PWGT 
     acur_cignew acur_ecignew acur_dualnew 
                 acur_alc acur_marijuana acur_painkiller  
     R02R_A_SEX age R02R_A_ETHRACECAT7 education R02R_A_AM0030 
R02_AX0092 
 378 
     SEXMALE_1 SEXFEMALE_2  
     AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud); 
*rename missings; 
array change _numeric_; 
do over change; 





proc contents data=LCA.w2contadultd; 
run; 
proc freq data=LCA.w2contadultd; 
table 
acur_cignew acur_ecignew acur_dualnew 
acur_alc acur_marijuana acur_painkiller 
depressed sleeping anxious ptsd 
lied attention listening bully fights restless answered; 
run; 
 
*These look good: 
*Exported to Aim 3 - Comparisons -> Data Sets as w2dataformplus232021; 
 
 
**data kept for network comparisons; 
data LCA.w2contadulte; 
set LCA.w2contadultc (keep =  
     acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana 
acur_painkiller  
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered); 
*rename missings; 
array change _numeric_; 
do over change; 




proc contents data=LCA.w2contadulte; 
run; 
 
*These look good: 







*Now to Wave 3 
*************** 
 Pull most recent version of W3 data created in LCA W3 SAS Program (lca.w3contadult) 
 Need to download formats for W3; 
libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Wave 3\Data Management"; 
 
*single w3 weights; 




*all waves weights; 






proc contents data=lca.w3; 
run; 


























*merge lca.w3allweights lca.w3singleweights; 
*by personid; 
*run; 





merge lca.w3contalladultweights lca.w3singleweights lca.w3allweights; 
by personid; 
run; 
proc contents data = lca.w3contadultweights; 
run; 
 
*Then limit the sample to only people from Wave 1; 









proc contents data=lca.w3contadult; 
run; 
 








*first do multinomial - 4 levels; 
if acur_cig=0 and acur_ecig=0 then acur_dual=0; 
else if acur_cig=1 and acur_ecig=0 then acur_dual=1; 
else if acur_cig=0 and acur_ecig=1 then acur_dual=2; 
 380 










*then do the dummies; 
data lca.w3contadultc; 
set lca.w3contadultb; 
if acur_dual = 1 then acur_cignew=1; 
else acur_cignew=0; 
if acur_dual = 2 then acur_ecignew=1; 
else acur_ecignew=0; 











*confirm marijuana is good; 




proc contents data=lca.w3contadultc; 
run; 
 
*proc print data=lca.w3contadultc; 
*var R03_A_SWGT R03_ADULTTYPE; 
*run; 
 





**SUMMARY STATS FOR WAVE 3; 
ods pdf; 
proc surveyfreq data= LCA.w3contadultc varmethod=BRR (fay=0.3); 
table acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller  
R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 R03_AX0092 
depressed sleeping anxious ptsd 








ods pdf close; 
 
****************************************** 
**data kept to run LCA again then compare; 
data LCA.w3contadultd; 
set LCA.w3contadultc (keep = caseid personid R03_A_SWGT 
     acur_cignew acur_ecignew acur_dualnew 
                 acur_alc acur_marijuana acur_painkiller  
     R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 
R03_AX0092 
     SEXMALE_1 SEXFEMALE_2  
     AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
 381 
     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud); 
*rename missings; 
array change _numeric_; 
do over change; 





proc contents data=LCA.w3contadultd; 
run; 
proc freq data=LCA.w3contadultd; 
table 
acur_cignew acur_ecignew acur_dualnew 
acur_alc acur_marijuana acur_painkiller 
depressed sleeping anxious ptsd 
lied attention listening bully fights restless answered; 
run; 
 
*These look good: 
*Exported to Aim 3 - Comparisons -> Data Sets as w3dataformplus332021; 
 
 
**data kept for network comparisons; 
data LCA.w3contadulte; 
set LCA.w3contadultc (keep =  
     acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana 
acur_painkiller  
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered); 
*rename missings; 
array change _numeric_; 
do over change; 




proc contents data=LCA.w3contadulte; 
run; 
 
*These look good: 






*THIS IS THE WRONG ONE; 
*LOOK AT LCA W1 4132021; 
*************************** 
**SUMMARY STATS FOR WAVE 1; 
*Overall W1 with new exclusive CC and EC, and dual variables for Table 1 Network Paper; 
 
libname LCA "C:\Users\blondinoct\Documents\LCA\Wave 1\Data Management"; 
 
proc surveyfreq data= LCA.W1mplusJuly2020weights varmethod=BRR (fay=0.3); 
table  
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030 
R01_AX0092 
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller  
depressed sleeping anxious ptsd 














*Wave 3 - merging weights with diff dataset to try to figure out missing on R03_A_AWGT 
************************************************************************************** 
 Pull most recent version of W3 data created in LCA W3 SAS Program (lca.w3contadult) 
 Need to download formats for W3; 
libname LCA "C:\Users\blondinoct\Documents\LCA\Wave 3\Data Management"; 
 





proc contents data=lca.w3contadult; 
run; 
*N = 26239; 

















merge lca.w3contadult lca.w3weights; 
by personid; 
run; 
proc contents data = lca.w3contadultweights; 
run; 
 
proc print data = lca.w3contadultweights (obs=20); 




*Then limit the sample to only people from Wave 1 that have weight info; 










if R03_ADULTTYPE=1 and R03_A_AWGT^=.; 
run; 
 













*first do multinomial - 4 levels; 
if acur_cig=0 and acur_ecig=0 then acur_dual=0; 
else if acur_cig=1 and acur_ecig=0 then acur_dual=1; 
else if acur_cig=0 and acur_ecig=1 then acur_dual=2; 










*then do the dummies; 
data lca.w3contadultc; 
set lca.w3contadultb; 
if acur_dual = 1 then acur_cignew=1; 
else acur_cignew=0; 
if acur_dual = 2 then acur_ecignew=1; 
else acur_ecignew=0; 











*confirm marijuana is good; 




proc print data=lca.w3contadultc; 
var R03_A_AWGT R03_ADULTTYPE; 
run; 
 





**SUMMARY STATS FOR WAVE 3; 
proc surveyfreq data= LCA.w3contadultc varmethod=BRR (fay=0.3); 
table acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller  
R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 R03_AX0092 
depressed sleeping anxious ptsd 










**data kept to run LCA again then compare; 
data LCA.w3contadultd; 
 384 
set LCA.w3contadultc (keep = caseid personid R03_A_AWGT 
     acur_cignew acur_ecignew acur_dualnew 
                 acur_alc acur_marijuana acur_painkiller  
     R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 
R03_AX0092 
     SEXMALE_1 SEXFEMALE_2  
     AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6 
     RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6 
     EDU_1 EDU_2 EDU_3 EDU_4 EDU_5 
     INC_1 INC_2 INC_3 INC_4 INC_5 
     SOC_1 SOC_2 SOC_3 SOC_4 SOC_5 
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered 
     weeklyuse timegetting timeusing socialprob reducedact withdraw 
usetoavoid 
     sud); 
*rename missings; 
array change _numeric_; 
do over change; 





proc contents data=LCA.w3contadultd; 
run; 
proc freq data=LCA.w3contadultd; 
table 
acur_cignew acur_ecignew acur_dualnew 
acur_alc acur_marijuana acur_painkiller 
depressed sleeping anxious ptsd 
lied attention listening bully fights restless answered; 
run; 
 
*These look good: 
*Exported to Aim 3 - Comparisons -> Data Sets as w3dataformplus2172021; 
 
 
**data kept for network comparisons; 
data LCA.w3contadulte; 
set LCA.w3contadultc (keep =  
     acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana 
acur_painkiller  
     depressed sleeping anxious ptsd 
     lied attention listening bully fights restless answered); 
*rename missings; 
array change _numeric_; 
do over change; 




proc contents data=LCA.w3contadulte; 
run; 
 
*These look good: 
*Exported to Aim 3 - Comparisons -> Data Sets as w3datafornetcomp2172021; 
 
 
R File name: Aim 3 – Network Comparisons Waves 1, 2, 3 – 4152021 
 

















#rename variables so they look nice on the network 
names(overall)[names(overall) == "acur_cignew"] <- "CIG" 
names(overall)[names(overall) == "acur_ecignew"] <- "ECIG" 
names(overall)[names(overall) == "acur_dualnew"] <- "Dual CIG + ECIG" 
names(overall)[names(overall) == "acur_alc"] <- "Alcohol" 
names(overall)[names(overall) == "acur_marijuana"] <- "Marijuana" 
names(overall)[names(overall) == "acur_painkiller"] <- "PDNP" 
names(overall)[names(overall) == "depressed"] <- "Depressed" 
names(overall)[names(overall) == "sleeping"] <- "Sleeping" 
names(overall)[names(overall) == "anxious"] <- "Anxious" 
names(overall)[names(overall) == "PTSD"] <- "Distressed/Past" 
names(overall)[names(overall) == "lied"] <- "Lied" 
names(overall)[names(overall) == "attention"] <- "Attention" 
names(overall)[names(overall) == "listening"] <- "Listening" 
names(overall)[names(overall) == "bully"] <- "Bully" 
names(overall)[names(overall) == "fights"] <- "Fights" 
names(overall)[names(overall) == "restless"] <- "Restless" 





















Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana",  "PDNP",        
          "Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",        
          "Attention" , "Listening" , "Bully" ,"Fights"  , "Restless",    
          "Answered") 
 
Traits <- rep(c( 
  'Substance Use', 
  'Negative Affect', 






     layout="spring", 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     minimum=0, 
     label.scale.equal=TRUE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 






Edges <- Wave1NetworkIF$graph 
print(Edges) 
write(Edges, file="OverallEdges.csv", sep=" ") 
 
 










Files/Wave Comparison Chapter") 
getwd() 
Wave2<-read.csv("/Users/courtneyblondino/Library/Mobile 
Documents/com~apple~CloudDocs/Dissertation Files/Wave Comparison 




#Have to tell R what missing means 
Wave2$acur_cignew[Wave2$acur_cignew==-99999] <- NA 
Wave2$acur_ecignew[Wave2$acur_ecignew==-99999] <- NA 
Wave2$acur_dualnew[Wave2$acur_dualnew==-99999] <- NA 
Wave2$acur_alc[Wave2$acur_alc==-99999] <- NA 
Wave2$acur_marijuana[Wave2$acur_marijuana==-99999] <- NA 
Wave2$acur_painkiller[Wave2$acur_painkiller==-99999] <- NA 
Wave2$depressed[Wave2$depressed==-99999] <- NA 
Wave2$sleeping[Wave2$sleeping==-99999] <- NA 
Wave2$anxious[Wave2$anxious==-99999] <- NA 
Wave2$ptsd[Wave2$ptsd==-99999] <- NA 
Wave2$lied[Wave2$lied==-99999] <- NA 
Wave2$attention[Wave2$attention==-99999] <- NA 
 387 
Wave2$listening[Wave2$listening==-99999] <- NA 
Wave2$bully[Wave2$bully==-99999] <- NA 
Wave2$fights[Wave2$fights==-99999] <- NA 
Wave2$restless[Wave2$restless==-99999] <- NA 
Wave2$answered[Wave2$answered==-99999] <- NA 
 
#rename variables so they look nice on the network 
names(Wave2)[names(Wave2) == "acur_cignew"] <- "CIG" 
names(Wave2)[names(Wave2) == "acur_ecignew"] <- "ECIG" 
names(Wave2)[names(Wave2) == "acur_dualnew"] <- "Dual CIG + ECIG" 
names(Wave2)[names(Wave2) == "acur_alc"] <- "Alcohol" 
names(Wave2)[names(Wave2) == "acur_marijuana"] <- "Marijuana" 
names(Wave2)[names(Wave2) == "acur_painkiller"] <- "PDNP" 
names(Wave2)[names(Wave2) == "depressed"] <- "Depressed" 
names(Wave2)[names(Wave2) == "sleeping"] <- "Sleeping" 
names(Wave2)[names(Wave2) == "anxious"] <- "Anxious" 
names(Wave2)[names(Wave2) == "ptsd"] <- "Distressed/Past" 
names(Wave2)[names(Wave2) == "lied"] <- "Lied" 
names(Wave2)[names(Wave2) == "attention"] <- "Attention" 
names(Wave2)[names(Wave2) == "listening"] <- "Listening" 
names(Wave2)[names(Wave2) == "bully"] <- "Bully" 
names(Wave2)[names(Wave2) == "fights"] <- "Fights" 
names(Wave2)[names(Wave2) == "restless"] <- "Restless" 
names(Wave2)[names(Wave2) == "answered"] <- "Answered" 
 
######################################## 









Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana",  "PDNP",        
          "Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",        
          "Attention" , "Listening" , "Bully" ,"Fights"  , "Restless",    
          "Answered") 
 
Traits <- rep(c( 
  'Substance Use', 
  'Negative Affect', 




     layout="spring", 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     minimum=0, 
     label.scale.equal=TRUE, 
     label.cex= 4.0, 
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     legend.cex = 0.4) 
 
#Results 
W2Results <- Wave2NetworkIF$results 
#write.csv(W2Results, file="W2Results.csv", sep=" ") 




Edges <- Wave2NetworkIF$graph 
print(Edges) 
 









Files/Wave Comparison Chapter") 
getwd() 
#Wave3<-read.csv("C:\\Users\\blondinoct\\Documents\\Aim 3 - Comparisons\\Data 
Sets\\w3datafornetcomp232021.csv", header=T, sep=',') 
#dim(Wave3) 
#names(Wave3) 
############NEW WAVE 3 , N = 25382 ################ 
#Wave3<-read.csv("/Users/courtneyblondino/Library/Mobile 
Documents/com~apple~CloudDocs/Dissertation Files/Wave Comparison 





Documents/com~apple~CloudDocs/Dissertation Files/Wave Comparison 




#Have to tell R what missing means 
Wave3$acur_cignew[Wave3$acur_cignew==-99999] <- NA 
Wave3$acur_ecignew[Wave3$acur_ecignew==-99999] <- NA 
Wave3$acur_dualnew[Wave3$acur_dualnew==-99999] <- NA 
Wave3$acur_alc[Wave3$acur_alc==-99999] <- NA 
Wave3$acur_marijuana[Wave3$acur_marijuana==-99999] <- NA 
Wave3$acur_painkiller[Wave3$acur_painkiller==-99999] <- NA 
Wave3$depressed[Wave3$depressed==-99999] <- NA 
Wave3$sleeping[Wave3$sleeping==-99999] <- NA 
Wave3$anxious[Wave3$anxious==-99999] <- NA 
Wave3$ptsd[Wave3$ptsd==-99999] <- NA 
Wave3$lied[Wave3$lied==-99999] <- NA 
Wave3$attention[Wave3$attention==-99999] <- NA 
Wave3$listening[Wave3$listening==-99999] <- NA 
Wave3$bully[Wave3$bully==-99999] <- NA 
Wave3$fights[Wave3$fights==-99999] <- NA 
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Wave3$restless[Wave3$restless==-99999] <- NA 
Wave3$answered[Wave3$answered==-99999] <- NA 
 
#rename variables so they look nice on the network 
names(Wave3)[names(Wave3) == "acur_cignew"] <- "CIG" 
names(Wave3)[names(Wave3) == "acur_ecignew"] <- "ECIG" 
names(Wave3)[names(Wave3) == "acur_dualnew"] <- "Dual CIG + ECIG" 
names(Wave3)[names(Wave3) == "acur_alc"] <- "Alcohol" 
names(Wave3)[names(Wave3) == "acur_marijuana"] <- "Marijuana" 
names(Wave3)[names(Wave3) == "acur_painkiller"] <- "PDNP" 
names(Wave3)[names(Wave3) == "depressed"] <- "Depressed" 
names(Wave3)[names(Wave3) == "sleeping"] <- "Sleeping" 
names(Wave3)[names(Wave3) == "anxious"] <- "Anxious" 
names(Wave3)[names(Wave3) == "ptsd"] <- "Distressed/Past" 
names(Wave3)[names(Wave3) == "lied"] <- "Lied" 
names(Wave3)[names(Wave3) == "attention"] <- "Attention" 
names(Wave3)[names(Wave3) == "listening"] <- "Listening" 
names(Wave3)[names(Wave3) == "bully"] <- "Bully" 
names(Wave3)[names(Wave3) == "fights"] <- "Fights" 
names(Wave3)[names(Wave3) == "restless"] <- "Restless" 
names(Wave3)[names(Wave3) == "answered"] <- "Answered" 
 
######################################## 









Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana",  "PDNP",        
          "Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",        
          "Attention" , "Listening" , "Bully" ,"Fights"  , "Restless",    
          "Answered") 
 
Traits <- rep(c( 
  'Substance Use', 
  'Negative Affect', 




     layout="spring", 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     minimum=0, 
     label.scale.equal=TRUE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 







Wave3Edges <- Wave3NetworkIF$graph 
print(Wave3Edges) 
write(Wave3Edges, file="Wave3Edges.csv", sep=" ") 
 






# Visually Compare using Average Layout    # 
############################################ 
 





     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     #label.scale.equal=TRUE, 
     legend=FALSE, 
     label.cex= 2.0, 
     legend.cex = 0.4, 
     title= "Wave 1", 
     maximum=Max) 
plot(Wave2NetworkIF, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     #label.scale.equal=TRUE, 
     label.cex= 2.0, 
     legend.cex = 0.4, 
     legend=FALSE, 
     title= "Wave 2", 
     maximum=Max) 
plot(Wave3NetworkIF, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     #label.scale.equal=TRUE, 
     label.cex= 2.0, 
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     legend.cex = 0.4, 
     title= "Wave 3", 











     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     labels=Names, 
     legend=FALSE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 
     title= "Wave 1", 
     maximum=Max) 
plot(Wave2NetworkIF, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 
     legend=FALSE, 
     title= "Wave 2", 





#perform NCT and interpret results 
 
NCTW1vsW2<- NCT(Wave1NetworkIF, Wave2NetworkIF, test.edges=TRUE, 
                it=100) 
 
 




#global strength values of individual networks 
NCTW1vsW2$glstrinv.sep 




#there's 100 since we did 100 permutations 
 
#Difference in global strength p-value 
NCTW1vsW2$glstrinv.pval 
#0.2673267- so not significantly different from one another in regard to global strength 
 





#there's 100 since we did 100 permutations 
 
#Maximum difference in edge weights 
NCTW1vsW2$nwinv.pval 
#0.2277228 - so not significantly different from one another in regard to number of edge weights 
 
#Which edges significantly differ? 
NCTW1vsW2$einv.pvals[which(NCTW1vsW2$einv.pvals[,3]<0.05),] 
#         Var1      Var2 p-value 
#69        CIG Marijuana 0.00990099 
#90  Marijuana      PDNP 0.00990099 
#120       CIG  Sleeping 0.03960396 
#155      ECIG      PTSD 0.02970297 
#179   Anxious      Lied 0.02970297 
#214      PTSD Listening 0.00990099 
#216 Attention Listening 0.01980198 
#252     Bully    Fights 0.03960396 










     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     labels=Names, 
     legend=FALSE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 
     title= "Wave 1", 
     maximum=Max) 
plot(Wave3NetworkIF, 
     layout=L, 
     cut=0, 
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     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 
     legend=FALSE, 
     title= "Wave 3", 
     maximum=Max) 
 
 
NCTW1vsW3<- NCT(Wave1NetworkIF, Wave3NetworkIF, test.edges=TRUE, 
                it=100) 
 
 




#global strength values of individual networks 
NCTW1vsW3$glstrinv.sep 
#55.99086 vs 59.99997 
 
NCTW1vsW3$glstrinv.perm  
#there's 100 since we did 100 permutations 
 
#Difference in global strength p-value 
NCTW1vsW3$glstrinv.pval 
#0.2376238 - so not significantly different from one another in regard to global strength 
 





#there's 100 since we did 100 permutations 
 
#Maximum difference in edge weights 
NCTW1vsW3$nwinv.pval 
#0.6039604 - so not significantly different from one another in regard to number of edge weights 
 
#Which edges significantly differ? 
NCTW1vsW3$einv.pvals[which(NCTW1vsW3$einv.pvals[,3]<0.05),] 
#                Var1      Var2 p-value 
#52              CIG   Alcohol 0.00990099 
#69              CIG Marijuana 0.00990099 
#90        Marijuana      PDNP 0.00990099 
#106         Alcohol Depressed 0.02970297 
#120             CIG  Sleeping 0.03960396 
#121            ECIG  Sleeping 0.03960396 
#159            PDNP      PTSD 0.03960396 
#162         Anxious      PTSD 0.04950495 
#174         Alcohol      Lied 0.00990099 
#175       Marijuana      Lied 0.01980198 
#178        Sleeping      Lied 0.02970297 
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#195        Sleeping Attention 0.03960396 
#207 Dual CIG + ECIG Listening 0.03960396 
#209       Marijuana Listening 0.01980198 
#214            PTSD Listening 0.04950495 
#216       Attention Listening 0.02970297 
#251       Listening    Fights 0.02970297 
#252           Bully    Fights 0.02970297 
#256             CIG  Restless 0.03960396 
#262       Depressed  Restless 0.00990099 
#263        Sleeping  Restless 0.01980198 














     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     labels=Names, 
     legend=FALSE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 
     title= "Wave 2", 
     maximum=Max) 
plot(Wave3NetworkIF, 
     layout=L, 
     cut=0, 
     theme="colorblind", 
     groups=Traits, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 4.0, 
     legend.cex = 0.4, 
     legend=FALSE, 
     title= "Wave 3", 
     maximum=Max) 
 
NCTW2vsW3<- NCT(Wave2NetworkIF, Wave3NetworkIF, test.edges=TRUE,  
                it=100) 
 
 





#global strength values of individual networks 
NCTW2vsW3$glstrinv.sep 
#59.29835 vs 59.99997 
 
NCTW2vsW3$glstrinv.perm  
#there's 100 since we did 100 permutations 
 
#Difference in global strength p-value 
NCTW2vsW3$glstrinv.pval 
#0.7524752 - so not significantly different from one another in regard to global strength 
 





#there's 100 since we did 100 permutations 
 
#Maximum difference in edge weights 
NCTW2vsW3$nwinv.pval 
#0.2277228 - so not significantly different from one another in regard to number of edge weights 
 
#Which edges significantly differ? 
NCTW2vsW3$einv.pvals[which(NCTW2vsW3$einv.pvals[,3]<0.05),] 
#              Var1      Var2 p-value 
#155            ECIG      PTSD 0.02970297 
#207 Dual CIG + ECIG Listening 0.01980198 
#209       Marijuana Listening 0.01980198 
#251       Listening    Fights 0.01980198 
#256             CIG  Restless 0.01980198 
#262       Depressed  Restless 0.01980198 
#265            PTSD  Restless 0.03960396 
#276         Alcohol  Answered 0.02970297 




R File name: W1W2W3 Merged Network 
 
#PATH WAVE 1, WAVE 2, WAVE 3 - SA 3 




# Read in merged dataset  # 
########################### 
 
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files") 
getwd() 
master<-read.csv("/Users/courtneyblondino/Library/Mobile 




#how many complete data 
master_complete_cases <- master[complete.cases(master),] 
## MASTER TOTAL          = 33106 
## MASTER COMPLETE CASES = 21353 
## MASTER MISSING        = 11753 
 
 
#select vars to keep for network modeling 
myvars <- c("W1_ACUR_CIG" , "W1_ACUR_ECI" , "W1_ACUR_DUA" , "W1_ACUR_ALC" , 
            "W1_ACUR_MAR" , "W1_ACUR_PAI" , 
            "W1_DEPRESS" ,  "W1_SLEEPING" , "W1_ANXIOUS"  , "W1_PTSD"  ,     
            "W1_LIED"   ,   "W1_ATTENTIO" , "W1_LISTENING" , "W1_BULLY" ,    
            "W1_FIGHTS"  ,  "W1_RESTLESS" , "W1_ANSWERED", 
             
            "W2_ACUR_CIG" , "W2_ACUR_ECI" , "W2_ACUR_DUA" , "W2_ACUR_ALC" , 
            "W2_ACUR_MAR" , "W2_ACUR_PAI" ,  
            "W2_DEPRESS" ,  "W2_SLEEPING" ,  "W2_ANXIOUS" , "W2_PTSD" , 
            "W2_LIED"    ,  "W2_ATTENTIO" , "W2_LISTENIN" , "W2_BULLY"   , 
            "W2_FIGHTS" ,   "W2_RESTLESS",  "W2_ANSWERED", 
             
            "W3_ACUR_CIG" , "W3_ACUR_ECI" , "W3_ACUR_DUA", "W3_ACUR_ALC" , 
            "W3_ACUR_MAR" , "W3_ACUR_PAI" , 
            "W3_DEPRESS",   "W3_SLEEPING" , "W3_ANXIOUS" ,  "W3_PTSD",  
            "W3_LIED" ,     "W3_ATTENTIO" , "W3_LISTENIN" , "W3_BULLY" , 
            "W3_FIGHTS"  ,  "W3_RESTLESS"  ,"W3_ANSWERED") 






#rename variables so they look nice on the network 
names(new_master)[names(new_master) == "W1_ACUR_CIG"] <- "W1 CIG" 
names(new_master)[names(new_master) == "W1_ACUR_ECI"] <- "W1 ECIG" 
names(new_master)[names(new_master) == "W1_ACUR_DUA"] <- "W1 Dual CIG + ECIG" 
names(new_master)[names(new_master) == "W1_ACUR_ALC"] <- "W1 Alcohol" 
names(new_master)[names(new_master) == "W1_ACUR_MAR"] <- "W1 Marijuana" 
names(new_master)[names(new_master) == "W1_ACUR_PAI"] <- "W1 PDNP" 
names(new_master)[names(new_master) == "W1_DEPRESS"] <- "W1 Depressed" 
names(new_master)[names(new_master) == "W1_SLEEPING"] <- "W1 Sleeping" 
names(new_master)[names(new_master) == "W1_ANXIOUS"] <- "W1 Anxious" 
names(new_master)[names(new_master) == "W1_PTSD"] <- "W1 Distressed/Past" 
names(new_master)[names(new_master) == "W1_LIED"] <- "W1 Lied" 
names(new_master)[names(new_master) == "W1_ATTENTIO"] <- "W1 Attention" 
names(new_master)[names(new_master) == "W1_LISTENING"] <- "W1 Listening" 
names(new_master)[names(new_master) == "W1_BULLY"] <- "W1 Bully" 
names(new_master)[names(new_master) == "W1_FIGHTS"] <- "W1 Fights" 
names(new_master)[names(new_master) == "W1_RESTLESS"] <- "W1 Restless" 
names(new_master)[names(new_master) == "W1_ANSWERED"] <- "W1 Answered" 
 
names(new_master)[names(new_master) == "W2_ACUR_CIG"] <- "W2 CIG" 
names(new_master)[names(new_master) == "W2_ACUR_ECI"] <- "W2 ECIG" 
names(new_master)[names(new_master) == "W2_ACUR_DUA"] <- "W2 Dual CIG + ECIG" 
names(new_master)[names(new_master) == "W2_ACUR_ALC"] <- "W2 Alcohol" 
names(new_master)[names(new_master) == "W2_ACUR_MAR"] <- "W2 Marijuana" 
names(new_master)[names(new_master) == "W2_ACUR_PAI"] <- "W2 PDNP" 
 397 
names(new_master)[names(new_master) == "W2_DEPRESS"] <- "W2 Depressed" 
names(new_master)[names(new_master) == "W2_SLEEPING"] <- "W2 Sleeping" 
names(new_master)[names(new_master) == "W2_ANXIOUS"] <- "W2 Anxious" 
names(new_master)[names(new_master) == "W2_PTSD"] <- "W2 Distressed/Past" 
names(new_master)[names(new_master) == "W2_LIED"] <- "W2 Lied" 
names(new_master)[names(new_master) == "W2_ATTENTIO"] <- "W2 Attention" 
names(new_master)[names(new_master) == "W2_LISTENIN"] <- "W2 Listening" 
names(new_master)[names(new_master) == "W2_BULLY"] <- "W2 Bully" 
names(new_master)[names(new_master) == "W2_FIGHTS"] <- "W2 Fights" 
names(new_master)[names(new_master) == "W2_RESTLESS"] <- "W2 Restless" 
names(new_master)[names(new_master) == "W2_ANSWERED"] <- "W2 Answered" 
 
names(new_master)[names(new_master) == "W3_ACUR_CIG"] <- "W3 CIG" 
names(new_master)[names(new_master) == "W3_ACUR_ECI"] <- "W3 ECIG" 
names(new_master)[names(new_master) == "W3_ACUR_DUA"] <- "W3 Dual CIG + ECIG" 
names(new_master)[names(new_master) == "W3_ACUR_ALC"] <- "W3 Alcohol" 
names(new_master)[names(new_master) == "W3_ACUR_MAR"] <- "W3 Marijuana" 
names(new_master)[names(new_master) == "W3_ACUR_PAI"] <- "W3 PDNP" 
names(new_master)[names(new_master) == "W3_DEPRESS"] <- "W3 Depressed" 
names(new_master)[names(new_master) == "W3_SLEEPING"] <- "W3 Sleeping" 
names(new_master)[names(new_master) == "W3_ANXIOUS"] <- "W3 Anxious" 
names(new_master)[names(new_master) == "W3_PTSD"] <- "W3 Distressed/Past" 
names(new_master)[names(new_master) == "W3_LIED"] <- "W3 Lied" 
names(new_master)[names(new_master) == "W3_ATTENTIO"] <- "W3 Attention" 
names(new_master)[names(new_master) == "W3_LISTENIN"] <- "W3 Listening" 
names(new_master)[names(new_master) == "W3_BULLY"] <- "W3 Bully" 
names(new_master)[names(new_master) == "W3_FIGHTS"] <- "W3 Fights" 
names(new_master)[names(new_master) == "W3_RESTLESS"] <- "W3 Restless" 















MasterNetworkIF <-estimateNetwork(new_master, default="IsingFit", missing="listwise") 
plot(MasterNetworkIF, layout = "spring", vsize = 10, cex=8) 
 
MasterTraits <- rep(c( 
  'Substance Use', 
  'Negative Affect', 
  'Externalizing', 
  'Substance Use', 
  'Negative Affect', 
  'Externalizing', 
  'Substance Use', 
  'Negative Affect', 







     layout="spring", 
     cut=0, 
     theme="colorblind", 
     groups=MasterTraits, 
     #labels=Names, 
     #nodeNames=Names, 
     #edge.color="black", 
     label.scale.equal=TRUE, 
     label.cex= 3, 
     legend.cex = 0.4, 





MasterEdges <- MasterNetworkIF$graph 
write.csv(MasterEdges, file="MasterEdges.csv") 
#this worked! 
#(do this for all other edge matrices) 
 
#Very little overlap across the waves, edges within the waves are weaker 
 
 
R File name: Checking for missing data from network 
 




#OVERALL WAVE 1# 
#setwd("C:\Users\blondinoct\\Documents\\PNASS\\Data Management\\CSVs to use in R") 
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files") 
getwd() 
overall<-read.csv("/Users/courtneyblondino/Library/Mobile 
Documents/com~apple~CloudDocs/Dissertation Files/overallwave1.csv", header=T, sep=',') 
 
 
#rename variables so they look nice on the network 
names(overall)[names(overall) == "ACUR_CIG"] <- "CC" 
names(overall)[names(overall) == "ACUR_ECI"] <- "EC" 
names(overall)[names(overall) == "ACUR_DUA"] <- "Dual CC + EC" 
names(overall)[names(overall) == "ACUR_ALC"] <- "Alcohol" 
names(overall)[names(overall) == "ACUR_MAR"] <- "Marijuana" 
names(overall)[names(overall) == "ACUR_PAI"] <- "PDNP" 
names(overall)[names(overall) == "DEPRESS"] <- "Depressed" 
names(overall)[names(overall) == "SLEEPING"] <- "Sleeping" 
names(overall)[names(overall) == "ANXIOUS"] <- "Anxious" 
names(overall)[names(overall) == "PTSD"] <- "PTSD" 
names(overall)[names(overall) == "LIED"] <- "Lied" 
names(overall)[names(overall) == "ATTENTIO"] <- "Attention" 
names(overall)[names(overall) == "LISTENING"] <- "Listening" 
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names(overall)[names(overall) == "BULLY"] <- "Bully" 
names(overall)[names(overall) == "FIGHTS"] <- "Fights" 
names(overall)[names(overall) == "RESTLESS"] <- "Restless" 
names(overall)[names(overall) == "ANSWERED"] <- "Answered" 
 
 
#delete obs with missing data 
overall_complete_cases <- overall[complete.cases(overall),] 
 
## W1 OVERALL TOTAL  = 32,320 
## W1 COMPLETE CASES = 15,299 




##WAVE 1 - MALE ONLY## 
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files") 
getwd() 
male<-read.csv("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation 




#rename variables so they look nice on the network 
names(male)[names(male) == "ACUR_CIG"] <- "CC" 
names(male)[names(male) == "ACUR_ECI"] <- "EC" 
names(male)[names(male) == "ACUR_DUA"] <- "Dual CC + EC" 
names(male)[names(male) == "ACUR_ALC"] <- "Alcohol" 
names(male)[names(male) == "ACUR_MAR"] <- "Marijuana" 
names(male)[names(male) == "ACUR_PAI"] <- "PDNP" 
names(male)[names(male) == "DEPRESS"] <- "Depressed" 
names(male)[names(male) == "SLEEPING"] <- "Sleeping" 
names(male)[names(male) == "ANXIOUS"] <- "Anxious" 
names(male)[names(male) == "PTSD"] <- "PTSD" 
names(male)[names(male) == "LIED"] <- "Lied" 
names(male)[names(male) == "ATTENTIO"] <- "Attention" 
names(male)[names(male) == "LISTENING"] <- "Listening" 
names(male)[names(male) == "BULLY"] <- "Bully" 
names(male)[names(male) == "FIGHTS"] <- "Fights" 
names(male)[names(male) == "RESTLESS"] <- "Restless" 
names(male)[names(male) == "ANSWERED"] <- "Answered" 
 
 
#delete obs with missing data 
malew1_complete_cases <- male[complete.cases(male),] 
 
## W1 MALE OVERALL TOTAL  = 16,306 
## W1 MALE COMPLETE CASES = 8,406 




##WAVE 1 - FEMALE ONLY## 








#rename variables so they look nice on the network 
names(female)[names(female) == "ACUR_CIG"] <- "CC" 
names(female)[names(female) == "ACUR_ECI"] <- "EC" 
names(female)[names(female) == "ACUR_DUA"] <- "Dual CC + EC" 
names(female)[names(female) == "ACUR_ALC"] <- "Alcohol" 
names(female)[names(female) == "ACUR_MAR"] <- "Marijuana" 
names(female)[names(female) == "ACUR_PAI"] <- "PDNP" 
names(female)[names(female) == "DEPRESS"] <- "Depressed" 
names(female)[names(female) == "SLEEPING"] <- "Sleeping" 
names(female)[names(female) == "ANXIOUS"] <- "Anxious" 
names(female)[names(female) == "PTSD"] <- "PTSD" 
names(female)[names(female) == "LIED"] <- "Lied" 
names(female)[names(female) == "ATTENTIO"] <- "Attention" 
names(female)[names(female) == "LISTENING"] <- "Listening" 
names(female)[names(female) == "BULLY"] <- "Bully" 
names(female)[names(female) == "FIGHTS"] <- "Fights" 
names(female)[names(female) == "RESTLESS"] <- "Restless" 
names(female)[names(female) == "ANSWERED"] <- "Answered" 
 
#delete obs with missing data 
femalew1_complete_cases <- female[complete.cases(female),] 
 
 
## W1 FEMALE OVERALL TOTAL  = 15,980 
## W1 FEMALE COMPLETE CASES = 6,888 




## W2 ## 
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files") 
getwd() 
Wave2<-read.csv("/Users/courtneyblondino/Library/Mobile 




#Have to tell R what missing means 
Wave2$acur_cignew[Wave2$acur_cignew==-99999] <- NA 
Wave2$acur_ecignew[Wave2$acur_ecignew==-99999] <- NA 
Wave2$acur_dualnew[Wave2$acur_dualnew==-99999] <- NA 
Wave2$acur_alc[Wave2$acur_alc==-99999] <- NA 
Wave2$acur_marijuana[Wave2$acur_marijuana==-99999] <- NA 
Wave2$acur_painkiller[Wave2$acur_painkiller==-99999] <- NA 
Wave2$depressed[Wave2$depressed==-99999] <- NA 
Wave2$sleeping[Wave2$sleeping==-99999] <- NA 
Wave2$anxious[Wave2$anxious==-99999] <- NA 
Wave2$ptsd[Wave2$ptsd==-99999] <- NA 
Wave2$lied[Wave2$lied==-99999] <- NA 
Wave2$attention[Wave2$attention==-99999] <- NA 
Wave2$listening[Wave2$listening==-99999] <- NA 
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Wave2$bully[Wave2$bully==-99999] <- NA 
Wave2$fights[Wave2$fights==-99999] <- NA 
Wave2$restless[Wave2$restless==-99999] <- NA 
Wave2$answered[Wave2$answered==-99999] <- NA 
 
#rename variables so they look nice on the network 
names(Wave2)[names(Wave2) == "acur_cignew"] <- "CC" 
names(Wave2)[names(Wave2) == "acur_ecignew"] <- "EC" 
names(Wave2)[names(Wave2) == "acur_dualnew"] <- "Dual CC + EC" 
names(Wave2)[names(Wave2) == "acur_alc"] <- "Alcohol" 
names(Wave2)[names(Wave2) == "acur_marijuana"] <- "Marijuana" 
names(Wave2)[names(Wave2) == "acur_painkiller"] <- "PDNP" 
names(Wave2)[names(Wave2) == "depressed"] <- "Depressed" 
names(Wave2)[names(Wave2) == "sleeping"] <- "Sleeping" 
names(Wave2)[names(Wave2) == "anxious"] <- "Anxious" 
names(Wave2)[names(Wave2) == "ptsd"] <- "PTSD" 
names(Wave2)[names(Wave2) == "lied"] <- "Lied" 
names(Wave2)[names(Wave2) == "attention"] <- "Attention" 
names(Wave2)[names(Wave2) == "listening"] <- "Listening" 
names(Wave2)[names(Wave2) == "bully"] <- "Bully" 
names(Wave2)[names(Wave2) == "fights"] <- "Fights" 
names(Wave2)[names(Wave2) == "restless"] <- "Restless" 
names(Wave2)[names(Wave2) == "answered"] <- "Answered" 
 
#delete obs with missing data 
w2_complete_cases <- Wave2[complete.cases(Wave2),] 
 
 
## W2 TOTAL          = 26,444 
## W2 COMPLETE CASES = 25,592 




## W3 ## 
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files") 
getwd() 
Wave3<-read.csv("/Users/courtneyblondino/Library/Mobile 




#Have to tell R what missing means 
Wave3$acur_cignew[Wave3$acur_cignew==-99999] <- NA 
Wave3$acur_ecignew[Wave3$acur_ecignew==-99999] <- NA 
Wave3$acur_dualnew[Wave3$acur_dualnew==-99999] <- NA 
Wave3$acur_alc[Wave3$acur_alc==-99999] <- NA 
Wave3$acur_marijuana[Wave3$acur_marijuana==-99999] <- NA 
Wave3$acur_painkiller[Wave3$acur_painkiller==-99999] <- NA 
Wave3$depressed[Wave3$depressed==-99999] <- NA 
Wave3$sleeping[Wave3$sleeping==-99999] <- NA 
Wave3$anxious[Wave3$anxious==-99999] <- NA 
Wave3$ptsd[Wave3$ptsd==-99999] <- NA 
Wave3$lied[Wave3$lied==-99999] <- NA 
Wave3$attention[Wave3$attention==-99999] <- NA 
Wave3$listening[Wave3$listening==-99999] <- NA 
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Wave3$bully[Wave3$bully==-99999] <- NA 
Wave3$fights[Wave3$fights==-99999] <- NA 
Wave3$restless[Wave3$restless==-99999] <- NA 
Wave3$answered[Wave3$answered==-99999] <- NA 
 
#rename variables so they look nice on the network 
names(Wave3)[names(Wave3) == "acur_cignew"] <- "CC" 
names(Wave3)[names(Wave3) == "acur_ecignew"] <- "EC" 
names(Wave3)[names(Wave3) == "acur_dualnew"] <- "Dual CC + EC" 
names(Wave3)[names(Wave3) == "acur_alc"] <- "Alcohol" 
names(Wave3)[names(Wave3) == "acur_marijuana"] <- "Marijuana" 
names(Wave3)[names(Wave3) == "acur_painkiller"] <- "PDNP" 
names(Wave3)[names(Wave3) == "depressed"] <- "Depressed" 
names(Wave3)[names(Wave3) == "sleeping"] <- "Sleeping" 
names(Wave3)[names(Wave3) == "anxious"] <- "Anxious" 
names(Wave3)[names(Wave3) == "ptsd"] <- "PTSD" 
names(Wave3)[names(Wave3) == "lied"] <- "Lied" 
names(Wave3)[names(Wave3) == "attention"] <- "Attention" 
names(Wave3)[names(Wave3) == "listening"] <- "Listening" 
names(Wave3)[names(Wave3) == "bully"] <- "Bully" 
names(Wave3)[names(Wave3) == "fights"] <- "Fights" 
names(Wave3)[names(Wave3) == "restless"] <- "Restless" 
names(Wave3)[names(Wave3) == "answered"] <- "Answered" 
 
 
#delete obs with missing data 
w3_complete_cases <- Wave3[complete.cases(Wave3),] 
 
 
## W3 TOTAL          = 26,239 
## W3 COMPLETE CASES = 25,359 

















#rename variables so they look nice on the network 
names(overall)[names(overall) == "ACUR_CIG"] <- "CIG" 
names(overall)[names(overall) == "ACUR_ECI"] <- "ECIG" 
names(overall)[names(overall) == "ACUR_DUA"] <- "Dual CIG + ECIG" 
names(overall)[names(overall) == "ACUR_ALC"] <- "Alcohol" 
names(overall)[names(overall) == "ACUR_MAR"] <- "Marijuana" 
names(overall)[names(overall) == "ACUR_PAI"] <- "PDNP" 
names(overall)[names(overall) == "DEPRESS"] <- "Depressed" 
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names(overall)[names(overall) == "SLEEPING"] <- "Sleeping" 
names(overall)[names(overall) == "ANXIOUS"] <- "Anxious" 
names(overall)[names(overall) == "PTSD"] <- "PTSD" 
names(overall)[names(overall) == "LIED"] <- "Lied" 
names(overall)[names(overall) == "ATTENTIO"] <- "Attention" 
names(overall)[names(overall) == "LISTENING"] <- "Listening" 
names(overall)[names(overall) == "BULLY"] <- "Bully" 
names(overall)[names(overall) == "FIGHTS"] <- "Fights" 
names(overall)[names(overall) == "RESTLESS"] <- "Restless" 
names(overall)[names(overall) == "ANSWERED"] <- "Answered" 
 
 
#delete obs with missing data 
overall_complete_cases <- overall[complete.cases(overall),] 
 
## W1 OVERALL TOTAL  = 32,320 
## W1 COMPLETE CASES = 30,211 













#rename variables so they look nice on the network 
names(male)[names(male) == "ACUR_CIG"] <- "CIG" 
names(male)[names(male) == "ACUR_ECI"] <- "ECIG" 
names(male)[names(male) == "ACUR_DUA"] <- "Dual CIG + ECIG" 
names(male)[names(male) == "ACUR_ALC"] <- "Alcohol" 
names(male)[names(male) == "ACUR_MAR"] <- "Marijuana" 
names(male)[names(male) == "ACUR_PAI"] <- "PDNP" 
names(male)[names(male) == "DEPRESS"] <- "Depressed" 
names(male)[names(male) == "SLEEPING"] <- "Sleeping" 
names(male)[names(male) == "ANXIOUS"] <- "Anxious" 
names(male)[names(male) == "PTSD"] <- "PTSD" 
names(male)[names(male) == "LIED"] <- "Lied" 
names(male)[names(male) == "ATTENTIO"] <- "Attention" 
names(male)[names(male) == "LISTENING"] <- "Listening" 
names(male)[names(male) == "BULLY"] <- "Bully" 
names(male)[names(male) == "FIGHTS"] <- "Fights" 
names(male)[names(male) == "RESTLESS"] <- "Restless" 
names(male)[names(male) == "ANSWERED"] <- "Answered" 
 
 
#delete obs with missing data 
malew1_complete_cases <- male[complete.cases(male),] 
 
## W1 MALE OVERALL TOTAL  = 16,306 
## W1 MALE COMPLETE CASES = 15,268 















#rename variables so they look nice on the network 
names(female)[names(female) == "ACUR_CIG"] <- "CIG" 
names(female)[names(female) == "ACUR_ECI"] <- "ECIG" 
names(female)[names(female) == "ACUR_DUA"] <- "Dual CIG + ECIG" 
names(female)[names(female) == "ACUR_ALC"] <- "Alcohol" 
names(female)[names(female) == "ACUR_MAR"] <- "Marijuana" 
names(female)[names(female) == "ACUR_PAI"] <- "PDNP" 
names(female)[names(female) == "DEPRESS"] <- "Depressed" 
names(female)[names(female) == "SLEEPING"] <- "Sleeping" 
names(female)[names(female) == "ANXIOUS"] <- "Anxious" 
names(female)[names(female) == "PTSD"] <- "PTSD" 
names(female)[names(female) == "LIED"] <- "Lied" 
names(female)[names(female) == "ATTENTIO"] <- "Attention" 
names(female)[names(female) == "LISTENING"] <- "Listening" 
names(female)[names(female) == "BULLY"] <- "Bully" 
names(female)[names(female) == "FIGHTS"] <- "Fights" 
names(female)[names(female) == "RESTLESS"] <- "Restless" 
names(female)[names(female) == "ANSWERED"] <- "Answered" 
 
#delete obs with missing data 
femalew1_complete_cases <- female[complete.cases(female),] 
 
 
## W1 FEMALE OVERALL TOTAL  = 15,980 
## W1 FEMALE COMPLETE CASES = 14,925 
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